mpw-10q_20210930.htm
false 2021 Q3 0001287865 --12-31 false 2021 Q3 0001524607 --12-31 false true P5Y http://fasb.org/us-gaap/2021-01-31#OtherAssets http://fasb.org/us-gaap/2021-01-31#OtherAssets http://fasb.org/us-gaap/2021-01-31#OtherAssets http://fasb.org/us-gaap/2021-01-31#OtherAssets http://fasb.org/us-gaap/2021-01-31#OtherAssets http://fasb.org/us-gaap/2021-01-31#OtherAssets http://fasb.org/us-gaap/2021-01-31#OtherAssets http://fasb.org/us-gaap/2021-01-31#OtherAssets 0001287865 2021-01-01 2021-09-30 xbrli:shares 0001287865 2021-11-01 0001287865 mpw:MptOperatingPartnershipLPMember 2021-01-01 2021-09-30 iso4217:USD 0001287865 2021-09-30 0001287865 2020-12-31 iso4217:USD xbrli:shares 0001287865 2021-07-01 2021-09-30 0001287865 2020-07-01 2020-09-30 0001287865 2020-01-01 2020-09-30 0001287865 us-gaap:CommonStockMember 2020-12-31 0001287865 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001287865 us-gaap:RetainedEarningsMember 2020-12-31 0001287865 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-12-31 0001287865 us-gaap:TreasuryStockMember 2020-12-31 0001287865 us-gaap:NoncontrollingInterestMember 2020-12-31 0001287865 us-gaap:RetainedEarningsMember 2021-01-01 2021-03-31 0001287865 us-gaap:NoncontrollingInterestMember 2021-01-01 2021-03-31 0001287865 2021-01-01 2021-03-31 0001287865 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-01-01 2021-03-31 0001287865 us-gaap:CommonStockMember 2021-01-01 2021-03-31 0001287865 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-03-31 0001287865 us-gaap:CommonStockMember 2021-03-31 0001287865 us-gaap:AdditionalPaidInCapitalMember 2021-03-31 0001287865 us-gaap:RetainedEarningsMember 2021-03-31 0001287865 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-03-31 0001287865 us-gaap:TreasuryStockMember 2021-03-31 0001287865 us-gaap:NoncontrollingInterestMember 2021-03-31 0001287865 2021-03-31 0001287865 us-gaap:RetainedEarningsMember 2021-04-01 2021-06-30 0001287865 us-gaap:NoncontrollingInterestMember 2021-04-01 2021-06-30 0001287865 2021-04-01 2021-06-30 0001287865 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-04-01 2021-06-30 0001287865 us-gaap:CommonStockMember 2021-04-01 2021-06-30 0001287865 us-gaap:AdditionalPaidInCapitalMember 2021-04-01 2021-06-30 0001287865 us-gaap:CommonStockMember 2021-06-30 0001287865 us-gaap:AdditionalPaidInCapitalMember 2021-06-30 0001287865 us-gaap:RetainedEarningsMember 2021-06-30 0001287865 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-06-30 0001287865 us-gaap:TreasuryStockMember 2021-06-30 0001287865 us-gaap:NoncontrollingInterestMember 2021-06-30 0001287865 2021-06-30 0001287865 us-gaap:RetainedEarningsMember 2021-07-01 2021-09-30 0001287865 us-gaap:NoncontrollingInterestMember 2021-07-01 2021-09-30 0001287865 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-07-01 2021-09-30 0001287865 us-gaap:CommonStockMember 2021-07-01 2021-09-30 0001287865 us-gaap:AdditionalPaidInCapitalMember 2021-07-01 2021-09-30 0001287865 us-gaap:CommonStockMember 2021-09-30 0001287865 us-gaap:AdditionalPaidInCapitalMember 2021-09-30 0001287865 us-gaap:RetainedEarningsMember 2021-09-30 0001287865 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-09-30 0001287865 us-gaap:TreasuryStockMember 2021-09-30 0001287865 us-gaap:NoncontrollingInterestMember 2021-09-30 0001287865 us-gaap:CommonStockMember 2019-12-31 0001287865 us-gaap:AdditionalPaidInCapitalMember 2019-12-31 0001287865 us-gaap:RetainedEarningsMember 2019-12-31 0001287865 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-12-31 0001287865 us-gaap:TreasuryStockMember 2019-12-31 0001287865 us-gaap:NoncontrollingInterestMember 2019-12-31 0001287865 2019-12-31 0001287865 us-gaap:RetainedEarningsMember 2020-01-01 2020-03-31 0001287865 us-gaap:NoncontrollingInterestMember 2020-01-01 2020-03-31 0001287865 2020-01-01 2020-03-31 0001287865 us-gaap:RetainedEarningsMember srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember us-gaap:AccountingStandardsUpdate201613Member 2019-12-31 0001287865 srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember us-gaap:AccountingStandardsUpdate201613Member 2019-12-31 0001287865 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-01-01 2020-03-31 0001287865 us-gaap:CommonStockMember 2020-01-01 2020-03-31 0001287865 us-gaap:AdditionalPaidInCapitalMember 2020-01-01 2020-03-31 0001287865 us-gaap:CommonStockMember 2020-03-31 0001287865 us-gaap:AdditionalPaidInCapitalMember 2020-03-31 0001287865 us-gaap:RetainedEarningsMember 2020-03-31 0001287865 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-03-31 0001287865 us-gaap:TreasuryStockMember 2020-03-31 0001287865 us-gaap:NoncontrollingInterestMember 2020-03-31 0001287865 2020-03-31 0001287865 us-gaap:RetainedEarningsMember 2020-04-01 2020-06-30 0001287865 us-gaap:NoncontrollingInterestMember 2020-04-01 2020-06-30 0001287865 2020-04-01 2020-06-30 0001287865 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-04-01 2020-06-30 0001287865 us-gaap:CommonStockMember 2020-04-01 2020-06-30 0001287865 us-gaap:AdditionalPaidInCapitalMember 2020-04-01 2020-06-30 0001287865 us-gaap:CommonStockMember 2020-06-30 0001287865 us-gaap:AdditionalPaidInCapitalMember 2020-06-30 0001287865 us-gaap:RetainedEarningsMember 2020-06-30 0001287865 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-06-30 0001287865 us-gaap:TreasuryStockMember 2020-06-30 0001287865 us-gaap:NoncontrollingInterestMember 2020-06-30 0001287865 2020-06-30 0001287865 us-gaap:RetainedEarningsMember 2020-07-01 2020-09-30 0001287865 us-gaap:NoncontrollingInterestMember 2020-07-01 2020-09-30 0001287865 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-07-01 2020-09-30 0001287865 us-gaap:CommonStockMember 2020-07-01 2020-09-30 0001287865 us-gaap:AdditionalPaidInCapitalMember 2020-07-01 2020-09-30 0001287865 us-gaap:CommonStockMember 2020-09-30 0001287865 us-gaap:AdditionalPaidInCapitalMember 2020-09-30 0001287865 us-gaap:RetainedEarningsMember 2020-09-30 0001287865 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-09-30 0001287865 us-gaap:TreasuryStockMember 2020-09-30 0001287865 us-gaap:NoncontrollingInterestMember 2020-09-30 0001287865 2020-09-30 0001287865 mpw:MptOperatingPartnershipLPMember 2021-09-30 0001287865 mpw:MptOperatingPartnershipLPMember 2020-12-31 0001287865 us-gaap:GeneralPartnerMember mpw:MptOperatingPartnershipLPMember 2021-09-30 0001287865 us-gaap:GeneralPartnerMember mpw:MptOperatingPartnershipLPMember 2020-12-31 0001287865 mpw:CommonUnitsMember mpw:MptOperatingPartnershipLPMember 2021-09-30 0001287865 mpw:CommonUnitsMember mpw:MptOperatingPartnershipLPMember 2020-12-31 0001287865 mpw:MptOperatingPartnershipLPMember 2021-07-01 2021-09-30 0001287865 mpw:MptOperatingPartnershipLPMember 2020-07-01 2020-09-30 0001287865 mpw:MptOperatingPartnershipLPMember 2020-01-01 2020-09-30 0001287865 mpw:MptOperatingPartnershipLPMember us-gaap:LimitedPartnerMember us-gaap:CommonStockMember 2020-12-31 0001287865 mpw:MptOperatingPartnershipLPMember us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-12-31 0001287865 mpw:MptOperatingPartnershipLPMember us-gaap:NoncontrollingInterestMember 2020-12-31 0001287865 mpw:MptOperatingPartnershipLPMember us-gaap:GeneralPartnerMember 2021-01-01 2021-03-31 0001287865 mpw:MptOperatingPartnershipLPMember us-gaap:LimitedPartnerMember us-gaap:CommonStockMember 2021-01-01 2021-03-31 0001287865 mpw:MptOperatingPartnershipLPMember us-gaap:NoncontrollingInterestMember 2021-01-01 2021-03-31 0001287865 mpw:MptOperatingPartnershipLPMember 2021-01-01 2021-03-31 0001287865 mpw:MptOperatingPartnershipLPMember us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-01-01 2021-03-31 0001287865 mpw:MptOperatingPartnershipLPMember us-gaap:GeneralPartnerMember 2021-03-31 0001287865 mpw:MptOperatingPartnershipLPMember us-gaap:LimitedPartnerMember us-gaap:CommonStockMember 2021-03-31 0001287865 mpw:MptOperatingPartnershipLPMember us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-03-31 0001287865 mpw:MptOperatingPartnershipLPMember us-gaap:NoncontrollingInterestMember 2021-03-31 0001287865 mpw:MptOperatingPartnershipLPMember 2021-03-31 0001287865 mpw:MptOperatingPartnershipLPMember us-gaap:GeneralPartnerMember 2021-04-01 2021-06-30 0001287865 mpw:MptOperatingPartnershipLPMember us-gaap:LimitedPartnerMember us-gaap:CommonStockMember 2021-04-01 2021-06-30 0001287865 mpw:MptOperatingPartnershipLPMember us-gaap:NoncontrollingInterestMember 2021-04-01 2021-06-30 0001287865 mpw:MptOperatingPartnershipLPMember 2021-04-01 2021-06-30 0001287865 mpw:MptOperatingPartnershipLPMember us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-04-01 2021-06-30 0001287865 mpw:MptOperatingPartnershipLPMember us-gaap:GeneralPartnerMember 2021-06-30 0001287865 mpw:MptOperatingPartnershipLPMember us-gaap:LimitedPartnerMember us-gaap:CommonStockMember 2021-06-30 0001287865 mpw:MptOperatingPartnershipLPMember us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-06-30 0001287865 mpw:MptOperatingPartnershipLPMember us-gaap:NoncontrollingInterestMember 2021-06-30 0001287865 mpw:MptOperatingPartnershipLPMember 2021-06-30 0001287865 mpw:MptOperatingPartnershipLPMember us-gaap:GeneralPartnerMember 2021-07-01 2021-09-30 0001287865 mpw:MptOperatingPartnershipLPMember us-gaap:LimitedPartnerMember us-gaap:CommonStockMember 2021-07-01 2021-09-30 0001287865 mpw:MptOperatingPartnershipLPMember us-gaap:NoncontrollingInterestMember 2021-07-01 2021-09-30 0001287865 mpw:MptOperatingPartnershipLPMember us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-07-01 2021-09-30 0001287865 mpw:MptOperatingPartnershipLPMember us-gaap:LimitedPartnerMember us-gaap:CommonStockMember 2021-09-30 0001287865 mpw:MptOperatingPartnershipLPMember us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-09-30 0001287865 mpw:MptOperatingPartnershipLPMember us-gaap:NoncontrollingInterestMember 2021-09-30 0001287865 mpw:MptOperatingPartnershipLPMember us-gaap:GeneralPartnerMember 2019-12-31 0001287865 mpw:MptOperatingPartnershipLPMember us-gaap:LimitedPartnerMember us-gaap:CommonStockMember 2019-12-31 0001287865 mpw:MptOperatingPartnershipLPMember us-gaap:LimitedPartnerMember mpw:LongTermIncentivePlanMember 2019-12-31 0001287865 mpw:MptOperatingPartnershipLPMember us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-12-31 0001287865 mpw:MptOperatingPartnershipLPMember us-gaap:NoncontrollingInterestMember 2019-12-31 0001287865 mpw:MptOperatingPartnershipLPMember 2019-12-31 0001287865 mpw:MptOperatingPartnershipLPMember us-gaap:GeneralPartnerMember 2020-01-01 2020-03-31 0001287865 mpw:MptOperatingPartnershipLPMember us-gaap:LimitedPartnerMember us-gaap:CommonStockMember 2020-01-01 2020-03-31 0001287865 mpw:MptOperatingPartnershipLPMember us-gaap:NoncontrollingInterestMember 2020-01-01 2020-03-31 0001287865 mpw:MptOperatingPartnershipLPMember 2020-01-01 2020-03-31 0001287865 mpw:MptOperatingPartnershipLPMember us-gaap:GeneralPartnerMember srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember us-gaap:AccountingStandardsUpdate201613Member 2019-12-31 0001287865 mpw:MptOperatingPartnershipLPMember us-gaap:LimitedPartnerMember us-gaap:CommonStockMember srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember us-gaap:AccountingStandardsUpdate201613Member 2019-12-31 0001287865 mpw:MptOperatingPartnershipLPMember srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember us-gaap:AccountingStandardsUpdate201613Member 2019-12-31 0001287865 mpw:MptOperatingPartnershipLPMember us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-01-01 2020-03-31 0001287865 mpw:MptOperatingPartnershipLPMember us-gaap:GeneralPartnerMember 2020-03-31 0001287865 mpw:MptOperatingPartnershipLPMember us-gaap:LimitedPartnerMember us-gaap:CommonStockMember 2020-03-31 0001287865 mpw:MptOperatingPartnershipLPMember us-gaap:LimitedPartnerMember mpw:LongTermIncentivePlanMember 2020-03-31 0001287865 mpw:MptOperatingPartnershipLPMember us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-03-31 0001287865 mpw:MptOperatingPartnershipLPMember us-gaap:NoncontrollingInterestMember 2020-03-31 0001287865 mpw:MptOperatingPartnershipLPMember 2020-03-31 0001287865 mpw:MptOperatingPartnershipLPMember us-gaap:GeneralPartnerMember 2020-04-01 2020-06-30 0001287865 mpw:MptOperatingPartnershipLPMember us-gaap:LimitedPartnerMember us-gaap:CommonStockMember 2020-04-01 2020-06-30 0001287865 mpw:MptOperatingPartnershipLPMember us-gaap:NoncontrollingInterestMember 2020-04-01 2020-06-30 0001287865 mpw:MptOperatingPartnershipLPMember 2020-04-01 2020-06-30 0001287865 mpw:MptOperatingPartnershipLPMember us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-04-01 2020-06-30 0001287865 mpw:MptOperatingPartnershipLPMember us-gaap:GeneralPartnerMember 2020-06-30 0001287865 mpw:MptOperatingPartnershipLPMember us-gaap:LimitedPartnerMember us-gaap:CommonStockMember 2020-06-30 0001287865 mpw:MptOperatingPartnershipLPMember us-gaap:LimitedPartnerMember mpw:LongTermIncentivePlanMember 2020-06-30 0001287865 mpw:MptOperatingPartnershipLPMember us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-06-30 0001287865 mpw:MptOperatingPartnershipLPMember us-gaap:NoncontrollingInterestMember 2020-06-30 0001287865 mpw:MptOperatingPartnershipLPMember 2020-06-30 0001287865 mpw:MptOperatingPartnershipLPMember us-gaap:GeneralPartnerMember 2020-07-01 2020-09-30 0001287865 mpw:MptOperatingPartnershipLPMember us-gaap:LimitedPartnerMember us-gaap:CommonStockMember 2020-07-01 2020-09-30 0001287865 mpw:MptOperatingPartnershipLPMember us-gaap:NoncontrollingInterestMember 2020-07-01 2020-09-30 0001287865 mpw:MptOperatingPartnershipLPMember us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-07-01 2020-09-30 0001287865 mpw:MptOperatingPartnershipLPMember us-gaap:GeneralPartnerMember 2020-09-30 0001287865 mpw:MptOperatingPartnershipLPMember us-gaap:LimitedPartnerMember us-gaap:CommonStockMember 2020-09-30 0001287865 mpw:MptOperatingPartnershipLPMember us-gaap:LimitedPartnerMember mpw:LongTermIncentivePlanMember 2020-09-30 0001287865 mpw:MptOperatingPartnershipLPMember us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-09-30 0001287865 mpw:MptOperatingPartnershipLPMember us-gaap:NoncontrollingInterestMember 2020-09-30 0001287865 mpw:MptOperatingPartnershipLPMember 2020-09-30 mpw:Facility mpw:State mpw:Country 0001287865 srt:EuropeMember 2021-09-30 0001287865 srt:SouthAmericaMember 2021-09-30 0001287865 us-gaap:LandAndLandImprovementsMember 2021-09-30 0001287865 us-gaap:LandAndLandImprovementsMember 2020-09-30 0001287865 us-gaap:BuildingMember 2021-09-30 0001287865 us-gaap:BuildingMember 2020-09-30 0001287865 mpw:IntangibleLeaseAssetsMember 2021-09-30 0001287865 mpw:IntangibleLeaseAssetsMember 2020-09-30 0001287865 mpw:EquityInvestmentsMember 2021-09-30 0001287865 us-gaap:MortgagesMember 2021-09-30 0001287865 us-gaap:MortgagesMember 2020-09-30 0001287865 mpw:OtherLoansAndOtherAssetsMember 2021-09-30 0001287865 mpw:OtherLoansAndOtherAssetsMember 2020-09-30 0001287865 mpw:IntangibleLeaseAssetsMember 2021-01-01 2021-09-30 0001287865 mpw:IntangibleLeaseAssetsMember 2020-01-01 2020-09-30 iso4217:GBP 0001287865 us-gaap:MortgagesMember mpw:PrioryGroupMember 2021-03-31 mpw:Property 0001287865 mpw:PrioryGroupMember 2021-06-30 0001287865 us-gaap:MortgagesMember mpw:StewardHealthCareSystemLLCMember 2020-09-30 mpw:Hospital 0001287865 mpw:StewardHealthCareSystemLLCMember 2020-01-01 2020-09-30 0001287865 country:GB mpw:WaterlandPrivateEquityFundVIICVMember 2021-01-19 2021-01-19 0001287865 mpw:WaterlandPrivateEquityFundVIICVMember 2021-06-25 0001287865 mpw:WaterlandPrivateEquityFundVIICVMember 2021-06-25 2021-06-25 0001287865 mpw:PrioryGroupMember 2021-06-25 0001287865 mpw:WaterlandPrivateEquityFundVIICVMember 2021-01-19 2021-01-19 xbrli:pure 0001287865 mpw:WaterlandPrivateEquityFundVIICVMember 2021-01-19 0001287865 mpw:WaterlandPrivateEquityFundVIICVMember mpw:InterimCreditFacilityMember 2021-01-15 0001287865 mpw:WaterlandPrivateEquityFundVIICVMember us-gaap:RevolvingCreditFacilityMember 2021-01-15 0001287865 mpw:GeneralAcuteCareHospitalsMember stpr:FL 2021-08-01 2021-08-01 0001287865 mpw:GeneralAcuteCareHospitalsMember stpr:FL mpw:StewardHealthCareSystemLLCMember 2021-08-01 0001287865 mpw:GeneralAcuteCareHospitalsMember stpr:FL mpw:StewardHealthCareSystemLLCMember 2021-08-01 2021-08-01 0001287865 mpw:GeneralAcuteCareHospitalsMember stpr:FL mpw:InterimCreditFacilityMember 2021-08-01 0001287865 mpw:AcuteCareHospitalMember mpw:LosAngelesCaliforniaMember 2021-07-06 2021-07-06 0001287865 mpw:OnCampusMedicalOfficeBuildingsMember mpw:LosAngelesCaliforniaMember 2021-07-06 2021-07-06 0001287865 mpw:AcuteCareHospitalAndOnCampusMedicalOfficeBuildingsMember mpw:LosAngelesCaliforniaMember 2021-07-06 2021-07-06 0001287865 mpw:AcuteCareHospitalMember mpw:StirlingScotlandMember 2021-07-06 2021-07-06 iso4217:CHF 0001287865 mpw:SwissMedicalNetworkMember 2021-04-16 0001287865 mpw:StewardHealthCareSystemLLCMember 2021-01-08 0001287865 mpw:AcuteCareHospitalMember country:CA mpw:PrimeHealthCareServicesMember 2020-08-13 2020-08-13 0001287865 stpr:UT mpw:StewardMember 2020-07-01 2020-07-08 0001287865 stpr:UT mpw:StewardMember mpw:DavisAndJordanValleyFacilitiesMember 2020-07-08 0001287865 mpw:AcuteCareHospitalMember country:GB mpw:BMIHealthcareMember 2020-01-08 2020-01-08 0001287865 mpw:AcuteCareHospitalMember country:GB mpw:BMIHealthcareMember 2020-06-16 2020-06-16 mpw:RenewalOption 0001287865 mpw:AcuteCareHospitalMember country:GB mpw:BMIHealthcareMember 2020-06-16 0001287865 mpw:AcuteCareHospitalMember country:GB mpw:BMIHealthcareMember 2021-01-01 2021-09-30 0001287865 mpw:SwissHealthcareRealEstateCompanyInfracoreSAMember 2020-06-24 0001287865 mpw:OtherLoansMember mpw:JointVenturePartnerMember 2020-05-13 0001287865 mpw:JointVenturePartnerMember 2020-05-13 0001287865 mpw:AcuteCareHospitalMember mpw:DarlingtonUnitedKingdomMember 2020-08-07 2020-08-07 0001287865 mpw:InpatientRehabilitationHospitalMember mpw:DahlenGermanyDEMember 2020-08-05 2020-08-05 iso4217:EUR 0001287865 mpw:InpatientRehabilitationAndAcuteCareHospitalMember 2020-01-01 2020-09-30 0001287865 mpw:ErnestHealthIncMember mpw:BakersfieldCaliforniaMember 2021-09-30 0001287865 mpw:ErnestHealthIncMember mpw:StocktonCaliforniaMember 2021-09-30 0001287865 mpw:ErnestHealthIncMember mpw:BakersfieldCaliforniaMember 2021-01-01 2021-09-30 0001287865 mpw:ErnestHealthIncMember mpw:StocktonCaliforniaMember 2021-01-01 2021-09-30 0001287865 mpw:AcuteCareHospitalMember mpw:BirminghamUkMember mpw:DevelopmentActivitiesMember mpw:CircleHealthMember 2020-04-01 2020-06-30 0001287865 mpw:InpatientRehabilitationHospitalMember mpw:BirminghamUkMember mpw:DevelopmentActivitiesMember mpw:CircleHealthMember 2020-04-01 2020-06-30 0001287865 mpw:BirminghamUkMember mpw:DevelopmentActivitiesMember mpw:CircleHealthMember 2020-04-01 2020-06-30 0001287865 mpw:MassachusettsBasedGeneralAcuteCareHospitalsMember 2021-08-28 0001287865 mpw:MassachusettsBasedGeneralAcuteCareHospitalsMember 2021-08-28 2021-08-28 0001287865 mpw:MassachusettsBasedGeneralAcuteCareHospitalsMember mpw:StewardHealthCareSystemLLCMember 2021-08-28 2021-08-28 0001287865 mpw:MassachusettsBasedGeneralAcuteCareHospitalsMember mpw:StewardHealthCareSystemLLCMember 2021-09-29 2021-09-30 0001287865 mpw:MassachusettsBasedGeneralAcuteCareHospitalsMember 2021-09-30 0001287865 srt:MinimumMember 2021-09-30 mpw:Lease 0001287865 mpw:ErnestHealthIncMember 2021-01-01 2021-09-30 0001287865 mpw:PrimeFacilitiesMember 2021-01-01 2021-09-30 0001287865 mpw:ProspectMedicalHoldingsIncMember 2021-01-01 2021-09-30 0001287865 mpw:COVID19PandemicMember 2021-09-30 0001287865 mpw:AdeptusHealthMember 2021-01-01 2021-09-30 0001287865 mpw:AdeptusHealthMember 2020-01-01 2020-03-31 0001287865 mpw:AdeptusHealthMember srt:MaximumMember 2021-09-30 0001287865 mpw:AlectoHealthcareServicesMember 2021-01-01 2021-03-31 0001287865 mpw:AlectoHealthcareServicesMember us-gaap:AssetsTotalMember us-gaap:CustomerConcentrationRiskMember srt:MaximumMember 2021-01-01 2021-09-30 0001287865 mpw:AlectoHealthcareServicesMember 2021-09-30 0001287865 mpw:AlectoHealthcareServicesMember 2020-01-01 2020-03-31 0001287865 mpw:AlectoHealthcareServicesMember 2020-01-01 2020-12-31 0001287865 mpw:AlectoHealthcareServicesMember 2021-01-01 2021-09-30 0001287865 mpw:PrimotopHoldingsSARLMember 2018-12-31 0001287865 mpw:StewardHealthCareSystemLLCMember 2021-01-01 2021-09-30 0001287865 mpw:StewardHealthCareSystemLLCMember 2021-01-01 2021-03-31 0001287865 mpw:AevisVictoriaSAMember 2021-01-01 2021-09-30 0001287865 mpw:AevisVictoriaSAMember 2021-09-30 0001287865 mpw:COVID19PandemicMember 2020-01-01 2020-09-30 0001287865 srt:ProFormaMember us-gaap:AssetsTotalMember us-gaap:CustomerConcentrationRiskMember 2021-09-30 0001287865 srt:ProFormaMember us-gaap:AssetsTotalMember us-gaap:CustomerConcentrationRiskMember 2020-12-31 0001287865 mpw:StewardHealthCareSystemLLCMember mpw:OperatorConcentrationRiskMember srt:MinimumMember us-gaap:SalesRevenueNetMember 2021-07-01 2021-09-30 0001287865 mpw:StewardHealthCareSystemLLCMember mpw:OperatorConcentrationRiskMember srt:MinimumMember us-gaap:SalesRevenueNetMember 2020-07-01 2020-09-30 0001287865 mpw:StewardHealthCareSystemLLCMember mpw:OperatorConcentrationRiskMember srt:MinimumMember us-gaap:SalesRevenueNetMember 2021-01-01 2021-09-30 0001287865 mpw:StewardHealthCareSystemLLCMember mpw:OperatorConcentrationRiskMember srt:MinimumMember us-gaap:SalesRevenueNetMember 2020-01-01 2020-09-30 0001287865 mpw:ProspectMedicalHoldingsIncMember mpw:OperatorConcentrationRiskMember srt:MinimumMember us-gaap:SalesRevenueNetMember 2020-07-01 2020-09-30 0001287865 mpw:ProspectMedicalHoldingsIncMember mpw:OperatorConcentrationRiskMember srt:MinimumMember us-gaap:SalesRevenueNetMember 2020-01-01 2020-09-30 0001287865 mpw:CircleHealthMember mpw:OperatorConcentrationRiskMember srt:MinimumMember us-gaap:SalesRevenueNetMember 2021-07-01 2021-09-30 0001287865 mpw:CircleHealthMember mpw:OperatorConcentrationRiskMember srt:MinimumMember us-gaap:SalesRevenueNetMember 2020-07-01 2020-09-30 0001287865 mpw:CircleHealthMember mpw:OperatorConcentrationRiskMember srt:MinimumMember us-gaap:SalesRevenueNetMember 2021-01-01 2021-09-30 0001287865 mpw:CircleHealthMember mpw:OperatorConcentrationRiskMember srt:MinimumMember us-gaap:SalesRevenueNetMember 2020-01-01 2020-09-30 0001287865 mpw:PrimeHealthCareServicesMember mpw:OperatorConcentrationRiskMember srt:MinimumMember us-gaap:SalesRevenueNetMember 2020-07-01 2020-09-30 0001287865 mpw:PrimeHealthCareServicesMember mpw:OperatorConcentrationRiskMember srt:MinimumMember us-gaap:SalesRevenueNetMember 2020-01-01 2020-09-30 0001287865 us-gaap:AssetsTotalMember country:US us-gaap:GeographicConcentrationRiskMember 2021-01-01 2021-09-30 0001287865 us-gaap:AssetsTotalMember country:US us-gaap:GeographicConcentrationRiskMember 2020-01-01 2020-12-31 0001287865 us-gaap:AssetsTotalMember srt:EuropeMember us-gaap:GeographicConcentrationRiskMember 2021-01-01 2021-09-30 0001287865 us-gaap:AssetsTotalMember srt:EuropeMember us-gaap:GeographicConcentrationRiskMember 2020-01-01 2020-12-31 0001287865 us-gaap:AssetsTotalMember country:AU us-gaap:GeographicConcentrationRiskMember 2021-01-01 2021-09-30 0001287865 us-gaap:AssetsTotalMember country:AU us-gaap:GeographicConcentrationRiskMember 2020-01-01 2020-12-31 0001287865 us-gaap:AssetsTotalMember srt:SouthAmericaMember us-gaap:GeographicConcentrationRiskMember 2021-01-01 2021-09-30 0001287865 us-gaap:AssetsTotalMember srt:SouthAmericaMember us-gaap:GeographicConcentrationRiskMember 2020-01-01 2020-12-31 0001287865 mpw:GeneralAcuteCareHospitalsMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2021-07-01 2021-09-30 0001287865 mpw:GeneralAcuteCareHospitalsMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2020-07-01 2020-09-30 0001287865 mpw:GeneralAcuteCareHospitalsMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2021-01-01 2021-09-30 0001287865 mpw:GeneralAcuteCareHospitalsMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2020-01-01 2020-09-30 0001287865 mpw:RehabilitationHospitalMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2021-07-01 2021-09-30 0001287865 mpw:RehabilitationHospitalMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2020-07-01 2020-09-30 0001287865 mpw:RehabilitationHospitalMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2021-01-01 2021-09-30 0001287865 mpw:RehabilitationHospitalMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2020-01-01 2020-09-30 0001287865 mpw:BehavioralHealthFreestandingERUrgentCareAndLongTermAcuteCareFacilitiesMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2021-07-01 2021-09-30 0001287865 mpw:BehavioralHealthFreestandingERUrgentCareAndLongTermAcuteCareFacilitiesMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2020-07-01 2020-09-30 0001287865 mpw:BehavioralHealthFreestandingERUrgentCareAndLongTermAcuteCareFacilitiesMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2021-01-01 2021-09-30 0001287865 mpw:BehavioralHealthFreestandingERUrgentCareAndLongTermAcuteCareFacilitiesMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2020-01-01 2020-09-30 0001287865 us-gaap:RevolvingCreditFacilityMember 2021-09-30 0001287865 us-gaap:RevolvingCreditFacilityMember 2020-12-31 0001287865 mpw:InterimCreditFacilityMember 2021-09-30 0001287865 mpw:TermLoanMember 2021-09-30 0001287865 mpw:TermLoanMember 2020-12-31 0001287865 mpw:TermLoanMember country:GB 2021-09-30 0001287865 mpw:TermLoanMember country:GB 2020-12-31 0001287865 mpw:TermLoanMember country:AU 2021-09-30 0001287865 mpw:TermLoanMember country:AU 2020-12-31 0001287865 mpw:FourPointZeroZeroZeroPercentageSeniorUnsecuredNotesDueTwoThousandTwentyTwoMember 2021-09-30 0001287865 mpw:FourPointZeroZeroZeroPercentageSeniorUnsecuredNotesDueTwoThousandTwentyTwoMember 2020-12-31 0001287865 mpw:TwoPointFiveFiveZeroPercentageSeniorUnsecuredNotesDueTwoThousandTwentyThreeMember 2021-09-30 0001287865 mpw:TwoPointFiveFiveZeroPercentageSeniorUnsecuredNotesDueTwoThousandTwentyThreeMember 2020-12-31 0001287865 mpw:ThreePointThreeTwoFivePercentageSeniorUnsecuredNotesDueTwoThousandTwentyFiveMember 2021-09-30 0001287865 mpw:ThreePointThreeTwoFivePercentageSeniorUnsecuredNotesDueTwoThousandTwentyFiveMember 2020-12-31 0001287865 mpw:TwoPointFiveZeroZeroPercentageSeniorUnsecuredNotesDueTwoThousandTwentySixMember 2021-09-30 0001287865 mpw:FivePointTwoFiveZeroPercentageSeniorUnsecuredNotesDueTwoThousandTwentySixMember 2021-09-30 0001287865 mpw:FivePointTwoFiveZeroPercentageSeniorUnsecuredNotesDueTwoThousandTwentySixMember 2020-12-31 0001287865 mpw:FivePointZeroZeroZeroPercentageSeniorUnsecuredNotesDueTwoThousandTwentySevenMember 2021-09-30 0001287865 mpw:FivePointZeroZeroZeroPercentageSeniorUnsecuredNotesDueTwoThousandTwentySevenMember 2020-12-31 0001287865 mpw:ThreePointSixNineTwoPercentageSeniorUnsecuredNotesDueTwoThousandTwentyEightMember 2021-09-30 0001287865 mpw:ThreePointSixNineTwoPercentageSeniorUnsecuredNotesDueTwoThousandTwentyEightMember 2020-12-31 0001287865 mpw:FourPointSixTwoFivePercentageSeniorUnsecuredNotesDueTwoThousandTwentyNineMember 2021-09-30 0001287865 mpw:FourPointSixTwoFivePercentageSeniorUnsecuredNotesDueTwoThousandTwentyNineMember 2020-12-31 0001287865 mpw:ThreePointThreeSevenFivePercentageSeniorUnsecuredNotesDueTwoThousandThirtyMember 2021-09-30 0001287865 mpw:ThreePointFiveZeroZeroPercentageSeniorUnsecuredNotesDueTwoThousandThirtyOneMember 2021-09-30 0001287865 mpw:ThreePointFiveZeroZeroPercentageSeniorUnsecuredNotesDueTwoThousandThirtyOneMember 2020-12-31 0001287865 mpw:TwoPointFiveZeroZeroPercentageSeniorUnsecuredNotesDueTwoThousandTwentySixMember 2020-12-31 0001287865 mpw:ThreePointThreeSevenFivePercentageSeniorUnsecuredNotesDueTwoThousandThirtyMember 2020-12-31 0001287865 mpw:GBPDenominatedBorrowingsMember 2021-09-30 0001287865 mpw:GBPDenominatedBorrowingsMember 2020-12-31 0001287865 mpw:BarclaysBankPLCMember mpw:InterimCreditFacilityMember 2021-07-27 0001287865 mpw:BarclaysBankPLCMember mpw:InterimCreditFacilityMember 2021-07-27 2021-07-27 0001287865 mpw:BarclaysBankPLCMember mpw:InterimCreditFacilityMember 2021-09-30 0001287865 mpw:BarclaysBankPLCMember mpw:InterimCreditFacilityMember stpr:FL 2021-08-01 0001287865 mpw:WaterlandPrivateEquityFundVIICVMember mpw:InterimCreditFacilityMember 2021-01-15 2021-01-15 0001287865 mpw:UnsecuredRevolvingCreditFacilityMember 2021-01-15 0001287865 mpw:UnsecuredRevolvingCreditFacilityMember 2021-01-15 2021-01-15 0001287865 mpw:TermLoanMember 2021-01-15 0001287865 mpw:TermLoanMember 2021-01-15 2021-01-15 0001287865 mpw:AlternateBaseRateMember srt:MinimumMember 2021-01-15 2021-01-15 0001287865 mpw:AlternateBaseRateMember srt:MaximumMember 2021-01-15 2021-01-15 0001287865 mpw:EurodollarLoansMember srt:MinimumMember 2021-01-15 2021-01-15 0001287865 mpw:EurodollarLoansMember srt:MaximumMember 2021-01-15 2021-01-15 0001287865 srt:MinimumMember 2021-01-15 2021-01-15 0001287865 srt:MaximumMember 2021-01-15 2021-01-15 0001287865 us-gaap:UnsecuredDebtMember 2021-03-24 0001287865 mpw:TwoPointFiveZeroZeroPercentageSeniorUnsecuredNotesDueTwoThousandTwentySixMember 2021-03-24 0001287865 mpw:TwoPointFiveZeroZeroPercentageSeniorUnsecuredNotesDueTwoThousandTwentySixMember 2021-01-01 2021-09-30 0001287865 mpw:TwoPointFiveZeroZeroPercentageSeniorUnsecuredNotesDueTwoThousandTwentySixMember 2021-03-24 2021-03-24 0001287865 mpw:ThreePointThreeSevenFivePercentageSeniorUnsecuredNotesDueTwoThousandThirtyMember 2021-03-24 0001287865 mpw:ThreePointThreeSevenFivePercentageSeniorUnsecuredNotesDueTwoThousandThirtyMember 2021-01-01 2021-09-30 0001287865 mpw:ThreePointThreeSevenFivePercentageSeniorUnsecuredNotesDueTwoThousandThirtyMember 2021-03-24 2021-03-24 0001287865 us-gaap:UnsecuredDebtMember mpw:InterimCreditFacilityMember 2021-03-26 2021-03-26 0001287865 us-gaap:UnsecuredDebtMember us-gaap:RevolvingCreditFacilityMember 2021-03-26 0001287865 mpw:TermLoanMember mpw:BankOfAmericaNAMember stpr:CA-BC 2020-01-06 0001287865 mpw:WaterlandPrivateEquityFundVIICVMember mpw:InterimCreditFacilityMember 2021-01-01 2021-09-30 0001287865 us-gaap:ForeignCountryMember 2021-04-01 2021-06-30 0001287865 us-gaap:ForeignCountryMember srt:MinimumMember 2020-07-01 2020-09-30 0001287865 us-gaap:ForeignCountryMember srt:MaximumMember 2020-07-01 2020-09-30 0001287865 srt:ScenarioForecastMember us-gaap:ForeignCountryMember 2023-04-01 2023-04-01 0001287865 us-gaap:ForeignCountryMember 2020-07-01 2020-09-30 0001287865 mpw:PublicOfferingMember 2021-01-11 0001287865 mpw:PublicOfferingMember 2021-01-11 2021-01-11 0001287865 us-gaap:CommonStockMember mpw:AtTheMarketEquityOfferingProgramMember 2021-01-01 2021-09-30 0001287865 us-gaap:CommonStockMember mpw:AtTheMarketEquityOfferingProgramMember 2020-01-01 2020-09-30 0001287865 mpw:AtTheMarketEquityOfferingProgramMember 2021-01-01 2021-09-30 0001287865 mpw:AtTheMarketEquityOfferingProgramMember 2020-01-01 2020-09-30 0001287865 mpw:MptOperatingPartnershipLPMember mpw:MedicalPropertiesTrustLimitedLiabilityCompanyMember 2021-01-01 2021-09-30 0001287865 mpw:MptOperatingPartnershipLPMember mpw:MPTTRSIncMember 2021-01-01 2021-09-30 0001287865 mpw:MptOperatingPartnershipLPMember mpw:OperatingPartnershipMember 2021-01-01 2021-09-30 0001287865 mpw:EquityIncentivePlanMember 2021-09-30 0001287865 us-gaap:FairValueMeasurementsRecurringMember mpw:AcquisitionLoanMember 2020-05-31 mpw:Health_Center 0001287865 us-gaap:FairValueMeasurementsRecurringMember mpw:AcquisitionLoanMember country:CO 2021-01-01 2021-09-30 0001287865 us-gaap:FairValueMeasurementsRecurringMember country:CO 2020-01-01 2020-12-31 0001287865 us-gaap:FairValueMeasurementsRecurringMember us-gaap:MortgagesMember 2021-09-30 0001287865 us-gaap:FairValueMeasurementsRecurringMember mpw:EquityMethodInvestmentAndOtherLoansMember 2021-09-30 0001287865 us-gaap:FairValueMeasurementsRecurringMember us-gaap:MortgagesMember 2020-12-31 0001287865 us-gaap:FairValueMeasurementsRecurringMember mpw:EquityMethodInvestmentAndOtherLoansMember 2020-12-31 0001287865 mpw:AcuteCareHospitalMember mpw:HCAHealthcareMember 2021-09-15 2021-09-15 0001287865 mpw:StewardHealthCareSystemLLCMember mpw:HCAHealthcareMember 2021-09-15 2021-09-15 0001287865 mpw:HCAHealthcareMember 2021-09-15 2021-09-15 0001287865 mpw:ZeroPointNineNineThreePercentageSeniorUnsecuredNotesDueTwoThousandTwentySixMember us-gaap:SubsequentEventMember 2021-10-06 0001287865 mpw:ZeroPointNineNineThreePercentageSeniorUnsecuredNotesDueTwoThousandTwentySixMember us-gaap:SubsequentEventMember 2021-10-06 2021-10-06 0001287865 mpw:FourPointZeroZeroZeroPercentageSeniorUnsecuredNotesDueTwoThousandTwentyTwoMember us-gaap:SubsequentEventMember 2021-10-22 0001287865 mpw:FourPointZeroZeroZeroPercentageSeniorUnsecuredNotesDueTwoThousandTwentyTwoMember us-gaap:SubsequentEventMember 2021-10-22 2021-10-22 0001287865 us-gaap:SubsequentEventMember mpw:InpatientBehavioralHealthHospitalFacilitiesMember mpw:SpringstoneMember 2021-10-19 2021-10-19 0001287865 us-gaap:SubsequentEventMember mpw:AcuteCareFacilitiesMember country:PT 2021-10-21 2021-10-21

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 10-Q

 

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2021

OR

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from                          to                         

Commission file number 001-32559

Commission file number 333-177186

MEDICAL PROPERTIES TRUST, INC.

MPT OPERATING PARTNERSHIP, L.P.

(Exact Name of Registrant as Specified in Its Charter)

 

 

 

 

 

maryland

delaware

 

20-0191742

20-0242069

(State or other jurisdiction of

incorporation or organization)

 

(I. R. S. Employer

Identification No.)

 

 

 

 

1000 URBAN CENTER DRIVE, SUITE 501

BIRMINGHAM, AL

 

35242

(Address of principal executive offices)

 

(Zip Code)

REGISTRANT’S TELEPHONE NUMBER, INCLUDING AREA CODE: (205) 969-3755

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes      No  

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).    Yes      No  

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer”, “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer

 

  (Medical Properties Trust, Inc. only)

  

Accelerated filer

 

Non-accelerated filer

 

  (MPT Operating Partnership, L.P. only)

  

Smaller reporting company

 

 

 

 

  

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.   

 

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common stock, par value $0.001 per share, of Medical Properties Trust, Inc.

MPW

The New York Stock Exchange

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes      No  

As of November 1, 2021, Medical Properties Trust, Inc. had 596.3 million shares of common stock, par value $0.001, outstanding.

 

 

 


 

 

EXPLANATORY NOTE

This report combines the Quarterly Reports on Form 10-Q for the three and nine months ended September 30, 2021 of Medical Properties Trust, Inc., a Maryland corporation, and MPT Operating Partnership, L.P., a Delaware limited partnership, through which Medical Properties Trust, Inc. conducts substantially all of its operations. Unless otherwise indicated or unless the context requires otherwise, all references in this report to “we,” “us,” “our,” “Medical Properties,” “MPT,” or the “company” refer to Medical Properties Trust, Inc. together with its consolidated subsidiaries, including MPT Operating Partnership, L.P. Unless otherwise indicated or unless the context requires otherwise, all references to “operating partnership” refer to MPT Operating Partnership, L.P. together with its consolidated subsidiaries.

 

 

 


 

 

MEDICAL PROPERTIES TRUST, INC. AND MPT OPERATING PARTNERSHIP, L.P.

AND SUBSIDIARIES

QUARTERLY REPORT ON FORM 10-Q

FOR THE QUARTERLY PERIOD ENDED September 30, 2021

Table of Contents

 

 

Page

PART I — FINANCIAL INFORMATION

3

Item 1 Financial Statements

3

Medical Properties Trust, Inc. and Subsidiaries

 

Condensed Consolidated Balance Sheets at September 30, 2021 and December 31, 2020

3

Condensed Consolidated Statements of Net Income for the Three and Nine Months Ended September 30, 2021 and 2020

4

Condensed Consolidated Statements of Comprehensive Income for the Three and Nine Months Ended September 30, 2021 and 2020

5

Condensed Consolidated Statements of Equity for the Three and Nine Months Ended September 30, 2021 and 2020

6

Condensed Consolidated Statements of Cash Flows for the Nine Months Ended September 30, 2021 and 2020

8

MPT Operating Partnership, L.P. and Subsidiaries

 

Condensed Consolidated Balance Sheets at September 30, 2021 and December 31, 2020

9

Condensed Consolidated Statements of Net Income for the Three and Nine Months Ended September 30, 2021 and 2020

10

Condensed Consolidated Statements of Comprehensive Income for the Three and Nine Months Ended September 30, 2021 and 2020

11

Condensed Consolidated Statements of Capital for the Three and Nine Months Ended September 30, 2021 and 2020

12

Condensed Consolidated Statements of Cash Flows for the Nine Months Ended September 30, 2021 and 2020

14

Medical Properties Trust, Inc. and MPT Operating Partnership, L.P.

 

Notes to Condensed Consolidated Financial Statements

15

Item 2 Management’s Discussion and Analysis of Financial Condition and Results of Operations

28

Item 3 Quantitative and Qualitative Disclosures about Market Risk

40

Item 4 Controls and Procedures

41

PART II — OTHER INFORMATION

42

Item 1 Legal Proceedings

42

Item 1A Risk Factors

42

Item 2 Unregistered Sales of Equity Securities and Use of Proceeds

42

Item 3 Defaults Upon Senior Securities

42

Item 4 Mine Safety Disclosures

42

Item 5 Other Information

42

Item 6 Exhibits

43

SIGNATURE

44

 

 

 

 

2


 

 

 

PART I — FINANCIAL INFORMATION

Item 1. Financial Statements.

MEDICAL PROPERTIES TRUST, INC. AND SUBSIDIARIES

Condensed Consolidated Balance Sheets

 

 

 

September 30,

2021

 

 

December 31,

2020

 

(In thousands, except per share amounts)

 

(Unaudited)

 

 

(Note 2)

 

Assets

 

 

 

 

 

 

 

 

Real estate assets

 

 

 

 

 

 

 

 

Land, buildings and improvements, intangible lease assets, and other

 

$

13,244,403

 

 

$

12,078,927

 

Investment in financing leases

 

 

2,042,585

 

 

 

2,010,922

 

Real estate held for sale

 

 

1,096,475

 

 

 

 

Mortgage loans

 

 

200,285

 

 

 

248,080

 

Gross investment in real estate assets

 

 

16,583,748

 

 

 

14,337,929

 

Accumulated depreciation and amortization

 

 

(936,289

)

 

 

(833,529

)

Net investment in real estate assets

 

 

15,647,459

 

 

 

13,504,400

 

Cash and cash equivalents

 

 

349,652

 

 

 

549,884

 

Interest and rent receivables

 

 

64,622

 

 

 

46,208

 

Straight-line rent receivables

 

 

661,429

 

 

 

490,462

 

Equity investments

 

 

1,170,171

 

 

 

1,123,623

 

Other loans

 

 

1,502,677

 

 

 

858,368

 

Other assets

 

 

315,977

 

 

 

256,069

 

Total Assets

 

$

19,711,987

 

 

$

16,829,014

 

Liabilities and Equity

 

 

 

 

 

 

 

 

Liabilities

 

 

 

 

 

 

 

 

Debt, net

 

$

10,581,023

 

 

$

8,865,458

 

Accounts payable and accrued expenses

 

 

595,003

 

 

 

438,750

 

Deferred revenue

 

 

19,739

 

 

 

36,177

 

Obligations to tenants and other lease liabilities

 

 

157,488

 

 

 

144,772

 

Total Liabilities

 

 

11,353,253

 

 

 

9,485,157

 

Equity

 

 

 

 

 

 

 

 

Preferred stock, $0.001 par value. Authorized 10,000 shares;

   no shares outstanding

 

 

 

 

 

 

Common stock, $0.001 par value. Authorized 750,000 shares;

   issued and outstanding — 596,145 shares at September 30, 2021 and

   541,419 shares at December 31, 2020

 

 

596

 

 

 

541

 

Additional paid-in capital

 

 

8,541,092

 

 

 

7,461,503

 

Distributions in excess of net income

 

 

(117,733

)

 

 

(71,411

)

Accumulated other comprehensive loss

 

 

(69,843

)

 

 

(51,324

)

Treasury shares, at cost

 

 

(777

)

 

 

(777

)

Total Medical Properties Trust, Inc. stockholders’ equity

 

 

8,353,335

 

 

 

7,338,532

 

Non-controlling interests

 

 

5,399

 

 

 

5,325

 

Total Equity

 

 

8,358,734

 

 

 

7,343,857

 

Total Liabilities and Equity

 

$

19,711,987

 

 

$

16,829,014

 

 

See accompanying notes to condensed consolidated financial statements.

3


 

MEDICAL PROPERTIES TRUST, INC. AND SUBSIDIARIES

Condensed Consolidated Statements of Net Income

(Unaudited)

 

 

For the Three Months

Ended September 30,

 

 

For the Nine Months

Ended September 30,

 

(In thousands, except per share amounts)

2021

 

 

2020

 

 

2021

 

 

2020

 

Revenues

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Rent billed

$

242,211

 

 

$

192,953

 

 

$

672,425

 

 

$

538,277

 

Straight-line rent

 

64,637

 

 

 

51,125

 

 

 

174,975

 

 

 

103,697

 

Income from financing leases

 

50,667

 

 

 

52,544

 

 

 

151,898

 

 

 

157,469

 

Interest and other income

 

33,264

 

 

 

32,836

 

 

 

136,038

 

 

 

115,989

 

Total revenues

 

390,779

 

 

 

329,458

 

 

 

1,135,336

 

 

 

915,432

 

Expenses

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Interest

 

94,132

 

 

 

82,263

 

 

 

273,409

 

 

 

243,538

 

Real estate depreciation and amortization

 

85,039

 

 

 

69,665

 

 

 

237,050

 

 

 

192,049

 

Property-related

 

7,128

 

 

 

5,897

 

 

 

31,265

 

 

 

19,178

 

General and administrative

 

36,694

 

 

 

31,718

 

 

 

107,312

 

 

 

97,121

 

Total expenses

 

222,993

 

 

 

189,543

 

 

 

649,036

 

 

 

551,886

 

Other income (expense)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gain (loss) on sale of real estate

 

9,294

 

 

 

(927

)

 

 

8,896

 

 

 

(2,703

)

Real estate impairment charges

 

 

 

 

 

 

 

 

 

 

(19,006

)

Earnings from equity interests

 

7,193

 

 

 

5,893

 

 

 

21,633

 

 

 

15,263

 

Debt refinancing and unutilized financing costs

 

 

 

 

 

 

 

(2,339

)

 

 

(611

)

Other (including mark-to-market adjustments on equity securities)

 

(2,276

)

 

 

2,461

 

 

 

4,747

 

 

 

(9,499

)

Total other income (expense)

 

14,211

 

 

 

7,427

 

 

 

32,937

 

 

 

(16,556

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Income before income tax

 

181,997

 

 

 

147,342

 

 

 

519,237

 

 

 

346,990

 

Income tax expense

 

(10,602

)

 

 

(15,985

)

 

 

(69,141

)

 

 

(24,824

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income

 

171,395

 

 

 

131,357

 

 

 

450,096

 

 

 

322,166

 

Net income attributable to non-controlling interests

 

(258

)

 

 

(251

)

 

 

(611

)

 

 

(600

)

Net income attributable to MPT common stockholders

$

171,137

 

 

$

131,106

 

 

$

449,485

 

 

$

321,566

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Earnings per common share — basic and diluted

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income attributable to MPT common stockholders

$

0.29

 

 

$

0.25

 

 

$

0.76

 

 

$

0.61

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average shares outstanding — basic

 

595,119

 

 

 

531,095

 

 

 

586,291

 

 

 

526,651

 

Weighted average shares outstanding — diluted

 

597,320

 

 

 

532,436

 

 

 

587,971

 

 

 

527,832

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Dividends declared per common share

$

0.28

 

 

$

0.27

 

 

$

0.84

 

 

$

0.81

 

 

See accompanying notes to condensed consolidated financial statements.

4


 

MEDICAL PROPERTIES TRUST, INC. AND SUBSIDIARIES

Condensed Consolidated Statements of Comprehensive Income

(Unaudited)

 

 

 

For the Three Months

Ended September 30,

 

 

For the Nine Months

Ended September 30,

 

(In thousands)

 

2021

 

 

2020

 

 

2021

 

 

2020

 

Net income

 

$

171,395

 

 

$

131,357

 

 

$

450,096

 

 

$

322,166

 

Other comprehensive income:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Unrealized gain (loss) on interest rate swaps, net of tax

 

 

8,847

 

 

 

(2,624

)

 

 

28,558

 

 

 

(35,635

)

Foreign currency translation (loss) gain

 

 

(25,191

)

 

 

19,983

 

 

 

(47,077

)

 

 

2,886

 

Total comprehensive income

 

 

155,051

 

 

 

148,716

 

 

 

431,577

 

 

 

289,417

 

Comprehensive income attributable to non-controlling interests

 

 

(258

)

 

 

(251

)

 

 

(611

)

 

 

(600

)

Comprehensive income attributable to MPT common

   stockholders

 

$

154,793

 

 

$

148,465

 

 

$

430,966

 

 

$

288,817

 

 

See accompanying notes to condensed consolidated financial statements.


5


 

 

MEDICAL PROPERTIES TRUST, INC. AND SUBSIDIARIES

 

Condensed Consolidated Statements of Equity

(Unaudited)

 

 

 

Preferred

 

 

Common

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(In thousands, except per share amounts)

 

Shares

 

 

Par

Value

 

 

Shares

 

 

Par

Value

 

 

Additional

Paid-in

Capital

 

 

Distributions

in

Excess of

Net Income

 

 

Accumulated

Other

Comprehensive

Loss

 

 

Treasury

Shares

 

 

Non-

Controlling

Interests

 

 

Total

Equity

 

Balance at December 31, 2020

 

 

 

 

$

 

 

 

541,419

 

 

$

541

 

 

$

7,461,503

 

 

$

(71,411

)

 

$

(51,324

)

 

$

(777

)

 

$

5,325

 

 

$

7,343,857

 

Net income

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

163,783

 

 

 

 

 

 

 

 

 

97

 

 

 

163,880

 

Unrealized gain on interest rate swaps, net

   of tax

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

15,504

 

 

 

 

 

 

 

 

 

15,504

 

Foreign currency translation loss

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(30,900

)

 

 

 

 

 

 

 

 

(30,900

)

Stock vesting and amortization of

   stock-based compensation

 

 

 

 

 

 

 

 

1,741

 

 

 

2

 

 

 

12,262

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

12,264

 

Distributions to non-controlling interests

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(193

)

 

 

(193

)

Proceeds from offering (net of

   offering costs)

 

 

 

 

 

 

 

 

39,949

 

 

 

40

 

 

 

779,201

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

779,241

 

Dividends declared ($0.28 per

   common share)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(163,443

)

 

 

 

 

 

 

 

 

 

 

 

(163,443

)

Balance at March 31, 2021

 

 

 

 

$

 

 

 

583,109

 

 

$

583

 

 

$

8,252,966

 

 

$

(71,071

)

 

$

(66,720

)

 

$

(777

)

 

$

5,229

 

 

$

8,120,210

 

Net income

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

114,565

 

 

 

 

 

 

 

 

 

256

 

 

 

114,821

 

Unrealized gain on interest rate swaps, net

   of tax

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

4,207

 

 

 

 

 

 

 

 

 

4,207

 

Foreign currency translation gain

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

9,014

 

 

 

 

 

 

 

 

 

9,014

 

Stock vesting and amortization of

   stock-based compensation

 

 

 

 

 

 

 

 

176

 

 

 

 

 

 

12,771

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

12,771

 

Distributions to non-controlling interests

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(142

)

 

 

(142

)

Proceeds from offering (net of

   offering costs)

 

 

 

 

 

 

 

 

5,679

 

 

 

6

 

 

 

121,327

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

121,333

 

Dividends declared ($0.28 per

   common share)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(165,133

)

 

 

 

 

 

 

 

 

 

 

 

(165,133

)

Balance at June 30, 2021

 

 

 

 

$

 

 

 

588,964

 

 

$

589

 

 

$

8,387,064

 

 

$

(121,639

)

 

$

(53,499

)

 

$

(777

)

 

$

5,343

 

 

$

8,217,081

 

Net income

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

171,137

 

 

 

 

 

 

 

 

 

258

 

 

 

171,395

 

Unrealized gain on interest rate swaps, net

   of tax

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

8,847

 

 

 

 

 

 

 

 

 

8,847

 

Foreign currency translation loss

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(25,191

)

 

 

 

 

 

 

 

 

(25,191

)

Stock vesting and amortization of

   stock-based compensation

 

 

 

 

 

 

 

 

218

 

 

 

 

 

 

13,555

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

13,555

 

Distributions to non-controlling interests

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(202

)

 

 

(202

)

Proceeds from offering (net of

   offering costs)

 

 

 

 

 

 

 

 

6,963

 

 

 

7

 

 

 

140,473

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

140,480

 

Dividends declared ($0.28 per

   common share)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(167,231

)

 

 

 

 

 

 

 

 

 

 

 

(167,231

)

Balance at September 30, 2021

 

 

 

 

$

 

 

 

596,145

 

 

$

596

 

 

$

8,541,092

 

 

$

(117,733

)

 

$

(69,843

)

 

$

(777

)

 

$

5,399

 

 

$

8,358,734

 

 

 

See accompanying notes to condensed consolidated financial statements.

 

6


 

 

MEDICAL PROPERTIES TRUST, INC. AND SUBSIDIARIES

 

Condensed Consolidated Statements of Equity

(Unaudited)

 

 

 

Preferred

 

 

Common

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(In thousands, except per share amounts)

 

Shares

 

 

Par

Value

 

 

Shares

 

 

Par

Value

 

 

Additional

Paid-in

Capital

 

 

Retained

Earnings

(Deficit)

 

 

Accumulated

Other

Comprehensive

Loss

 

 

Treasury

Shares

 

 

Non-

Controlling

Interests

 

 

Total

Equity

 

Balance at December 31, 2019

 

 

 

 

$

 

 

 

517,522

 

 

$

518

 

 

$

7,008,199

 

 

$

83,012

 

 

$

(62,905

)

 

$

(777

)

 

$

107

 

 

$

7,028,154

 

Net income

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

80,992

 

 

 

 

 

 

 

 

 

165

 

 

 

81,157

 

Cumulative effect of change in accounting

   principles

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(8,399

)

 

 

 

 

 

 

 

 

 

 

 

(8,399

)

Unrealized loss on interest rate swaps, net

   of tax

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(25,103

)

 

 

 

 

 

 

 

 

(25,103

)

Foreign currency translation loss

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(23,272

)

 

 

 

 

 

 

 

 

(23,272

)

Stock vesting and amortization of

   stock-based compensation

 

 

 

 

 

 

 

 

2,312

 

 

 

2

 

 

 

10,034

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

10,036

 

Distributions to non-controlling interests

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(165

)

 

 

(165

)

Proceeds from offering (net of

   offering costs)

 

 

 

 

 

 

 

 

2,601

 

 

 

2

 

 

 

61,680

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

61,682

 

Dividends declared ($0.27 per

   common share)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(141,580

)

 

 

 

 

 

 

 

 

 

 

 

(141,580

)

Balance at March 31, 2020

 

 

 

 

$

 

 

 

522,435

 

 

$

522

 

 

$

7,079,913

 

 

$

14,025

 

 

$

(111,280

)

 

$

(777

)

 

$

107

 

 

$

6,982,510

 

Net income

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

109,468

 

 

 

 

 

 

 

 

 

184

 

 

 

109,652

 

Unrealized loss on interest rate swaps, net

   of tax

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(7,908

)

 

 

 

 

 

 

 

 

(7,908

)

Foreign currency translation gain

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

6,175

 

 

 

 

 

 

 

 

 

6,175

 

Stock vesting and amortization of

   stock-based compensation

 

 

 

 

 

 

 

 

189

 

 

 

1

 

 

 

12,191

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

12,192

 

Distributions to non-controlling interests

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(185

)

 

 

(185

)

Proceeds from offering (net of

   offering costs)

 

 

 

 

 

 

 

 

6,017

 

 

 

6

 

 

 

108,099

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

108,105

 

Dividends declared ($0.27 per

   common share)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(143,264

)

 

 

 

 

 

 

 

 

 

 

 

(143,264

)

Balance at June 30, 2020

 

 

 

 

$

 

 

 

528,641

 

 

$

529

 

 

$

7,200,203

 

 

$

(19,771

)

 

$

(113,013

)

 

$

(777

)

 

$

106

 

 

$

7,067,277

 

Net income

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

131,106

 

 

 

 

 

 

 

 

 

251

 

 

 

131,357

 

Unrealized loss on interest rate swaps, net

   of tax

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(2,624

)

 

 

 

 

 

 

 

 

(2,624

)

Foreign currency translation gain

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

19,983

 

 

 

 

 

 

 

 

 

19,983

 

Stock vesting and amortization of

   stock-based compensation

 

 

 

 

 

 

 

 

188

 

 

 

 

 

 

12,372

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

12,372

 

Sale of non-controlling interests

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

5,073

 

 

 

5,073

 

Distributions to non-controlling interests

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(194

)

 

 

(194

)

Proceeds from offering (net of

   offering costs)

 

 

 

 

 

 

 

 

6,745

 

 

 

7

 

 

 

124,580

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

124,587

 

Dividends declared ($0.27 per

   common share)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(144,954

)

 

 

 

 

 

 

 

 

 

 

 

(144,954

)

Balance at September 30, 2020

 

 

 

 

$

 

 

 

535,574

 

 

$

536

 

 

$

7,337,155

 

 

$

(33,619

)

 

$

(95,654

)

 

$

(777

)

 

$

5,236

 

 

$

7,212,877

 

 

 

See accompanying notes to condensed consolidated financial statements.

7


 

MEDICAL PROPERTIES TRUST, INC. AND SUBSIDIARIES

Condensed Consolidated Statements of Cash Flows

(Unaudited)

 

 

 

For the Nine Months

Ended September 30,

 

 

 

2021

 

 

2020

 

 

 

(In thousands)

 

Operating activities

 

 

 

 

 

 

 

 

Net income

 

$

450,096

 

 

$

322,166

 

Adjustments to reconcile net income to net cash provided by operating activities:

 

 

 

 

 

 

 

 

Depreciation and amortization

 

 

246,117

 

 

 

200,807

 

Amortization of deferred financing costs and debt discount

 

 

12,079

 

 

 

9,773

 

Straight-line rent revenue and other

 

 

(208,756

)

 

 

(161,163

)

Share-based compensation

 

 

38,590

 

 

 

34,600

 

(Gain) loss from sale of real estate

 

 

(8,896

)

 

 

2,703

 

Impairment charges

 

 

 

 

 

19,006

 

Straight-line rent and other (recovery) write-off

 

 

(1,601

)

 

 

27,098

 

Debt refinancing and unutilized financing costs

 

 

2,339

 

 

 

611

 

Pre-acquisition rent collected - Circle Transaction

 

 

 

 

 

(35,020

)

Tax rate and other changes

 

 

42,746

 

 

 

9,661

 

Other adjustments

 

 

15,468

 

 

 

(6,418

)

Changes in:

 

 

 

 

 

 

 

 

Interest and rent receivables

 

 

(19,150

)

 

 

(6,189

)

Other assets

 

 

516

 

 

 

12,117

 

Accounts payable and accrued expenses

 

 

25,527

 

 

 

(21,139

)

Deferred revenue

 

 

(17,588

)

 

 

33,605

 

Net cash provided by operating activities

 

 

577,487

 

 

 

442,218

 

Investing activities

 

 

 

 

 

 

 

 

Cash paid for acquisitions and other related investments

 

 

(4,279,147

)

 

 

(3,524,910

)

Net proceeds from sale of real estate

 

 

66,891

 

 

 

93,042

 

Principal received on loans receivable

 

 

1,234,839

 

 

 

738,036

 

Return of equity investment

 

 

11,000

 

 

 

63,122

 

Capital additions and other investments, net

 

 

(253,512

)

 

 

(116,297

)

Net cash used for investing activities

 

 

(3,219,929

)

 

 

(2,747,007

)

Financing activities

 

 

 

 

 

 

 

 

Proceeds from term debt, net of discount

 

 

2,489,735

 

 

 

915,950

 

Payments of term debt

 

 

(689,450

)

 

 

 

Revolving credit facilities, net

 

 

80,963

 

 

 

225,000

 

Dividends paid

 

 

(476,242

)

 

 

(423,005

)

Lease deposits and other obligations to tenants

 

 

14,819

 

 

 

7,584

 

Proceeds from sale of common shares, net of offering costs

 

 

1,041,054

 

 

 

294,374

 

Payment of debt refinancing, deferred financing costs, and other financing activities

 

 

(24,245

)

 

 

(2,143

)

Net cash provided by financing activities

 

 

2,436,634

 

 

 

1,017,760

 

Decrease in cash, cash equivalents, and restricted cash for period

 

 

(205,808

)

 

 

(1,287,029

)

Effect of exchange rate changes

 

 

1,748

 

 

 

9,116

 

Cash, cash equivalents, and restricted cash at beginning of period

 

 

556,369

 

 

 

1,467,991

 

Cash, cash equivalents, and restricted cash at end of period

 

$

352,309

 

 

$

190,078

 

Interest paid

 

$

256,724

 

 

$

231,257

 

Supplemental schedule of non-cash financing activities:

 

 

 

 

 

 

 

 

Dividends declared, unpaid

 

$

167,231

 

 

$

144,954

 

Cash, cash equivalents, and restricted cash are comprised of the following:

 

 

 

 

 

 

 

 

Beginning of period:

 

 

 

 

 

 

 

 

Cash and cash equivalents

 

$

549,884

 

 

$

1,462,286

 

Restricted cash, included in Other assets

 

 

6,485

 

 

 

5,705

 

 

 

$

556,369

 

 

$

1,467,991

 

End of period:

 

 

 

 

 

 

 

 

Cash and cash equivalents

 

$

349,652

 

 

$

183,794

 

Restricted cash, included in Other assets

 

 

2,657

 

 

 

6,284

 

 

 

$

352,309

 

 

$

190,078

 

 

See accompanying notes to condensed consolidated financial statements.

8


 

MPT OPERATING PARTNERSHIP, L.P. AND SUBSIDIARIES

Condensed Consolidated Balance Sheets

 

 

 

September 30,

2021

 

 

December 31,

2020

 

(In thousands)

 

(Unaudited)

 

 

(Note 2)

 

Assets

 

 

 

 

 

 

 

 

Real estate assets

 

 

 

 

 

 

 

 

Land, buildings and improvements, intangible lease assets, and other

 

$

13,244,403

 

 

$

12,078,927

 

Investment in financing leases

 

 

2,042,585

 

 

 

2,010,922

 

Real estate held for sale

 

 

1,096,475

 

 

 

 

Mortgage loans

 

 

200,285

 

 

 

248,080

 

Gross investment in real estate assets

 

 

16,583,748

 

 

 

14,337,929

 

Accumulated depreciation and amortization

 

 

(936,289

)

 

 

(833,529

)

Net investment in real estate assets

 

 

15,647,459

 

 

 

13,504,400

 

Cash and cash equivalents

 

 

349,652

 

 

 

549,884

 

Interest and rent receivables

 

 

64,622

 

 

 

46,208

 

Straight-line rent receivables

 

 

661,429

 

 

 

490,462

 

Equity investments

 

 

1,170,171

 

 

 

1,123,623

 

Other loans

 

 

1,502,677

 

 

 

858,368

 

Other assets

 

 

315,977

 

 

 

256,069

 

Total Assets

 

$

19,711,987

 

 

$

16,829,014

 

Liabilities and Capital

 

 

 

 

 

 

 

 

Liabilities

 

 

 

 

 

 

 

 

Debt, net

 

$

10,581,023

 

 

$

8,865,458

 

Accounts payable and accrued expenses

 

 

427,382

 

 

 

290,757

 

Deferred revenue

 

 

19,739

 

 

 

36,177

 

Obligations to tenants and other lease liabilities

 

 

157,488

 

 

 

144,772

 

Payable due to Medical Properties Trust, Inc.

 

 

167,231

 

 

 

147,603

 

Total Liabilities

 

 

11,352,863

 

 

 

9,484,767

 

Capital

 

 

 

 

 

 

 

 

General Partner — issued and outstanding — 5,962 units at

   September 30, 2021 and 5,414 units at December 31, 2020

 

 

84,312

 

 

 

73,977

 

Limited Partners — issued and outstanding — 590,183 units at

   September 30, 2021 and 536,005 units at December 31, 2020

 

 

8,339,256

 

 

 

7,316,269

 

Accumulated other comprehensive loss

 

 

(69,843

)

 

 

(51,324

)

Total MPT Operating Partnership, L.P. capital

 

 

8,353,725

 

 

 

7,338,922

 

Non-controlling interests

 

 

5,399

 

 

 

5,325

 

Total Capital

 

 

8,359,124

 

 

 

7,344,247

 

Total Liabilities and Capital

 

$

19,711,987

 

 

$

16,829,014

 

 

See accompanying notes to condensed consolidated financial statements.

9


 

MPT OPERATING PARTNERSHIP, L.P. AND SUBSIDIARIES

Condensed Consolidated Statements of Net Income

(Unaudited)

 

 

 

For the Three Months

Ended September 30,

 

 

For the Nine Months

Ended September 30,

 

(In thousands, except per unit amounts)

 

2021

 

 

2020

 

 

2021

 

 

2020

 

Revenues

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Rent billed

 

$

242,211

 

 

$

192,953

 

 

$

672,425

 

 

$

538,277

 

Straight-line rent

 

 

64,637

 

 

 

51,125

 

 

 

174,975

 

 

 

103,697

 

Income from financing leases

 

 

50,667

 

 

 

52,544

 

 

 

151,898

 

 

 

157,469

 

Interest and other income

 

 

33,264

 

 

 

32,836

 

 

 

136,038

 

 

 

115,989

 

Total revenues

 

 

390,779

 

 

 

329,458

 

 

 

1,135,336

 

 

 

915,432

 

Expenses

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Interest

 

 

94,132

 

 

 

82,263

 

 

 

273,409

 

 

 

243,538

 

Real estate depreciation and amortization

 

 

85,039

 

 

 

69,665

 

 

 

237,050

 

 

 

192,049

 

Property-related

 

 

7,128

 

 

 

5,897

 

 

 

31,265

 

 

 

19,178

 

General and administrative

 

 

36,694

 

 

 

31,718

 

 

 

107,312

 

 

 

97,121

 

Total expenses

 

 

222,993

 

 

 

189,543

 

 

 

649,036

 

 

 

551,886

 

Other income (expense)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gain (loss) on sale of real estate

 

 

9,294

 

 

 

(927

)

 

 

8,896

 

 

 

(2,703

)

Real estate impairment charges

 

 

 

 

 

 

 

 

 

 

 

(19,006

)

Earnings from equity interests

 

 

7,193

 

 

 

5,893

 

 

 

21,633

 

 

 

15,263

 

Debt refinancing and unutilized financing costs

 

 

 

 

 

 

 

 

(2,339

)

 

 

(611

)

Other (including mark-to-market adjustments on equity securities)

 

 

(2,276

)

 

 

2,461

 

 

 

4,747

 

 

 

(9,499

)

Total other income (expense)

 

 

14,211

 

 

 

7,427

 

 

 

32,937

 

 

 

(16,556

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Income before income tax

 

 

181,997

 

 

 

147,342

 

 

 

519,237

 

 

 

346,990

 

Income tax expense

 

 

(10,602

)

 

 

(15,985

)

 

 

(69,141

)

 

 

(24,824

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income

 

 

171,395

 

 

 

131,357

 

 

 

450,096

 

 

 

322,166

 

Net income attributable to non-controlling interests

 

 

(258

)

 

 

(251

)

 

 

(611

)

 

 

(600

)

Net income attributable to MPT Operating Partnership

   partners

 

$

171,137

 

 

$

131,106

 

 

$

449,485

 

 

$

321,566

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Earnings per unit — basic and diluted

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income attributable to MPT Operating Partnership partners

 

$

0.29

 

 

$

0.25

 

 

$

0.76

 

 

$

0.61

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average units outstanding — basic

 

 

595,119

 

 

 

531,095

 

 

 

586,291

 

 

 

526,651

 

Weighted average units outstanding — diluted

 

 

597,320

 

 

 

532,436

 

 

 

587,971

 

 

 

527,832

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Dividends declared per unit

 

$

0.28

 

 

$

0.27

 

 

$

0.84

 

 

$

0.81

 

 

See accompanying notes to condensed consolidated financial statements.

10


 

MPT OPERATING PARTNERSHIP, L.P. AND SUBSIDIARIES

Condensed Consolidated Statements of Comprehensive Income

(Unaudited)

 

 

 

For the Three Months

Ended September 30,

 

 

For the Nine Months

Ended September 30,

 

(In thousands)

 

2021

 

 

2020

 

 

2021

 

 

2020

 

Net income

 

$

171,395

 

 

$

131,357

 

 

$

450,096

 

 

$

322,166

 

Other comprehensive income:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Unrealized gain (loss) on interest rate swaps, net of tax

 

 

8,847

 

 

 

(2,624

)

 

 

28,558

 

 

 

(35,635

)

Foreign currency translation (loss) gain

 

 

(25,191

)

 

 

19,983

 

 

 

(47,077

)

 

 

2,886

 

Total comprehensive income

 

 

155,051

 

 

 

148,716

 

 

 

431,577

 

 

 

289,417

 

Comprehensive income attributable to non-controlling interests

 

 

(258

)

 

 

(251

)

 

 

(611

)

 

 

(600

)

Comprehensive income attributable to MPT Operating Partnership

   partners

 

$

154,793

 

 

$

148,465

 

 

$

430,966

 

 

$

288,817

 

 

See accompanying notes to condensed consolidated financial statements.

11


 

MPT OPERATING PARTNERSHIP, L.P. AND SUBSIDIARIES

Condensed Consolidated Statements of Capital

(Unaudited)

 

 

 

General

 

 

Limited Partners

 

 

Accumulated

 

 

 

 

 

 

 

 

 

 

 

Partner

 

 

Common

 

 

Other

 

 

Non-

 

 

 

 

 

(In thousands, except per unit amounts)

 

Units

 

 

Unit

Value

 

 

Units

 

 

Unit

Value

 

 

Comprehensive

Loss

 

 

Controlling

Interests

 

 

Total

Capital

 

Balance at December 31, 2020

 

 

5,414

 

 

$

73,977

 

 

 

536,005

 

 

$

7,316,269

 

 

$

(51,324

)

 

$

5,325

 

 

$

7,344,247

 

Net income

 

 

 

 

 

1,638

 

 

 

 

 

 

162,145

 

 

 

 

 

 

97

 

 

 

163,880

 

Unrealized gain on interest rate swaps, net

   of tax

 

 

 

 

 

 

 

 

 

 

 

 

 

 

15,504

 

 

 

 

 

 

15,504

 

Foreign currency translation loss

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(30,900

)

 

 

 

 

 

(30,900

)

Unit vesting and amortization of unit-based

   compensation

 

 

17

 

 

 

123

 

 

 

1,724

 

 

 

12,141

 

 

 

 

 

 

 

 

 

12,264

 

Distributions to non-controlling interests

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(193

)

 

 

(193

)

Proceeds from offering (net of offering

   costs)

 

 

399

 

 

 

7,792

 

 

 

39,550

 

 

 

771,449

 

 

 

 

 

 

 

 

 

779,241

 

Distributions declared ($0.28 per unit)

 

 

 

 

 

(1,634

)

 

 

 

 

 

(161,809

)

 

 

 

 

 

 

 

 

(163,443

)

Balance at March 31, 2021

 

 

5,830

 

 

$

81,896

 

 

 

577,279

 

 

$

8,100,195

 

 

$

(66,720

)

 

$

5,229

 

 

$

8,120,600

 

Net income

 

 

 

 

 

1,146

 

 

 

 

 

 

113,419

 

 

 

 

 

 

256

 

 

 

114,821

 

Unrealized gain on interest rate swaps, net

   of tax

 

 

 

 

 

 

 

 

 

 

 

 

 

 

4,207

 

 

 

 

 

 

4,207

 

Foreign currency translation gain

 

 

 

 

 

 

 

 

 

 

 

 

 

 

9,014

 

 

 

 

 

 

9,014

 

Unit vesting and amortization of unit-based

   compensation

 

 

2

 

 

 

128

 

 

 

174

 

 

 

12,643

 

 

 

 

 

 

 

 

 

12,771

 

Distributions to non-controlling interests

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(142

)

 

 

(142

)

Proceeds from offering (net of offering

   costs)

 

 

58

 

 

 

1,213

 

 

 

5,621

 

 

 

120,120

 

 

 

 

 

 

 

 

 

121,333

 

Distributions declared ($0.28 per unit)

 

 

 

 

 

(1,651

)

 

 

 

 

 

(163,482

)

 

 

 

 

 

 

 

 

(165,133

)

Balance at June 30, 2021

 

 

5,890

 

 

$

82,732

 

 

 

583,074

 

 

$

8,182,895

 

 

$

(53,499

)

 

$

5,343

 

 

$

8,217,471

 

Net income

 

 

 

 

 

1,711

 

 

 

 

 

 

169,426

 

 

 

 

 

 

258

 

 

 

171,395

 

Unrealized gain on interest rate swaps, net

   of tax

 

 

 

 

 

 

 

 

 

 

 

 

 

 

8,847

 

 

 

 

 

 

8,847

 

Foreign currency translation loss

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(25,191

)

 

 

 

 

 

(25,191

)

Unit vesting and amortization of unit-based

   compensation

 

 

2

 

 

 

136

 

 

 

216

 

 

 

13,419

 

 

 

 

 

 

 

 

 

13,555

 

Distributions to non-controlling interests

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(202

)

 

 

(202

)

Proceeds from offering (net of offering

   costs)

 

 

70

 

 

 

1,405

 

 

 

6,893

 

 

 

139,075

 

 

 

 

 

 

 

 

 

140,480

 

Distributions declared ($0.28 per unit)

 

 

 

 

 

(1,672

)

 

 

 

 

 

(165,559

)

 

 

 

 

 

 

 

 

(167,231

)

Balance at September 30, 2021

 

 

5,962

 

 

$

84,312

 

 

 

590,183

 

 

$

8,339,256

 

 

$

(69,843

)

 

$

5,399

 

 

$

8,359,124

 

 

See accompanying notes to condensed consolidated financial statements.

12


 

MPT OPERATING PARTNERSHIP, L.P. AND SUBSIDIARIES

Condensed Consolidated Statements of Capital

(Unaudited)

 

 

 

General

 

 

Limited Partners

 

 

Accumulated

 

 

 

 

 

 

 

 

 

 

 

Partner

 

 

Common

 

 

LTIPs

 

 

Other

 

 

Non-

 

 

 

 

 

(In thousands, except per unit amounts)

 

Units

 

 

Unit

Value

 

 

Units

 

 

Unit

Value

 

 

Units

 

 

Unit

Value

 

 

Comprehensive

Loss

 

 

Controlling

Interests

 

 

Total

Capital

 

Balance at December 31, 2019

 

 

5,176

 

 

$

70,939

 

 

 

512,346

 

 

$

7,020,403

 

 

 

232

 

 

$

 

 

$

(62,905

)

 

$

107

 

 

$

7,028,544

 

Net income

 

 

 

 

 

810

 

 

 

 

 

 

80,182

 

 

 

 

 

 

 

 

 

 

 

 

165

 

 

 

81,157

 

Cumulative effect of change in accounting

   principles

 

 

 

 

 

(84

)

 

 

 

 

 

(8,315

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(8,399

)

Unrealized loss on interest rate swaps, net

   of tax

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(25,103

)

 

 

 

 

 

(25,103

)

Foreign currency translation loss

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(23,272

)

 

 

 

 

 

(23,272

)

Unit vesting and amortization of unit-based

   compensation

 

 

23

 

 

 

100

 

 

 

2,289

 

 

 

9,936

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

10,036

 

Distributions to non-controlling interests

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(165

)

 

 

(165

)

Proceeds from offering (net of offering

   costs)

 

 

26

 

 

 

617

 

 

 

2,575

 

 

 

61,065

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

61,682

 

Distributions declared ($0.27 per unit)

 

 

 

 

 

(1,416

)

 

 

 

 

 

(140,164

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(141,580

)

Balance at March 31, 2020

 

 

5,225

 

 

$

70,966

 

 

 

517,210

 

 

$

7,023,107

 

 

 

232

 

 

$

 

 

$

(111,280

)

 

$

107

 

 

$

6,982,900

 

Net income

 

 

 

 

 

1,095

 

 

 

 

 

 

108,373

 

 

 

 

 

 

 

 

 

 

 

 

184

 

 

 

109,652

 

Unrealized loss on interest rate swaps, net

   of tax

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(7,908

)

 

 

 

 

 

(7,908

)

Foreign currency translation gain

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

6,175

 

 

 

 

 

 

6,175

 

Unit vesting and amortization of unit-based

   compensation

 

 

2

 

 

 

122

 

 

 

187

 

 

 

12,070

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

12,192

 

Distributions to non-controlling interests

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(185

)

 

 

(185

)

Proceeds from offering (net of offering

   costs)

 

 

60

 

 

 

1,081

 

 

 

5,957

 

 

 

107,024

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

108,105

 

Distributions declared ($0.27 per unit)

 

 

 

 

 

(1,433

)

 

 

 

 

 

(141,831

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(143,264

)

Balance at June 30, 2020

 

 

5,287

 

 

$

71,831

 

 

 

523,354

 

 

$

7,108,743

 

 

 

232

 

 

$

 

 

$

(113,013

)

 

$

106

 

 

$

7,067,667

 

Net income

 

 

 

 

 

1,311

 

 

 

 

 

 

129,795

 

 

 

 

 

 

 

 

 

 

 

 

251

 

 

 

131,357

 

Unrealized loss on interest rate swaps, net

   of tax

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(2,624

)

 

 

 

 

 

(2,624

)

Foreign currency translation gain

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

19,983

 

 

 

 

 

 

19,983

 

Unit vesting and amortization of unit-based

   compensation

 

 

2

 

 

 

124

 

 

 

186

 

 

 

12,248

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

12,372

 

Sale of non-controlling interests

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

5,073

 

 

 

5,073

 

Distributions to non-controlling interests

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(194

)

 

 

(194

)

Proceeds from offering (net of offering

   costs)

 

 

67

 

 

 

1,246

 

 

 

6,678

 

 

 

123,341

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

124,587

 

Distributions declared ($0.27 per unit)

 

 

 

 

 

(1,450

)

 

 

 

 

 

(143,504

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(144,954

)

Balance at September 30, 2020

 

 

5,356

 

 

$

73,062

 

 

 

530,218

 

 

$

7,230,623

 

 

$

232

 

 

$

 

 

$

(95,654

)

 

$

5,236

 

 

$

7,213,267

 

 

 

See accompanying notes to condensed consolidated financial statements.

13


 

MPT OPERATING PARTNERSHIP, L.P. AND SUBSIDIARIES

Condensed Consolidated Statements of Cash Flows

(Unaudited)

 

 

 

For the Nine Months

Ended September 30,

 

 

 

2021

 

 

2020

 

 

 

(In thousands)

 

Operating activities

 

 

 

 

 

 

 

 

Net income

 

$

450,096

 

 

$

322,166

 

Adjustments to reconcile net income to net cash provided by operating activities:

 

 

 

 

 

 

 

 

Depreciation and amortization

 

 

246,117

 

 

 

200,807

 

Amortization of deferred financing costs and debt discount

 

 

12,079

 

 

 

9,773

 

Straight-line rent revenue and other

 

 

(208,756

)

 

 

(161,163

)

Unit-based compensation

 

 

38,590

 

 

 

34,600

 

(Gain) loss from sale of real estate

 

 

(8,896

)

 

 

2,703

 

Impairment charges

 

 

 

 

 

19,006

 

Straight-line rent and other (recovery) write-off

 

 

(1,601

)

 

 

27,098

 

Debt refinancing and unutilized financing costs

 

 

2,339

 

 

 

611

 

Pre-acquisition rent collected - Circle Transaction

 

 

 

 

 

(35,020

)

Tax rate and other changes

 

 

42,746

 

 

 

9,661

 

Other adjustments

 

 

15,468

 

 

 

(6,418

)

Changes in:

 

 

 

 

 

 

 

 

Interest and rent receivables

 

 

(19,150

)

 

 

(6,189

)

Other assets

 

 

516

 

 

 

12,117

 

Accounts payable and accrued expenses

 

 

25,527

 

 

 

(21,139

)

Deferred revenue

 

 

(17,588

)

 

 

33,605

 

Net cash provided by operating activities

 

 

577,487

 

 

 

442,218

 

Investing activities

 

 

 

 

 

 

 

 

Cash paid for acquisitions and other related investments

 

 

(4,279,147

)

 

 

(3,524,910

)

Net proceeds from sale of real estate

 

 

66,891

 

 

 

93,042

 

Principal received on loans receivable

 

 

1,234,839

 

 

 

738,036

 

Return of equity investment

 

 

11,000

 

 

 

63,122

 

Capital additions and other investments, net

 

 

(253,512

)

 

 

(116,297

)

Net cash used for investing activities

 

 

(3,219,929

)

 

 

(2,747,007

)

Financing activities

 

 

 

 

 

 

 

 

Proceeds from term debt, net of discount

 

 

2,489,735

 

 

 

915,950

 

Payments of term debt

 

 

(689,450

)

 

 

 

Revolving credit facilities, net

 

 

80,963

 

 

 

225,000

 

Distributions paid

 

 

(476,242

)

 

 

(423,005

)

Lease deposits and other obligations to tenants

 

 

14,819

 

 

 

7,584

 

Proceeds from sale of units, net of offering costs

 

 

1,041,054

 

 

 

294,374

 

Payment of debt refinancing, deferred financing costs, and other financing activities

 

 

(24,245

)

 

 

(2,143

)

Net cash provided by financing activities

 

 

2,436,634

 

 

 

1,017,760

 

Decrease in cash, cash equivalents, and restricted cash for period

 

 

(205,808

)

 

 

(1,287,029

)

Effect of exchange rate changes

 

 

1,748

 

 

 

9,116

 

Cash, cash equivalents, and restricted cash at beginning of period

 

 

556,369

 

 

 

1,467,991

 

Cash, cash equivalents, and restricted cash at end of period

 

$

352,309

 

 

$

190,078

 

Interest paid

 

$

256,724

 

 

$

231,257

 

Supplemental schedule of non-cash financing activities:

 

 

 

 

 

 

 

 

Distributions declared, unpaid

 

$

167,231

 

 

$

144,954

 

Cash, cash equivalents, and restricted cash are comprised of the following:

 

 

 

 

 

 

 

 

Beginning of period:

 

 

 

 

 

 

 

 

Cash and cash equivalents

 

$

549,884

 

 

$

1,462,286

 

Restricted cash, included in Other assets

 

 

6,485

 

 

 

5,705

 

 

 

$

556,369

 

 

$

1,467,991

 

End of period:

 

 

 

 

 

 

 

 

Cash and cash equivalents

 

$

349,652

 

 

$

183,794

 

Restricted cash, included in Other assets

 

 

2,657

 

 

 

6,284

 

 

 

$

352,309

 

 

$

190,078

 

 

See accompanying notes to condensed consolidated financial statements.

14


 

MEDICAL PROPERTIES TRUST, INC. AND MPT OPERATING PARTNERSHIP, L.P.

AND SUBSIDIARIES

Notes to Condensed Consolidated Financial Statements

(Unaudited)

1. Organization

Medical Properties Trust, Inc., a Maryland corporation, was formed on August 27, 2003, under the Maryland General Corporation Law for the purpose of engaging in the business of investing in, owning, and leasing healthcare real estate. Our operating partnership subsidiary, MPT Operating Partnership, L.P. (the “Operating Partnership”), through which we conduct all of our operations, was formed in September 2003. At present, we own all of the partnership interests in the Operating Partnership and have elected to report our required disclosures and that of the Operating Partnership on a combined basis, except where material differences exist.

We operate as a real estate investment trust (“REIT”). Accordingly, we will generally not be subject to United States (“U.S.”) federal income tax, provided that we continue to qualify as a REIT and our distributions to our stockholders equal or exceed our taxable income. Certain non-real estate activities we undertake are conducted by entities which we elected to be treated as taxable REIT subsidiaries (“TRS”). Our TRS entities are subject to both U.S. federal and state income taxes. For our properties located outside the U.S., we are subject to the local taxes of the jurisdictions where our properties reside and/or legal entities are domiciled; however, we do not expect to incur additional taxes in the U.S. from foreign-based income as the majority of such income flows through our REIT.

Our primary business strategy is to acquire and develop real estate and improvements, primarily for long-term lease to providers of healthcare services, such as operators of general acute care hospitals, inpatient physical rehabilitation hospitals, behavioral health facilities, long-term acute care hospitals, and freestanding ER/urgent care facilities. We also make mortgage and other loans to operators of similar facilities. In addition, we may obtain profits or equity interests in our tenants, from time-to-time, in order to enhance our overall return.

Our business model facilitates acquisitions and recapitalizations, and allows operators of healthcare facilities to unlock the value of their real estate to fund facility improvements, technology upgrades, and other investments in operations. At September 30, 2021, we have investments in 426 facilities in 32 states in the U.S., in six countries in Europe, one country in South America, and across Australia. We manage our business as a single business segment.

2. Summary of Significant Accounting Policies

Unaudited Interim Condensed Consolidated Financial Statements: The accompanying unaudited interim condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the U.S. for interim financial information, including rules and regulations of the Securities and Exchange Commission (“SEC”). Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles (“GAAP”) for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair statement have been included. Operating results for the three and nine months ended September 30, 2021, are not necessarily indicative of the results that may be expected for the year ending December 31, 2021. The condensed consolidated balance sheet at December 31, 2020 has been derived from the audited financial statements at that date but does not include all of the information and footnotes required by accounting principles generally accepted in the U.S. for complete financial statements.

The preparation of our condensed consolidated financial statements in conformity with GAAP requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. We believe the estimates and assumptions underlying our condensed consolidated financial statements are reasonable and supportable based on the information available as of September 30, 2021 (particularly as it relates to our assessments of the recoverability of our real estate and the adequacy of our credit loss reserves on loans and financing receivables). Although COVID-19 vaccines continue to roll out worldwide and hospitals around the world have generally returned to their normal operations, the ultimate impact to our tenants’ results of operations and liquidity and their ability to pay our rent and interest due to the impact of COVID-19 and related variants cannot be predicted with 100% confidence. This makes any estimates and assumptions as of September 30, 2021 inherently less certain than they would be absent the potential impact of COVID-19. Actual results may ultimately differ from our estimates.

 

 

15


 

 

For information about significant accounting policies, refer to the consolidated financial statements and footnotes thereto included in our Annual Report on Form 10-K for the year ended December 31, 2020. There have been no material changes to these significant accounting policies other than the following:

Recent Accounting Developments

Reference Rate Reform

In March 2020, the Financial Accounting Standards Board (“FASB”) issued ASU No. 2020-04, “Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting” (“ASU 2020-04”) to simplify the accounting for contract modifications made to replace LIBOR or other reference rates that are expected to be discontinued because of reference rate reform. The guidance provides optional expedients and exceptions for applying GAAP to contracts, hedging relationships, and other transactions affected by reference rate reform if certain criterion are met. The optional expedients and exceptions can be applied to contract modifications made until December 31, 2022. On January 7, 2021, the FASB issued ASU No. 2021-01, “Reference Rate Reform (Topic 848)” (“ASU 2021-01”), which clarifies that certain optional expedients and exceptions in Topic 848 for contract modifications and hedge accounting apply to derivatives that are affected by the transition. We have evaluated our contracts that are referenced to LIBOR or other reference rates expected to be discontinued. We expect our British pound sterling term loan and corresponding interest rate swap to be modified with a replacement reference rate during the fourth quarter of 2021, and we expect to account for such modifications using the expedients and exceptions provided for in ASU 2020-04 and ASU 2021-01. We are continuing to evaluate the need to modify our U.S. dollar LIBOR contracts, such as our unsecured credit facility, but the requirement to replace the U.S. dollar LIBOR has been extended to June 30, 2023. Moreover, we do not expect any impact to our Australian dollar term loan and corresponding interest rate swap, as these contracts are not referenced to rates that are expected to be discontinued.

Reclassifications

Certain amounts in the condensed consolidated financial statements for prior periods have been reclassified to conform to the current period presentation.

Variable Interest Entities

At September 30, 2021, we had loans and/or equity investments in certain variable interest entities approximating $360 million, which represents our maximum exposure to loss as a result of our involvement in such entities. We have determined that we were not the primary beneficiary of any variable interest entity in which we hold a variable interest because we do not control the activities (such as the day-to-day operations) that most significantly impact the economic performance of these entities.

3. Real Estate and Other Activities

New Investments

We acquired or invested in the following net assets (in thousands):

 

 

 

For the Nine Months

Ended September 30,

 

 

 

2021

 

 

2020

 

 

 

 

 

 

 

 

 

 

Land and land improvements

 

$

562,742

 

 

$

330,941

 

Buildings

 

 

1,670,741

 

 

 

2,610,197

 

Intangible lease assets — subject to amortization (weighted-average useful

   life of 36.1 years for 2021 and 27.6 years for 2020)

 

 

197,735

 

 

 

364,006

 

Equity investments

 

 

108,710

 

 

 

 

Mortgage loans

 

 

1,090,400

 

 

 

47,641

 

Other loans and assets

 

 

736,936

 

 

 

306,328

 

Liabilities assumed

 

 

(65,525

)

 

 

(134,203

)

Total assets acquired

 

 

4,301,739

 

 

 

3,524,910

 

Loans repaid(1)

 

 

(1,090,400

)

 

 

(737,242

)

Total net assets acquired

 

$

3,211,339

 

 

$

2,787,668

 

 

 

(1)

The 2021 column includes an £800 million mortgage loan advanced to the Priory Group (“Priory”) in the first quarter of 2021 and converted to fee simple ownership in a portfolio of 35 properties in the second quarter of 2021 as described below. The 2020 column includes $737 million of loans advanced to Steward Health Care, Inc. (“Steward”) in 2017 and exchanged for the fee simple real estate of two hospitals as described below.

16


 

 

2021 Activity

Priory Group Transaction

On January 19, 2021, we completed the first of two phases in the Priory transaction in which we funded an £800 million interim mortgage loan on an identified portfolio of Priory real estate assets in the United Kingdom. On June 25, 2021, we completed the second phase of the transaction in which we converted this mortgage loan to fee simple ownership in a portfolio of 35 select real estate assets from Priory (which is currently owned by Waterland Private Equity Fund VII C.V. (“Waterland VII”)) in individual sale-and-leaseback transactions. The applicable purchase price for the assets was paid by us by proportionally converting and reducing the principal balance of the interim mortgage loan we made to Waterland VII in phase one. Therefore, the net aggregate purchase price for the real estate assets we acquired from Priory was approximately £800 million, plus customary stamp duty, tax, and other transaction costs. As part of the real estate acquisition (for which some of the assets were acquired by the share purchase of real estate holding entities), we incurred deferred income tax liabilities of approximately £47.1 million.

In addition to the real estate investment, on January 19, 2021, we made a £250 million acquisition loan to Waterland VII, in connection with the closing of Waterland VII’s acquisition of Priory, which was repaid in full plus interest on October 22, 2021.

Finally, we also acquired a 9.9% passive equity interest in the Waterland VII affiliate that indirectly owns Priory.

We funded this total investment using £500 million from an interim credit facility that was originated in January 2021, as described in Note 4, £350 million from our revolving facility, and the remainder from cash on-hand.

Other

On August 1, 2021, we completed the acquisition of five general acute care hospitals located in South Florida for approximately $900 million, plus closing and other transaction costs. These hospitals are leased to Steward pursuant to the master lease, with annual inflation-based escalators, that was recently extended by 10 years to 2041. We funded this acquisition with cash on-hand and $650 million of borrowings from an interim credit facility that was originated in July 2021 as described in Note 4.

On July 6, 2021, we acquired four acute care hospitals and two on-campus medical office buildings in Los Angeles, California for $215 million. These hospitals are leased to Pipeline Health Systems pursuant to a long-term lease with annual inflation-based escalators.

On July 6, 2021, we also acquired an acute care hospital in Stirling, Scotland for £15.6 million. This hospital is leased to Circle Health Ltd. (“Circle”) pursuant to a long-term lease with annual inflation-based escalators.

On April 16, 2021, we made a CHF 145 million investment in Swiss Medical Network, our tenant via our Infracore SA (“Infracore”) equity investment.

On January 8, 2021, we made a $335 million loan to affiliates of Steward, all of the proceeds of which were used to redeem a similarly sized convertible loan from Steward’s former private equity sponsor.

2020 Activity

Circle Transaction

On January 8, 2020, we acquired a portfolio of 30 acute care hospitals located throughout the United Kingdom for approximately £1.5 billion from affiliates of BMI Healthcare, Inc. (“BMI”). In a related transaction, affiliates of Circle entered into definitive agreements to acquire BMI and assume its operations in the United Kingdom subject to customary regulatory conditions. As part of our acquisition, we inherited 30 existing leases with the operator that had initial fixed terms ending in 2050, with no renewal options but with annual inflation-based escalators. Once final regulatory approval was received in the 2020 second quarter, these 30 leases with Circle were amended (effective June 16, 2020) to include two five-year renewal options and improve the annual inflation-based escalators. These 30 leases are cross-defaulted and guaranteed by Circle.

Other

On August 13, 2020, we acquired a general acute care hospital in Lynwood, California for a total investment of approximately $300 million. This property is leased to Prime Healthcare Services, Inc. (“Prime”) pursuant to a long-term master lease with annual escalations and multiple extension options.

On July 8, 2020, we acquired the fee simple real estate of two general acute care hospitals located in the Salt Lake City, Utah area, Davis Hospital & Medical Center and Jordan Valley Medical Center, in exchange for the reduction of the mortgage loans made to Steward for such properties and additional cash consideration of $200 million based on their relative fair value. The approximate $950 million investment in these two facilities is subject to the Steward master lease.

On June 24, 2020, we originated a CHF 45 million secured loan to Infracore, which was paid in full on December 2, 2020.

17


 

On May 13, 2020, we formed a joint venture for the purpose of investing in the operations of international hospitals. As part of the formation, we originated a $205 million acquisition loan. We have a 49% interest in this joint venture and are accounting for our investment using the fair value option election. The joint venture simultaneously purchased from Steward the rights and existing assets related to all present and future international opportunities previously owned by Steward for strategic, regulatory, and risk management purposes.

Other acquisitions throughout the first nine months of 2020 included one inpatient rehabilitation hospital and one general acute care hospital totaling approximately $56 million.

Development Activities

 

See table below for a status summary of our current development projects (in thousands):

 

Property

 

Commitment

 

 

Costs

Incurred as of

September 30, 2021

 

 

Estimated Rent

Commencement

Date

Ernest (Bakersfield, California)

 

$

47,929

 

 

$

39,544

 

 

4Q 2021

Ernest (Stockton, California)

 

 

47,700

 

 

 

24,990

 

 

2Q 2022

 

 

$

95,629

 

 

$

64,534

 

 

 

During the 2020 second quarter, we completed construction on one general acute care facility and one inpatient rehabilitation facility, both located in Birmingham, England. We began recognizing revenue on these two properties on June 29, 2020. These facilities are being leased to Circle pursuant to a long-term lease.

During the 2020 first quarter, we completed construction and began recording rental income on a general acute care facility located in Idaho Falls, Idaho. This facility commenced rent on January 21, 2020 and is being leased to Surgery Partners, Inc. pursuant to an existing long-term lease.

Disposals

2021 Activity

Joint Venture Transaction

On August 28, 2021, we entered into a definitive agreement with Macquarie Asset Management (“MAM”) to form a partnership (the “Macquarie Transaction”), pursuant to which a fund managed by MAM will acquire, for cash consideration, a 50% interest in a portfolio of eight Massachusetts-based general acute care hospitals that we currently own and lease to Steward. The transaction values the portfolio at approximately $1.8 billion. We expect to recognize a gain, net of transaction costs, of approximately $0.6 billion from this transaction, which we expect to close by the 2022 first quarter.

The partnership plans to raise nonrecourse secured debt of up to 55% of asset value, and we expect to receive total proceeds, including proceeds from the expected secured debt, of approximately $1.3 billion. There is no certainty as to the amount or terms of expected secured debt financing, and the ultimate amount and terms may affect the transaction value, proceeds, and gain on real estate. At September 30, 2021, the eight facilities subject to the joint venture were designated as held for sale and included the following net assets (in thousands):

 

 

As of September 30, 2021

 

Real estate held for sale

 

$

1,096,475

 

Straight-line rent receivables

 

 

113,923

 

Other assets, net

 

 

5,917

 

Total

 

$

1,216,315

 

Other

During the first nine months of 2021, we completed the sale of nine facilities and an ancillary property for approximately $67 million, resulting in a net gain on real estate of approximately $9 million.

2020 Activity

During the first nine months of 2020, we completed the disposition of nine facilities and six ancillary properties for approximately $93 million. The transactions resulted in a net loss on real estate of $2.7 million.

18


 

Leasing Operations (Lessor)

We acquire and develop healthcare facilities and lease the facilities to healthcare operating companies under long-term net leases (typical initial fixed terms of at least 15 years) and most include renewal options at the election of our tenants, generally in five year increments. Approximately 99% of our leases provide annual rent escalations based on increases in the Consumer Price Index (or similar index outside the U.S.) and/or fixed minimum annual rent escalations. Many of our domestic leases contain purchase options with pricing set at various terms but in no case less than our total investment. For five properties with a carrying value of $231 million, our leases require a residual value guarantee from the tenant. Our leases typically require the tenant to handle and bear most of the costs associated with our properties including repair/maintenance, property taxes, and insurance. We routinely inspect our properties to ensure the residual value of each of our assets is being maintained. Except for leases classified as financing leases as noted below, all of our leases are classified as operating leases.

At September 30, 2021, leases on 13 Ernest Health, Inc. (“Ernest”) facilities and five Prime facilities are accounted for as direct financing leases and leases on 13 of our Prospect Medical Holdings, Inc. (“Prospect”) facilities and five of our Ernest facilities are accounted for as a financing. The components of our total investment in financing leases consisted of the following (in thousands):

 

 

 

As of September 30,

2021

 

 

As of December 31,

2020

 

Minimum lease payments receivable

 

$

1,195,133

 

 

$

1,228,966

 

Estimated residual values

 

 

203,818

 

 

 

203,818

 

Less: Unearned income and allowance for credit loss

 

 

(931,275

)

 

 

(969,061

)

Net investment in direct financing leases

 

 

467,676

 

 

 

463,723

 

Other financing leases (net of allowance for credit loss)

 

 

1,574,909

 

 

 

1,547,199

 

Total investment in financing leases

 

$

2,042,585

 

 

$

2,010,922

 

 

COVID-19 Rent Deferrals

In the first nine months of 2021, we collected $2.2 million of rent previously deferred due to the COVID-19 pandemic. Pursuant to our agreements with certain tenants, we expect the remaining outstanding deferred rent balance of approximately $9.2 million as of September 30, 2021, to be paid over specified periods in the future, with interest.

Adeptus Health

As discussed in previous filings, our original real estate portfolio of approximately 60 properties leased to Adeptus Health, Inc. (“Adeptus”) has gone through significant changes starting with Adeptus filing for Chapter 11 bankruptcy in 2017. During 2020, we transitioned the remaining facilities away from Adeptus, which resulted in impairment charges including approximately $9.9 million in the first half of 2020, along with a charge to writeoff straight-line rent and other receivables, partially offset by a draw on a $9.1 million letter of credit. However, these transition measures have also provided for new tenant relationships being formed with strong credit worthy operators like Ochsner Health System, Dignity Health, UC Health (University of Colorado), and HCA Healthcare, Inc. (“HCA”), that are now leasing approximately 40 of these transitional facilities under long-term leases. At September 30, 2021, 11 of these transitional properties, representing less than 1% of our total assets, remain vacant, and each of these properties are in various stages of being re-leased or sold. At September 30, 2021, we believe our investment in these real estate assets are fully recoverable, but no assurances can be given that we will not have any further impairments in future periods.

Alecto Facilities

As noted in previous filings, we originally leased four acute care facilities to and had a mortgage loan on a fifth property (Olympia Medical Center) with Alecto Healthcare Services LLC (“Alecto”). During the first quarter of 2020, we donated the Wheeling facility to a local municipality, resulting in a $9.1 million real estate impairment charge. In addition, we re-leased one acute care facility and sold another facility in 2020. In the first quarter of 2021, Alecto completed the sale of Olympia Medical Center to the UCLA Health System. Our proceeds of approximately $51 million from this sale were used to pay off the mortgage and working capital loans in full, with the remaining proceeds used to recover certain previously reserved past due receivables. At September 30, 2021, we continue to lease one acute care facility to Alecto representing less than 0.1% of our total assets.

Loans

The following is a summary of our loans (net of allowance for credit loss) (in thousands):

 

 

 

As of September 30,

2021

 

 

As of December 31,

2020

 

Mortgage loans

 

$

200,285

 

 

$

248,080

 

Acquisition loans

 

 

676,042

 

 

 

338,273

 

Other loans

 

 

826,635

 

 

 

520,095

 

Total

 

$

1,702,962

 

 

$

1,106,448

 

19


 

 

 

The increase in acquisition loans relates to the £250 million loan funded in connection with the Priory Group Transaction (as more fully described above in Note 3).

 

Other loans consist of loans to our tenants for working capital and other purposes and include our shareholder loan made in 2018 to the joint venture with Primotop Holdings S.à.r.l. in the amount of €297 million. The increase in other loans is primarily related to the $335 million loan to affiliates of Steward (as more fully described above in this Note 3), partially offset by the repayment of $75 million in other loans from Prime.

Other Investment Activities

Pursuant to our existing 9.9% equity interest in Steward, we received an $11 million cash distribution during the first quarter of 2021, which was accounted for as a return of capital.

Pursuant to our 4.9% stake in Aevis Victoria SA (“Aevis”), we recorded a $2.8 million favorable non-cash fair value adjustment to mark our investment in Aevis stock to market during the first nine months of 2021; whereas, this was a $5.2 million unfavorable non-cash fair value adjustment for the same period of 2020.

Concentrations of Credit Risk

We monitor concentration risk in several ways due to the nature of our real estate assets that are vital to the communities in which they are located and given our history of being able to replace inefficient operators of our facilities, if needed, with more effective operators:

 

1)

Facility concentration – At September 30, 2021, our largest single property represented approximately 3% of our total assets, similar to December 31, 2020.

 

2)

Operator concentration – For the three and nine months ended September 30, 2021, revenue from Steward and Circle, individually, represented more than 10% of our total revenues. In comparison, Steward, Prospect, Circle, and Prime, individually, represented more than 10% of our total revenues for the three and nine months ended September 30, 2020.

 

3)

Geographic concentration – At September 30, 2021, investments in the U.S., Europe, Australia, and South America represented approximately 65%, 29%, 5%, and 1%, respectively, of our total assets, compared to 65%, 28%, 6%, and 1%, respectively, at December 31, 2020.

 

4)

Facility type concentration – For the three and nine months ended September 30, 2021 and 2020, approximately 80% of our revenues were generated from our general acute care facilities, while revenues from our rehabilitation facilities approximated 10% for each period. Revenues from our behavioral health, freestanding ER/urgent care, and long-term acute care facilities combined to make up approximately 10% of our revenues for all periods presented.


20


 

 

4. Debt

The following is a summary of debt (amounts in thousands):

 

 

 

As of September 30,

2021

 

 

As of December 31,

2020

 

Revolving credit facility(A)

 

$

245,227

 

 

$

165,407

 

Interim credit facilities

 

 

650,000

 

 

 

 

Term loan

 

 

200,000

 

 

 

200,000

 

British pound sterling term loan(B)

 

 

943,180

 

 

 

956,900

 

Australian term loan facility(B)

 

 

867,240

 

 

 

923,280

 

4.000% Senior Unsecured Notes due 2022(B)

 

 

579,000

 

 

 

610,800

 

2.550% Senior Unsecured Notes due 2023(B)

 

 

538,960

 

 

 

546,800

 

3.325% Senior Unsecured Notes due 2025(B)

 

 

579,000

 

 

 

610,800

 

2.500% Senior Unsecured Notes due 2026(B)

 

 

673,700

 

 

 

 

5.250% Senior Unsecured Notes due 2026

 

 

500,000

 

 

 

500,000

 

5.000% Senior Unsecured Notes due 2027

 

 

1,400,000

 

 

 

1,400,000

 

3.692% Senior Unsecured Notes due 2028(B)

 

 

808,440

 

 

 

820,200

 

4.625% Senior Unsecured Notes due 2029

 

 

900,000

 

 

 

900,000

 

3.375% Senior Unsecured Notes due 2030(B)

 

 

471,590

 

 

 

 

3.500% Senior Unsecured Notes due 2031

 

 

1,300,000

 

 

 

1,300,000

 

 

 

$

10,656,337

 

 

$

8,934,187

 

Debt issue costs and discount, net

 

 

(75,314

)

 

 

(68,729

)

 

 

$

10,581,023

 

 

$

8,865,458

 

 

 

(A)

Includes £182 million and £121 million of GBP-denominated borrowings that reflect the exchange rate at September 30, 2021 and December 31, 2020, respectively.

 

(B)

Non-U.S. dollar denominated debt reflects the exchange rate at September 30, 2021 and December 31, 2020.

As of September 30, 2021, principal payments due on our debt (which exclude the effects of any discounts, premiums, or debt issue costs recorded) are as follows (amounts in thousands):

 

2021

 

$

 

2022

 

 

1,229,000

 

2023

 

 

538,960

 

2024

 

 

1,112,467

 

2025

 

 

1,522,180

 

Thereafter

 

 

6,253,730

 

Total

 

$

10,656,337

 

2021 Activity

Interim Credit Facilities

July 2021 Interim Credit Facility

On July 27, 2021, we entered into a $1 billion interim credit facility with Barclays Bank PLC as administrative agent (“July 2021 Interim Credit Facility”), and several lenders from time-to-time are parties thereto. This facility matures on July 28, 2022 and bears interest at a variable rate. As previously discussed in Note 3, we used $650 million of this facility to acquire the five South Florida facilities in August 2021. At September 30, 2021, the outstanding balance under this facility remains $650 million at a rate of 1.340%.

January 2021 Interim Credit Facility

As previously discussed in Note 3, we entered into a $900 million interim credit facility on January 15, 2021 (“January 2021 Interim Credit Facility”), of which we borrowed £500 million. We paid off and terminated this facility on March 26, 2021.

21


 

Credit Facility Amendment

On January 15, 2021, we amended our unsecured credit facility (“Credit Facility”). The amendment extended the maturity of our $1.3 billion revolving facility to February 1, 2024 and can be extended for an additional 12 months at our option. The maturity date of our $200 million unsecured term loan facility was extended to February 1, 2026.

In addition to extending the maturity date, the amendment improved interest rate pricing for both facilities. Under the amended Credit Facility and at our election, loans may be made as either ABR Loans or Eurocurrency Loans. The applicable margin for term loans that are ABR Loans is adjustable on a sliding scale from 0.00% to 0.85% based on our current credit rating. The applicable margin for term loans that are Eurocurrency Loans is adjustable on a sliding scale from 0.85% to 1.85% based on our current credit rating. The applicable margin for revolving loans that are ABR Loans is adjustable on a sliding scale from 0.00% to 0.55% based on our current credit rating. The applicable margin for revolving loans that are Eurocurrency Loans is adjustable on a sliding scale from 0.825% to 1.55% based on our current credit rating. The amended Credit Facility retained the facility fee that is adjustable on a sliding scale from 0.125% to 0.30% based on our current credit rating and is payable on the revolving loan facility.

Senior Unsecured Notes

On March 24, 2021, we completed an £850 million senior unsecured notes offering in two tranches. See below for details of each tranche:

2.500% Senior Unsecured Notes due 2026

On March 24, 2021, we completed a £500 million senior unsecured notes offering. The notes were issued at 99.937% of par value, and interest on the notes is payable annually on March 24 of each year, commencing on March 24, 2022. The notes pay interest in cash at a rate of 2.500% and mature on March 24, 2026.

3.375% Senior Unsecured Notes due 2030

On March 24, 2021, we completed a £350 million senior unsecured notes offering. The notes were issued at 99.448% of par value, and interest on the notes is payable annually on April 24 of each year, commencing on April 24, 2022. The notes pay interest in cash at a rate of 3.375% and mature on April 24, 2030.

We used proceeds from the £850 million senior unsecured notes offering to payoff the January 2021 Interim Credit Facility and reduce our revolving facility by approximately £340 million on March 26, 2021.

2020 Activity

British Pound Sterling Term Loan

On January 6, 2020, we entered into a £700 million unsecured sterling-denominated term loan to help finance the Circle Transaction as described in Note 3.

Debt Refinancing and Unutilized Financing Costs

With the amendment of our Credit Facility and the termination of our January 2021 Interim Credit Facility, we incurred approximately $2.3 million of debt refinancing costs in the first nine months of 2021.

Covenants

Our debt facilities impose certain restrictions on us, including restrictions on our ability to: incur debts; create or incur liens; provide guarantees in respect of obligations of any other entity; make redemptions and repurchases of our capital stock; prepay, redeem, or repurchase debt; engage in mergers or consolidations; enter into affiliated transactions; dispose of real estate or other assets; and change our business. In addition, the credit agreements governing our Credit Facility limit the amount of dividends we can pay as a percentage of normalized adjusted funds from operations (“NAFFO”), as defined in the agreements, on a rolling four quarter basis. At September 30, 2021, the dividend restriction was 95% of NAFFO. The indentures governing our senior unsecured notes also limit the amount of dividends we can pay based on the sum of 95% of NAFFO, proceeds of equity issuances, and certain other net cash proceeds. Finally, our senior unsecured notes require us to maintain total unencumbered assets (as defined in the related indenture) of not less than 150% of our unsecured indebtedness.

22


 

In addition to these restrictions, the Credit Facility contains customary financial and operating covenants, including covenants relating to our total leverage ratio, fixed charge coverage ratio, secured leverage ratio, consolidated adjusted net worth, unsecured leverage ratio, and unsecured interest coverage ratio. The Credit Facility also contains customary events of default, including among others, nonpayment of principal or interest, material inaccuracy of representations, and failure to comply with our covenants. If an event of default occurs and is continuing under the Credit Facility, the entire outstanding balance may become immediately due and payable. At September 30, 2021, we were in compliance with all such financial and operating covenants.

5. Income Taxes

During the 2021 second quarter, the United Kingdom enacted an increase in its corporate income tax rates from 19% to 25% effective April 1, 2023, which resulted in a one-time adjustment to our net deferred tax liabilities of approximately $43 million. Similarly, in the 2020 third quarter, we incurred an approximate $9 million charge for the change in the corporate income tax rate from 17% to 19% in the United Kingdom.

6. Common Stock/Partners’ Capital

Medical Properties Trust, Inc.

On January 11, 2021, we completed an underwritten public offering of 36.8 million shares of our common stock, resulting in net proceeds of approximately $711 million, after deducting underwriting discounts and commissions and offering expenses.

In addition, we sold 15.8 million shares of common stock under our at-the-market equity offering program during the first nine months of 2021, resulting in net proceeds of approximately $330 million; while in the first nine months of 2020, we sold 15.4 million shares of common stock under our at-the-market equity offering program, resulting in net proceeds of approximately $294 million.

MPT Operating Partnership, L.P.

At September 30, 2021, the Operating Partnership is made up of a general partner, Medical Properties Trust, LLC (“General Partner”) and limited partners, including the Company (which owns 100% of the General Partner) and MPT TRS, Inc. (which is 100% owned by the General Partner). By virtue of its ownership of the General Partner, the Company has a 100% ownership interest in the Operating Partnership. During the nine months ended September 30, 2021 and 2020, the Operating Partnership issued approximately 52.6 million and 15.4 million units, respectively, in direct response to the common stock offerings by Medical Properties Trust, Inc. during the same periods.

7. Stock Awards

We adopted the 2019 Equity Incentive Plan (the “Equity Incentive Plan”) during the second quarter of 2019, which authorizes the issuance of common stock options, restricted stock, restricted stock units, deferred stock units, stock appreciation rights, performance units, and other stock-based awards. The Equity Incentive Plan is administered by the Compensation Committee of the Board of Directors, and we have reserved 12.9 million shares of common stock for awards, out of which 5.7 million shares remain available for future stock awards as of September 30, 2021. Share-based compensation expense totaled $38.6 million and $34.6 million for the nine months ended September 30, 2021 and 2020, respectively.

8. Fair Value of Financial Instruments

We have various assets and liabilities that are considered financial instruments. We estimate that the carrying value of cash and cash equivalents and accounts payable and accrued expenses approximate their fair values. We estimate the fair value of our interest and rent receivables using Level 2 inputs such as discounting the estimated future cash flows using the current rates at which similar receivables would be made to others with similar credit ratings and for the same remaining maturities. The fair value of our mortgage loans and other loans are estimated by using Level 2 inputs such as discounting the estimated future cash flows using the current rates which similar loans would be made to borrowers with similar credit ratings and for the same remaining maturities. We determine the fair value of our senior unsecured notes using Level 2 inputs such as quotes from securities dealers and market makers. We estimate the fair value of our revolving credit facility and term loans using Level 2 inputs based on the present value of future payments, discounted at a rate which we consider appropriate for such debt.

Fair value estimates are made at a specific point in time, are subjective in nature, and involve uncertainties and matters of significant judgment. Settlement of such fair value amounts may not be a prudent management decision.

23


 

The following table summarizes fair value estimates for our financial instruments (in thousands):

 

 

 

As of September 30, 2021

 

 

As of December 31, 2020

 

Asset (Liability)

 

Book

Value

 

 

Fair

Value

 

 

Book

Value

 

 

Fair

Value

 

Interest and rent receivables

 

$

64,622

 

 

$

64,967

 

 

$

46,208

 

 

$

45,381

 

Loans(1)

 

 

1,350,394

 

 

 

1,348,187

 

 

 

751,341

 

 

 

756,608

 

Debt, net

 

 

(10,581,023

)

 

 

(10,920,597

)

 

 

(8,865,458

)

 

 

(9,226,564

)

 

(1)

Excludes the $205 million acquisition loan made in May 2020 to our international joint venture (see Note 3 for further details) and the related subsequent investment in the real estate of three hospitals in Colombia, as these assets are accounted for under the fair value option method.

Items Measured at Fair Value on a Recurring Basis

Our equity investment and related loan to the international joint venture and our loan investment in the real estate of three hospitals operated by subsidiaries of the international joint venture in Colombia are measured at fair value on a recurring basis as we elected to account for these investments using the fair value option at the point of initial investment during 2020. We elected to account for these investments at fair value due to the size of the investments and because we believe this method was more reflective of current values.

At September 30, 2021 and December 31, 2020, the amounts recorded under the fair value option method were as follows (in thousands):

 

 

 

As of September 30, 2021

 

 

As of December 31, 2020

 

 

 

Asset (Liability)

 

Fair Value

 

 

Original

Cost

 

 

Fair Value

 

 

Original

Cost

 

 

Asset Type Classification

Mortgage loans

 

$

130,148

 

 

$

130,148

 

 

$

136,332

 

 

$

136,332

 

 

Mortgage loans

Equity investment and other loans

 

 

222,420

 

 

 

222,420

 

 

 

218,775

 

 

 

218,775

 

 

Equity investments/Other loans

Our loans to the international joint venture and its subsidiaries are recorded at fair value based on Level 2 inputs by discounting the estimated cash flows using the market rates at which similar loans would be made to borrowers with similar credit ratings and the same remaining maturities. Our equity investment in the international joint venture is recorded at fair value based on Level 3 inputs, by using a discounted cash flow model, which requires significant estimates of our investee such as projected revenue and expenses and appropriate consideration of the underlying risk profile of the forecasted assumptions associated with the investee. We classify the equity investment as Level 3, as we use certain unobservable inputs to the valuation methodology that are significant to the fair value measurement, and the valuation requires management judgment due to absence of quoted market prices. For this cash flow model, our observable inputs include use of a capitalization rate and discount rate (which is based on a weighted-average cost of capital) and our unobservable input includes an adjustment for a marketability discount (“DLOM”).

In regards to the underlying projections used in the discounted cash flow model, such projections are provided by the investee. However, we will modify such projections as needed based on our review and analysis of historical results, meetings with key members of management, and our understanding of trends and developments within the healthcare industry. Given our equity investment is in an entity that was a start-up company in 2020, we have not recognized any unrealized gain/loss on such investment in 2020 or 2021.

Items Measured at Fair Value on a Nonrecurring Basis

In addition to items that are measured at fair value on a recurring basis, we have assets and liabilities that are measured, from time-to-time, at fair value on a nonrecurring basis, such as for long-lived asset impairment purposes. In these cases, fair value is based on estimated cash flows discounted at a risk-adjusted rate of interest by using Level 2 inputs.

24


 

9. Earnings Per Share/Unit

Medical Properties Trust, Inc.

Our earnings per share were calculated based on the following (amounts in thousands):

 

 

 

For the Three Months

Ended September 30,

 

 

 

2021

 

 

2020

 

Numerator:

 

 

 

 

 

 

 

 

Net income

 

$

171,395

 

 

$

131,357

 

Non-controlling interests’ share in net income

 

 

(258

)

 

 

(251

)

Participating securities’ share in earnings

 

 

(328

)

 

 

(435

)

Net income, less participating securities’ share in earnings

 

$

170,809

 

 

$

130,671

 

Denominator:

 

 

 

 

 

 

 

 

Basic weighted-average common shares

 

 

595,119

 

 

 

531,095

 

Dilutive potential common shares

 

 

2,201

 

 

 

1,341

 

Diluted weighted-average common shares

 

 

597,320

 

 

 

532,436

 

 

 

 

For the Nine Months

Ended September 30,

 

 

 

2021

 

 

2020

 

Numerator:

 

 

 

 

 

 

 

 

Net income

 

$

450,096

 

 

$

322,166

 

Non-controlling interests’ share in net income

 

 

(611

)

 

 

(600

)

Participating securities’ share in earnings

 

 

(1,088

)

 

 

(1,386

)

Net income, less participating securities’ share in earnings

 

$

448,397

 

 

$

320,180

 

Denominator:

 

 

 

 

 

 

 

 

Basic weighted-average common shares

 

 

586,291

 

 

 

526,651

 

Dilutive potential common shares

 

 

1,680

 

 

 

1,181

 

Diluted weighted-average common shares

 

 

587,971

 

 

 

527,832

 

 

MPT Operating Partnership, L.P.

Our earnings per common unit were calculated based on the following (amounts in thousands):

 

 

 

For the Three Months

Ended September 30,

 

 

 

2021

 

 

2020

 

Numerator:

 

 

 

 

 

 

 

 

Net income

 

$

171,395

 

 

$

131,357

 

Non-controlling interests’ share in net income

 

 

(258

)

 

 

(251

)

Participating securities’ share in earnings

 

 

(328

)

 

 

(435

)

Net income, less participating securities’ share in earnings

 

$

170,809

 

 

$

130,671

 

Denominator:

 

 

 

 

 

 

 

 

Basic weighted-average units

 

 

595,119

 

 

 

531,095

 

Dilutive potential units

 

 

2,201

 

 

 

1,341

 

Diluted weighted-average units

 

 

597,320

 

 

 

532,436

 

25


 

 

 

 

 

For the Nine Months

Ended September 30,

 

 

 

2021

 

 

2020

 

Numerator:

 

 

 

 

 

 

 

 

Net income

 

$

450,096

 

 

$

322,166

 

Non-controlling interests’ share in net income

 

 

(611

)

 

 

(600

)

Participating securities’ share in earnings

 

 

(1,088

)

 

 

(1,386

)

Net income, less participating securities’ share in earnings

 

$

448,397

 

 

$

320,180

 

Denominator:

 

 

 

 

 

 

 

 

Basic weighted-average units

 

 

586,291

 

 

 

526,651

 

Dilutive potential units

 

 

1,680

 

 

 

1,181

 

Diluted weighted-average units

 

 

587,971

 

 

 

527,832

 

 

10. Commitments and Contingencies

Commitments

On September 15, 2021, we entered into definitive agreements to lease five general acute care hospitals located in Utah to HCA following an agreement by HCA to purchase the operations of these five facilities from Steward. Upon completion of the transaction between HCA and Steward, we will enter into a new master lease with HCA for these five facilities (the “HCA Transaction”). The consummation of the HCA Transaction, which is subject to regulatory approval, is expected in the first half of 2022.

Contingencies

We are a party to various legal proceedings incidental to our business. In the opinion of management, after consultation with legal counsel, the ultimate liability, if any, with respect to those proceedings is not presently expected to materially affect our financial position, results of operations, or cash flows.

11. Other Assets

The following is a summary of our other assets on our condensed consolidated balance sheets (in thousands):

 

 

 

As of September 30,

2021

 

 

As of December 31,

2020

 

Debt issue costs, net(1)

 

$

6,147

 

 

$

192

 

Other corporate assets

 

 

196,900

 

 

 

167,929

 

Prepaids and other assets

 

 

112,930

 

 

 

87,948

 

Total other assets

 

$

315,977

 

 

$

256,069

 

 

(1)

Relates to our revolving credit facility.

Other corporate assets include land and improvements associated with our corporate offices, furniture and fixtures, equipment, corporate vehicles, aircraft, enterprise and other software, deposits, and right-of-use assets associated with certain corporate leases. Included in prepaids and other assets is prepaid insurance, prepaid taxes, deferred income tax assets (net of valuation allowances, if any), and lease inducements made to tenants, among other items.

 

12. Subsequent Events

0.993% Senior Unsecured Notes due 2026

On October 6, 2021, we completed a €500 million unsecured notes offering. The notes were issued at par value, and interest on the notes is payable annually on October 15 of each year, commencing on October 15, 2022. The notes pay interest in cash at a rate of 0.993% and mature on October 15, 2026.

With proceeds from this offering, on October 22, 2021, we redeemed all of our outstanding €500 million aggregate principal amount of 4.000% Senior Unsecured Notes due 2022, including accrued and unpaid interest. As a result of this redemption, we incurred a charge of approximately €18 million (including redemption premiums and accelerated amortization of deferred debt issuance costs).

 

26


 

 

Other

On October 19, 2021, we acquired 18 inpatient behavioral health facilities throughout the U.S. and an interest in the operations of Springstone, LLC (“Springstone”) for total consideration of $950 million, plus closing and other transaction costs. These facilities are leased to Springstone pursuant to a long-term master lease with annual escalations and multiple extension options. We funded this acquisition with a combination of borrowings from the July 2021 Interim Credit Facility, the revolving credit facility, and cash on-hand.

On October 21, 2021, we acquired an acute care facililty in Portugal for €17.8 million. This facility is leased to Atrys Health pursuant to a long-term master lease with annual escalations.

Subsequent to September 30, 2021, we completed the sales of our equity interest in the operations of German acute hospital operator ATOS Clinics International and separately of our equity interest in the operations of German post-acute operator MEDIAN at a gain.

 

27


 

 

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

The following discussion and analysis of the consolidated financial condition and consolidated results of operations are presented on a combined basis for Medical Properties Trust, Inc. and MPT Operating Partnership, L.P. as there are no material differences between these two entities. Such discussion and analysis should be read together with the condensed consolidated financial statements and notes thereto contained in this Form 10-Q and the consolidated financial statements and notes thereto contained in our Annual Report on Form 10-K for the year ended December 31, 2020.

As the economy continues to recover from the downturn caused by COVID-19 and vaccines continue to roll out, we expect to receive substantially all rent and interest payments in the future, and we are collecting rent, as expected, that we previously deferred in 2020, with interest. However, no assurances can be made that if the pandemic continues for an extended period of time that our rent and interest payments will not be delayed into the future until our tenants can recover.

Forward-Looking Statements.

This Quarterly Report on Form 10-Q contains certain “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause our actual results or future performance, achievements or transactions or events to be materially different from those expressed or implied by such forward-looking statements, including, but not limited to, the risks described in our Annual Report on Form 10-K and as updated in our quarterly reports on Form 10-Q for future periods, and current reports on Form 8-K as we file them with the SEC under the Exchange Act. Such factors include, among others, the following:

 

the political, economic, business, real estate, and other market conditions in the U.S. (both national and local), Europe (in particular the United Kingdom, Germany, Switzerland, Spain, Italy, and Portugal), Australia, South America (in particular Colombia), and other foreign jurisdictions where we may own healthcare facilities or transact business, which may have a negative effect on the following, among other things:

 

o

the financial condition of our tenants, our lenders, or institutions that hold our cash balances or are counterparties to certain hedge agreements, which may expose us to increased risks of default by these parties;

 

o

our ability to obtain equity or debt financing on attractive terms or at all, which may adversely impact our ability to pursue acquisition and development opportunities, refinance existing debt, and our future interest expense; and

 

o

the value of our real estate assets, which may limit our ability to dispose of assets at attractive prices or obtain or maintain debt financing secured by our real estate assets or on an unsecured basis.

 

the impact of COVID-19 on our business, our joint ventures, and the business of our tenants/borrowers and the economy in general, as well as other factors that may affect our business, our joint ventures or that of our tenants/borrowers that are beyond our control, including natural disasters, health crises, or other pandemics and subsequent government actions in reaction to such matters;

 

the risk that a condition to closing under the agreements governing any or all of our pending transactions (including the transactions disclosed in Note 3 and Note 10) that have not closed as of the date hereof may not be satisfied;

 

the possibility that the anticipated benefits from any or all of the transactions we enter into will take longer to realize than expected or will not be realized at all;

 

the competitive environment in which we operate;

 

the execution of our business plan;

 

financing risks;

 

acquisition and development risks;

 

potential environmental contingencies and other liabilities;

 

adverse developments affecting the financial health of one or more of our tenants, including insolvency;

 

other factors affecting the real estate industry generally or the healthcare real estate industry in particular;

 

our ability to maintain our status as a REIT for income tax purposes;

 

our ability to attract and retain qualified personnel;

 

changes in foreign currency exchange rates;

 

changes in federal, state, or local tax laws in the U.S., Europe, Australia, South America, or other jurisdictions in which we may own healthcare facilities or transact business; and

28


 

 

healthcare and other regulatory requirements of the U.S., Europe, Australia, South America, and other foreign countries.

Key Factors that May Affect Our Operations

Our revenue is derived from rents we earn pursuant to the lease agreements with our tenants, from interest income from loans to our tenants and other facility owners, and from profits or equity interests in certain of our tenants’ operations. Our tenants operate in the healthcare industry, generally providing medical, surgical, rehabilitative, and behavioral health care to patients. The capacity of our tenants to pay our rents and interest is dependent upon their ability to conduct their operations at profitable levels. We believe that the business environment of the industry segments in which our tenants operate is generally positive for efficient operators. However, our tenants’ operations are subject to economic, regulatory, market, and other conditions (such as the impact of the COVID-19 pandemic) that may affect their profitability, which could impact our results. Accordingly, we monitor certain key performance indicators that we believe provide us with early indications of conditions that could affect the level of risk in our portfolio.

Key factors that we consider in underwriting prospective tenants and in our ongoing monitoring of our tenants’ (and guarantors’) performance include the following:

 

admission levels and surgery/procedure/diagnosis volumes by type;

 

the current, historical, and prospective operating profit (measured by earnings before interest, taxes, depreciation, amortization, and facility rent) of each tenant or borrower and at each facility;

 

the ratio of our tenants’ or borrowers’ operating profit both to facility rent and to facility rent plus other fixed costs, including debt costs;

 

changes in sources of our tenants’ or borrowers’ revenue, including the relative mix of public payors (including Medicare, Medicaid/MediCal, and managed care in the U.S., pension funds in Germany, and National Health Services in the United Kingdom) and private payors (including commercial insurance and private pay patients);

 

trends in tenants’ cash collections, including comparison to recorded net patient service revenues;

 

tenants’ free cash flows;

 

the potential impact of healthcare pandemics/epidemics, legislation, and other regulations (including changes in reimbursement) on our tenants’ or borrowers’ profitability and liquidity; and

 

the competition and demographics of the local and surrounding areas in which our tenants or borrowers operate.

Certain business factors, in addition to those described above that directly affect our tenants and borrowers, will likely materially influence our future results of operations. These factors include:

 

trends in the cost and availability of capital, including market interest rates, that our prospective tenants may use for their real estate assets instead of financing their real estate assets through lease structures;

 

changes in healthcare regulations that may limit the opportunities for physicians to participate in the ownership of healthcare providers and healthcare real estate;

 

reductions in reimbursements from Medicare, state healthcare programs, and commercial insurance providers that may reduce our tenants’ or borrowers’ profitability and our revenues;

 

competition from other financing sources; and

 

the ability of our tenants and borrowers to access funds in the credit markets.

CRITICAL ACCOUNTING POLICIES

Refer to our 2020 Annual Report on Form 10-K for a discussion of our critical accounting policies, which include investments in real estate, purchase price allocation, loans, credit losses, losses from rent and interest receivables, and our accounting policy on consolidation. During the nine months ended September 30, 2021, there were no material changes to these policies.

29


 

Overview

We are a self-advised REIT focused on investing in and owning net-leased healthcare facilities across the U.S. and selectively in foreign jurisdictions. Medical Properties Trust, Inc. was incorporated under Maryland law on August 27, 2003, and MPT Operating Partnership, L.P. was formed under Delaware law on September 10, 2003. We conduct substantially all of our business through MPT Operating Partnership, L.P. We acquire and develop healthcare facilities and lease the facilities to healthcare operating companies under long-term net leases, which require the tenant to bear most of the costs associated with the property. We also make mortgage loans to healthcare operators collateralized by their real estate assets. In addition, we selectively make loans to certain of our operators through our taxable REIT subsidiaries, the proceeds of which are typically used for acquisitions and working capital. Finally, from time-to-time, we acquire a profits or other equity interest in our tenants that gives us a right to share in such tenant’s profits and losses.

At September 30, 2021, our portfolio consisted of 426 properties leased or loaned to 51 operators, of which two are under development and four are in the form of mortgage loans.

Our investments in healthcare real estate, including mortgage loans, as well as any loans made to and equity investments in our tenants are considered a single reportable segment. At September 30, 2021, all of our investments are located in the U.S., Europe, Australia, and South America. Our total assets are made up of the following (dollars in thousands):

 

 

 

As of

September 30,

2021

 

 

% of

Total

 

 

As of

December 31,

2020

 

 

% of

Total

 

Real estate assets - at cost

 

$

16,583,748

 

 

 

84.1

%

 

$

14,337,929

 

 

 

85.2

%

Accumulated real estate depreciation and amortization

 

 

(936,289

)

 

 

-4.7

%

 

 

(833,529

)

 

 

-5.0

%

Cash and cash equivalents

 

 

349,652

 

 

 

1.8

%

 

 

549,884

 

 

 

3.3

%

Equity investments

 

 

1,170,171

 

 

 

5.9

%

 

 

1,123,623

 

 

 

6.7

%

Other loans

 

 

1,502,677

 

 

 

7.6

%

 

 

858,368

 

 

 

5.1

%

Other

 

 

1,042,028

 

 

 

5.3

%

 

 

792,739

 

 

 

4.7

%

Total assets

 

$

19,711,987

 

 

 

100.0

%

 

$

16,829,014

 

 

 

100.0

%

 

Additional Concentration Details

 

On a pro forma gross asset basis (as defined in the “Reconciliation of Non-GAAP Financial Measures” section of Item 2 of this Quarterly Report on Form 10-Q), our concentration as of September 30, 2021 as compared to December 31, 2020 is as follows (dollars in thousands):

Total Pro Forma Gross Assets by Operator

 

 

 

As of September 30, 2021

 

 

As of December 31, 2020

 

Operators

 

Total Pro Forma

Gross Assets

 

 

Percentage of

Total Pro Forma

Gross Assets

 

 

Total Pro Forma

Gross Assets

 

 

Percentage of

Total Pro Forma

Gross Assets

 

Steward

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Florida market

 

$

1,260,206

 

 

 

5.7

%

 

$

215,105

 

 

 

1.1

%

Massachusetts market

 

 

1,162,101

 

 

 

5.3

%

 

 

1,500,915

 

 

 

7.3

%

Texas/Arkansas/Louisiana market

 

 

1,060,506

 

 

 

4.8

%

 

 

1,045,982

 

 

 

5.1

%

Arizona market

 

 

319,760

 

 

 

1.4

%

 

 

332,239

 

 

 

1.6

%

Ohio/Pennsylvania market

 

 

133,751

 

 

 

0.6

%

 

 

151,785

 

 

 

0.7

%

Utah market(1)

 

 

 

 

 

 

 

 

1,260,147

 

 

 

6.2

%

Circle

 

 

2,470,658

 

 

 

11.2

%

 

 

2,520,019

 

 

 

12.3

%

Prospect

 

 

1,623,254

 

 

 

7.3

%

 

 

1,597,950

 

 

 

7.8

%

Swiss Medical Network

 

 

1,242,022

 

 

 

5.6

%

 

 

1,177,520

 

 

 

5.8

%

HCA

 

 

1,235,498

 

 

 

5.6

%

 

 

8,844

 

 

 

 

Other operators

 

 

10,508,227

 

 

 

47.5

%

 

 

9,826,336

 

 

 

48.2

%

Other assets

 

 

1,110,337

 

 

 

5.0

%

 

 

792,739

 

 

 

3.9

%

Total

 

$

22,126,320

 

 

 

100.0

%

 

$

20,429,581

 

 

 

100.0

%

 

(1)

2021 column is shown pro forma for the transaction discussed in Note 10 to Item 1 of this Form 10-Q.

 

30


 

 

Total Pro Forma Gross Assets by U.S. State and Country

 

 

 

As of September 30, 2021

 

 

As of December 31, 2020

 

U.S. States and Other Countries

 

Total Pro Forma

Gross Assets

 

 

Percentage of

Total Pro Forma

Gross Assets

 

 

Total Pro Forma

Gross Assets

 

 

Percentage of

Total Pro Forma

Gross Assets

 

Texas

 

$

2,178,399

 

 

 

9.8

%

 

$

1,923,440

 

 

 

9.4

%

California

 

 

1,656,353

 

 

 

7.5

%

 

 

1,382,663

 

 

 

6.8

%

Florida

 

 

1,286,016

 

 

 

5.8

%

 

 

240,915

 

 

 

1.2

%

Utah

 

 

1,255,468

 

 

 

5.7

%

 

 

1,295,329

 

 

 

6.4

%

Massachusetts

 

 

1,167,501

 

 

 

5.3

%

 

 

1,506,315

 

 

 

7.4

%

All other states

 

 

5,024,965

 

 

 

22.7

%

 

 

4,607,471

 

 

 

22.5

%

Other domestic assets

 

 

725,314

 

 

 

3.3

%

 

 

680,678

 

 

 

3.3

%

Total U.S.

 

$

13,294,016

 

 

 

60.1

%

 

$

11,636,811

 

 

 

57.0

%

United Kingdom

 

$

4,352,007

 

 

 

19.7

%

 

$

4,636,634

 

 

 

22.7

%

Germany

 

 

1,279,598

 

 

 

5.8

%

 

 

1,361,019

 

 

 

6.6

%

Switzerland

 

 

1,242,022

 

 

 

5.6

%

 

 

1,177,520

 

 

 

5.7

%

Australia

 

 

1,038,165

 

 

 

4.6

%

 

 

997,878

 

 

 

4.9

%

Spain

 

 

214,566

 

 

 

1.0

%

 

 

221,134

 

 

 

1.1

%

All other countries

 

 

320,923

 

 

 

1.5

%

 

 

286,524

 

 

 

1.4

%

Other international assets

 

 

385,023

 

 

 

1.7

%

 

 

112,061

 

 

 

0.6

%

Total international

 

$

8,832,304

 

 

 

39.9

%

 

$

8,792,770

 

 

 

43.0

%

Grand total

 

$

22,126,320

 

 

 

100.0

%

 

$

20,429,581

 

 

 

100.0

%

 

On an individual property basis, we had no investment in any single property greater than 3% of our total pro forma gross assets as of September 30, 2021.

On an adjusted revenues basis (as defined in the “Reconciliation of Non-GAAP Financial Measures” section of Item 2 of this Quarterly Report on Form 10-Q), concentration for the three months ended September 30, 2021 as compared to the prior year is as follows (dollars in thousands):

 

Total Adjusted Revenues by Operator

 

 

 

For the Three Months Ended September 30,

 

 

 

2021

 

 

2020

 

Operators

 

Total Adjusted

Revenues

 

 

Percentage of

Total Adjusted

Revenues

 

 

Total Adjusted

Revenues

 

 

Percentage of

Total Adjusted

Revenues

 

Steward

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Massachusetts market

 

$

35,965

 

 

 

8.5

%

 

$

34,521

 

 

 

9.7

%

Utah market

 

 

31,879

 

 

 

7.5

%

 

 

31,333

 

 

 

8.8

%

Texas/Arkansas/Louisiana market

 

 

21,740

 

 

 

5.1

%

 

 

15,700

 

 

 

4.4

%

Florida market

 

 

16,929

 

 

 

4.0

%

 

 

3,632

 

 

 

1.0

%

Arizona market

 

 

8,126

 

 

 

1.9

%

 

 

8,193

 

 

 

2.3

%

Ohio/Pennsylvania market

 

 

3,236

 

 

 

0.8

%

 

 

3,260

 

 

 

0.9

%

Circle

 

 

52,612

 

 

 

12.4

%

 

 

48,145

 

 

 

13.5

%

Prospect

 

 

37,864

 

 

 

8.9

%

 

 

38,676

 

 

 

10.8

%

Prime

 

 

29,035

 

 

 

6.8

%

 

 

36,032

 

 

 

10.1

%

Priory

 

 

27,238

 

 

 

6.4

%

 

 

 

 

 

 

Other operators

 

 

159,284

 

 

 

37.7

%

 

 

137,465

 

 

 

38.5

%

Total

 

$

423,908

 

 

 

100.0

%

 

$

356,957

 

 

 

100.0

%

 

31


 

 

Total Adjusted Revenues by U.S. State and Country

 

 

 

For the Three Months Ended September 30,

 

 

 

2021

 

 

2020

 

U.S. States and Other Countries

 

Total Adjusted

Revenues

 

 

Percentage of

Total Adjusted

Revenues

 

 

Total Adjusted

Revenues

 

 

Percentage of

Total Adjusted

Revenues

 

California

 

$

40,850

 

 

 

9.6

%

 

$

39,768

 

 

 

11.1

%

Texas

 

 

38,007

 

 

 

9.0

%

 

 

29,948

 

 

 

8.4

%

Massachusetts

 

 

36,123

 

 

 

8.5

%

 

 

34,680

 

 

 

9.7

%

Utah

 

 

32,837

 

 

 

7.7

%

 

 

32,283

 

 

 

9.1

%

Pennsylvania

 

 

19,972

 

 

 

4.7

%

 

 

20,101

 

 

 

5.6

%

All other states

 

 

104,667

 

 

 

24.8

%

 

 

94,327

 

 

 

26.4

%

Total U.S.

 

$

272,456

 

 

 

64.3

%

 

$

251,107

 

 

 

70.3

%

United Kingdom

 

$

90,141

 

 

 

21.3

%

 

$

54,745

 

 

 

15.4

%

Germany

 

 

25,755

 

 

 

6.1

%

 

 

25,294

 

 

 

7.1

%

All other countries

 

 

35,556

 

 

 

8.3

%

 

 

25,811

 

 

 

7.2

%

Total international

 

$

151,452

 

 

 

35.7

%

 

$

105,850

 

 

 

29.7

%

Grand total

 

$

423,908

 

 

 

100.0

%

 

$

356,957

 

 

 

100.0

%

 

Total Adjusted Revenues by Facility Type

 

 

 

For the Three Months Ended September 30,

 

 

 

2021

 

 

2020

 

Facility Types

 

Total Adjusted

Revenues

 

 

Percentage of

Total Adjusted

Revenues

 

 

Total Adjusted

Revenues

 

 

Percentage of

Total Adjusted

Revenues

 

General acute care hospitals

 

$

334,239

 

 

 

78.8

%

 

$

299,090

 

 

 

83.8

%

Inpatient rehabilitation hospitals

 

 

44,825

 

 

 

10.6

%

 

 

42,463

 

 

 

11.9

%

Behavioral health facilities

 

 

32,843

 

 

 

7.8

%

 

 

2,978

 

 

 

0.8

%

Long-term acute care hospitals

 

 

8,120

 

 

 

1.9

%

 

 

8,604

 

 

 

2.4

%

Freestanding ER/urgent care facilities

 

 

3,881

 

 

 

0.9

%

 

 

3,822

 

 

 

1.1

%

Total

 

$

423,908

 

 

 

100.0

%

 

$

356,957

 

 

 

100.0

%

 

 

 

Results of Operations

Three Months Ended September 30, 2021 Compared to September 30, 2020

Net income for the three months ended September 30, 2021, was $171.1 million ($0.29 per diluted share), compared to $131.1 million ($0.25 per diluted share) for the three months ended September 30, 2020. This 30% increase in net income is primarily due to incremental revenue from new investments made in the second half of 2020 and the first nine months of 2021, partially offset by higher interest expense (from additional debt to partially finance these new investments), depreciation expense, and general and administrative costs due to the growth of the company. In addition, our gain on sale of real estate was greater in the 2021 third quarter compared to the prior year; while, income taxes were lower in the 2021 third quarter due to the tax rate increase in the United Kingdom in the 2020 third quarter. Normalized funds from operations (“FFO”), after adjusting for certain items (as more fully described in the “Reconciliation of Non-GAAP Financial Measures”), was $262.8 million for the 2021 third quarter, or $0.44 per diluted share, as compared to $220.7 million, or $0.41 per diluted share, for the 2020 third quarter. Similar to net income, this 19% increase in Normalized FFO is primarily due to incremental revenue from new investments made in the second half of 2020 and the first nine months of 2021.

32


 

A comparison of revenues for the three month periods ended September 30, 2021 and 2020 is as follows (dollar amounts in thousands):

 

 

 

2021

 

 

% of

Total

 

 

2020

 

 

% of

Total

 

 

Year over

Year

Change

 

Rent billed

 

$

242,211

 

 

 

62.0

%

 

$

192,953

 

 

 

58.6

%

 

 

25.5

%

Straight-line rent

 

 

64,637

 

 

 

16.5

%

 

 

51,125

 

 

 

15.5

%

 

 

26.4

%

Income from financing leases

 

 

50,667

 

 

 

13.0

%

 

 

52,544

 

 

 

15.9

%

 

 

-3.6

%

Interest and other income

 

 

33,264

 

 

 

8.5

%

 

 

32,836

 

 

 

10.0

%

 

 

1.3

%

Total revenues

 

$

390,779

 

 

 

100.0

%

 

$

329,458

 

 

 

100.0

%

 

 

18.6

%

 

Our total revenue for the 2021 third quarter is up $61.3 million, or 19%, over the prior year. This increase is made up of the following:

 

Operating lease revenue (includes rent billed and straight-line rent) – up $62.8 million over the prior year of which approximately $49.6 million is incremental revenue from acquisitions made in 2020 and 2021 (including $18.4 million from the Priory transaction as described in Note 3 to the condensed consolidated financial statements), $6.3 million is from the reclassification of properties from deferred financing leases to operating leases due to certain lease modifications in the fourth quarter of 2020, $3.3 million is from capital additions in 2021, $1.0 million is from the commencement of rent on two development properties, and approximately $4.0 million is from favorable foreign currency fluctuations. This increase is partially offset by lower revenues from disposals.

 

Income from financing leases – down $1.9 million due to the impact from the reclassification of properties from deferred financing leases to operating leases due to certain lease modifications in the fourth quarter of 2020, partially offset by revenue from new financing leases in the 2020 fourth quarter as part of the conversion of Ernest mortgage loans to fee simple asset ownership.

 

Interest and other income – up $0.4 million from the prior year due to the following:

 

o

Interest from loans – up $0.3 million over the prior year due to $13.9 million of incremental revenue earned on loan investments in late 2020 and the first nine months of 2021, including $5.2 million earned on the £250 million loan made to Priory in 2021 and $2.8 million from the loans made for three Colombia properties in 2020. This increase is partially offset by $1.1 million of lower interest revenue related to Steward mortgage loans converted to fee simple assets in the third quarter of 2020, $3.0 million of lower interest revenue related to Ernest mortgage loans converted to fee simple assets in the fourth quarter of 2020, and $9.2 million related to the repayment of Prime loans in the fourth quarter of 2020.

 

o

Other income – up $0.1 million from the prior year as we received more direct reimbursements from our tenants for ground lease, property taxes, and insurance.

Interest expense for the quarters ended September 30, 2021 and 2020 totaled $94.1 million and $82.3 million, respectively. This increase is primarily related to new debt issuances in late 2020 and 2021 to fund new investments, as our weighted-average interest rate of 3.4% for the three months ended September 30, 2021 is lower than the 3.8% in the same period in 2020.

Real estate depreciation and amortization during the third quarter of 2021 increased to $85.0 million from $69.7 million in 2020 due to new investments made after September 30, 2020.

Property-related expenses totaled $7.1 million and $5.9 million for the quarters ended September 30, 2021 and 2020, respectively. Approximately $4.0 million represents costs that were reimbursed by our tenants and included in “Interest and other income” line on our condensed consolidated statements of net income for each quarter ended September 30, 2021 and 2020.

As a percentage of revenue, general and administrative expenses represented 9.4% for the 2021 third quarter, slightly lower than 9.6% in the prior year. On a dollar basis, general and administrative expenses totaled $36.7 million for the 2021 third quarter, which is a $5.0 million increase from the prior year third quarter and reflective of the growth of the company, in particular our continued international expansion.

During the three months ended September 30, 2021, we disposed of four facilities resulting in a net gain of $9.3 million. During the three months ended September 30, 2020, we disposed of four facilities and two ancillary properties resulting in a net loss of $0.9 million.

33


 

Earnings from equity interests was $7.2 million for the quarter ended September 30, 2021, up $1.3 million from the same period in 2020, primarily due to $1.1 million more income generated on our equity investment in Infracore, which we increased our ownership in during the 2020 fourth quarter.

Income tax expense includes U.S. federal and state income taxes on our domestic TRS entities, as well as non-U.S. income based or withholding taxes on certain investments located in jurisdictions outside the U.S. The $10.6 million income tax expense for the three months ended September 30, 2021 is primarily based on the income generated by our investments in the United Kingdom, Colombia, and Australia. In comparison, we incurred $16.0 million in income tax expense in the third quarter of 2020, primarily from income generated by our investments in the United Kingdom, including an adjustment of approximately $9 million to reflect an increase in the United Kingdom corporate tax rate from 17% to 19%. Excluding the one-time adjustment for the increase in United Kingdom tax rates, the increase in income tax expense is primarily related to an increase in foreign taxable income as a result of investments made in 2020 and 2021.

We utilize the asset and liability method of accounting for income taxes. Deferred tax assets are recorded to the extent we believe these assets will more likely than not be realized. In making such determination, all available positive and negative evidence is considered, including scheduled reversals of deferred tax liabilities, projected future taxable income, tax planning strategies, and recent financial performance. Based upon our review of all positive and negative evidence, including our three-year cumulative pre-tax book loss position in certain entities, we concluded that a valuation allowance of approximately $44 million should be reflected against certain of our international and domestic net deferred tax assets at September 30, 2021. In the future, if we determine that it is more likely than not that we will realize our net deferred tax assets, we will reverse the applicable portion of the valuation allowance, recognize an income tax benefit in the period in which such determination is made, and incur higher income taxes in future periods as income is earned.

Nine Months Ended September 30, 2021 Compared to September 30, 2020

Net income for the nine months ended September 30, 2021, was $449.5 million ($0.76 per diluted share), compared to $321.6 million ($0.61 per diluted share) for the nine months ended September 30, 2020. This 40% increase in net income is primarily due to incremental revenue from new investments made in late 2020 and the first nine months of 2021, partially offset by higher interest expense (from additional debt to partially finance these new investments), depreciation expense, general and administrative costs, and income taxes due to the growth of the company, including approximately $43 million of income tax expense charged in 2021 related to the increase in corporate tax rates in the United Kingdom compared to $9 million in 2020. Normalized FFO, after adjusting for certain items (as more fully described in the “Reconciliation of Non-GAAP Financial Measures”), was $757.3 million for the first nine months of 2021, or $1.29 per diluted share, as compared to $611.5 million, or $1.16 per diluted share, for the first nine months of 2020. Similar to net income, this 24% increase in Normalized FFO is primarily due to incremental revenue from new investments in 2020 and the first half of 2021.

A comparison of revenues for the nine month periods ended September 30, 2021 and 2020 is as follows (dollar amounts in thousands):

 

 

 

2021

 

 

% of

Total

 

 

2020

 

 

% of

Total

 

 

Year over

Year

Change

 

Rent billed

 

$

672,425

 

 

 

59.2

%

 

$

538,277

 

 

 

58.8

%

 

 

24.9

%

Straight-line rent

 

 

174,975

 

 

 

15.4

%

 

 

103,697

 

 

 

11.3

%

 

 

68.7

%

Income from financing leases

 

 

151,898

 

 

 

13.4

%

 

 

157,469

 

 

 

17.2

%

 

 

-3.5

%

Interest and other income

 

 

136,038

 

 

 

12.0

%

 

 

115,989

 

 

 

12.7

%

 

 

17.3

%

Total revenues

 

$

1,135,336

 

 

 

100.0

%

 

$

915,432

 

 

 

100.0

%

 

 

24.0

%

 

Our total revenue for the first nine months of 2021 is up $219.9 million, or 24%, from the prior year. This increase is made up of the following:

 

Operating lease revenue (includes rent billed and straight-line rent) – up $205.4 million over the prior year of which approximately $115.5 million is incremental revenue from acquisitions made in 2020 and 2021 (including $51.3 million from the two Steward properties in Utah that were acquired from proceeds of the mortgage loan conversions in the third quarter of 2020), $23.3 million is from more straight-line rent write-offs in 2020, $19.3 million is due to the Circle lease amendment in the second quarter of 2020 (as described in Note 3 to the condensed consolidated financial statements), $19.0 million is from the reclassification of properties from deferred financing leases to operating leases due to certain lease modifications in the fourth quarter of 2020, $9.0 million is from capital additions in 2021, $6.9 million is from the commencement of rent on three development properties, and approximately $17.6 million is from favorable foreign currency fluctuations. This increase is partially offset by lower revenues from disposals and properties vacated since the 2020 third quarter.

34


 

 

Income from financing leases – down $5.6 million due to the impact from the reclassification of properties from deferred financing leases to operating leases due to certain lease modifications in the fourth quarter of 2020, partially offset by revenue from new financing leases in the 2020 fourth quarter as part of the conversion of Ernest mortgage loans to fee simple asset ownership.

 

Interest and other income – up $20.0 million from the prior year due to the following:

 

o

Interest from loans – up $7.9 million over the prior year due to $73.7 million of incremental revenue earned on loan investments in 2020 and the first nine months of 2021, including $40.4 million earned on the two loans made to Priory in 2021 and $15.0 million from the loans made to the international joint venture and for three Colombia properties in 2020, along with $0.9 million of favorable foreign currency fluctuations. This increase is partially offset by $30.6 million of lower interest revenue related to Steward mortgage loans converted to fee simple assets in the third quarter of 2020, $9.0 million of lower interest revenue related to Ernest mortgage loans converted to fee simple assets in the fourth quarter of 2020, and $27.6 million related to the repayment of Prime loans in the fourth quarter of 2020.

 

o

Other income – up $12.1 million from the prior year as we received more direct reimbursements from our tenants for ground lease, property taxes, and insurance. Additionally, other income is higher in 2021 due to an approximate $1 million write-off of straight-line rent related to ground leases on certain Adeptus facilities in the 2020 first quarter.

Interest expense for the nine months ended September 30, 2021 and 2020, totaled $273.4 million and $243.5 million, respectively. This increase is primarily related to new debt issuances in 2020 and 2021, as our weighted-average interest rate of 3.4% for the nine months ended September 30, 2021 was lower than the 3.9% in the same period in 2020.

Real estate depreciation and amortization during the first nine months of 2021 increased to $237.1 million from $192.0 million in the same period of 2020 due to new investments made after September 30, 2020.

Property-related expenses totaled $31.3 million and $19.2 million for the nine months ended September 30, 2021 and 2020, respectively. Of the property expenses in the first nine months of 2021 and 2020, approximately $23.1 million and $10.9 million, respectively, represents costs that were reimbursed by our tenants and included in “Interest and other income” line on our condensed consolidated statements of net income.

As a percentage of revenue, general and administrative expenses represented 9.5% for the first nine months of 2021, which is lower than the 10.6% in same period of the prior year. On a dollar basis, general and administrative expenses totaled $107.3 million for the first nine months of 2021, which is a $10.2 million increase from the same period of the prior year and reflective of the growth of the company, in particular our continued international expansion.

During the nine months ended September 30, 2021, we disposed of nine facilities and one ancillary property resulting in a net gain of $9.0 million. During the nine months ended September 30, 2020, we disposed of nine facilities and six ancillary properties resulting in a net loss of $2.7 million. In addition, we made a $19.0 million adjustment to lower the carrying value of the real estate on certain Adeptus properties and one Alecto facility in the first quarter of 2020 (see Note 3 to the condensed consolidated financial statements for further details).

Earnings from equity interests was $21.6 million for the first nine months of 2021, up $6.4 million from the same period of 2020, primarily due to $4.6 million more income generated on our equity investment in Infracore, which we increased our ownership in during the 2020 fourth quarter.

Debt refinancing and unutilized financing costs were $2.3 million in the first nine months of 2021 as a result of the early termination of our January 2021 Interim Credit Facility and the amendment to our Credit Facility in the first quarter of 2021 (see Note 4 to the condensed consolidated financial statements for more detail). In the first nine months of 2020, we incurred $0.6 million of accelerated commitment fee amortization expense associated with our British pound sterling term loan.

In the first nine months of 2021, we recorded a favorable non-cash fair value adjustment of $2.8 million to mark our investment in Aevis Victoria SA stock to market. This adjustment (reflected in the “Other” line of our condensed consolidated statements of net income) was a $5.2 million unfavorable adjustment in the first nine months of 2020, primarily due to the decline of this stock during 2020 due to the COVID-19 pandemic.

Income tax expense typically includes U.S. federal and state income taxes on our TRS entities, as well as non-U.S. income based or withholding taxes on certain investments located in jurisdictions outside the U.S. The $69.1 million income tax expense for the nine months ended September 30, 2021, is primarily based on the income generated by our investments in the United Kingdom, Colombia, and Australia, including a one-time adjustment to our net deferred tax liabilities of approximately $43 million to reflect an increase in the United Kingdom corporate tax rate from 19% to 25% in the second quarter of 2021. In comparison, we recorded $24.8

35


 

million of income tax expense in the first nine months of 2020 from income generated by our investments in the United Kingdom and Australia, including tax adjustments of $9 million to reflect corporate tax rate changes in the United Kingdom and elsewhere. Excluding the one-time adjustments for the increase in tax rates, the increase in income tax expense is primarily related to higher foreign taxable income earned as a result of investments made in 2020 and the first nine months of 2021.

We utilize the asset and liability method of accounting for income taxes. Deferred tax assets are recorded to the extent we believe these assets will more likely than not be realized. In making such determination, all available positive and negative evidence is considered, including scheduled reversals of deferred tax liabilities, projected future taxable income, tax planning strategies, and recent financial performance. Based upon our review of all positive and negative evidence, including our three-year cumulative pre-tax book loss position in certain entities, we concluded that a valuation allowance of approximately $44 million should be reflected against certain of our international and domestic net deferred tax assets at September 30, 2021. In the future, if we determine that it is more likely than not that we will realize our net deferred tax assets, we will reverse the applicable portion of the valuation allowance, recognize an income tax benefit in the period in which such determination is made, and incur higher income taxes in future periods as income is earned.

Reconciliation of Non-GAAP Financial Measures

Investors and analysts following the real estate industry utilize funds from operations, or FFO, as a supplemental performance measure. FFO, reflecting the assumption that real estate asset values rise or fall with market conditions, principally adjusts for the effects of GAAP depreciation and amortization of real estate assets, which assumes that the value of real estate diminishes predictably over time. We compute FFO in accordance with the definition provided by the National Association of Real Estate Investment Trusts, or Nareit, which represents net income (loss) (computed in accordance with GAAP), excluding gains (losses) on sales of real estate and impairment charges on real estate assets, plus real estate depreciation and amortization and after adjustments for unconsolidated partnerships and joint ventures.

In addition to presenting FFO in accordance with the Nareit definition, we disclose normalized FFO, which adjusts FFO for items that relate to unanticipated or non-core events or activities or accounting changes that, if not noted, would make comparison to prior period results and market expectations less meaningful to investors and analysts.

We believe that the use of FFO, combined with the required GAAP presentations, improves the understanding of our operating results among investors and the use of normalized FFO makes comparisons of our operating results with prior periods and other companies more meaningful. While FFO and normalized FFO are relevant and widely used supplemental measures of operating and financial performance of REITs, they should not be viewed as a substitute measure of our operating performance since the measures do not reflect either depreciation and amortization costs or the level of capital expenditures and leasing costs necessary to maintain the operating performance of our properties, which can be significant economic costs that could materially impact our results of operations. FFO and normalized FFO should not be considered an alternative to net income (loss) (computed in accordance with GAAP) as indicators of our financial performance or to cash flow from operating activities (computed in accordance with GAAP) as an indicator of our liquidity.

36


 

The following table presents a reconciliation of net income attributable to MPT common stockholders to FFO and Normalized FFO for the three and nine months ended September 30, 2021 and 2020 (amounts in thousands except per share data):

 

 

 

For the Three Months Ended

 

 

For the Nine Months Ended

 

 

 

September 30, 2021

 

 

September 30, 2020

 

 

September 30, 2021

 

 

September 30, 2020

 

FFO information:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income attributable to MPT common stockholders

 

$

171,137

 

 

$

131,106

 

 

$

449,485

 

 

$

321,566

 

Participating securities’ share in earnings

 

 

(328

)

 

 

(435

)

 

 

(1,088

)

 

 

(1,386

)

Net income, less participating securities’ share in earnings

 

$

170,809

 

 

$

130,671

 

 

$

448,397

 

 

$

320,180

 

Depreciation and amortization

 

 

98,492

 

 

 

80,841

 

 

 

277,089

 

 

 

223,166

 

(Gain) loss on sale of real estate

 

 

(9,294

)

 

 

927

 

 

 

(8,896

)

 

 

2,703

 

Real estate impairment charges

 

 

 

 

 

 

 

 

 

 

 

19,006

 

Funds from operations

 

$

260,007

 

 

$

212,439

 

 

$

716,590

 

 

$

565,055

 

Write-off (recovery) of straight-line rent and other

 

 

3,650

 

 

 

1,266

 

 

 

(1,601

)

 

 

27,098

 

Non-cash fair value adjustments

 

 

(819

)

 

 

(1,575

)

 

 

(2,763

)

 

 

9,030

 

Tax rate and other changes

 

 

 

 

 

8,535

 

 

 

42,746

 

 

 

9,661

 

Debt refinancing and unutilized financing costs

 

 

 

 

 

 

 

 

2,339

 

 

 

611

 

Normalized funds from operations

 

$

262,838

 

 

$

220,665

 

 

$

757,311

 

 

$

611,455

 

Per diluted share data:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income, less participating securities’ share in earnings

 

$

0.29

 

 

$

0.25

 

 

$

0.76

 

 

$

0.61

 

Depreciation and amortization

 

 

0.17

 

 

 

0.15

 

 

 

0.48

 

 

 

0.42

 

(Gain) loss on sale of real estate

 

 

(0.02

)

 

 

 

 

 

(0.02

)

 

 

0.01

 

Real estate impairment charges

 

 

 

 

 

 

 

 

 

 

 

0.03

 

Funds from operations

 

$

0.44

 

 

$

0.40

 

 

$

1.22

 

 

$

1.07

 

Write-off (recovery) of straight-line rent and other

 

 

 

 

 

 

 

 

 

 

 

0.05

 

Non-cash fair value adjustments

 

 

 

 

 

 

 

 

 

 

 

0.02

 

Tax rate and other changes

 

 

 

 

 

0.01

 

 

 

0.07

 

 

 

0.02

 

Debt refinancing and unutilized financing costs

 

 

 

 

 

 

 

 

 

 

 

 

Normalized funds from operations

 

$

0.44

 

 

$

0.41

 

 

$

1.29

 

 

$

1.16

 

 

Pro Forma Gross Assets

Pro forma gross assets is total assets before accumulated depreciation/amortization (adjusted for our unconsolidated joint ventures) and assumes all real estate commitments on new investments and unfunded amounts on development deals and commenced capital improvement projects as of the applicable reporting periods are fully funded, and assumes cash on hand is used in these transactions. We believe total pro forma gross assets is useful to investors as it provides a more current view of our portfolio and allows for a better understanding of our concentration levels as our commitments close and our other commitments are fully funded. The following table presents a reconciliation of total assets to total pro forma gross assets (in thousands):

 

 

 

As of

 

 

As of

 

 

 

September 30, 2021

 

 

December 31, 2020

 

Total assets

 

$

19,711,987

 

 

$

16,829,014

 

Add:

 

 

 

 

 

 

 

 

Real estate commitments on new investments(1)

 

 

990,002

 

 

 

1,901,087

 

Unfunded amounts on development deals and commenced

   capital improvement projects(2)

 

 

180,529

 

 

 

166,258

 

Accumulated depreciation and amortization

 

 

936,289

 

 

 

833,529

 

Incremental gross assets of our joint ventures and other(3)

 

 

1,752,842

 

 

 

1,287,077

 

Less:

 

 

 

 

 

 

 

 

Cash used for funding the transactions above(4)

 

 

(1,445,329

)

 

 

(587,384

)

Total pro forma gross assets

 

$

22,126,320

 

 

$

20,429,581

 

 

(1)

The 2021 column reflects investments made or committed to subsequent to September 30, 2021, including the commitment to invest $950 million in a behavioral health platform across nine states and the commitment to acquire one facility in Portugal for €18 million. The 2020 column reflects investments made in 2021, including the acquisition of 35 facilities in the United Kingdom on January 19, 2021.

37


 

(2)

Includes $31.1 million and $65.5 million of unfunded amounts on ongoing development projects and $149.4 million and $100.8 million of unfunded amounts on capital improvement projects, as of September 30, 2021 and December 31, 2020, respectively.

(3)

Includes an adjustment to reflect our share of our joint ventures’ gross assets.

(4)

Includes cash available on-hand plus cash generated from activities subsequent to period-end such as loan repayments or dispositions (including the Macquarie Transaction discussed in Note 3 to Item 1 to this Form 10-Q).

Adjusted revenues

Adjusted revenues are total revenues adjusted for our pro rata portion of similar revenues in our real estate joint venture arrangements. We believe adjusted revenues are useful to investors as it provides a more complete view of revenues across all of our investments and allows for better understanding of our revenue concentration. The following table presents a reconciliation of total revenues to total adjusted revenues (in thousands):

 

 

 

For the Three Months Ended September 30,

 

 

 

2021

 

 

2020

 

Total revenues

 

$

390,779

 

 

$

329,458

 

Revenues from real estate properties owned through joint venture

   arrangements

 

 

33,129

 

 

 

27,499

 

Total adjusted revenues

 

$

423,908

 

 

$

356,957

 

 

 

LIQUIDITY AND CAPITAL RESOURCES

2021 Cash Flow Activity

During the first nine months of 2021, we generated approximately $577 million of cash flows from operating activities, primarily consisting of rent and interest from mortgage and other loans. We used these operating cash flows, along with $11 million received from Steward in the first quarter of 2021 as a return of capital distribution, to fund our dividends of $476 million and certain investment activities. In addition, we invested approximately $3.2 billion in real estate and other assets, including the £1.1 billion Priory Group Transaction (as more fully described in Note 3 to Item 1 of this Form 10-Q), using a combination of cash on-hand and cash generated from the $1.0 billion of net proceeds from the sales of stock during the first nine months of 2021, £850 million from the issuance of senior unsecured notes, approximately $140 million in loan principal repayments, and $650 million in borrowings under the July 2021 Interim Credit Facility.

See Note 12 to Item 1 of this Form 10-Q for cash flow activity occurring subsequent to September 30, 2021 as it relates to debt and additional investments.

2020 Cash Flow Activity

During the first nine months of 2020, we generated approximately $442 million of cash flows from operating activities (which did not include approximately $35 million of revenue earned on the Circle Transaction as such rent was prepaid before the acquisition closed), primarily consisting of rent and interest from mortgage and other loans. We used these operating cash flows to fund our dividends of $423 million. In addition, we invested approximately $2.8 billion in real estate and other assets, including the £1.5 billion Circle Transaction (as more fully described in Note 3 to Item 1 of this Form 10-Q), using a combination of cash on-hand, proceeds from a £700 million British pound sterling term loan, the sale of 15.4 million shares of common stock under our at-the-market equity offering program, resulting in net proceeds of approximately $294 million, and $225 million from our revolving portion of the Credit Facility.

Short-term Liquidity Requirements:

At November 1, 2021 and including receipt of £250 million repaid by Waterland VII pursuant to the Priory acquisition loan (as described in Note 3 to Item 1 of this Form 10-Q) and borrowings to fund new investments made subsequent to September 30, 2021 (as described in Note 12 to Item 1 of this Form 10-Q), our liquidity approximates $1.0 billion. We believe this liquidity along with our current monthly cash receipts from rent and loan interest, regular distributions from our joint venture arrangements, approximately $250 million of availability under our at-the-market equity program, and expected cash proceeds from the Macquarie Transaction of approximately $1.3 billion (as described in Note 3 to Item 1 of this Form 10-Q) is sufficient to fund our operations, dividends in order to comply with REIT requirements, our current firm commitments (capital expenditures and expected funding requirements on development projects), and debt service obligations for the next twelve months (including contractual interest payments and the repayment of the $990 million principal balance outstanding on the July 2021 Interim Credit Facility due in July 2022). We expect that other capital recycling transactions (that could include sales of single facilities) will further improve our liquidity and our leverage ratio, although no assurances can be given that our capital recycling efforts (including the closing of the Macquarie Transaction) will be successful.

38


 

Long-term Liquidity Requirements:

As of November 1, 2021, our liquidity approximates $1.0 billion. We believe that our liquidity, along with our current monthly cash receipts from rent and loan interest, regular distributions from our joint venture arrangements, approximately $250 million of availability under our at-the-market equity program, and expected cash proceeds from the Macquarie Transaction of approximately $1.3 billion, is sufficient to fund our operations, debt and interest obligations, our firm commitments, and dividends in order to comply with REIT requirements for the foreseeable future.

However, in order to make additional investments, to fund debt maturities coming due starting in 2022 and beyond, to strategically refinance any existing debt in order to reduce interest rates, or to further improve our leverage ratios, we may need to access one or a combination of the following sources of capital:

 

strategic property sales or joint ventures;

 

sale of equity securities;

 

new bank term loans;

 

new USD, EUR, or GBP denominated debt securities, including senior unsecured notes; and/or

 

new secured loans on real estate.

There is no assurance that conditions will be favorable for such possible transactions (particularly in light of the ongoing COVID-19 pandemic) or that our plans (including the closing of the Macquarie Transaction) will be successful.

Principal payments due on our debt (which exclude the effects of any discounts, premiums, or debt issue costs recorded) as of November 1, 2021 are as follows (in thousands):

 

2021

 

$

 

2022

 

 

990,000

 

2023

 

 

547,280

 

2024

 

 

1,632,160

 

2025

 

 

1,535,640

 

Thereafter

 

 

6,861,790

 

Total

 

$

11,566,870

 

Contractual Commitments

We presented our contractual commitments in our Annual Report on Form 10-K for the fiscal year ended December 31, 2020 and updated the schedule in the second quarter of 2021. Except for changes to our purchase obligations and debt, as more fully described in Note 12 to Item 1 of this Quarterly Report on Form 10-Q, there have been no other significant changes through November 1, 2021.

The following table updates our contractual commitments schedule for these updates as of November 1, 2021 (in thousands):

 

Contractual Commitments

 

2021(1)

 

 

2022

 

 

2023

 

 

2024

 

 

2025

 

 

Thereafter

 

 

Total

 

0.993% Senior Unsecured Notes due

   2026(2)

 

$

 

 

$

5,880

 

 

$

5,738

 

 

$

5,738

 

 

$

5,739

 

 

$

583,639

 

 

$

606,734

 

Purchase obligations

 

 

47,895

 

 

 

188,347

 

 

 

157,012

 

 

 

111,723

 

 

 

77,248

 

 

 

131,945

 

 

 

714,170

 

 

(1)

This column represents obligations post November 1, 2021.

 

(2)

We used the proceeds from this offering to redeem all of our outstanding €500 million aggregate principal amount of 4.000% Senior Unsecured Notes due 2022 as more fully described in Note 12 to Item 1 of this Quarterly Report on Form 10-Q.

39


 

Distribution Policy

The table below is a summary of our distributions declared during the two year period ended September 30, 2021:

 

Declaration Date

 

Record Date

 

Date of Distribution

 

Distribution

per Share

 

August 19, 2021

 

September 16, 2021

 

October 14, 2021

 

$

0.28

 

May 26, 2021

 

June 17, 2021

 

July 8, 2021

 

$

0.28

 

February 18, 2021

 

March 18, 2021

 

April 8, 2021

 

$

0.28

 

November 12, 2020

 

December 10, 2020

 

January 7, 2021

 

$

0.27

 

August 13, 2020

 

September 10, 2020

 

October 8, 2020

 

$

0.27

 

May 21, 2020

 

June 18, 2020

 

July 16, 2020

 

$

0.27

 

February 14, 2020

 

March 12, 2020

 

April 9, 2020

 

$

0.27

 

November 21, 2019

 

December 12, 2019

 

January 9, 2020

 

$

0.26

 

 

We intend to pay to our stockholders, within the time periods prescribed by the Internal Revenue Code of 1986, as amended (“Code”), all or substantially all of our annual taxable income, including taxable gains from the sale of real estate and recognized gains on the sale of securities. It is our policy to make sufficient cash distributions to stockholders in order for us to maintain our status as a REIT under the Code and to avoid corporate income and excise taxes on undistributed income. However, our Credit Facility limits the amount of dividends we can pay - see Note 4 in Item 1 to this Form 10-Q for further information.

Item 3. Quantitative and Qualitative Disclosures About Market Risk.

Market risk includes risks that arise from changes in interest rates, foreign currency exchange rates, commodity prices, equity prices, and other market changes that affect market-sensitive instruments. We seek to mitigate the effects of fluctuations in interest rates by matching the terms of new investments with new long-term fixed rate borrowings to the extent possible. We may or may not elect to use financial derivative instruments to hedge interest rate or foreign currency exposure. For interest rate hedging, these decisions are principally based on our policy to match investments with comparable borrowings, but are also based on the general trend in interest rates at the applicable dates and our perception of the future volatility of interest rates. For foreign currency hedging, these decisions are principally based on how our investments are financed, the long-term nature of our investments, the need to repatriate earnings back to the U.S., and the general trend in foreign currency exchange rates.

In addition, the value of our facilities will be subject to fluctuations based on changes in local and regional economic conditions and changes in the ability of our tenants to generate profits.

Our primary exposure to market risks relates to fluctuations in interest rates and foreign currency. The following analyses present the sensitivity of the market value, earnings, and cash flows of our significant financial instruments to hypothetical changes in interest rates and exchange rates as if these changes had occurred. The hypothetical changes chosen for these analyses reflect our view of changes that are reasonably possible over a one-year period. These forward looking disclosures are selective in nature and only address the potential impact from these hypothetical changes. They do not include other potential effects which could impact our business as a result of changes in market conditions (such as the impact caused by COVID-19). In addition, they do not include measures we may take to minimize our exposure such as entering into future interest rate swaps to hedge against interest rate increases on our variable rate debt.

Interest Rate Sensitivity

For fixed rate debt, interest rate changes affect the fair market value but do not impact net income to common stockholders or cash flows. Conversely, for floating rate debt, interest rate changes generally do not affect the fair market value but do impact net income to common stockholders and cash flows, assuming other factors are held constant. At September 30, 2021, our outstanding debt totaled $10.6 billion, which consisted of fixed-rate debt of approximately $9.5 billion (after considering interest rate swaps in-place) and variable rate debt of $1.1 billion. If market interest rates increase by 1%, the fair value of our debt at September 30, 2021 would decrease by approximately $7.5 million. Changes in the fair value of our fixed rate debt will not have any impact on us unless we decided to repurchase the debt in the open market.

If market rates of interest on our variable rate debt increase by 1%, the increase in annual interest expense on our variable rate debt would decrease future earnings and cash flows by $0.1 million per year. If market rates of interest on our variable rate debt decrease by 1%, the decrease in interest expense on our variable rate debt would increase future earnings and cash flows by $0.1 million per year. This assumes that the average amount outstanding under our variable rate debt for a year is $1.1 billion, the balance of such variable rate debt at September 30, 2021.

40


 

Foreign Currency Sensitivity

With our investments in the United Kingdom, Germany, Spain, Italy, Portugal, Switzerland, Australia, and Colombia, we are subject to fluctuations in the British pound, euro, Swiss franc, Australian dollar, and Colombian peso to U.S. dollar currency exchange rates. Although we generally deem investments in these countries to be of a long-term nature, are able to match any non-U.S. dollar borrowings with investments in such currencies, and historically have not needed to repatriate a material amount of earnings back to the U.S., increases or decreases in the value of the respective non-U.S. dollar currencies to U.S. dollar exchange rates may impact our financial condition and/or our results of operations. Based solely on our 2021 operating results and on an annualized basis, a 5% change to the following exchange rates would have impacted our net income and FFO by the amounts below (in thousands):

 

 

 

Net Income Impact

 

 

FFO Impact

 

British pound (£)(1)

 

$

5,738

 

 

$

9,721

 

Euro (€)

 

 

132

 

 

 

2,025

 

Swiss franc (CHF)

 

 

551

 

 

 

1,624

 

Australian dollar (AUD $)

 

 

652

 

 

 

1,730

 

Colombian peso (COP)

 

 

524

 

 

 

524

 

 

(1)

Excludes impact from the one-time tax adjustment discussed in Note 5 in Item 1 to this Form 10-Q.

Item 4. Controls and Procedures.

Medical Properties Trust, Inc. and MPT Operating Partnership, L.P.

We have adopted and maintain disclosure controls and procedures that are designed to ensure that information required to be disclosed in our reports under the Securities Exchange Act of 1934, as amended, is recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow for timely decisions regarding required disclosure. In designing and evaluating the disclosure controls and procedures, management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, and management is required to apply its judgment in evaluating the cost-benefit relationship of possible controls and procedures.

As required by Rule 13a-15(b), under the Securities Exchange Act of 1934, as amended, we have carried out an evaluation, under the supervision and with the participation of management, including our Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures as of the end of the quarter covered by this report. Based on the foregoing, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures are effective in providing reasonable assurance that information required to be disclosed by us in the reports that we file under the Securities Exchange Act of 1934 is recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms.

There has been no change in our internal control over financial reporting during our most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

41


 

PART II — OTHER INFORMATION

The information contained in Note 10 “Commitments and Contingencies” to the condensed consolidated financial statements is incorporated by reference into this Item 1.

Item 1A. Risk Factors.

There have been no material changes to the Risk Factors as presented in our Annual Report on Form 10-K for the year ended December 31, 2020.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

(a)

None.

(b)

Not applicable.

(c)

None.

Item 3. Defaults Upon Senior Securities.

None.

Item 4. Mine Safety Disclosures.

None.

Item 5. Other Information.

(a)

None.

(b)

None.

42


 

 

Item 6. Exhibits

 

Exhibit Number

 

 

Description

 

 

 

10.1*

 

Amended and Restated Master Lease Agreement between certain subsidiaries of MPT Operating Partnership, L.P. as Lessor and certain subsidiaries of Steward Health Care System LLC, Lessee

 

 

 

10.2*

 

Amendment to Amended and Restated Revolving Credit and Term Loan Agreement, dated as of September 29, 2021, among Medical Properties Trust, Inc., MPT Operating Partnership, L.P., the several lenders from time to time party thereto, Bank of America, N.A., as syndication agent, and JPMorgan Chase Bank, N.A., as administrative agent

 

 

 

31.1*

 

Certification of Chief Executive Officer pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934. (Medical Properties Trust, Inc.)

 

 

 

31.2*

 

Certification of Chief Financial Officer pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934. (Medical Properties Trust, Inc.)

 

 

 

31.3*

 

Certification of Chief Executive Officer pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934. (MPT Operating Partnership, L.P.)

 

 

 

31.4*

 

Certification of Chief Financial Officer pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934. (MPT Operating Partnership, L.P.)

 

 

 

32.1**

 

Certification of Chief Executive Officer and Chief Financial Officer pursuant to Rule 13a-14(b) under the Securities Exchange Act of 1934 and 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. (Medical Properties Trust, Inc.)

 

 

 

32.2**

 

Certification of Chief Executive Officer and Chief Financial Officer pursuant to Rule 13a-14(b) under the Securities Exchange Act of 1934 and 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. (MPT Operating Partnership, L.P.)

 

 

 

Exhibit 101.INS*

 

XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.

 

 

 

Exhibit 101.SCH*

 

Inline XBRL Taxonomy Extension Schema Document

 

 

 

Exhibit 101.CAL*

 

Inline XBRL Taxonomy Extension Calculation Linkbase Document

 

 

 

Exhibit 101.DEF*

 

Inline XBRL Taxonomy Extension Definition Linkbase Document

 

 

 

Exhibit 101.LAB*

 

Inline XBRL Taxonomy Extension Label Linkbase Document

 

 

 

Exhibit 101.PRE*

 

Inline XBRL Taxonomy Extension Presentation Linkbase Document

 

 

 

 

Exhibit 104*

 

Cover Page Interactive Data File (formatted as Inline XBRL with applicable taxonomy extension information contained in Exhibits 101.*)

 

*

Filed herewith.

**

Furnished herewith.

43


 

 

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrants have duly caused this report to be signed on their behalf by the undersigned thereunto duly authorized.

 

MEDICAL PROPERTIES TRUST, INC.

 

 

 

By:

 

/s/ J. Kevin Hanna

 

 

J. Kevin Hanna

 

 

Vice President, Controller, Assistant Treasurer, and Chief Accounting Officer

(Principal Accounting Officer)

 

MPT OPERATING PARTNERSHIP, L.P.

 

 

 

By:

 

/s/ J. Kevin Hanna

 

 

J. Kevin Hanna

 

 

Vice President, Controller, Assistant Treasurer, and Chief Accounting Officer

of the sole member of the general partner

of MPT Operating Partnership, L.P.

(Principal Accounting Officer)

 

Date: November 9, 2021

 

44

mpw-ex101_157.htm

EXHIBIT 10.1

AMENDED AND RESTATED MASTER LEASE AGREEMENT

 

 

 

 

BY AND AMONG

 

 

 

 

THE ENTITIES LISTED ON SCHEDULE 1-A ATTACHED HERETO,

 

(collectively, jointly and severally, “Lessor”)

 

 

AND

 

 

THE ENTITIES LISTED ON SCHEDULE 1-B ATTACHED HERETO,

 

(collectively, jointly and severally, as “Lessee”)

 

August 27, 2021

 

 

 

4834-1440-2281v12


 

 

Table of Contents

Page

 

ARTICLE I. DEFINITIONS

 

3

 

 

 

1.1.  Certain Defined Terms

 

3

1.2.  Interpretation; Terms Generally

 

47

1.3.  Accounting Terms

 

48

1.4.  Certain Matters Relating to References to Leased Property

 

48

 

 

 

ARTICLE II. LEASED PROPERTY; TERM

 

49

 

 

 

ARTICLE III. RENT

 

50

 

 

 

3.1.  Rent

 

50

3.2.  Additional Charges

 

52

3.3.  Continuation of Ground Lease Base Rent with Respect to Severed Ground Leases

 

52

3.4.  Acknowledgement of Certain Inducement Fees

 

53

3.5.  Certain Deferred Rent

 

53

3.6.  Lease Severance Fee

 

53

3.7.  Advance for Capital Improvements

 

55

 

 

 

ARTICLE IV. IMPOSITIONS

 

55

 

 

 

4.1.  Payment of Impositions

 

55

4.2.  Adjustment of Impositions

 

56

4.3.  Utility Charges

 

56

4.4.  Insurance Premiums

 

56

 

 

 

ARTICLE V. ABSOLUTE NET LEASE; NO TERMINATION; TERMINATION WITH RESPECT TO FEWER THAN ALL PROPERTIES

 

57

 

 

 

5.1.  Absolute Net Lease; No Termination

 

57

5.2.  Termination with Respect to Fewer than All Properties

 

57

 

 

 

ARTICLE VI. OWNERSHIP OF LEASED PROPERTY AND PERSONAL PROPERTY

 

58

 

 

 

6.1.  Ownership of the Leased Property

 

58

6.2.  Lessee’s Personal Property

 

58

 

 

 

ARTICLE VII. CONDITION AND USE OF LEASED PROPERTY

 

58

 

 

 

7.1.  Condition of the Leased Property

 

58

 

i

 

4834-1440-2281v12


 

7.2.  Use of the Leased Property

 

59

7.3.  Lessor to Grant Easements

 

60

 

 

 

ARTICLE VIII. LEGAL AND INSURANCE REQUIREMENTS

 

61

 

 

 

8.1.  Compliance with Legal and Insurance Requirements

 

61

8.2.  Hazardous Materials and Medical Waste

 

61

8.3.  Healthcare Laws

 

64

8.4.  Organizational Covenants

 

65

8.5.  Covenants under CHS Purchase Agreement

 

65

8.6.  Covenants under Tenet Purchase Agreement

 

65

 

 

 

ARTICLE IX. REPAIRS

 

66

 

 

 

9.1.  Maintenance; Repair and Remodel

 

66

9.2.  Encroachments; Restrictions

 

67

 

 

 

ARTICLE X. CAPITAL ADDITIONS

 

67

 

 

 

10.1.  Construction of Capital Additions to the Leased Property

 

67

10.2.  Capital Additions Financed by Lessee

 

68

10.3.  Capital Additions Funded by Lessor

 

69

10.4.  Salvage

 

72

 

 

 

ARTICLE XI. LIENS

 

72

 

 

 

11.1.  General Restrictions; Acknowledgment of Intercreditor

 

72

 

 

 

ARTICLE XII. PERMITTED CONTESTS

 

72

 

 

 

12.1.  Permitted Contests

 

72

 

 

 

ARTICLE XIII. INSURANCE

 

73

 

 

 

13.1.  General Insurance Requirements

 

73

13.2.  Additional Insurance

 

75

13.3.  Endorsements and Other Requirements

 

75

13.4.  Evidence of Insurance

 

76

13.5.  Increase in Limits

 

77

13.6.  Blanket Policy

 

77

13.7.  No Separate Insurance

 

77

 

 

 

 

ii

 

4834-1440-2281v12


 

ARTICLE XIV. FIRE AND CASUALTY

 

78

 

 

 

14.1.  Insurance Proceeds

 

78

14.2.  Reconstruction in the Event of Damage or Destruction Covered by Insurance

 

78

14.3.  Reconstruction in the Event of Damage or Destruction Not Covered by Insurance

 

78

14.4.  Lessee’s Personal Property

 

79

14.5.  Restoration of Lessee’s Property

 

79

14.6.  No Abatement of Rent

 

79

14.7.  Damage Near End of Term

 

79

14.8.  Waiver

 

79

 

 

 

ARTICLE XV. CONDEMNATION

 

79

 

 

 

15.1.  Parties’ Rights and Obligations

 

79

15.2.  Total Taking

 

79

15.3.  Partial Taking

 

80

15.4.  Award Distribution

 

80

15.5.  Temporary Taking

 

80

 

 

 

ARTICLE XVI. DEFAULT

 

80

 

 

 

16.1.  Events of Default

 

80

16.2.  Additional Expenses

 

87

16.3.  Waivers

 

87

16.4.  Application of Funds

 

88

16.5.  Notices by Lessor

 

88

16.6.  Equity Cure Right

 

88

16.7.  Financial Covenant Testing with Respect to Certain New Properties

 

89

 

 

 

ARTICLE XVII. LESSOR’S RIGHT TO CURE

 

89

 

 

 

ARTICLE XVIII. INTENTIONALLY OMITTED

 

89

 

 

 

ARTICLE XIX. HOLDING OVER

 

89

19.1.  Holding Over

 

89

 

 

 

ARTICLE XX. PASS-THROUGH LEASES

 

90

 

 

 

ARTICLE XXI. RISK OF LOSS

 

92

 

 

 

 

 

 

ARTICLE XXII. INDEMNIFICATION

 

92

 

iii

 

4834-1440-2281v12


 

 

 

 

ARTICLE XXIII. ASSIGNMENT, SUBLETTING AND SUBLEASE

 

 

 

 

 

SUBORDINATION

 

94

 

 

 

23.1.  Assignment and Subletting

 

94

23.2.  Sublease Limitations

 

95

23.3.  Sublease Subordination and Non-Disturbance

 

95

23.4.  Existing Subleases

 

96

 

 

 

ARTICLE XXIV. OFFICER’S CERTIFICATES; FINANCIAL STATEMENTS;

 

 

 

 

 

NOTICES AND OTHER CERTIFICATES

 

96

 

 

 

ARTICLE XXV. INSPECTIONS

 

99

 

 

 

ARTICLE XXVI. NO WAIVER

 

99

 

 

 

ARTICLE XXVII. REMEDIES CUMULATIVE

 

99

 

 

 

ARTICLE XXVIII. SURRENDER

 

99

 

 

 

ARTICLE XXIX. NO MERGER OF TITLE

 

99

 

 

 

ARTICLE XXX. TRANSFERS BY LESSOR; SEVERANCE RIGHTS

 

100

30.1.  Transfers by Lessor

 

100

30.2.  Lessor Severance Rights

 

100

 

 

 

ARTICLE XXXI. QUIET ENJOYMENT

 

101

 

 

 

ARTICLE XXXII. NOTICES

 

101

 

 

 

ARTICLE XXXIII. APPRAISAL

 

102

 

 

 

ARTICLE XXXIV. PURCHASE RIGHTS

 

103

34.1.  Lessor’s Option to Purchase Lessee’s Personal Property

 

103

34.2.  Lessee’s First Right of Refusal

 

103

 

 

 

 

iv

 

4834-1440-2281v12


 

ARTICLE XXXV. INTENTIONALLY OMITTED

 

105

 

 

 

ARTICLE XXXVI. FINANCING OF THE LEASED PROPERTY

 

105

 

 

 

ARTICLE XXXVII. SUBORDINATION AND NON-DISTURBANCE

 

105

 

 

 

ARTICLE XXXVIII. LICENSES

 

106

 

 

 

38.1.  Maintenance of Licenses

 

106

38.2.  No Transfers or Alterations of Licenses

 

106

38.3.  Notifications; Corrective Actions

 

106

38.4.  Termination of Lease

 

107

38.5.  Material Condition of Lease

 

107

38.6.  Cooperation; Applicable Transfer Requirements

 

107

 

 

 

ARTICLE XXXIX. MISCELLANEOUS

 

108

 

 

 

39.1.  General

 

108

39.2.  Bankruptcy Waivers

 

108

39.3.  Lessor’s Expenses

 

109

39.4.  Prevailing Party Expenses

 

109

39.5.  Entire Agreement; Modifications; Effect of

 

 

 

 

 

Amendment and Restatement

 

109

 

 

 

39.6.  Lessor Securities Offering and Filings

 

110

39.7.  Non-Recourse as to Parties

 

110

39.8.  Covenants, Restrictions and Reciprocal Easements

 

111

39.9.  Force Majeure

 

111

39.10.  Management Agreements

 

111

39.11.  Non-Competition

 

111

39.12.  Governing Law

 

112

39.13.  Jurisdiction and Venue

 

112

39.14.  True Operating Lease

 

112

39.15.  Intentionally Omitted

 

113

39.16.  Compliance with Anti-Terrorism Laws

 

113

39.17.  Electronically Transmitted Signatures

 

113

39.18.  Waiver of Jury Trial

 

113

39.19.  Counterparts

 

114

39.20.  Survival

 

114

39.21.  Continuation of Defaults

 

114

39.22.  Specific Performance

 

114

39.23.  Joint Drafting

 

114

 

v

 

4834-1440-2281v12


 

39.24.  Joint and Several Obligations

 

114

39.25.  Representations, Agreements and Covenants relating to Certain Properties

 

114

39.26.  Necessary Actions

 

115

39.27.  Intentionally Omitted

 

115

39.28.  Intercreditor Agreement

 

115

39.29.  Lessee Representative

 

115

39.30.  State Specific Provisions

 

115

 

 

 

ARTICLE XLI. MEMORANDUM OF LEASE

 

115

 

LIST OF EXHIBITS AND SCHEDULES

 

 

 

 

vi

 

4834-1440-2281v12


 

 

 

AMENDED AND RESTATED MASTER LEASE Agreement

This AMENDED AND RESTATED MASTER LEASE (the “Lease”) is dated this 27th day of August, 2021 (the “Effective Date”), and is by and among the entities listed on Schedule 1-A attached hereto and made a part hereof by reference and incorporation (collectively, jointly and severally, the “Lessor”), having their principal office at c/o MPT Operating Partnership, L.P., 1000 Urban Center Drive, Suite 501, Birmingham, Alabama 35242, and the entities listed on Schedule 1-B attached hereto and made a part hereof by reference and incorporation (collectively, jointly and severally, the “Lessee”), having their principal office at c/o Steward Health Care System LLC, 1900 Pear Street, Suite 2400, Dallas, Texas 75201, Attn: Chief Executive Officer.

STATEMENT OF INTENT

Subject to Articles V, XIV, XV, XXX and Section 16.1, this Lease constitutes one unitary, indivisible, non-severable true lease of all the Leased Property.  This Lease does not constitute separate leases contained in one document each governed by similar terms.  The use of the expression “unitary lease” to describe this Lease is not merely for convenient reference.  It is the conscious choice of a substantive appellation to express the intent of Lessor and Lessee in regard to an integral part of this transaction, which is to accomplish the creation of an indivisible lease.  Lessor and Lessee agree that from an economic point of view the portions of the Leased Property leased pursuant to this Lease constitute one economic unit and that the Rent and all other provisions have been negotiated and agreed to based upon a lease of all the portions of the Leased Property as a single, composite, inseparable transaction.  Except as expressly provided in this Lease for specific isolated purposes (and in such cases only to the extent expressly so stated), all provisions of this Lease, including definitions, commencement and expiration dates, rental provisions, use provisions, renewal provisions, breach, default, enforcement, termination and assignment and subletting provisions, shall apply equally and uniformly to all the Leased Property as one unit and are not severable.  The economic terms of this Lease would have been substantially different had separate leases or a “divisible” lease been acceptable to Lessor.  A default of any of the terms or conditions of this Lease occurring with respect to any particular Property shall constitute a default under this Lease with respect to all the Leased Property.  Except as expressly provided in this Lease for specific isolated purposes (and in such cases only to the extent expressly so stated), Lessor and Lessee agree that the provisions of this Lease shall at all times be construed, interpreted and applied such that the intention of Lessor and Lessee to create a unitary lease shall be preserved and maintained.  Lessor and Lessee agree that for the purposes of any assumption, rejection or assignment of this Lease under 11 U.S.C. Section 365 or any amendment or successor section thereof, this is one indivisible and non-severable lease dealing with and covering one legal and economic unit which must be assumed, rejected or assigned as a whole with respect to all (and only all) the Leased Property.

 

W I T N E S S E T H:

WHEREAS, Lessor is the current owner of that certain real property more particularly described on Exhibits A-1 et seq. attached hereto and incorporated herein by reference (each together with all hereditaments, easements, mineral rights, rights of way, and other appurtenances  related thereto, and any other parcel of land acquired or leased and made subject to this Lease

1

 

4834-1440-2281v12


 

collectively, the “Land”), and is also the current owner of all of the Leased Improvements (as hereinafter defined) located on the Land (subject, as applicable, to the terms of the Pass-Through Leases (as hereinafter defined));

WHEREAS, the parties acknowledge that (a) a portion of the Hialeah Property (as herein defined) consists of a certain tract of land which is subject to the Hialeah Pass-Through Lease (as herein defined), (b) a portion of the Hialeah Palmetto Property (as herein defined) consists of certain tracts of land which are subject to the Hialeah Palmetto Pass-Through Leases (as herein defined), (c) a portion of the Lauderdale Lakes Property (as herein defined) consists of certain tracts of land which are subject to the Lauderdale Lakes Pass-Through Leases (as herein defined), and (d) a portion of the Miami Property (as herein defined) consists of a certain tract of land which is subject to the Miami Pass-Through Lease (as herein defined);

WHEREAS, pursuant to those certain Assignments and Assumptions of Leases, each dated as of July 31, 2021 to be effective as of August 1, 2021, certain Affiliates of Tenet Healthcare Corporation, a Nevada corporation, assigned (a) to Hialeah Lessor (as defined herein) all of their right, title, and interest in, to, and under the Hialeah Pass-Through Lease (as defined herein), (b) to Hialeah Palmetto Lessor (as defined herein) all of their right, title, and interest in, to, and under the Hialeah Palmetto Pass-Through Leases (as defined herein), (c) to Lauderdale Lakes Lessor (as defined herein) all of their right, title, and interest in, to, and under the Lauderdale Lakes Pass-Through Leases (as defined herein), and (d) to Miami Lessor (as defined herein) all of their right, title, and interest in, to, and under the Miami Pass-Through Lease;

WHEREAS, pursuant to that certain Master Lease Agreement, dated October 3, 2016 (as the same has been modified, amended, supplemented, or restated, from time to time, the “Original Lease”), by and between Lessor and Lessee, Lessor leased (or subleased, as applicable) the Land and Leased Improvements to Lessee, and Lessee leased (or subleased, as applicable) the same from Lessor;

WHEREAS, pursuant to Article II of the Original Lease, Lessee has the option to extend the “Fixed Term” (as defined in the Original Lease) for three (3) additional periods of five (5) years each;

WHEREAS, Lessee desires to exercise the first two (2) of the five (5) year extension options to extend the “Fixed Term” for an additional period of ten (10) years (without prejudice to its third extension option);

WHEREAS, Lessor desires to continue to lease (or sublease, as applicable) the Land and Leased Improvements to Lessee, and Lessee desires to continue to lease (or sublease, as applicable) the same from Lessor, on the terms and conditions hereinafter provided; and

WHEREAS, Lessor and Lessee desire to amend and restate the Original Lease, effective as of the Effective Date, to reflect Lessee’s exercise the first two (2) of the five (5) year extension options (without prejudice to its third option) and to amend certain other provisions of the Original Lease as set forth herein.  

NOW, THEREFORE, the parties hereby amend and restate the Original Lease in its entirety and agree as follows:

2

 

4834-1440-2281v12


 

ARTICLE I.

DEFINITIONS

1.1.Certain Defined Terms.  Capitalized terms used herein shall have the respective meanings ascribed to them in this Section 1.1.

ABL Credit Agreement:  That certain Credit Agreement, dated as of October 3, 2016, among Citibank, N.A., as administrative agent on behalf of itself and the other lenders a party thereto, Steward Health and its Subsidiaries and applicable Affiliates a party thereto, as the same has been or hereafter may be amended, modified, or restated from time to time.

Additional Charges:  As defined in Section 3.2.

Adeptus Texas Master Agreement: That certain Master Agreement (Adeptus - Texas Properties), dated as of July 11, 2018, among Steward Health and certain Affiliates of Lessor, as the same has been or hereafter may be amended, modified, or restated from time to time.

Adjustment Date:  As defined in Section 3.1(b).

Affiliate:  With respect to any Person, (i) any Person that, directly or indirectly, controls or is controlled by or is under common control with such Person, or (ii) any other Person that owns, beneficially, directly or indirectly, 25% or more of the outstanding capital stock, shares or Equity Interests of such Person.  For the purposes of this definition, “control” (including the correlative meanings of the terms “controlled by” and “under common control with”), as used with respect to any Person, shall mean the possession, directly or indirectly, of the power to direct or cause the direction of the management and policies of such Person, through the ownership of voting securities or otherwise; provided that Ralph de la Torre, M.D. shall not be deemed to be an Affiliate of Steward Health or any Facility Lessee.

AI:  The Appraisal Institute, or any successor organization.

Allocated Base Rent:  With respect to each Property, the portion of the Base Rent payable with respect to such Property.

Ancillary Land: That certain real property more particularly described on Exhibit A-26 attached hereto and made a part hereof by reference and incorporation, together with all hereditaments, easements, mineral rights, rights of way and other appurtenances related thereto.

 

Ancillary Property; Ancillary Properties: The Ancillary Land and all Leased Improvements located thereon as described on Schedule 1-D attached hereto and made a part hereof by reference and incorporation.

 

Ancillary Property Lessees:  Individually and collectively, those certain Affiliates of Lessee which lease the Ancillary Property from the Ancillary Property Lessors as set forth on Schedule 1-D attached hereto and made a part hereof by reference and incorporation.

 

3

 

4834-1440-2281v12


 

 

Ancillary Property Lessors: Individually and collectively, those certain Affiliates of Lessor which lease the Ancillary Property to the Ancillary Property Lessee as set forth on Schedule 1-D attached hereto and made a part hereof by reference and incorporation.

 

Anti-Terrorism Laws:  Any applicable laws, statutes and regulations relating to terrorism or money laundering, including Executive Order No. 13224 (effective September 24, 2001), the Patriot Act, the laws, statutes and regulations comprising or implementing the Bank Secrecy Act, and the laws, statutes and regulations administered by OFAC.

Applicable Lease Rate: With respect to each (i) Property (other than a New Property or New Project that becomes subject to this Lease after June 1, 2021) and each Massachusetts New Project, the applicable per annum rate described on Schedule 3.1(b) attached hereto and made a part hereof by reference and incorporation, subject to the applicable Escalator set forth in Section 3.1(b)(i), and (ii) New Property or New Project (other than a Massachusetts New Project) that becomes subject to this Lease after June 1, 2021, the per annum New Property/Project Lease Rate described on Schedule 3.1(b) attached hereto and made a part hereof by reference and incorporation, subject to the applicable New Property/Project Escalator set forth in Section 3.1(b)(ii).

Arizona Master Agreement: That certain Master Agreement (Arizona Property), dated as of December 14, 2018, among Steward Health, Mountain Vista Medical Center, LP, and MPT of Florence, LLC, as the same has been or hereafter may be amended, modified, or restated from time to time.

Arizona Property: Collectively, the Mountain Vista Property, the St. Luke's Property, the St. Luke's Behavioral Property, the Tempe Property, that portion of the Ancillary Property located in the State of Arizona, and the Florence Property.

Award:  All compensation, sums or anything of value awarded, paid or received from a total or partial Condemnation.

Bankruptcy Code:  Title 11 of the United States Code, § 101, et seq.

Base Rent:  As defined in Section 3.1(a).

Big Spring Facility: That certain facility operated for the applicable Primary Intended Use located at the Big Spring Land.

Big Spring Land: That certain real property located in Howard County, Texas as more particularly described on Exhibit A-35 attached hereto and made a part hereof by reference and incorporation, together with all hereditaments, easements, mineral rights, rights of way and other appurtenances related thereto.

Big Spring Lessee: Collectively, Steward Texas Hospital Holdings LLC, a Delaware limited liability company, and Permian Premier Health Services, Inc., a Texas nonprofit corporation that is certified as a nonprofit health organization by the Texas Medical Board, together with their respective successors and permitted assigns.

4

 

4834-1440-2281v12


 

Big Spring Lessor: MPT of Big Spring-Steward, LLC, a Delaware limited liability company, together with its successors and assigns.

Big Spring Master Agreement: That certain Big Spring Master Agreement, dated as of April 12, 2019, among Steward Health, Steward Texas Hospital Holdings LLC, Permian Premier Health Services, Inc., and MPT of Big Spring-Steward, LLC, as the same may be modified, amended, or restated from time to time.

Big Spring Property: The Big Spring Land and related Leased Improvements located thereon relating to the Big Spring Facility.

Binding Agreement:  As defined in Section 34.2(a).

Blocked Person:  Any Person: (a) listed in the annex to, or is otherwise subject to the provisions of, Executive Order No. 13224, (b) owned or controlled by, or acting for or on behalf of, any Person that is listed in the annex to, or is otherwise subject to the provisions of, Executive Order No. 13224, (c) with which any lender is prohibited from dealing or otherwise engaging in any transaction by any Anti-Terrorism Law, (d) that commits, threatens or conspires to commit or supports “terrorism” as defined in Executive Order No. 13224, or (e) that is named a “specially designated national” or “security blocked person” on the OFAC List.

Borrower Affiliates: MPT of West Jordan-Steward Property, LLC and MPT of Layton-Steward Property, LLC, each a Delaware limited liability company, as successor by assignment, respectively, to Jordan Valley Medical Center, LP and Davis Hospital & Medical Center, LP, each a Delaware limited partnership.

 

Business: With respect to each of the Properties, the primary operation of a healthcare facility thereon and ancillary facilities related thereto, and, in each case, the engagement in and pursuit and conduct of any business venture or activity incident thereto.

Business Day:  Each Monday, Tuesday, Wednesday, Thursday and Friday that is not a day on which money centers in the City of New York, New York are authorized or obligated by law or executive order to close.

Capital Additions:  With respect to each Property, (a) extraordinary renovations or expansions of buildings, structures or other improvements currently located on that Property (or on additional parcels added to such Property), (b) the addition of one or more parcels of land to such Property (whether by purchase or ground lease), or (c) the addition of one or more new buildings or additional structures placed on such Property or any such additional parcels of land, including, without limitation, the construction of a new wing or new story.

Capital Lease Obligations: With respect to any Person, the obligations of such Person to pay rent or other amounts under any lease of (or other arrangement conveying the right to use) real or personal property, or a combination thereof, which obligations are required to be classified and accounted for as capital leases on a balance sheet of such Person under GAAP, and the amount of such obligations shall be the capitalized amount thereof determined in accordance with GAAP.

5

 

4834-1440-2281v12


 

Carney Facility: That certain one hundred fifty-nine (159)-licensed bed general acute care hospital facility operated at the Carney Land, commonly known as “Carney Hospital.”

Carney Land: That certain real property located in Suffolk County, Massachusetts more particularly described on Exhibit A-33 attached hereto and made a part hereof by reference and incorporation, together with all hereditaments, easements, mineral rights, rights of way and other appurtenances related thereto.

Carney Lessee: Steward Carney Hospital, Inc., a Delaware corporation, together with its successors and permitted assigns.

Carney Lessor: MPT of Dorchester-Steward, LLC, a Delaware limited liability company, together with its successors and assigns.

Carney Property: The Carney Land and related Leased Improvements located thereon relating to the Carney Facility.

Casualty Impacted Property:  As defined in Section 14.2(a).

CERCLA:  As defined in the definition of “Hazardous Materials Laws.”

Change of Control Transaction:  Shall mean (i) Steward Health ceasing to own, in the aggregate, directly or indirectly, one hundred percent (100%) of the voting Equity Interests of any Facility Lessee, or (ii) a majority of the voting Equity Interests of Steward Health or Steward Health Care Holdings, LLC are sold or transferred to a Person, and, following such sale or transfer, (A) such Person is not a Qualified Transferee or, (B) after giving pro forma effect to such sale or transfer, there exists a breach of Section 16.1(j) or (k), without the prior written consent of Lessor, which consent shall not be unreasonably withheld, conditioned or delayed; provided, however, that notwithstanding the foregoing, neither (w) the sale or transfer of Equity Interests of Steward Health or Steward Health Care Holdings, LLC between or to the existing holders of the Equity Interests of Steward Health or Steward Health Care Holdings, LLC, as of the Effective Date, (x) the sale or transfer of Equity Interests held directly or indirectly by Ralph de la Torre, M.D. between or to any other Person either (1) to any member(s) of his Immediate Family, for estate planning purposes, or in the event of his death or permanent disability or (2) for which Ralph de la Torre, M.D. or any member(s) of his Immediate Family owns, beneficially, directly or indirectly, 51% or more of the outstanding capital stock, shares or Equity Interests of such Person, (y) an internal reorganization that involves the dissolution, liquidation or winding up of Steward Health or Steward Health Care Holdings, LLC, but only if the assets and liabilities of Steward Health or Steward Health Care Holdings, LLC are transferred to another direct or indirect wholly-owned subsidiary of Steward Health Care Investors LLC, nor (z) a Qualified Public Offering shall constitute a Change of Control.  For the avoidance of doubt, the entering into a written agreement or the granting of an option to acquire Equity Interests or the issuance of debt convertible into Equity Interests shall be deemed to be the issuance of Equity Interests for purposes of determining whether a Change of Control Transaction has occurred.  For the purposes of this definition, “control” (including the correlative meanings of the terms “controlled by” and “under common control with”), as used with respect to any Person, shall mean the possession, directly or indirectly, of the power to direct or cause the direction of the management and policies of such Person, through the ownership of voting securities or otherwise.

6

 

4834-1440-2281v12


 

CHIP: The Children’s Health Insurance Program administered by the United States Department of Health and Human Services, which program was formerly known as the State Children’s Health Insurance Program, and any successor program.

CHS Land:  Collectively, the Hillside Land, the Northside Medical Land, the Sebastian Land, the Sharon Land, the Trumbull Land, the Wuesthoff Melbourne Land, and the Wuesthoff Rockledge Land.

CHS Master Agreement:  That certain CHS Master Agreement, dated as of February 16, 2017, among Steward Health, Hillside Lessor, Northside Lessor, Sebastian Lessor, Sharon Lessor, Trumbull Lessor, Wuesthoff Melbourne Lessor, Wuesthoff Rockledge Lessor, and certain of their Affiliates, as the same has been or hereafter may be amended, modified, or restated from time to time.

CHS Property:  Collectively, the CHS Land, including all herediments, easements, rights of way and other appurtenances related thereto, and all buildings, improvements and fixtures located thereon.

CHS Purchase Agreement: That certain Asset Purchase Agreement, dated as of February 16, 2017 by and among Steward Health and CHS/Community Health Systems, Inc., a Delaware corporation, as the same has been or hereafter may be amended, modified, or restated from time to time.

Claim:  As defined in Section 8.2(c).

CMS:  As defined in Section 38.1.

COBRA: The Consolidated Omnibus Budget Reconciliation Act of 1985, as amended.

Code:  The United States Internal Revenue Code of 1986, as amended, and all regulations thereunder. Any reference herein to a specific section or sections of the Code shall be deemed to include a reference to any corresponding provision of future law.

Commencement Date:  The Initial Commencement Date, provided that as to any New Property, Commencement Date shall mean the date that such New Property becomes subject to this Lease.

Completion Date: With respect to any New Project, the date of "Completion" thereof pursuant to the applicable Project Development Agreement for such New Project.

Condemnation: Either (a) the exercise of any governmental power, whether by legal proceedings or otherwise, by a Condemnor or (b) a voluntary sale or transfer by Lessor to any Condemnor, either under threat of Condemnation or while legal proceedings for Condemnation are pending, in all of the foregoing cases with respect to any portion of the Leased Property.

Condemnor:   Any public or quasi-public authority having the power of Condemnation.

7

 

4834-1440-2281v12


 

Consolidated Fixed Charges:  For any period, for Steward Health and its Subsidiaries on a consolidated basis, an amount equal to the sum for such period of (a) scheduled rent payments, plus, (b) consolidated interest charges, plus (c) consolidated maintenance capital expenditures, plus (d) scheduled principal payments of consolidated funded debt.

Contribution Agreement: That certain Contribution Agreement, dated as of May 11, 2020, among Steward Health, Davis Lessee, West Jordan Lessee, Davis Lessor, West Jordan Lessor, MPT of Utah-Steward Holdings, LLC, and MPT of Utah-Steward, LLC, as the same has been or hereafter may be amended, modified, or restated from time to time.

Construction Period: With respect to any New Project, the "Construction Period" under and as defined in the applicable Project Development Agreement.

Construction Period Accrual: With respect to any New Project, during the applicable Construction Period, an amount equal to the product of (a) the amount of all costs funded by Lessor pursuant to the applicable Project Development Agreement, multiplied on a per diem basis by (b) the Applicable Lease Rate for the applicable Property (based upon a three hundred sixty (360) day year).

Coral Gables Facility: That certain two hundred forty-five (245)-licensed bed general acute care hospital facility operated at the Coral Gables Land, commonly known as “Coral Gables Hospital”.

Coral Gables Land: Coral Gables Land: That certain real property located in Miami-Dade County, Florida as more particularly described on Exhibit A-30 attached hereto and made a part hereof by reference and incorporation, together with all hereditaments, easements, mineral rights, rights of way and other appurtenances related thereto.

Coral Gables Lessee: Steward CGH, Inc., a Delaware corporation, together with its successors and permitted assigns.

Coral Gables Lessor:  MPT of Coral Gables-Steward, LLC, a Delaware limited liability company, together with its successors and assigns.

Coral Gables Property:  The Coral Gables Land and related Leased Improvements located thereon relating to the Coral Gables Facility.

CPI:  The Consumer Price Index, all urban consumers, all items, U.S. City Average, published by the United States Department of Labor, Bureau of Labor Statistics, in which 1982-1984 equals one hundred (100).  If the Consumer Price Index is discontinued or revised during the term of this Lease, such other governmental index or computation with which it is replaced shall be used in order to obtain substantially the same result as would be obtained if the Consumer Price Index had not been discontinued or revised.

Credit Enhancements:  With respect to each Property, all security deposits, security interests, letters of credit, pledges, guaranties, prepaid rent or other sums, deposits or interests held by Lessee, if any, with respect to such Property, and the Tenant Leases relating to such Property for the Tenants or subtenants thereunder.

8

 

4834-1440-2281v12


 

Date of Taking:  The date the Condemnor has the right to possession of the property being condemned.

Davis Facility: That certain Two-Hundred and Twenty (220)-licensed bed general acute care hospital facility operated at the Davis Land, commonly known as “Davis Hospital and Medical Center” and that certain free standing emergency room operated at the Davis Land, commonly known as “Davis Hospital - Weber Campus.”

Davis Land: That certain real property, a portion of which is located in Davis County, Utah and a portion of which is located in Weber County, Utah, as more particularly described on Exhibit A-37 attached hereto and made a part hereof by reference and incorporation, together with all hereditaments, easements, mineral rights, rights of way and other appurtenances related thereto.

Davis Lessee: Davis Hospital & Medical Center, LP, a Delaware limited partnership, together with its successors and permitted assigns.

Davis Lessor: MPT of Layton-Steward Property, LLC, a Delaware limited liability company, together with its successors and assigns.

Davis PFDA: That certain Project Funding and Development Agreement, dated as of September 11, 2020, by and among Davis Lessor, Steward Health, and Davis Lessee, as the same has been or hereafter may be amended, modified, or restated from time to time.

Davis Project: The "Project" under and as defined in the Davis PFDA.

Davis Project Completion Date: The date of "Completion" under and as defined in the Davis PFDA; subject, however, to the rights of Davis Lessor pursuant to the Davis PFDA to establish the Davis Project Completion Date upon the occurrence of certain other events.

Davis Project Development Costs: The sum of (a) all costs funded by Davis Lessor for the Davis Project pursuant to the Davis PFDA, and (b) the “Construction Period Accrual” under and as defined in the Davis PFDA.

Davis Property: The Davis Land and related Leased Improvements located thereon relating to the Davis Facility.

Decision Period:  As defined in Section 34.2(a).

Declarations:  As defined in Section 39.8.

Defaulted Property:  As defined in Section 16.1B.

Deferred Utah Rent: As defined in Section 3.5.

Deferred Utah Rent Payment: As defined in Section 3.5.  

DHS:  As defined in Section 38.1.

DHHS:  As defined in Section 38.1.

9

 

4834-1440-2281v12


 

EBITDAR:  For any period of four consecutive fiscal quarters of Steward Health, Net Income for such period plus, to the extent not otherwise included in the determination of Net Income for such period, all proceeds of business interruption insurance policies, if any, received during such period, in an amount representing the earnings for the applicable period that such proceeds are intended to replace; plus (a) without duplication and to the extent deducted in determining Net Income for such period, the sum of (i) Interest Expense for such period, (ii) income tax expense for such period, (iii) all amounts attributable to depreciation and amortization expense for such period, (iv) rent expense for realty for such period, (v) (A) any non-cash extraordinary expenses, losses or charges for such period, (B) any severance costs or early retirement expenses incurred or paid in such period and (C) any other unusual or non-recurring expenses, losses or charges for such period provided the aggregate amount of items in this clause (C) shall not exceed (I) $35,000,000 for any such period ending on or prior to December 31, 2016 and (II) 10% of EBITDAR for any such period ending after December 31, 2016 (without giving effect to the adjustments in this clause (v)(C) or clauses (x) and (y) of clause (xiv)(B) below), (vi) any expenses, losses or charges from disposed, abandoned or discontinued operations for such period, (vii) any other non-cash expenses, losses or charges for such period (but excluding any non-cash expense, loss or charge in respect of an item that was included in Net Income in a prior period and any non-cash expense, loss or charge that relates to the write-down or write-off of inventory), (viii) any up-front fees, transaction costs, commissions, expenses, premiums or charges incurred or paid prior to the date of this Lease related to the issuance of Equity Interests, any investment, any acquisition, any asset sale or other disposition, any recapitalization or any incurrence of Indebtedness (in each case whether or not consummated) during such period, including (A) such fees, expenses or charges related to this Lease or the ABL Credit Agreement and any amendment or other modification of this Lease or the ABL Credit Agreement and (B) such fees, expenses or charges incurred or paid in such period prior to the date of this Lease by Steward Health or any of its Subsidiaries in connection with any acquisition consummated by Steward Health or any of its Subsidiaries prior to the date of this Lease, (ix) any non-cash interest expense for such period in respect of any Plan, (x) any non-cash losses realized in such period in connection with adjustments to any Plan due to changes in actuarial assumptions, valuations or studies, (xi) any net working capital adjustment, earn-out or other deferred purchase price payment incurred in connection with any investment permitted under this Lease or any investment consummated prior to the date of this Lease, and paid or accrued during such period, (xii) any management, monitoring, consulting or advisory fees or expenses paid to Cerberus Capital Management, L.P. or any of its Affiliates (or any accruals relating to such fees and expenses) during such period to the extent otherwise permitted under this Lease, (xiii)(A) any charge, expense or loss to the extent that a corresponding amount is received in cash by Steward Health or any of its Subsidiaries from a Person other than Steward Health Care Holdings, LLC or any of its Subsidiaries under any agreement or insurance providing for reimbursement of such expense or (B) any charge, expense or loss with respect to any liability or casualty event, business interruption or product recall to the extent covered by insurance proceeds received in cash during such period, and (xiv)(A) any up-front fees, transaction costs, commissions, expenses, premiums or charges incurred or paid on or after the date of this Lease related to the issuance of Equity Interests, any investment, any acquisition, any asset sale or other disposition, any recapitalization or any incurrence of Indebtedness permitted hereunder (in each case whether or not consummated) during such period, including (I) such fees, expenses or charges related to this Lease or the ABL Credit Agreement and any amendment or other modification of this Lease or the ABL Credit Agreement and (II) such fees, expenses or charges incurred or paid in such period on or after the date of this Lease by Steward Health or any of its Subsidiaries in connection with any acquisition consummated by Steward Health or any of its Subsidiaries prior to the date of this Lease and (B) the amount of (I) any restructuring charges or reserves or non-recurring integration costs or business optimization expenses for such period, including any one-time costs incurred in connection with acquisitions permitted by this Lease and costs related to the closure and/or consolidation of facilities (including costs relating to initiatives aimed at profitability) and (II) any net cost savings and synergies projected by  Steward Health in good faith to be realized as a result of specified actions taken prior to or during such period or to be taken within the first twelve months following of the end of such period; provided that in no event shall the sum of (x) the aggregate amounts under clause (xiv)(B) plus (y) the aggregate amount of any fees, costs, expenses, premiums or charges payable in respect of liabilities or fines paid or payable by Steward Health or its Subsidiaries pursuant to the Stark law (also known as the physician self-referral law) included in any calculation pursuant to this clause (a), exceed 15% of EBITDAR for such period (without giving effect to the adjustments described in the foregoing clauses (x) and (y)); minus (b) without duplication and to the extent included in Net Income, (i) any cash payments made during such period in respect of non-cash expenses, losses or charges described in clause (a)(vii) taken in a prior period, (ii) any extraordinary gains and any extraordinary non-cash items of income for such period, all calculated for Steward Health and its Subsidiaries on a consolidated basis and (iii) any gains or income from disposed, abandoned or discontinued operations for such period (without giving effect to the financial results or accounts of the Excluded Subsidiaries) in accordance with GAAP.

Effective Date: As defined in the preamble to this Lease.

Entered Property:  As defined in Section 16.1A.

Environmental Indemnification Agreement: That certain Environmental Indemnification Agreement, dated as of the Initial Commencement Date, executed and delivered by each Guarantor to and in favor of Lessor and certain of its Affiliates, as the same has been or hereafter may be amended, modified, or restated from time to time.

Equity Cure Expiration Date. As defined in Section 16.6.

Equity Cure Right. As defined in Section 16.6.

Equity Interests:  With respect to any Person, the voting power, ownership, or other equitable interests of such Person, including any interest represented by any capital stock, convertible or participating debt instruments, membership interest, partnership interest, or any similar interest therein.

Equity Purchase Agreement:  That certain Equity Purchase Agreement, dated as of September 26, 2016, among Steward Health, MPT and certain of their respective Affiliates, as the same has been or hereafter may be amended, modified, or restated from time to time.

ERISA: means the Employee Retirement Income Security Act of 1974, as amended from time to time.

10

 

4834-1440-2281v12


 

ERISA Affiliate: Any trade or business (whether or not incorporated) that, together with an Obligor, is treated as a single employer under Section 414(b) or (c) of the Code or, solely for purposes of Section 302 of ERISA and Section 412 of the Code, is treated as a single employer under Section 414 of the Code.

Escalator:  The (i) Legacy Escalator, with respect to each Property (other than a New Property or New Project that becomes subject to this Lease after June 1, 2021) and each Massachusetts New Project and (ii) New Property/Project Escalator, with respect to each New Property or New Project that becomes subject to this Lease after June 1, 2021 (other than a Massachusetts New Project).

Escrow Invoice: As defined in Section 3.2.

Event of Default:  As defined in Section 16.1.

Excluded Subsidiary:  Any now existing or hereafter acquired direct or indirect subsidiary of a Steward Health, if (a) such subsidiary is identified on Exhibit D, (b) such subsidiary is not wholly-owned by Steward Health or any of its Subsidiaries and Steward Health or its Subsidiaries own in aggregate less than 80% of the voting stock of such subsidiary, (c) such subsidiary is a controlled foreign corporation (as that term is defined in the Code), (d) such subsidiary is organized as a non-profit corporation and does not distribute its surplus funds to its equity-holders or (e) such subsidiary is prohibited by applicable law from being, or otherwise requires the consent of any Governmental Body (which has not been obtained after Steward Health has used commercially reasonable efforts to obtain such consent) having jurisdiction over it to be, joined as a Lessee hereunder or under any other Obligation Document.

Existing Subleases:  As defined in Section 23.4.

Extension Notice:   As defined in Article II.

Extension Term:   As defined in Article II.

Facility: Each of the Good Samaritan Facility, the Holy Family Facility, the Morton Facility, the St. Anne’s Facility, the St. Elizabeth Facility, the Hillside Facility, the Northside Medical Facility, the Sebastian Facility, the Sharon Facility, the Trumbull Facility, the Wuesthoff Melbourne Facility, the Wuesthoff Rockledge Facility, the Glenwood Facility, the Jordan Valley Facility, the Odessa Facility, the Mountain Point Facility, the Mountain Vista Facility, the Salt Lake Facility, the Southeast Texas Facility, the Southwest General Facility, the St. Luke's Facility, the St. Luke's Behavioral Facility, the Tempe Facility, the Wadley Facility, the Norwood Facility, the Nashoba Facility, the Holy Family Merrimack Facility, the St. Joseph Facility, the Carney Facility, the Big Spring Facility, the Florence Facility, the West Jordan Facility, the Davis Facility, the Coral Gables Facility, the Lauderdale Lake Facility, the Hialeah Facility, the Hialeah Palmetto Facility, and the Miami Facility, sometimes collectively referred to as the "Facilities."

 

Facility Instrument:  A note (whether secured or unsecured), loan agreement, credit agreement, guaranty, security agreement, mortgage, deed of trust or other agreement pursuant to which a Facility Lender has provided financing to Lessor in connection with the Leased Property or any part thereof, or funding provided to Lessee, if such funding is provided by Lessor or any

11

 

4834-1440-2281v12


 

Affiliate of Lessor (other than any Obligor) or in connection with a Capital Addition, and any and all renewals, replacements, modifications, supplements, consolidations and extensions thereof.

Facility Lender: A holder (which may include any Affiliate of Lessor) of any Facility Instrument.

Facility Lessee: The Good Samaritan Lessee, with respect to the Good Samaritan Property; the Holy Family Lessee, with respect to the Holy Family Property; the Morton Lessee, with respect to the Morton Property; the St. Anne’s Lessee, with respect to the St. Anne’s Property; the St. Elizabeth Lessee, with respect to the St. Elizabeth Property; the Hillside Lessee, with respect to the Hillside Property; the Northside Medical Lessee, with respect to the Northside Medical Property; the Sebastian Lessee, with respect to the Sebastian Property; the Sharon Lessee, with respect to the Sharon Property; the Trumbull Lessee, with respect to the Trumbull Property; the Wuesthoff Melbourne Lessee, with respect to the Wuesthoff Melbourne Property; the Wuesthoff Rockledge Lessee, with respect to the Wuesthoff Rockledge Property; the Glenwood Lessee, with respect to the Glenwood Property; the Jordan Valley Lessee, with respect to the Jordan Valley Property; the Odessa Lessee, with respect to the Odessa Property; the Mountain Point Lessee, with respect to the Mountain Point Property; the Mountain Vista Lessee, with respect to the Mountain Vista Property; the Salt Lake Lessee, with respect to the Salt Lake Property; the Southeast Texas Lessee, with respect to the Southeast Texas Property; the Southwest General Lessee, with respect to the Southwest General Property; the St. Luke's Lessee, with respect to the St. Luke's Property; the St. Luke's Behavioral Lessee, with respect to the St. Luke's Behavioral Property; the Tempe Lessee, with respect to the Tempe Property; the Wadley Lessee, with respect to the Wadley Property; the Ancillary Property Lessees, as applicable, with respect to each Ancillary Property; the Nashoba Lessee, with respect to the Nashoba Property; the Norwood Lessee, with respect to the Norwood Property; the St. Anne's Lessee, with respect to the St. Anne's Fall River Parking Lot Property; the Holy Family Lessee, with respect to the Holy Family Merrimack Property; the St. Joseph Lessee, with respect to the St. Joseph Property; the Carney Lessee, with respect to the Carney Property; the Big Spring Lessee, with respect to the Big Spring Property; the Florence Lessee, with respect to the Florence Property; the West Jordan Lessee, with respect to the West Jordan Property; the Davis Lessee, with respect to the Davis Property; the Coral Gables Lessee, with respect to the Coral Gables Property; the Lauderdale Lakes Lessee, with respect to the Lauderdale Lakes Property; the Hialeah Lessee, with respect to the Hialeah Property; the Hialeah Palmetto Lessee, with respect to the Hialeah Palmetto Property; the Miami Lessee, with respect to the Miami Property; and the Lessee party thereto, with respect to any New Property.

 

Facility Lessor: The Good Samaritan Lessor, with respect to the Good Samaritan Property; the Holy Family Lessor, with respect to the Holy Family Property; the Morton Lessor, with respect to the Morton Property; the St. Anne’s Lessor, with respect to the St. Anne’s Property; the St. Elizabeth Lessor, with respect to the St. Elizabeth Property; the Hillside Lessor, with respect to the Hillside Property; the Northside Medical Lessor, with respect to the Northside Medical Property; the Sebastian Lessor, with respect to the Sebastian Property; the Sharon Lessor, with respect to the Sharon Property; the Trumbull Lessor, with respect to the Trumbull Property; the Wuesthoff Melbourne Lessor, with respect to the Wuesthoff Melbourne Property; the Wuesthoff Rockledge Lessor, with respect to the Wuesthoff Rockledge Property; the Glenwood Lessor, with respect to the Glenwood Property; the Jordan Valley Lessor, with respect to the Jordan Valley Property; the Odessa Lessor, with respect to the Odessa Property; the Mountain Point Lessor, with

12

 

4834-1440-2281v12


 

respect to the Mountain Point Property; the Mountain Vista Lessor, with respect to the Mountain Vista Property; the Salt Lake Lessor, with respect to the Salt Lake Property; the Southeast Texas Lessor, with respect to the Southeast Texas Property; the Southwest General Lessor, with respect to the Southwest General Property; the St. Luke's Lessor, with respect to the St. Luke's Property; the St. Luke's Behavioral Lessor, with respect to the St. Luke's Behavioral Property; the Tempe Lessor, with respect to the Tempe Property; the Wadley Lessor, with respect to the Wadley Property; the Ancillary Lessors, as applicable, with respect to each Ancillary Property; the Nashoba Lessor, with respect to the Nashoba Property; the Norwood Lessor, with respect to the Norwood Property; the St. Anne's Lessor, with respect to the St. Anne's Fall River Parking Lot Property; the Holy Family Merrimack Lessor, with respect to the Holy Family Merrimack Property; the St. Joseph Lessor, with respect to the St. Joseph Property; the Carney Lessor, with respect to the Carney Property; the Big Spring Lessor, with respect to the Big Spring Property; the Florence Lessor, with respect to the Florence Property; the West Jordan Lessor, with respect to the West Jordan Property; the Davis Lessor, with respect to the Davis Property; the Coral Gables Lessor, with respect to the Coral Gables Property; the Lauderdale Lakes Lessor, with respect to the Lauderdale Lakes Property; the Hialeah Lessor, with respect to the Hialeah Property; the Hialeah Palmetto Lessor, with respect to the Hialeah Palmetto Property; the Miami Lessor, with respect to the Miami Property; and the Lessor party thereto, with respect to any New Property.

Facility Loan:  A loan made by a Facility Lender.

Fair Market Value:  With respect to each Property, the Fair Market Value of such Property, including all Capital Additions with respect thereto, (a) as shall be determined in accordance with the appraisal procedures set forth in Article XXXIII or in such other manner as shall be mutually acceptable to Lessor and Lessee, and (b) which shall not take into account any reduction in value resulting from any damage, destruction or condemnation of any part of such Property or any indebtedness to which such Property is subject (other than indebtedness owed to Lessor that is secured by the Property) and which encumbrance Lessee or Lessor is otherwise required to remove pursuant to any provision of this Lease or agrees to remove at or prior to the closing of the transaction as to which such Fair Market Value determination is being made.  With respect to each Property, and notwithstanding anything contained in this Lease to the contrary, any appraisal of such Property shall assume the Lease is in place for a term of twenty (20) years, and shall not take into account any purchase options.  

Fall River Master Agreement: That certain Fall River Master Agreement, dated as of March 16, 2018, among Steward Health, St. Anne’s Lessee, and MPT of Fall River-Steward Lender, LLC, as the same has been or hereafter may be amended, modified, or restated from time to time.

Financial Statements:  For any fiscal year or other accounting period for the applicable Person, balance sheets, statements of operations and capital accounts, and statements of cash flows setting forth in comparative form the corresponding figures for the year-earlier fiscal period, all prepared in accordance with GAAP.

Fixed Term:  As defined in Article II.

Fixtures:  All equipment, machinery, fixtures, and other items of real property, including all components thereof, now and hereafter located in, on, or used in connection with, and that are, in each case, permanently affixed to the Land, or affixed or incorporated into the buildings and

13

 

4834-1440-2281v12


 

structures on the Land, including, without limitation, all affixed furnaces, boilers, heaters, electrical equipment, heating, plumbing, lighting, ventilating, refrigerating, incineration, air and water pollution control, waste disposal, air-cooling and air-conditioning systems and apparatus, sprinkler systems and fire and theft protection equipment, and built-in oxygen and vacuum systems, all of which, to the greatest extent permitted by law, are hereby deemed by the parties to constitute real estate, together with all replacements, modifications, alterations and additions thereto.

Florence Facility: That certain thirty-six (36)-licensed bed general acute care hospital facility operated at the Florence Land, previously known as “Florence Hospital at Anthem.”

 

Florence Land: That certain real property located in Pinal County, Arizona as more particularly described on Exhibit A-34 attached hereto and made a part hereof by reference and incorporation, together with all hereditaments, easements, mineral rights, rights of way and other appurtenances related thereto.

 

Florence Lease Inducement Fee: As defined in Section 3.4(b).

Florence Lessee: Mountain Vista Medical Center, LP, a Delaware limited partnership, together with its successors and permitted assigns.

 

Florence Lessor: MPT of Florence, LLC, a Delaware limited liability company, together with its successors and assigns.

 

Florence Property: The Florence Land and related Leased Improvements located thereon relating to the Florence Facility.

 

Florida Property: Collectively, the Sebastian Property, the Wuesthoff Melbourne Property, the Wuesthoff Rockledge Property, the Coral Gables Property, the Lauderdale Lakes Property, the Miami Property, the Hialeah Property, and the Hialeah Palmetto Property.

 

Force Majeure:  As defined in Section 39.9.

Funding Amount:  As defined in Section 3.7.

GAAP:  Generally accepted accounting principles in the United States as in effect from time to time and applied consistently throughout the periods involved.

Glenwood Facility: That certain Two Hundred Seventy-Eight (278)-licensed bed general acute care hospital facility operated at the Glenwood Land, commonly known as "Glenwood Regional Medical Center."

 

Glenwood Land: That certain real property located in Ouachita Parish, Louisiana as more particularly described on Exhibit A-13 attached hereto and made a part hereof by reference and incorporation, together with all hereditaments, easements, mineral rights, rights of way and other appurtenances related thereto.

 

14

 

4834-1440-2281v12


 

 

Glenwood Lessee:  IASIS Glenwood Regional Medical Center, LP, a Delaware limited partnership, together with its successors and permitted assigns.

 

Glenwood Lessor:  MPT of West Monroe, LLC, a Delaware limited liability company, together with its successors and assigns.

 

Glenwood Property:  The Glenwood Land and related Leased Improvements located thereon relating to the Glenwood Facility.

 

Good Samaritan Facility: That certain two hundred twenty-four (224)-licensed bed general acute care hospital facility operated at the Good Samaritan Land, commonly known as “Good Samaritan Medical Center.”

Good Samaritan Land: That certain real property located in Plymouth County, Massachusetts as more particularly described on Exhibit A-1 attached hereto and made a part hereof by reference and incorporation, together with all hereditaments, easements, mineral rights, rights of way and other appurtenances related thereto.

Good Samaritan Lessee:  Steward Good Samaritan Medical Center, Inc., a Delaware corporation, together with its successors and permitted assigns.

Good Samaritan Lessor:  MPT of Brockton-Steward, LLC, a Delaware limited liability company, together with its successors and assigns.

Good Samaritan Property:  The Good Samaritan Land and related Leased Improvements located thereon relating to the Good Samaritan Facility.

Governmental Body:  Any United States federal, state or local, or any supra national or non U.S., government, political subdivision, governmental, regulatory or administrative authority, instrumentality, agency body or commission, court, tribunal or judicial or arbitral body, in each case of competent jurisdiction, including the Securities and Exchange Commission.

Guarantor:  Steward Health, its successors and permitted assigns.

Guaranty:  That certain Guaranty, dated as of the Initial Commencement Date, executed and delivered by Guarantor in favor of Lessor and certain of its Affiliates, as the same has been or hereafter may be amended, modified, or restated from time to time.

Hazardous Materials:  Any substance deemed hazardous under any Hazardous Materials Laws, including without limitation, asbestos, the group of organic compounds known as polychlorinated biphenyls, flammable explosives, radioactive materials, infectious wastes, biomedical and medical wastes, chemicals known to cause cancer or reproductive toxicity, lead and lead-based paints, radon, and any items included in the definition of hazardous or toxic wastes, materials or substances under any Hazardous Materials Laws.

Hazardous Materials Laws:  Each federal, state and local law and regulation relating to pollution or protection or preservation of human health (to the extent related to exposure to or management of Hazardous Materials) or protection of the environment, including ambient air,

15

 

4834-1440-2281v12


 

surface water, ground water, land surface or subsurface strata, and natural resources, and including each law and regulation relating to emissions, discharges, releases or threatened releases of Hazardous Materials, or otherwise relating to the manufacturing, processing, distribution, use, treatment, generation, storage, containment (whether above ground or underground), disposal, transport or handling of Hazardous Materials, and each law and regulation with regard to record keeping, notification, disclosure and reporting requirements respecting Hazardous Materials, including, without limitation, the Resource Conservation and Recovery Act of 1976 (“RCRA”), the Comprehensive Environmental Response, Compensation and Liability Act of 1980 (“CERCLA”), as amended by the Superfund Amendments and Reauthorization Act of 1986 (“SARA”), the Hazardous Materials Transportation Act, the Federal Water Pollution Control Act, the Clean Air Act, the Clean Water Act, the Toxic Substances Control Act, the Safe Drinking Water Act, and all similar federal, state and local environmental statutes and ordinances, and the regulations, orders, and decrees now or hereafter promulgated thereunder, in each case as amended from time to time.

Health Benefit Laws: Laws relating to the licensure, certification, qualification or authority to transact business relating to the provision of, or payment for, or both the provision of and payment for, health benefits, health care or insurance coverage, including ERISA, COBRA, HIPAA, CHIP, Medicare, Medicaid, CHAMPUS/TriCare, and laws relating to the regulation of workers compensation and coordination of benefits.

Health Compliance Laws:  All applicable laws pertaining to billing, kickbacks, false claims, self-referral, claims processing, marketing, HIPAA security standards for the storage, maintenance, transmission, utilization and access to and privacy of patient information, and HIPAA and state standards for electronic transactions and data code sets, including, without limitation, the False Claims Act (31 U.S.C. Section 3729 et seq.), the Anti-Kickback Act of 1986 (41 U.S.C. Section 51 et seq.), the Federal Health Care Programs Anti-Kickback Statute (42 U.S.C. Section 1320a-7a(b)), the Stark Law, the Civil Monetary Penalties Law (42 U.S.C. Section 1320a-7a), and any other applicable federal health care law or equivalent state statutes or any rule or regulation promulgated by an applicable Governmental Body with respect to any of the foregoing, as any of the same may be amended, modified and/or restated from time to time.  

Healthcare Laws:  Health Benefit Laws, Health Compliance Laws and Information Privacy and Security Laws.

Hialeah Facility: That certain three hundred sixty-six (366)-licensed bed general acute care hospital facility operated at the Hialeah Land, commonly known as “Hialeah Hospital.”

Hialeah Land: That certain real property located in Miami-Dade County, Florida as more particularly described on Exhibit A-38 attached hereto and made a part hereof by reference and incorporation, together with all hereditaments, easements, mineral rights, rights of way and other appurtenances related thereto.

 

Hialeah Lessee: Steward HH, Inc., a Delaware corporation, together with its successors and permitted assigns.

 

16

 

4834-1440-2281v12


 

 

Hialeah Lessor:  MPT of Hialeah-Steward, LLC, a Delaware limited liability company, together with its successors and assigns.

 

Hialeah Pass-Through Lease: That certain Ground Lease, dated October 8, 2010, between Hialeah Lessor (as successor by assignment from Hialeah Hospital, Inc. f/k/a Tenet Hialeah Healthsystem, Inc.), as lessor, and VCREC II-Hialeah, LLC (as successor by assignment from AW Hialeah, LLC, the successor by assignment from BH-AW Hialeah, LLC), as lessee (with respect to property located at 777 E. 25th St.), as the same has been or may be amended, modified, or restated from time to time.  

 

Hialeah Property:  The Hialeah Land and related Leased Improvements located thereon relating to the Hialeah Facility.

 

Hialeah Palmetto Facility: That certain three hundred sixty-eight (368)-licensed bed general acute care hospital facility operated at the Hialeah Palmetto Land, commonly known as “Palmetto General Hospital.”

 

Hialeah Palmetto Land: That certain real property located in Miami-Dade County, Florida as more particularly described on Exhibit A-39 attached hereto and made a part hereof by reference and incorporation, together with all hereditaments, easements, mineral rights, rights of way and other appurtenances related thereto.

 

Hialeah Palmetto Lessee: Steward PGH, Inc., a Delaware corporation, together with its successors and permitted assigns.

 

Hialeah Palmetto Lessor:  MPT of Hialeah Palmetto-Steward, LLC, a Delaware limited liability company, together with its successors and assigns.

 

Hialeah Palmetto Pass-Through Leases: Individually, and collectively, (i) that certain Ground Lease, dated October 8, 2010, between Hialeah Palmetto Lessor (as successor by assignment from Lifemark Hospitals, Inc.), as lessor, and HTA-AW Palmetto, LLC, as lessee (as successor by assignment from BH-AW Palmetto, LLC) (with respect to property located at 7100 W. 20th Ave.), and (ii) that certain Ground Lease Agreement, dated December 22, 2020, between Hialeah Palmetto Lessor (as successor by assignment from Lifemark Hospitals, Inc.), as lessor, and HTA-AW Palmetto II, LLC, as lessee (with respect to property located at 7150 W. 20th and Pal-Med MOB & Mall), as either of the same has been or may be amended, modified, or restated from time to time.  

 

Hialeah Palmetto Property:  The Hialeah Palmetto Land and related Leased Improvements located thereon relating to the Hialeah Palmetto Facility.

 

Hillside Facility: That certain Sixty-Nine (69)-licensed bed general acute care hospital facility operated at the Hillside Land, commonly known as “Hillside Rehabilitation Hospital.”

 

17

 

4834-1440-2281v12


 

 

Hillside Land: That certain real property located in Trumbull County, Ohio as more particularly described on Exhibit A-6 attached hereto and made a part hereof by reference and incorporation, together with all hereditaments, easements, mineral rights, rights of way and other appurtenances related thereto.

 

Hillside Lessee:  Steward Hillside Rehabilitation Hospital, Inc., a Delaware corporation, together with its successors and permitted assigns.

 

Hillside Lessor:  MPT of Hillside-Steward, LLC, a Delaware limited liability company, together with its successors and assigns.

 

Hillside Property:  The Hillside Land and related Leased Improvements located thereon relating to the Hillside Facility.

 

Holy Family Facility: That certain two hundred twenty-three (223)-licensed bed general acute care hospital facility operated at the Holy Family Land, commonly known as “Holy Family Hospital.”

Holy Family Land: That certain real property located in Essex County, Massachusetts, as more particularly described on Exhibit A-2 attached hereto and made a part hereof by reference and incorporation, together with all hereditaments, easements, mineral rights, rights of way and other appurtenances related thereto.

Holy Family Lessee:  Steward Holy Family Hospital, Inc., a Delaware corporation, together with its successors and permitted assigns.

Holy Family Lessor:  MPT of Methuen-Steward, LLC, a Delaware limited liability company, together with its successors and assigns.

Holy Family Merrimack Facility: That certain one hundred twenty-four (124)-licensed bed general acute care hospital facility operated at the Holy Family Merrimack Land, commonly known as “Merrimack Valley Hospital.”

Holy Family Merrimack Land: That certain real property located in Essex County, Massachusetts, as more particularly described on Exhibit A-32 attached hereto and made a part hereof by reference and incorporation, together with all hereditaments, easements, mineral rights, rights of way and other appurtenances related thereto.

Holy Family Merrimack Lessor: MPT of Haverhill-Steward, LLC, a Delaware limited liability company, together with its successors and assigns.

Holy Family Merrimack Property: The Holy Family Merrimack Land and related Leased Improvements located thereon relating to the Holy Family Merrimack Facility.

Holy Family Property:  The Holy Family Land and related Leased Improvements located thereon relating to the Holy Family Facility.

18

 

4834-1440-2281v12


 

HIPAA:  The Health Insurance Portability and Accountability Act of 1996, as the same may be amended, modified or supplemented from time to time, and any successor statute thereto, and any and all rules or regulations promulgated from time to time thereunder.

IASIS Borrowers: Collectively, Davis Hospital & Medical Center, LP, a Delaware limited partnership, and Jordan Valley Medical Center, LP, a Delaware limited partnership, together with their successors and assigns.

IASIS Master Agreement: That certain IASIS (Project Ignite) Master Agreement, dated as of May 18, 2017, among Steward Health and certain Affiliates of Lessor, as the same has been or hereafter may be amended, modified, or restated from time to time.

IASIS Property: Collectively, the Glenwood Property, the Jordan Valley Property, the Odessa Property, the Mountain Point Property, the Mountain Vista Property, the Salt Lake Property, the Southeast Texas Property, the Southwest General Property, the St. Luke's Property, the St. Luke's Behavioral Property, the Tempe Property, the Wadley Property, the St. Joseph Property, and the Ancillary Properties.

IASIS Real Estate Contract: That certain Real Property Asset Purchase Agreement, dated as of May 18, 2017 among IASIS Healthcare Corporation, a Delaware Corporation and certain of its Affiliates and certain Affiliates of Lessor, as amended by that certain Joinder to Real Property Asset Purchase Agreement, dated as of June 8, 2017, as the same has been or hereafter may be amended, modified, or restated from time to time.

 

IASIS Realty Agreement: That certain Realty Agreement, dated as of September 29, 2017, among IASIS Healthcare Corporation, a Delaware Corporation and certain of its Affiliates and certain Affiliates of Lessor, as the same has been or hereafter may be amended, modified, or restated from time to time.

 

Immediate Family: With respect to any Person, such Person’s current spouse and lineal descendants (whether by blood or by adoption).

Impositions:  Collectively, with respect to each Property, all civil monetary penalties, fines and overpayments imposed by state and federal regulatory authorities, all Real Estate Taxes, all state and local sales and use taxes, single business, gross receipts, transaction privilege, rent or similar taxes, all assessments, charges and costs imposed under the Permitted Exceptions (including, without limitation, all penalties, fines, damages, costs and expenses for any violation of or a default under any of the Permitted Exceptions), Massachusetts excise taxes, franchise taxes (including but not limited to taxes based on capital, net worth or assets), license, business entity, annual report, registration and statutory representation fees and other taxes imposed on any business entities, including limited partnerships, limited liability companies and other “pass through” entities, and any such items imposed on Lessor or Lessor’s Affiliates (including Lessor’s parent organizations), all assessments for utilities, public improvements or benefits, ground rents, water, wastewater, sewer, sanitary sewer or other rents and charges, excises, tax levies, fees (including, without limitation, impact, development, license, permit, inspection, authorization and similar fees), and all other governmental charges, in each case whether general or special, ordinary or extraordinary, or foreseen or unforeseen, of every character in respect of such Property, the Rent

19

 

4834-1440-2281v12


 

relating thereto (including all interest and penalties thereon due to any failure in payment by Lessee), and all other reasonable, out-of-pocket fees, costs and expenses which at any time prior to, during or in respect of the Term may be charged, assessed or imposed on or in respect of or be a lien upon (a) Lessor or Lessor’s interest in such Property, (b) such Property or any part thereof or any rent therefrom or any estate, right, title or interest therein, or (c) any occupancy, operation, use or possession of, sales from, or activity conducted on, or in connection with, such Property or the leasing or use of such Property or any part thereof.  Notwithstanding any provision hereof to the contrary, nothing contained in this Lease shall be construed to require Lessee to pay (1) any tax based on net income (whether denominated as a financial institutions or other tax) imposed on Lessor, including, but not limited to, any franchise tax or business entity tax (other than any components of such tax which constitute a franchise or capital tax), or (2) any branch profits taxes imposed by the United States or any similar tax imposed by any other jurisdiction in which Lessor is located; (3) any transfer tax of Lessor, or (4) any tax imposed with respect to the sale, exchange or other disposition by Lessor of any Property or the proceeds thereof or (5) any interest, additions to tax or penalties in respect of the foregoing clauses (1) through (5) except as expressly provided elsewhere in this Lease, any principal or interest on any Lien on any Property, except to the extent that any tax, assessment, tax levy or charge which Lessee is obligated to pay pursuant to the first sentence of this definition and which is in effect at any time during the Term is totally or partially repealed, and a tax, assessment, tax levy or charge set forth in clause (1) or (2) is levied, assessed or imposed expressly in lieu thereof, in which case the substitute tax, assessment, tax levy or charge shall be deemed to be an Imposition.

Indebtedness: With respect to any Person means, without duplication, (a) all obligations of such Person for borrowed money or with respect to deposits or advances of any kind, (b) all obligations of such Person evidenced by bonds, debentures, notes or similar instruments, (c) all obligations of such Person upon which interest charges are customarily paid, (d) all obligations of such Person under conditional sale or other title retention agreements relating to property acquired by such Person, (e) all obligations of such Person in respect of the deferred purchase price of property or services (excluding trade payables and other accounts payable in each case, incurred in the ordinary course of business), (f) all Indebtedness of others secured by (or for which the holder of such Indebtedness has an existing right, contingent or otherwise, to be secured by) any Lien on property owned or acquired by such Person, whether or not the Indebtedness secured thereby has been assumed; provided that if such Person has not assumed such obligations, then the amount of Indebtedness of such Person for purposes of this clause (f) shall be equal to the lesser of the amount of the obligations of the holder of such obligations and the fair market value of the assets of such Person which secure such obligations, (g) all Steward Guarantees by such Person of Indebtedness of others, (h) all Capital Lease Obligations of such Person, (i) all obligations, contingent or otherwise, of such Person as an account party in respect of letters of credit and letters of guaranty, (j) all obligations, contingent or otherwise, of such Person in respect of bankers’ acceptances, (k) all obligations of such Person under any liquidated earn-out and (l) any other Off-Balance Sheet Liability of such Person.  The Indebtedness of any Person shall include the Indebtedness of any other entity (including any partnership in which such Person is a general partner) to the extent such Person is liable therefor as a result of such Person’s ownership interest in or other relationship with such entity, except to the extent the terms of such Indebtedness provide that such Person is not liable therefor.

20

 

4834-1440-2281v12


 

Information Privacy and Security Laws: HIPAA and any other laws concerning the privacy and/or security of personal information, including but not limited to the Gramm-Leach-Bliley Act, state data breach notification laws, state health information privacy laws, the Federal Trade Commission Act and state consumer protection laws.

Initial Commencement Date:  October 3, 2016.

Insurance Premiums:  As defined in Section 4.4.

Insurance Requirements:  All terms of any insurance policy required by this Lease and all requirements of the issuer of any such policy.

Intercreditor Agreement: That certain Intercreditor Agreement, dated as of the Initial Commencement Date, among Lessor, the MPT Lenders and Citibank, N.A. (as administrative agent on behalf of itself and the other lenders under the ABL Credit Agreement), as the same has been or hereafter may be amended, modified, or restated from time to time.

Interest Expense: For any period, total interest expense (including that attributable to Capital Lease Obligations) of  Steward Health and its Subsidiaries for such period with respect to all outstanding Indebtedness of Steward Health and its Subsidiaries, including all commissions, discounts and other fees and charges owed with respect to letters of credit and bankers’ acceptances and net costs under any Swap Agreements in respect of interest rates to the extent such net costs are allocable to such period in accordance with GAAP, calculated on a consolidated basis for Steward Health and its Subsidiaries for such period in accordance with GAAP.

Interim Capital Addition Rent: As defined in Section 3.1(a).

Joint Commission:  As defined in Article XXIV.

Jordan Valley Facility: That certain One Hundred and Two (102)-licensed bed general acute care hospital facility operated at the Jordan Valley Land, commonly known as "Jordan Valley Medical Center, West Valley Campus."

 

Jordan Valley Land: That certain real property located in Salt Lake County, Utah, as more particularly described on Exhibit A-14 attached hereto and made a part hereof by reference and incorporation, together with all hereditaments, easements, mineral rights, rights of way and other appurtenances related thereto.

 

Jordan Valley Lessee:  Jordan Valley Medical Center, LP, a Delaware limited partnership, together with its successors and permitted assigns.

 

Jordan Valley Lessor:  MPT of West Valley City, LLC, a Delaware limited liability company, together with its successors and assigns.

 

Jordan Valley Property: The Jordan Valley Land and related Leased Improvements located thereon relating to the Jordan Valley Facility.

 

Land:  As defined in the Recitals.

21

 

4834-1440-2281v12


 

Late Payment Penalty:  Shall mean an amount equal to the product of Five Percent (5%) and the amount of any overdue and unpaid amount under this Lease.

Lauderdale Lakes Facility: That certain four hundred fifty-nine (459)-licensed bed general acute care hospital facility operated at the Lauderdale Lakes Land, commonly known as “Florida Medical Center.”

 

Lauderdale Lakes Land: That certain real property located in Broward County, Florida as more particularly described on Exhibit A-31 attached hereto and made a part hereof by reference and incorporation, together with all hereditaments, easements, mineral rights, rights of way and other appurtenances related thereto.

 

Lauderdale Lakes Lessee: Steward NSMC, Inc., a Delaware corporation, together with its successors and permitted assigns.

 

Lauderdale Lakes Lessor:  MPT of Lauderdale Lakes-Steward, LLC, a Delaware limited liability company, together with its successors and assigns.

 

Lauderdale Lakes Pass-Through Leases: Individually, and collectively, (i) that certain Ground Lease, dated October 8, 2010, between Lauderdale Lakes Lessor (as successor by assignment from Douglas E. Rabe, as successor trustee pursuant to the FMC Land Trust Agreement Number 1001), as lessor, and HTA-AW Florida Medical Center North, LLC (as successor by assignment from BH-AW FMC North, LLC), as lessee (with respect to property located at 4900 W. Oakland Park Blvd.), (ii) that certain Ground Lease, dated October 8, 2010, between Lauderdale Lakes Lessor (as successor by assignment from Douglas E. Rabe, as successor trustee pursuant to the FMC Land Trust Agreement Number 1001), as lessor, and HTA-AW Florida Medical Center East, LLC (as successor by assignment from BH-AW FMC East, LLC), as lessee (with respect to property located at 3001 NW 49th Ave.), (iii) that certain Ground Lease, dated October 8, 2010, between Lauderdale Lakes Lessor (as successor by assignment from Douglas E. Rabe, as successor trustee pursuant to the FMC Land Trust Agreement Number 1001), as lessor, and HTA-AW Florida Medical Center Central, LLC (as successor by assignment from BH-AW FMC Central, LLC), as lessee (with respect to property located at 2951 NW 49th Ave.), and (iv) that certain Ground Lease, dated October 8, 2010, between Lauderdale Lakes Lessor (as successor by assignment from Douglas E. Rabe, as successor trustee pursuant to the FMC Land Trust Agreement Number 1001), as lessor, and Bluescape Altera FMC, LLC (as successor by assignment from AW Florida Medical Center Mall, LLC, as successor by assignment from BH-AW FMC Medical Mall, LLC), as lessee (with respect to property located at 4850 W. Oakland Park Blvd.), as each of the same has been or may be amended, modified, or restated from time to time.

 

Lauderdale Lakes Property:  The Lauderdale Lakes Land and related Leased Improvements located thereon relating to the Lauderdale Lakes Facility.

 

Lease:  As defined in the Preamble.

22

 

4834-1440-2281v12


 

Lease Assignments:  Those certain Assignments of Rents and Leases, executed and delivered by each Facility Lessee to and in favor of Lessor, as the same has been or hereafter may be amended, modified, or restated from time to time.

Lease Base:  As to each Property, as defined on Schedule 3.1(a) attached hereto and made a part hereof by reference and incorporation.

Lease Severance Fee: As defined in Section 3.6(a).

Lease Severance Fee Properties: As defined in Section 3.6(a).

Leased Improvements:  As defined in Article II(b).

Leased Property:  Collectively, those items described in Article II, as well as all Capital Additions thereto.

Legacy Escalator: As defined in Section 3.1(b)(i).

Legal Requirements:  With respect to each Property and the conduct of the Business thereon, all federal, state, county, municipal and other governmental statutes, laws, rules, orders, regulations, ordinances, judgments, decrees and injunctions affecting such Property, Lessee’s operation of the Business on such Property, or the construction, use or alteration of such Property (including, without limitation, the Americans with Disabilities Act and Section 504 of the Rehabilitation Act of 1973), whether now or hereafter enacted and in force, including any which may (a) require repairs, modifications, or alterations in or to such Property, or (b) in any way adversely affect the use and enjoyment thereof, and all permits, licenses, authorizations and regulations relating thereto, and all covenants, agreements, variances, restrictions and encumbrances contained in any instruments, either of record or known to Lessee, at any time in force affecting such Property.

Lessee:  As defined in the preamble to this Lease.

Lessee Parties: As defined in Section 39.7(b).

Lessee Representative: As defined in Section 39.29.

Lessor:  As defined in the preamble to this Lease.

Lessor’s Notice Address:  As defined in Section 13.3.

Lessor Parties:  As defined in Section 39.7(a).

Licenses: As defined in Section 38.1.

Liens:  As defined in Article XXXVI.

Limited Remedy Event of Default: As defined in Section 16.1L.

23

 

4834-1440-2281v12


 

LLC Agreement: That certain Sixth Amended and Restated Limited Liability Company Agreement of Steward Health, dated as of May 11, 2020, as the same has been or hereafter may be amended, modified, or restated from time to time.

Loan Guaranty: That certain Guaranty, dated as of May 1, 2017, executed and delivered by Lessee in favor of the MPT Lenders, as the same has been or hereafter may be amended, modified, or restated from time to time.

Louisiana Property: The Glenwood Property.

 

Lump Sum Severance Fee: As defined in Section 3.6(g).

Major Event of Default:  The occurrence of (i) an Event of Default under clause (a), (j), or (k) of Section 16.1; (ii) an Event of Default by the Guarantor under clause (c) or (g) of Section 16.1; or (iii) a “Major Event of Default” under and as defined in the Mortgage Loan Agreement.

Management Agreement: Any contract or agreement for the provision of management services to a Facility Lessee with respect to the operation of a healthcare facility on the applicable Property.

Management Company:  Any person, firm, corporation or other entity or individual who or which will provide management services to a Facility Lessee with respect to the operation of a healthcare facility on a Property.

Material Obligation:  Any obligation of the Guarantor or any Facility Lessee (other than any obligations owing to Lessor or any of its Affiliates) which is in excess of Two Hundred Million and No/100 Dollars ($200,000,000.00).

Massachusetts New Project: Means a New Project commencing on or after June 1, 2021 at any Property in the Commonwealth of Massachusetts other than the Norwood Property.

Medicaid: The medical assistance program established by Title XIX of the Social Security Act (42 U.S.C. Sections 1396 et seq.) and any statute succeeding thereto.

Medical Waste: The medical waste of each Facility, including, but not limited to, (a) pathological waste, (b) blood, (c) sharps, (d) wastes from surgery or autopsy, (e) dialysis waste, including contaminated disposable equipment and supplies, (f) cultures and stocks of infectious agents and associated biological agents, (g) contaminated animals, (h) isolation wastes, (i) contaminated equipment, (j) laboratory waste and (k) various other biological waste and discarded materials contaminated with or exposed to blood, excretion, or secretions from human beings or animals.  “Medical Waste” also includes any substance, pollutant, material, or contaminant listed or regulated under the Medical Waste Tracking Act of 1988, 42 U.S.C. § 6992, et seq. (“MWTA”), and applicable state law.

Medical Waste Laws: Each federal, state, regional, county, municipal, or other local laws, regulations, and ordinances insofar as they purport to regulate Medical Waste, or impose requirements relating to Medical Waste, including regulations promulgated and orders issued thereunder, all as may be amended from time to time, including without limitation,  the MWTA,

24

 

4834-1440-2281v12


 

the U.S. Public Vessel Medical Waste Anti-Dumping Act of 1988, 33 USCA § 2501 et seq., the Marine Protection, Research, and Sanctuaries Act of 1972, 33 USCA § 1401 et seq., The Occupational Safety and Health Act, 29 USCA § 651 et seq., the United States Department of Health and Human Services, National Institute for Occupations Self-Safety and Health Infectious Waste Disposal Guidelines, Publication No. 88-119.

Medicare:  The health insurance program for the aged and disabled established by Title XVIII of the Social Security Act (42 U.S.C. Sections 1395 et seq.) and any statute succeeding thereto.

Miami Facility: That certain three hundred thirty-seven (337)-licensed bed general acute care hospital facility operated at the Miami Land, commonly known as “North Shore Medical Center.”

Miami Land: That certain real property located in Miami-Dade County, Florida as more particularly described on Exhibit A-40 attached hereto and made a part hereof by reference and incorporation, together with all hereditaments, easements, mineral rights, rights of way and other appurtenances related thereto.

Miami Lessee: Steward NSMC, Inc., a Delaware corporation, together with its successors and permitted assigns.

Miami Lessor: MPT of Miami-Steward, LLC, a Delaware limited liability company, together with its successors and assigns.

Miami Pass-Through Lease: That certain Ground Lease, dated October 8, 2010, between Miami Lessor (as successor by assignment from North Shore Medical Center, Inc., f/k/a Tenet Healthsystem North Shore, Inc.), as lessor, and HTA-AW North Shore, LLC (as successor by assignment from BH-AW North Shore, LLC), as lessee (with respect to property located at 1100 NW 95th St.), as the same has been or may be amended, modified, or restated.

Miami Property: The Miami Land and related Leased Improvements located thereon relating to the Miami Facility.

Monthly Escrow Amount:  As defined in Section 3.2.

Mortgages: The “Mortgages” under and as defined in the Mortgage Loan Agreement.

Mortgage Conversion Purchase Agreement: That certain Purchase and Sale Agreement, dated as of May 18, 2018, by and among certain Affiliates of Lessor and certain Affiliates of Lessee, as the same has been or hereafter may be amended, modified, or restated from time to time.

Mortgage Loan Agreement: That certain Mortgage Loan Agreement, dated as of the Initial Commencement Date, executed by the Borrower Affiliates (as successors by assignment from the IASIS Borrowers) and the MPT Lenders, as the same has been or hereafter may be amended, modified, or restated from time to time.

25

 

4834-1440-2281v12


 

Mortgage Loan Documents: The Mortgage Loan Agreement, the Mortgage Loan Note, the Mortgages, and the other "Loan Documents" under and as defined in the Mortgage Loan Agreement, as the same has been or hereafter may be amended, modified, or restated from time to time.

Mortgage Loan Note: The “Note” under and as defined in the Mortgage Loan Agreement.

Morton Facility: That certain one hundred twenty (120)-licensed bed general acute care hospital facility operated at the Morton Land, commonly known as “Morton Hospital.”

Morton Land: That certain real property located in Bristol County, Massachusetts more particularly described on Exhibit A-3 attached hereto and made a part hereof by reference and incorporation, together with all hereditaments, easements, mineral rights, rights of way and other appurtenances related thereto.

Morton Lessee:  Morton Hospital, A Steward Family Hospital, Inc. a Delaware corporation, together with its successors and permitted assigns.

Morton Lessor:  MPT of Taunton-Steward, LLC, a Delaware limited liability company, together with its successors and assigns.

Morton PFDA: That certain Project Funding and Development Agreement, dated as of December 18, 2020, by and among Morton Lessor, Steward Health, and Morton Lessee, as the same has been or hereafter may be amended, modified, or restated from time to time.

Morton Project: The “Project” under and as defined in the Morton PFDA.

Morton Project Completion Date: The date of “Completion” under and as defined in the Morton PFDA; subject, however, to the rights of Morton Lessor pursuant to the Morton PFDA to establish the Morton Project Completion Date upon the occurrence of certain other events.

Morton Project Development Costs: The sum of (a) all costs funded by Morton Lessor for the Morton Project pursuant to the Morton PFDA, and (b) the applicable “Construction Period Accrual” under and as defined in the Morton PFDA.

Morton Property:  The Morton Land and related Leased Improvements located thereon relating to the Morton Facility.  

Mountain Point Facility: That certain forty (40)-licensed bed general acute care hospital facility operated at the Mountain Point Land, commonly known as "Mountain Point Medical Center."

 

Mountain Point Land: That certain real property located in Utah County, Utah as more particularly described on Exhibit A-16 attached hereto and made a part hereof by reference and incorporation, together with all hereditaments, easements, mineral rights, rights of way and other appurtenances related thereto.

 

26

 

4834-1440-2281v12


 

 

Mountain Point Lessee:  Jordan Valley Medical Center, LP, a Delaware limited partnership, together with its successors and permitted assigns.

 

Mountain Point Lessor:  MPT of Lehi-Steward, LLC, a Delaware limited liability company, together with its successors and assigns.

 

Mountain Point Property: The Mountain Point Land and related Leased Improvements located thereon relating to the Mountain Point Facility.

 

Mountain Vista Facility: That certain One Hundred Seventy-Eight (178)-licensed bed general acute care hospital facility operated at the Mountain Vista Land, commonly known as "Mountain Vista Medical Center."

 

Mountain Vista Land: That certain real property located in Maricopa County, Arizona as more particularly described on Exhibit A-17 attached hereto and made a part hereof by reference and incorporation, together with all hereditaments, easements, mineral rights, rights of way and other appurtenances related thereto.

 

Mountain Vista Lessee: Mountain Vista Medical Center, LP, a Delaware limited partnership, together with its successors and permitted assigns.

 

Mountain Vista Lessor: MPT of Mesa, LLC, a Delaware limited liability company, together with its successors and assigns.

 

Mountain Vista Property: The Mountain Vista Land and related Leased Improvements located thereon relating to the Mountain Vista Facility.

 

MPT:  MPT Operating Partnership, L.P., a Delaware limited partnership.

MPT Damages: As defined in Section 8.2(c).

MPT Indemnified Parties: As defined in Section 8.2(c).

MPT Lenders: Collectively, MPT of West Jordan-Steward, LLC and MPT of Layton-Steward, LLC, each a Delaware limited liability company.

 

MPT Opco: MPT Sycamore Opco, LLC, a Delaware limited liability company.

MPT Required Provisions:  Any covenant, restriction or waivers added to the LLC Agreement and the respective Organizational Documents of Steward Health and any of its Subsidiaries as required under the Real Estate Contract, and any comparable covenant, restriction or waivers added to any Organizational Documents of any Subsidiaries of Steward Health  that is formed or organized after the Initial Commencement Date and becomes an Obligor.

MPT-Steward JV: MPT of Utah-Steward, LLC, a Delaware limited liability company, together with its successors and assigns.

27

 

4834-1440-2281v12


 

MPT-Steward JV LLC Agreement: That certain Limited Liability Company Agreement of MPT-Steward JV, dated July 7, 2020, as the same has been or hereafter may be amended, modified, or restated from time to time.

MWTA: As defined in the definition of Medical Waste.

Nashoba Facility: That certain seventy-three (73)-licensed bed general acute care hospital facility operated at the Nashoba Land, commonly known as “Nashoba Valley Medical Center.”

Nashoba Land: That certain real property located in Middlesex County, Massachusetts more particularly described on Exhibit A-27 attached hereto and made a part hereof by reference and incorporation, together with all hereditaments, easements, mineral rights, rights of way and other appurtenances related thereto.

Nashoba Lessee: Nashoba Valley Medical Center, A Steward Family Hospital, Inc., a Delaware corporation, together with its successors and permitted assigns.

Nashoba Lessor: MPT of Ayer-Steward, LLC, a Delaware limited liability company, together with its successors and assigns.

Nashoba Property: The Nashoba Land and related Leased Improvements located thereon relating to the Nashoba Facility.

Net Income:  For any period, the consolidated net income (or loss) of Steward Health and its Subsidiaries, determined on a consolidated basis in accordance with GAAP; provided that there shall be excluded (a) the income (or deficit) of any Person accrued prior to the date it becomes a Subsidiary or is merged into or consolidated with Steward Health or any of its Subsidiaries, (b) the income (or deficit) of any Person (other than a Subsidiary) in which Steward Health or any of its Subsidiaries has an ownership interest, except to the extent that any such income is actually received by Steward Health or such Subsidiary in the form of dividends or similar distributions, (c) the undistributed earnings of any Subsidiary to the extent that the declaration or payment of dividends or similar distributions by such Subsidiary is not at the time permitted by the terms of any contractual obligation (other than under any Obligation Document), the Organizational Documents or Legal Requirements applicable to such Subsidiary and (d) to the extent treated as income, any incentive payments received by Steward Health and its Subsidiaries from Medicare or Medicaid pursuant to The American Recovery and Reinvestment Act of 2009 relating to expenditures made in respect of electronic health record technology.

Net Proceeds:  As defined in Section 3.6(h).

New Project: The Sebastian Project, the Pharmacy Improvements Project, the St. Elizabeth Project, the Wuesthoff Melbourne Project, the Odessa Project, the West Jordan Project, the Davis Project, the Morton Project, and the development of a Capital Addition relating to any existing Property, in each case, pursuant to a Project Development Agreement.

New Property:  Any real property (other than real property constituting a Capital Addition to a Property that is already subject to this Lease) that becomes subject to this Lease after the Initial Commencement Date.

28

 

4834-1440-2281v12


 

New Property/Project Lease Rate:  With respect to each New Property or New Project that becomes subject to this Lease after June 1, 2021 (other than a Massachusetts New Project), the per annum rate described on Schedule 3.1(b) attached hereto and made a part hereof by reference and incorporation, subject to the New Property/Project Escalator set forth in Section 3.1(b)(ii).

New Property/Project Escalator: As defined in Section 3.1(b)(ii).

Non-Competition Agreement:  That certain Non-Competition Agreement, dated as of the Initial Commencement Date, executed by Steward Health in favor of Lessor and certain of its Affiliates, as the same has been or hereafter may be amended, modified, or restated from time to time.

Non-Permitted Assignee:  Any Person identified (i) on Schedule 1-C, (ii) by the Lessee to Lessor in writing, subject to Lessor’s consent, not to be unreasonably withheld, conditioned or delayed (provided, that, in evaluating Lessor’s reasonable consent, Lessor may consider such Person’s historical and stated future intentions concerning competitive activities and financial and operational capabilities with respect to such activities), as (A) a Person that is engaged primarily in the operation of hospitals or the business of managed care and (B) a direct competitor of the Obligors, or (iii) any Person that does not then possess the financial ability and wherewithal to satisfy all of the obligations of Lessor and MPT Lenders under and pursuant to this Lease and the Mortgage Loan Agreement.  

Non-Recourse Party: As defined in Section 39.7(b).

Northside Medical Facility: That certain Three Hundred Eighty-Nine (389)-licensed bed general acute care hospital facility operated at the Northside Medical Land, commonly known as “Northside Medical Center.”

 

Northside Medical Land: That certain real property located in Trumbull and Mahoning Counties, Ohio as more particularly described on Exhibit A-7 attached hereto and made a part hereof by reference and incorporation, together with all hereditaments, easements, mineral rights, rights of way and other appurtenances related thereto.

 

Northside Medical Lessee: Collectively, jointly and severally, Steward Northside Medical Center, Inc., a Delaware corporation, Steward Medical Group, Inc., a Massachusetts corporation, and SHC Youngstown Ohio PSC LLC, a Delaware limited liability company, together with their successors and permitted assigns.

 

Northside Medical Lessor:  MPT of Youngstown-Steward, LLC, a Delaware limited liability company, together with its successors and assigns.

 

Northside Medical Property:  The Northside Medical Land and related Leased Improvements located thereon relating to the Northside Facility.

 

Norwood Facility: That certain two hundred twenty-eight (228)-licensed bed general acute care hospital facility operated at the Norwood Land, commonly known as “Norwood Hospital.”

29

 

4834-1440-2281v12


 

Norwood Land: That certain real property located in Norfolk County, Massachusetts more particularly described on Exhibit A-28 attached hereto and made a part hereof by reference and incorporation, together with all hereditaments, easements, mineral rights, rights of way and other appurtenances related thereto.

Norwood Lessee: Steward Norwood Hospital, Inc., a Delaware corporation, together with its successors and permitted assigns.

Norwood Lessor: MPT of Norwood-Steward, LLC, a Delaware limited liability company, together with its successors and assigns.

Norwood Property: The Norwood Land and related Leased Improvements located thereon relating to the Norwood Facility.

Obligation Documents: Individually and collectively, this Lease, the Real Estate Contract, the LLC Agreement (solely with respect to the MPT Required Provisions), the Strategic Agreement, the Mortgage Loan Documents, the CHS Master Agreement, the IASIS Real Estate Contract, the IASIS Master Agreement, the IASIS Realty Agreement, the Tenet Master Agreement, the St. Joseph Purchase Agreement, the Fall River Master Agreement, the Pikes Peak Master Agreement, the Mortgage Conversion Purchase Agreement, the Adeptus Texas Master Agreement, the Project Development Agreements, the Term Loan Promissory Note, the Arizona Master Agreement, the Big Spring Master Agreement, the Guaranty, the Pledge Agreement, the Security Agreement, the Stand Alone Security Agreements, the Lease Assignments, the Environmental Indemnification Agreement, the Non-Competition Agreement, the Loan Guaranty, the Contribution Agreement, the MPT-Steward JV LLC Agreement, and all other leases, promissory notes, and agreements entered into between Lessor or any Affiliate of Lessor, on the one hand, and any Facility Lessee, Guarantor or any of their respective Affiliates, on the other hand, relating to the transactions contemplated under this Lease, under the Mortgage Loan Documents, under the Term Loan Promissory Note, and under the Contribution Agreement, as any of the same has been or hereafter may be amended, modified, or restated from time to time; provided however, that the Equity Purchase Agreement shall be excluded from the Obligation Documents for purposes of this Lease.

Obligors:  Collectively, Lessee, the Borrower Affiliates, the Guarantor, and their respective successors and permitted assigns.

Occurrence Date: As defined in Section 16.1L.

 

Odessa Facility: That certain Two Hundred Twenty-Five (225)-licensed bed general acute care hospital facility operated at the Odessa Land, commonly known as "Odessa Regional Medical Center."

 

Odessa Land: That certain real property located in Ector County, Texas as more particularly described on Exhibit A-15 attached hereto and made a part hereof by reference and incorporation, together with all hereditaments, easements, mineral rights, rights of way and other appurtenances related thereto.

 

30

 

4834-1440-2281v12


 

 

Odessa Lessee:  Odessa Regional Hospital, LP, a Delaware limited partnership, together with its successors and permitted assigns.

 

Odessa Lessor:  MPT of Odessa-Steward, LLC, a Delaware limited liability company, together with its successors and assigns.

 

Odessa PFDA: That certain Project Funding and Development Agreement, dated as of March 12, 2020, by and among Odessa Lessor, Steward Health, and Odessa Lessee, as the same has been or hereafter may be amended, modified, or restated from time to time.

 

Odessa Project: The "Project" under and as defined in the Odessa PFDA.

 

Odessa Project Completion Date: The date of "Completion" under and as defined in the Odessa PFDA; subject, however, to the rights of Odessa Lessor pursuant to the Odessa PFDA to establish the Odessa Project Completion Date upon the occurrence of certain other events.

 

Odessa Project Development Costs: The sum of (a) all costs funded by Odessa Lessor for the Odessa Project pursuant to the Odessa PFDA, and (b) the “Construction Period Accrual” under and as defined in the Odessa PFDA.

 

Odessa Property:  The Odessa Land and related Leased Improvements located thereon relating to the Odessa Facility.

 

OFAC:  The U.S. Department of Treasury Office of Foreign Assets Control.

OFAC List:  The list of specially designated nationals and blocked persons subject to financial sanctions that is maintained and published by the U.S. Treasury Department, Office of Foreign Assets Control and any other similar list maintained and published by the U.S. Treasury Department, Office of Foreign Assets Control pursuant to any law, including, without limitation, trade embargo, economic sanctions, or other prohibitions imposed by Executive Order of the President of the United States. The OFAC List currently is accessible through the internet website https://www.treasury.gov/ofac/downloads/sdnlist.pdf.

Off-Balance Sheet Liability: With respect to any Person means (a) any repurchase obligation or liability of such Person with respect to accounts or notes receivable sold by such Person, (b) any indebtedness, liability or obligation under any so-called “synthetic lease” transaction entered into by such Person, or (c) any indebtedness, liability or obligation arising with respect to any other transaction which is the functional equivalent of or takes the place of borrowing but which does not constitute a liability on the balance sheets of such Person (other than operating leases).

Officer’s Certificate:  With respect to each Facility Lessee, a certificate of such Facility Lessee signed by the representative(s) authorized to so sign by the governing body of such Facility Lessee, or any other Person whose power and authority to act has been properly authorized.

Ohio Property: Collectively, the Northside Medical Property, the Hillside Property, and the Trumbull Property.

31

 

4834-1440-2281v12


 

OIG:  As defined in Article XXIV.

Operating Agreements:  With respect to each Facility Lessee, all material written agreements that exceed $7,500,000 annually, to which such Facility Lessee is a party with respect to the ownership, operation or management of the Business at a Property, including, without limitation, any and all service and maintenance contracts, management agreements, equipment leases, consulting agreements, laboratory servicing agreements, pharmaceutical contracts and physician, other clinician or other professional services provider contracts, but excluding employment contracts and any Participation Agreements, as the same has been or hereafter may be amended, modified, restated, terminated, supplemented, or renewed from time to time.

Organizational Documents:  With respect to any Person, the articles of incorporation or organization, certificate of incorporation or formation or other formation document, together with all other documents creating and governing such Person, including stockholder agreements, limited liability company or operating agreements, partnership agreements and bylaws.

Other Credit Enhancements:  As defined in Section 30.2.

Overdue Rate:  On any date, the highest Applicable Lease Rate plus Five Percent (5%).

Participation Agreements:  With respect to each Facility Lessee, all material third-party payor participation or reimbursement agreements that exceed $7,500,000 annually, and provider numbers and provider agreements, to which such Facility Lessee is a party relating to rights to payment or reimbursement from, and claims against, private insurers, managed care plans and contracts, employee assistance programs, Blue Cross and/or Blue Shield, governmental authorities, Medicare, Medicaid and TRICARE, and other third-party payors, as the same may from time to time be terminated, amended, restated, extended, supplemented or modified, together with all rights, privileges and entitlements thereunder.

Pass-Through Leases: Individually, and collectively, each of the Hialeah Pass-Through Lease, the Hialeah Palmetto Pass-Through Leases, the Lauderdale Lakes Pass-Through Leases, and the Miami Pass-Through Lease.

Pass-Through Lease Improvements: All buildings, structures, Fixtures, and other improvements now or hereafter located on the Pass-Through Lease Land, which are owned by the lessee or tenant under any Pass-Through Lease.  

Pass-Through Lease Land: That portion of the Land subject to the Pass-Through Leases.

 

Patriot Act:  The Uniting and Strengthening America by Providing Appropriate Tools Required to Intercept and Obstruct Terrorism Act of 2001, Pub. L. 107-56, as the same may be amended, modified or restated from time to time.

Pennsylvania Property: The Sharon Property.

Permitted Exceptions:  The matters set forth in Exhibit B-1 et seq.

32

 

4834-1440-2281v12


 

Person:  An individual, a corporation, a limited liability company, a general or limited partnership, an unincorporated association, a joint venture, a Governmental Body or another entity or group.

Personal Property:  With respect to a Facility Lessee, all of such Facility Lessee’s consumable inventory and supplies, machinery, equipment, furniture, furnishings, trailers, movable walls or partitions, computers, trade fixtures and other tangible or intangible personal property (including all such items not permanently affixed to the applicable Property), currently owned and acquired after the execution of this Lease, and necessary, used, or useful in the operation of the applicable Facility, but excluding any items within the definition of Fixtures.

Pharmacy Improvements PFDA: That certain Project Funding and Development Agreement, dated as of November 30, 2018, by and among Steward Health, certain of its Affiliates, certain Lessors, and certain MPT Lenders, as the same has been or hereafter may be amended, modified, or restated from time to time.

Pharmacy Improvements Project: The "Project" under and as defined in the Pharmacy Improvements PFDA.

Pharmacy Improvements Project Completion Date:  The date of "Completion" under and as defined in the Pharmacy Improvements PFDA; subject, however, to the rights of the applicable Lessors pursuant to the Pharmacy Improvements PFDA to establish the Pharmacy Improvements Project Completion Date upon the occurrence of certain other events.  

Pharmacy Improvements Project Development Costs:  The sum of (a) all costs funded by the applicable Lessors (and MPT of West Jordan-Steward, LLC and MPT of Layton-Steward, LLC) for the Pharmacy Improvements Project pursuant to the Pharmacy Improvements PFDA, and (b) the applicable Construction Period Accrual.

Pharmacy PFDA Lease Inducement Fee: As defined in Section 3.4(a).

Pikes Peak Master Agreement: That certain Dr. Wever Specialty Clinic Real Estate Master Agreement (Pikes Peak Transaction), dated as of March 30, 2018, among Steward Health, Brim Healthcare of Colorado, LLC, and MPT of Woodland Park RE-Steward, LLC, as the same has been or hereafter may be amended, modified, or restated from time to time.

Plan: Any employee pension benefit plan (other than a Multiemployer Plan as defined in Section 4001(a)(3) of ERISA) subject to the provisions of Title IV of ERISA or Section 412 of the Code or Section 302 of ERISA, and in respect of which any Obligor or any ERISA Affiliate is (or, if such plan were terminated, would under Section 4069 of ERISA be deemed to be) an “employer” as defined in Section 3(5) of ERISA.

Pledge Agreement:  That certain Pledge Agreement, dated as of the Initial Commencement Date, by and among the “Pledgors” (as defined therein), the other “Pledged Obligors” (as defined therein), Lender and certain of its Affiliates, as the same has been or hereafter may be amended, modified, or restated from time to time.

33

 

4834-1440-2281v12


 

Portfolio Sale:  Any (i) sale, transfer, assignment or conveyance by Medical Properties Trust, Inc., MPT, any Facility Lessor or any of their respective Affiliates of a group or portfolio of healthcare facilities that includes certain Steward Assets that are proposed to be included in such sale, transfer, assignment or conveyance and other healthcare facilities (the “Proposed Portfolio Transaction”); provided, that, the aggregate lease or loan amounts allocated under the Real Estate Contract (or similar future agreement) to such Steward Assets that are proposed to be included in such sale, transfer, assignment or conveyance are (a) greater than $100,000,000, and (b) less than twenty percent (20%) of aggregate purchase price of such Proposed Portfolio Transaction, or (ii) as applicable, sale of equity, merger, combination, sale of all or substantially all of the assets of or similar transaction involving Medical Properties Trust, Inc., MPT, or their respective Affiliates and any other Person.

Primary Intended Use:  As defined in Section 7.2.

Project Development Agreements: Collectively, the Sebastian PFDA, the Pharmacy Improvements PFDA, the St. Elizabeth PFDA, the Wuesthoff Melbourne PFDA, the Odessa PFDA, the West Jordan PFDA, the Davis PFDA, the Morton PFDA, and any other Project Funding and Development Agreement executed between or among Lessor, Lessee, or any of their respective Affiliates in connection with a New Project, as the same has been or hereafter may be amended, modified, or restated from time to time.

Properties; Property: Individually and collectively, all of the Holy Family Property, the Good Samaritan Property, the St. Anne’s Property, the Morton Property, the St. Elizabeth Property, the Hillside Property, the Northside Medical Property, the Sebastian Property, the Sharon Property, the Trumbull Property, the Wuesthoff Melbourne Property, the Wuesthoff Rockledge Property, the Glenwood Property, the Jordan Valley Property, the Odessa Property, the Mountain Point Property, the Mountain Vista Property, the Salt Lake Property, the Southeast Texas Property, the Southwest General Property, the St. Luke's Property, the St. Luke's Behavioral Property, the Tempe Property, the Wadley Property, the Ancillary Properties, the Nashoba Property, the Norwood Property, the St. Anne's Fall River Parking Lot Property, the Holy Family Merrimack Property, the St. Joseph Property, the Carney Property, the Big Spring Property, the Florence Property, the West Jordan Property, the Davis Property, the Coral Gables Property, the Lauderdale Lakes Property, the Hialeah Property, the Hialeah Palmetto Property, the Miami Property, and, following the Initial Commencement Date, any New Property, each sometimes individually referred to as a "Property.

Proposed Portfolio Transaction:  As defined in the definition of “Portfolio Sale.”

Public Corporation: As defined in the definition of “Qualified Public Offering.”

Qualified Public Offering: A public offering by Steward Health or any entity into which Steward Health is merged, converted or consolidated into or to which the Equity Interests of Steward Health are contributed, as determined by Steward Health’s board as being advisable or convenient to create a suitable vehicle for a public offering (the resulting entity, the “Public Corporation”), of the Equity Interests in Steward Health or any Public Corporation, which public offering is registered with the United States Securities and Exchange Commission.

Qualified Transferee Credit Enhancements:  As defined in Section 23.1(a).

34

 

4834-1440-2281v12


 

Qualified Transferee:  A Person that, at the date of determination:

 

(a)

is a Person, or an Affiliate of a Person, that owns or operates, has owned and/or operated, or procures the services of a Person that has owned or operated, (i) at least six (6) hospitals or (ii) one (1) or more hospitals having an aggregated annual net revenue of $500,000,000 or more;

 

(b)

if such sale or transfer is in connection with an asset based transfer, such Qualified Transferee and its Affiliates have executed and delivered to Lessor the Qualified Transferee Credit Enhancements which are acceptable to Lessor in its reasonable discretion;

 

(c)

has not, and neither have any of such Person’s senior officers or directors:  (A) had any license or certification to operate any healthcare facility or any other similar business irrevocably revoked by any Governmental Body, or caused any such revocation, due to any actual fault, (B) been found to have been grossly negligent or to have committed willful or intentional misconduct in any lawsuit alleging any wrongdoing by such Person or any of such senior officers, directors, shareholders or members relating to patient care, (C) been permanently excluded from providing services in connection with the operation of any healthcare facility or any other similar business by any applicable state healthcare licensing authority, or (D) been permanently excluded or restricted from participation in Medicare, Medicaid or any other governmental payor program; and (ii) has not, and neither have any of such Person’s senior officers or directors, been the subject of a pending investigation or proceeding within the past 5 years that is reasonably likely to result in any of the foregoing; and

 

(d)

has not: (i) made an assignment of all or substantially all of its property for the benefit of creditors, (ii) had a receiver, trustee or liquidator appointed for any of its property (unless such appointment was discharged within 60 days after the date of such appointment), (iii) filed a voluntary petition under any federal bankruptcy law or state Legal Requirements to be adjudicated as bankrupt or for any arrangement or other debtor’s relief, or (iv) had an involuntary filing of such a petition against any such Person by any other Person (unless such petition was dismissed within 90 days after filing).

RCRA:  As defined in the definition of “Hazardous Materials Law.”

Real Estate Contract: That certain Real Property Asset Purchase Agreement, dated as of September 26, 2016, by and among Steward Health, Lessee, and certain of their respective Affiliates, the MPT Lenders, and Lessor, as the same has been or hereafter may be amended, modified, or restated from time to time.

Real Estate Taxes:  All taxes, assessments and special assessments, and dues which are levied or imposed upon the Leased Property.

35

 

4834-1440-2281v12


 

Realty Payments:  For any period, the sum of the payment obligations of Steward Health and its Subsidiaries under (a) this Lease, (b) the Mortgage Loan Note, and (c) under any other hospital real estate lease or mortgage loan with any other Person.

Rent:  Collectively, the Base Rent (as increased in accordance with the provisions of Section 3.1(b)), the Additional Charges, the Severed Ground Lease Base Rent, and the Lease Severance Fee.  

Rent Schedule:  As defined in Section 3.1(c).

Request:  As defined in Section 10.3.

Revised Rent Schedule: As defined in Section 3.1(c).

Revised Sale Terms:  As defined in Section 34.2(b).

ROFO Exercise Notice:  As defined in Section 10.3(a).

Salt Lake Facility: That certain One Hundred Fifty-Eight (158)-licensed bed general acute care hospital facility operated at the Salt Lake Land, commonly known as "Salt Lake Regional Medical Center."

 

Salt Lake Land: That certain real property located in Salt Lake County, Utah as more particularly described on Exhibit A-18 attached hereto and made a part hereof by reference and incorporation, together with all hereditaments, easements, mineral rights, rights of way and other appurtenances related thereto.

 

Salt Lake Lessee:  Salt Lake Regional Medical Center, LP, a Delaware limited partnership, together with its successors and permitted assigns.

 

Salt Lake Lessor:  MPT of Salt Lake City-Steward, LLC, a Delaware limited liability company, together with its successors and assigns.

 

Salt Lake Property:  The Salt Lake Land and related Leased Improvements located thereon relating to the Salt Lake Facility.

 

SARA:  As defined in the definition of “Hazardous Materials Law.”

Sebastian Facility: That certain One-Hundred Fifty-Four (154)-licensed bed general acute care hospital facility operated at the Sebastian Land, commonly known as “Sebastian River Medical Center.”

 

Sebastian Land: That certain real property located in Indian River County, Florida as more particularly described on Exhibit A-8 attached hereto and made a part hereof by reference and incorporation, together with all hereditaments, easements, mineral rights, rights of way and other appurtenances related thereto.

 

36

 

4834-1440-2281v12


 

 

Sebastian Lessee:  Steward Sebastian River Medical Center, Inc., a Delaware corporation, together with its successors and permitted assigns.

 

Sebastian Lessor:  MPT of Sebastian-Steward, LLC, a Delaware limited liability company, together with its successors and assigns.

 

Sebastian PFDA:  That certain Project Funding and Development Agreement, dated as of November 30, 2018, by and among Sebastian Lessor, Steward Health, and Sebastian Lessee, as the same has been or hereafter may be amended, modified, or restated from time to time.

 

Sebastian Project:  The "Project" under and as defined in the Sebastian PFDA.

 

Sebastian Project Completion Date:  September 22, 2020.

 

Sebastian Project Development Costs:  The sum of (a) all costs funded by Sebastian Lessor for the Sebastian Project pursuant to the Sebastian PFDA, and (b) the applicable Construction Period Accrual.

 

Sebastian Property:  The Sebastian Land and related Leased Improvements located thereon relating to the Sebastian Facility.

 

Security Agreement:  That certain Security Agreement, dated as of the Initial Commencement Date, among Lessee, the Borrower Affiliates, Lessor and certain of its Affiliates, as the same has been or hereafter may be amended, modified, or restated from time to time.

Severance Date:  As defined in Section 30.2.

Severance Fee Escalator: As defined in Section 3.6(e).

Severance Fee Rate: As defined in Section 3.6(d).

Severance Notice:  As defined in Section 30.2.

Severed Facility: Any healthcare facility or other real property which was subject to the Original Lease, but, which prior to the Effective Date, was severed and released from the Original Lease.

Severed Facility Amendment: Means any amendment to the Original Lease pursuant to which a Severed Facility was severed and released from the Original Lease.

Severed Ground Lease: Collectively, the Severed De Zavala Ground Lease and the Severed Potranco Ground Lease.

Severed Ground Lease Base Rent: With respect to each Severed Ground Lease, all “Base Rent” (as defined in the applicable Severed Ground Lease) with respect to the Severed Ground Lease Property under the Severed Ground Leases.

37

 

4834-1440-2281v12


 

Severed Ground Lease Property: Collectively, any real property and/or improvements subject to a Severed Ground Lease.

Severed De Zavala Ground Lease: That certain Ground Lease, dated effective as of September 4, 2015, as amended by (i) that certain First Amendment to Ground Lease, dated effective as of November 3, 2015, and (ii) that certain Second Amendment to Ground Lease, dated effective as of April 29, 2016, between MPT of DeZavala FCER, LLC (as successor by assignment from De Zavala Medical Center LLC) as tenant, and Randal Shepherd, as Trustee of the 2013 Shepherd Family Trust (as successor by assignment from 12805 I-10, LLC, a Texas limited liability company), as landlord, as the same has been or may be modified, amended or restated from time to time.

Severed Potranco Ground Lease: That certain Ground Lease, dated effective as of October 9, 2015, between MPT of Potranco FCER, LLC (as successor by assignment from Legacy Trails Medical Center LLC) as tenant, and C&C Potranco West-27, LP, a Texas limited partnership, as landlord, as the same has been or may be modified, amended or restated from time to time.

Severed Lease:  As defined in Section 30.2.

Severed Property:  As defined in Section 30.2.

Sharon Facility: That certain Two Hundred Fifty-One (251)-licensed bed general acute care hospital facility operated at the Sharon Land, commonly known as “Sharon Regional Health System.”

 

Sharon Land: That certain real property located in Mercer County, Pennsylvania as more particularly described on Exhibit A-9 attached hereto and made a part hereof by reference and incorporation, together with all hereditaments, easements, mineral rights, rights of way and other appurtenances related thereto.

 

Sharon Lessee:  Steward Sharon Regional Health System, Inc., a Delaware corporation, together with its successors and permitted assigns.

 

Sharon Lessor:  MPT of Sharon-Steward, LLC, a Delaware limited liability company, together with its successors and assigns.

 

Sharon Property:  The Sharon Land and related Leased Improvements located thereon relating to the Sharon Facility.

 

Southeast Texas Facility: That certain One Hundred Ninety-Nine (199)-licensed bed general acute care hospital facility operated at the Southeast Texas Land, commonly known as "The Medical Center of Southeast Texas."

 

Southeast Texas Land: That certain real property located in Jefferson County, Texas, as more particularly described on Exhibit A-19 attached hereto and made a part hereof by reference and incorporation, together with all hereditaments, easements, mineral rights, rights of way and other appurtenances related thereto.

38

 

4834-1440-2281v12


 

 

Southeast Texas Lessee:  The Medical Center of Southeast Texas, LP, a Delaware limited partnership, together with its successors and permitted assigns.

 

Southeast Texas Lessor:  MPT of Port Arthur, LLC, a Delaware limited liability company, together with its successors and assigns.

 

Southeast Texas Property:  The Southeast Texas Land and related Leased Improvements located thereon relating to the Southeast Texas Facility.

 

Southwest General Facility: That certain Three Hundred Twenty-Seven (327)-licensed bed general acute care hospital facility operated at the Southwest General Land, commonly known as "Southwest General Hospital."

 

Southwest General Land: That certain real property located in Bexar County, Texas as more particularly described on Exhibit A-20 attached hereto and made a part hereof by reference and incorporation, together with all hereditaments, easements, mineral rights, rights of way and other appurtenances related thereto.

 

Southwest General Lessee:  Southwest General Hospital, LP, a Delaware limited partnership, together with its successors and permitted assigns.

 

Southwest General Lessor:  MPT of San Antonio-Steward, LLC, a Delaware limited liability company, together with its successors and assigns.

 

Southwest General Property:  The Southwest General Land and related Leased Improvements located thereon relating to the Southwest General Facility.

 

Specified Equity Contribution: As defined in Section 16.6.

St. Anne’s Facility: That certain one hundred seventy-five (175)-licensed bed general acute care hospital facility operated at the St. Anne’s Land, commonly known as “St. Anne’s Hospital.”

St. Anne’s Fall River Parking Lot Land: That certain real property located in Bristol County, Massachusetts more particularly described on Exhibit A-29 attached hereto and made a part hereof by reference and incorporation, together with all hereditaments, easements, mineral rights, rights of way and other appurtenances related thereto.

St. Anne’s Fall River Parking Lot Property: The Fall River Parking Lot Land and related Leased Improvements located thereon.

St. Anne’s Land: That certain real property located in Bristol County, Massachusetts more particularly described on Exhibit A-4 attached hereto and made a part hereof by reference and incorporation, together with all hereditaments, easements, mineral rights, rights of way and other appurtenances related thereto.

39

 

4834-1440-2281v12


 

St. Anne’s Lessee:  Steward St. Anne’s Hospital Corporation, a Delaware corporation, together with its successors and permitted assigns.

St. Anne’s Lessor:  MPT of Fall River-Steward, LLC, a Delaware limited liability company, together with its successors and assigns.

St. Anne’s Property:  The St. Anne’s Land and related Leased Improvements located thereon relating to the St. Anne’s Facility.

St. Elizabeth Facility:  That certain two hundred sixty-seven (267)-licensed bed general acute care hospital facility operated at the St. Elizabeth Land, commonly known as “St. Elizabeth’s Medical Center.”

St. Elizabeth Land: That certain real property located in Suffolk County, Massachusetts more particularly described on Exhibit A-5 attached hereto and made a part hereof by reference and incorporation, together with all hereditaments, easements, mineral rights, rights of way and other appurtenances related thereto.

St. Elizabeth Lessee: Steward St. Elizabeth’s Medical Center of Boston, Inc., a Delaware corporation, together with its successors and permitted assigns.

St. Elizabeth Lessor:  MPT of Brighton-Steward, LLC, a Delaware limited liability company, together with its successors and assigns.

St. Elizabeth PFDA: That certain Project Funding and Development Agreement, dated as of February 15, 2019, by and among St. Elizabeth Lessor, Steward Health, and St. Elizabeth Lessee, as the same has been or hereafter may be amended, modified, or restated from time to time.

St. Elizabeth Project: The “Project” under and as defined in the St. Elizabeth PFDA.

St. Elizabeth Project Completion Date: The date of “Completion” under and as defined in the St. Elizabeth PFDA; subject, however, to the rights of St. Elizabeth Lessor pursuant to the St. Elizabeth PFDA to establish the St. Elizabeth Project Completion Date upon the occurrence of certain other events.

St. Elizabeth Project Development Costs: The sum of (a) all costs funded by St. Elizabeth Lessor for the St. Elizabeth Project pursuant to the St. Elizabeth PFDA, and (b) the applicable Construction Period Accrual.

St. Elizabeth Property:  The St. Elizabeth Land and related Leased Improvements located thereon relating to the St. Elizabeth Facility.

St. Joseph Closing Date: The date of the closing of the transactions contemplated in the St. Joseph Purchase Agreement.

 

St. Joseph Facility: That certain seven hundred ninety (790)-licensed bed general acute care hospital facility operated at the St. Joseph Land, commonly known as “St. Joseph Medical Center.”

40

 

4834-1440-2281v12


 

St. Joseph Land: That certain real property located in Harris County, Texas more particularly described on Exhibit A-21 attached hereto and made a part hereof by reference and incorporation, together with all hereditaments, easements, mineral rights, rights of way and other appurtenances related thereto.

 

St. Joseph Lessee: SJ Medical Center, LLC, a Texas limited liability company, together with its successors and permitted assigns.

 

St. Joseph Lessor: MPT of Houston-Steward, LLC, a Delaware limited liability company, together with its successors and assigns.

 

St. Joseph Property: The St. Joseph Land and related Leased Improvements located thereon relating to the St. Joseph Facility.

 

St. Joseph Purchase Agreement: That certain St. Joseph Medical Center Real Estate Purchase and Sale Agreement, dated as of the St. Joseph Closing Date, among Steward, St. Joseph Lessee, St. Joseph Lessor,  and MPT of Houston RE-Steward, LLC, a Delaware limited liability company, as the same has been or hereafter may be amended, modified, or restated from time to time.

 

St. Luke's Facility: That certain Two Hundred (200)-licensed bed general acute care hospital facility operated at the St. Luke's Land, commonly known as "St. Luke's Medical Center."

 

St. Luke's Land: That certain real property located in Maricopa County, Arizona as more particularly described on Exhibit A-22 attached hereto and made a part hereof by reference and incorporation, together with all hereditaments, easements, mineral rights, rights of way and other appurtenances related thereto.

 

St. Luke's Lessee:  St. Luke's Medical Center, LP, a Delaware limited partnership, together with its successors and permitted assigns.

 

St. Luke's Lessor:  MPT of Phoenix-Steward, LLC, a Delaware limited liability company, together with its successors and assigns.

 

St. Luke's Property:  The St. Luke's Land and related Leased Improvements located thereon relating to the St. Luke's Facility.

 

St. Luke's Behavioral Facility: That certain One Hundred Twenty-Four (124)-licensed bed general acute care hospital facility operated at the St. Luke's Behavioral Land, commonly known as "St. Luke's Behavioral Health Center."

 

St. Luke's Behavioral Land: That certain real property located in Maricopa County, Arizona as more particularly described on Exhibit A-23 attached hereto and made a part hereof by reference and incorporation, together with all hereditaments, easements, mineral rights, rights of way and other appurtenances related thereto.

 

41

 

4834-1440-2281v12


 

 

St. Luke's Behavioral Lessee:  St. Luke's Behavioral Hospital, LP, a Delaware limited partnership, together with its successors and permitted assigns.

 

St. Luke's Behavioral Lessor:  MPT of Phoenix Behavioral-Steward, LLC, a Delaware limited liability company, together with its successors and assigns.

 

St. Luke's Behavioral Property:  The St. Luke's Behavioral Land and related Leased Improvements located thereon relating to the St. Luke's Behavioral Facility.

 

Stand Alone Security Agreements: Collectively, (i) that certain Security Agreement, dated as of September 29, 2017, between Jordan Valley Medical Center, LP, a Delaware limited partnership and MPT of West Jordan-Steward, LLC, a Delaware limited liability company and (ii) that certain Security Agreement, dated as of September 29, 2017, between Davis Hospital & Medical Center, LP, a Delaware limited partnership, and MPT of Layton-Steward, LLC, a Delaware limited liability company, as each of the same has been or hereafter may be amended, modified, or restated from time to time.

 

State Regulatory Authorities:  As applicable to each Facility, the state licensing and certification agencies, together with all applicable statutes and regulations, related to the licensure and operation of healthcare facilities in each respective state.

Steward Assets:  Those properties which are leased by MPT or any of its Affiliates to Steward Health or any of its Subsidiaries, and those properties which are subject to a mortgage loan from MPT or any of its Affiliates to Steward Health or any of its Subsidiaries.

Steward Guarantee:  With respect to any Person (the “guarantor”) means any obligation, contingent or otherwise, of the guarantor guaranteeing or having the economic effect of guaranteeing any Indebtedness or other obligation of any other Person (the “primary obligor”) in any manner, whether directly or indirectly, and including any obligation of the guarantor, direct or indirect, (a) to purchase or pay (or advance or supply funds for the purchase or payment of) such Indebtedness or other obligation or to purchase (or to advance or supply funds for the purchase of) any security for the payment thereof, (b) to purchase or lease property, securities or services for the purpose of assuring the owner of such Indebtedness or other obligation of the payment thereof, (c) to maintain working capital, equity capital or any other financial statement condition or liquidity of the primary obligor so as to enable the primary obligor to pay such Indebtedness or other obligation or (d) as an account party in respect of any letter of credit or letter of guaranty issued to support such Indebtedness or obligation; provided that the term Steward Guarantee shall not include endorsements for collection or deposit in the ordinary course of business or indemnity obligations entered into in connection with any acquisition or disposition of assets permitted under this Agreement.  The amount of any Steward Guarantee shall be deemed to be an amount equal to the stated or determinable amount of the related primary obligation, or portion thereof, in respect of which such Steward Guarantee is made or, if not stated or determinable, the maximum reasonably anticipated liability in respect thereof as determined by the guaranteeing Person in good faith.

Steward Health: Steward Health Care System LLC, a Delaware limited liability company.

42

 

4834-1440-2281v12


 

Strategic Agreement:  That certain Strategic Agreement, dated as of the Initial Commencement Date, between Steward Health and MPT, as the same has been or hereafter may be amended, modified, or restated from time to time.

Subsidiary or Subsidiaries:  With respect to any Person, any other Person, of which an amount of the voting securities, voting ownership or voting partnership interests of which is sufficient to elect at least a majority of its board of directors or other governing body (or, if there are no such voting interests, 50% or more of the Equity Interests of which), is owned directly or indirectly by such first Person. For the purposes hereof, the term Subsidiary shall include all Subsidiaries of such Subsidiary.

Swap Agreement: Any agreement with respect to any swap, forward, spot, future, credit default or derivative transaction or option or similar agreement involving, or settled by reference to, one or more rates, currencies, commodities, equity or debt instruments or securities, or economic, financial or pricing indices or measures of economic, financial or pricing risk or value or any similar transaction or any combination of these transactions; provided that no phantom stock or similar plan providing for payments only on account of services provided by current or former directors, officers, employees or consultants of Steward Health or its Subsidiaries shall be a Swap Agreement.

Taking:  A taking or voluntary conveyance during the Term of all or part of any Property, or any interest therein or right accruing thereto or use thereof, as the result of, or in settlement of, any Condemnation or other eminent domain proceeding threatened or affecting such portion of the Leased Property.

Tempe Facility: That certain eighty-seven (87)-licensed bed general acute care hospital facility operated at the Tempe Land, commonly known as "Tempe Medical Center."

 

Tempe Land: That certain real property located in Maricopa County, Arizona as more particularly described on Exhibit A-24 attached hereto and made a part hereof by reference and incorporation, together with all hereditaments, easements, mineral rights, rights of way and other appurtenances related thereto.

 

Tempe Lessee:  St. Luke's Medical Center, LP, a Delaware limited partnership, together with its successors and permitted assigns.

 

Tempe Lessor:  MPT of Tempe-Steward, LLC, a Delaware limited liability company, together with its successors and assigns.

 

Tempe Property:  The Tempe Land and related Leased Improvements located thereon relating to the Tempe Facility.

 

Tenant(s):  The lessees, tenants, licensees, sublessees or subtenants under the Tenant Leases, if any.

Tenant Leases:  All written leases, subleases, licenses and other rental agreements (now or hereafter in effect) with annual rental payments in excess of One Million and No/100 Dollars

43

 

4834-1440-2281v12


 

($1,000,000), if any, including any Existing Subleases, pursuant to which any Facility Lessee has granted a possessory interest in and to any space in or any part of the Leased Property, or that otherwise provide possessory rights with respect to the Leased Property, and all Credit Enhancements, if any, held in connection therewith.

Tenet Master Agreement: That certain Tenet Master Agreement, dated as of June 16, 2021, among Steward Health, Miami Lessor, Coral Gables Lessor, Lauderdale Lakes Lessor, Hialeah Lessor, and Hialeah Palmetto Lessor, as modified, amended, or restated from time to time.

Tenet Property: Collectively, the Coral Gables Property, the Lauderdale Lakes Property, the Hialeah Property, the Hialeah Palmetto Property, and the Miami Property.

Tenet Purchase Agreement: That certain Asset Purchase Agreement, dated as of June 16, 2021 by and among Steward Health and certain of its Affiliates and Tenet Healthcare Corporation, a Nevada corporation, and certain of its Affiliates, as modified, amended, or restated from time to time.

Term:  With respect to a particular Property, the actual duration of this Lease, including the Fixed Term and the Extension Term (if extended by Lessee).

Term Loan Promissory Note:  That certain Second Amended and Restated Promissory Note, dated as of June 30, 2020, made by Steward Health in favor of MPT TRS Lender-Steward, LLC, in the original principal amount of Eighty Five Million Five Hundred Fifty Three Thousand Eighty One and 50/100 Dollars ($85,553,081.50), as the same has been or hereafter may be amended, modified, or restated from time to time.

Terminated Property:  As defined in Section 16.1D.

Texas Property: Collectively, the Odessa Property, the Southeast Texas Property, the Southwest General Property, that portion of the Ancillary Property that is located in the State of Texas, the St. Joseph Property, and the Big Spring Property.

 

Third Party Offer:  As defined in Section 34.2(a).

Third Party Offer Notice:  As defined in Section 34.2(a).

Traco:  As defined in Section 13.1(a).

Transfer Requirements: As defined in Section 38.6.

Trumbull Facility: That certain Two Hundred Ninety-Two (292)-licensed bed general acute care hospital facility operated at the Trumbull Land, commonly known as “Trumbull Memorial Hospital.”

 

Trumbull Land: That certain real property located in Trumbull County, Ohio as more particularly described on Exhibit A-10 attached hereto and made a part hereof by reference and incorporation, together with all hereditaments, easements, mineral rights, rights of way and other appurtenances related thereto.

44

 

4834-1440-2281v12


 

 

Trumbull Lessee: Steward Trumbull Memorial Hospital, Inc., a Delaware corporation, together with its successors and permitted assigns.

 

Trumbull Lessor:  MPT of Warren-Steward, LLC, a Delaware limited liability company, together with its successors and assigns.

 

Trumbull Property:  The Trumbull Land and related Leased Improvements located thereon relating to the Trumbull Facility.

 

Unsuitable for Its Use or Unsuitable for Its Primary Intended Use:  As used anywhere in this Lease, the terms “Unsuitable for Its Use” or “Unsuitable for Its Primary Intended Use” shall mean that, with respect to any Property or part thereof, by reason of damage or destruction or a partial Taking by Condemnation, such Property cannot be operated on a commercially practicable basis for its Primary Intended Use, taking into account, all relevant factors (including, without limitation, anticipated repairs and/or restorations), and the effect of such damage or destruction or partial Taking.

USPAP:  The Uniform Standards of Professional Appraisal Practice, as amended from time to time.

Utah Property: Collectively, the Jordan Valley Property, the Mountain Point Property, the Salt Lake Property, that portion of the Ancillary Property that is located in the State of Utah, the Davis Property, and the West Jordan Property.

Vacated Property:  As defined in Section 16.1A.

Wadley Facility: That certain seventy-nine (79)-licensed bed general acute care hospital facility operated at the Wadley Land, commonly known as "Wadley Regional Medical Center at Hope."

 

Wadley Land: That certain real property located in Hempstead County, Arkansas as more particularly described on Exhibit A-25 attached hereto and made a part hereof by reference and incorporation, together with all hereditaments, easements, mineral rights, rights of way and other appurtenances related thereto.

 

Wadley Lessee:  Brim Holding Company, Inc., a Delaware corporation, together with its successors and permitted assigns.

 

Wadley Lessor:  MPT of Hope-Steward, LLC, a Delaware limited liability company, together with its successors and assigns.

 

Wadley Property:  The Wadley Land and related Leased Improvements located thereon relating to the Wadley Facility.

 

45

 

4834-1440-2281v12


 

 

West Jordan Project Development Costs: The sum of (a) all costs funded by West Jordan Lessor and MPT of West Jordan-Steward, LLC for the West Jordan Project pursuant to the West Jordan PFDA, and (b) the “Construction Period Accrual” under and as defined in the West Jordan PFDA.

 

West Jordan Facility: That certain One Hundred Seventy-One (171)-licensed bed general acute care hospital facility operated at the West Jordan Land, commonly known as “Jordan Valley Medical Center.”

 

West Jordan Land: That certain real property located in Salt Lake County, Utah as more particularly described on Exhibit A-36 attached hereto and made a part hereof by reference and incorporation, together with all hereditaments, easements, mineral rights, rights of way and other appurtenances related thereto.

 

West Jordan Lessee: Jordan Valley Medical Center, LP, a Delaware limited partnership, together with its successors and permitted assigns.

 

West Jordan Lessor: MPT of West Jordan-Steward Property, LLC, a Delaware limited liability company, together with its successors and assigns.

 

West Jordan PFDA: That certain Project Funding and Development Agreement, dated as of March 12, 2020, by and among MPT of West Jordan-Steward Property, LLC (as successor by assignment to MPT of West Jordan-Steward, LLC), Steward Health, and Jordan Valley Medical Center, LP, as the same has been or hereafter may be amended, modified, or restated from time to time.

 

West Jordan Project: The “Project” under and as defined in the West Jordan PFDA.

 

West Jordan Project Completion Date: December 3, 2020.  

 

West Jordan Property: The West Jordan Land and related Leased Improvements located thereon relating to the West Jordan Facility.

 

Wuesthoff Melbourne Facility: That certain One Hundred Nineteen (119)-licensed bed general acute care hospital facility operated at the Wuesthoff Melbourne Land, commonly known as “Wuesthoff Medical Center - Melbourne.”

 

Wuesthoff Melbourne Land: That certain real property located in Brevard County, Florida as more particularly described on Exhibit A-11 attached hereto and made a part hereof by reference and incorporation, together with all hereditaments, easements, mineral rights, rights of way and other appurtenances related thereto.

 

Wuesthoff Melbourne Lessee:  Collectively, jointly and severally, Steward Melbourne Hospital, Inc., a Delaware corporation, and Brevard SHC Holdings LLC, a Delaware limited liability company, together with their successors and permitted assigns.

 

46

 

4834-1440-2281v12


 

 

Wuesthoff Melbourne Lessor:  MPT of Melbourne-Steward, LLC, a Delaware limited liability company, together with its successors and assigns.

 

Wuesthoff Melbourne PFDA: That certain Project Funding and Development Agreement, dated as of March 12, 2020, by and among Wuesthoff Melbourne Lessor, Steward Health, and Wuesthoff Melbourne Lessee, as the same has been or may hereafter be modified, amended, or restated from time to time.

 

Wuesthoff Melbourne Project: The "Project" under and as defined in the Wuesthoff Melbourne PFDA.

 

Wuesthoff Melbourne Project Completion Date: The date of "Completion" under and as defined in the Wuesthoff Melbourne PFDA; subject, however, to the rights of Wuesthoff Melbourne Lessor pursuant to the Wuesthoff Melbourne PFDA to establish the Wuesthoff Melbourne Project Completion Date upon the occurrence of certain other events.

 

Wuesthoff Melbourne Project Development Costs: The sum of (a) all costs funded by Wuesthoff Melbourne Lessor for the Wuesthoff Melbourne Project pursuant to the Wuesthoff Melbourne PFDA, and (b) the “Construction Period Accrual” under and as defined in the Wuesthoff Melbourne PFDA.

 

Wuesthoff Melbourne Property: The Wuesthoff Melbourne Land and related Leased Improvements located thereon relating to the Wuesthoff Melbourne Facility.

 

Wuesthoff Rockledge Facility: That certain Two Hundred Ninety-Eight (298)-licensed bed general acute care hospital facility operated at the Wuesthoff Rockledge Land, commonly known as “Wuesthoff Medical Center - Rockledge.”

 

Wuesthoff Rockledge Land: That certain real property located in Brevard County, Florida as more particularly described on Exhibit A-12 attached hereto and made a part hereof by reference and incorporation, together with all hereditaments, easements, mineral rights, rights of way and other appurtenances related thereto.

 

Wuesthoff Rockledge Lessee: Collectively, jointly and severally, Steward Rockledge Hospital, Inc., a Delaware corporation, Steward Medical Group, Inc., a Massachusetts corporation, Steward SHC Holdings LLC, a Delaware limited liability company, and Steward Florida ASC LLC, a Delaware limited liability company, together with their successors and permitted assigns.

 

Wuesthoff Rockledge Lessor:  MPT of Rockledge-Steward, LLC, a Delaware limited liability company, together with its successors and assigns.

 

Wuesthoff Rockledge Property: The Wuesthoff Rockledge Land and related Leased Improvements located thereon relating to the Wuesthoff Rockledge Facility.

 

1.2.Interpretation; Terms Generally.  The definitions set forth in Section 1.1 and elsewhere in this Lease shall apply equally to both the singular and plural forms of the terms defined.  Whenever the context may require, any pronoun shall include the corresponding

47

 

4834-1440-2281v12


 

masculine, feminine and neuter forms.  Unless otherwise indicated, the words “include”, “includes” and “including” shall be deemed to be followed by the phrase “without limitation.” The words “herein”, “hereof and “hereunder” and words of similar import shall be deemed to refer to this Lease (including the Schedules and Exhibits) in its entirety and not to any part hereof, unless the context shall otherwise require.  All references herein to Articles, Sections, Schedules and Exhibits shall be deemed to refer to Articles, Sections and Schedules of, and Exhibits to, this Lease, unless the context shall otherwise require.  Unless the context shall otherwise require, any references to any agreement or other instrument or statute or regulation are to it as amended and supplemented from time to time (and, in the case of a statute or regulation, to any corresponding provisions of successor statutes or regulations).  Any reference in this Lease to a “day” or number of “days” that does not refer explicitly to a “Business Day” or “Business Days” shall be interpreted as a reference to a calendar day or number of calendar days. If any action or notice is to be taken or given on or by a particular calendar day, and such calendar day is not a Business Day, then such action or notice shall be deferred until, or may be taken or given on, the next Business Day. For all purposes hereunder, whenever reference is made to “continuance” or “continuation” of an Event of Default (or words of similar import), such reference shall mean that the relevant Event of Default has not been waived in writing by the Lessor (or Affiliate of Lessor) or (as to any Event of Default that is subject to cure) cured within the applicable cure period.

1.3.Accounting Terms.  All accounting terms not specifically defined herein shall be construed in accordance with GAAP. Defined terms and calculations in connection with the covenants and other provisions of this Lease, including Section 16.1(j) and (k), shall be based upon and utilize GAAP applied in a manner consistent with that used in preparing the financial statements referred to in Article XXIV(b)(i)-(iii). If at any time any change in GAAP would affect the computation of any financial ratio or requirement set forth in this Lease, Lessor and Lessee shall negotiate in good faith to amend such ratio or requirement to preserve the original intent thereof in light of such change in GAAP; provided, that, until so amended, (a) such ratio or requirement shall continue to be computed in accordance with GAAP prior to such change therein and (b) Lessee shall provide to Lessor financial statements and other documents required under this Lease or as reasonably requested hereunder setting forth a reconciliation between calculations of such ratio or requirement made before and after giving effect to such change in GAAP. Without limiting the foregoing, operating leases in effect on the date of this Lease shall continue to be classified and accounted for as such for all purposes of this Lease, notwithstanding any change in GAAP relating thereto, unless the parties hereto shall enter into a mutually acceptable amendment addressing such changes.

1.4.Certain Matters Relating to References to Leased Property.  References herein to “a portion” of the Leased Property (or words or phrases of similar import) shall mean, unless the context clearly indicates otherwise, a specific Property.

48

 

4834-1440-2281v12


 

ARTICLE II.
LEASED PROPERTY; TERM

Upon and subject to the terms and conditions hereinafter set forth, Lessor leases to Lessee and Lessee rents from Lessor all of Lessor’s rights and interest in and to the following property (collectively, and as modified from time to time pursuant to the terms of this Lease, the “Leased Property”):

(a)the Land; and

(b)the existing improvements on the Land and the buildings and any improvements constructed on the Land, including, but not limited to, all buildings, structures, Fixtures, and other improvements of every kind, alleyways, and connecting tunnels, sidewalks, utility pipes, conduits, and lines (on-site and off-site), parking areas and roadways appurtenant to such buildings and structures presently or hereafter situated upon the Land, Capital Additions, and all hereditaments, easements, rights of way, and other appurtenances related thereto, but excluding the Pass-Through Lease Improvements (collectively, the “Leased Improvements”).

SUBJECT, HOWEVER, to all Permitted Exceptions, Lessee shall have and hold the Leased Property for a fixed term (the “Fixed Term”) commencing on the Initial Commencement Date and ending at midnight on the last day of the Three Hundredth (300th) full month after the Initial Commencement Date, unless sooner terminated or extended as herein provided.

So long as no Event of Default then exists and no event has then occurred which with the giving of notice or the passage of time or both would constitute such an Event of Default, Lessee shall have the option to extend the Fixed Term on the same terms and conditions set forth herein for one (1) additional period of five (5) years (an “Extension Term”); it being understood and agreed that Lessee’s exercise of such extension option must apply to the entire Leased Property.   Lessee may exercise such option by giving written notice to Lessor at least one hundred eighty (180) days prior to the expiration of the Fixed Term (the “Extension Notice”).  If, during the period following the delivery of the Extension Notice to Lessor and prior to the effective date of such extension, an Event of Default shall occur which is continuing on the commencement date of the Extension Term, at Lessor’s option, the Term shall not be so extended and Lessee shall be deemed to have forfeited all subsequent options to extend the Fixed Term of this Lease, if any. If Lessee elects not to exercise its option to extend, all subsequent options to extend, if any, shall be deemed to have lapsed and be of no further force or effect. In the event that, prior to the expiration of the Fixed Term, Accounting Standards Update, Leases (Topic 842), or any other accounting standard or official pronouncement of United States generally accepted accounting principles is adopted, which causes this Lease not to be an operating lease as defined in Accounting Standards Codification Topic 840, then Lessor and Lessee shall discuss modifications to this Lease and potential alternative and additional security arrangements under this Lease and the other Obligation Documents.

49

 

4834-1440-2281v12


 

ARTICLE III.
RENT

3.1.Rent.  During the Term, Lessee shall pay to Lessor, in advance and without notice, demand, set off or counterclaim, in lawful money of the United States of America, at Lessor’s address set forth herein or at such other place or to such other person, firm or entity as Lessor may designate from time to time in writing, following reasonable prior written notice, in accordance with Article XXXII, the Rent as provided in this Lease.   All payments to be made by Lessee under this Lease shall be made in lawful money of the United States of America by wire transfer in immediately available and freely transferable funds, and any such payments received by Lessor prior to 2:00 p.m. local time on a Business Day in Birmingham, Alabama shall be credited prior to close of business, while other payments may, at the option of Lessor, not be credited until immediately available to the Lessor prior to 2:00 p.m. local time at said place of payment on a day on which Lessor is open for business.   With respect to each Facility, Rent shall be calculated and payable as follows:

(a)Allocated Base Rent. With respect to each Property, subject to adjustment as provided herein (including adjustments set forth in Section 3.1(b) below), Lessee shall pay to Lessor in advance on the twelfth (12th) day of each calendar month during the Term base rent (the “Base Rent”) for such calendar month, equal to the aggregate sum of all Allocated Base Rent for all Properties, which Allocated Base Rent with respect to each Property shall be an amount equal to the product of (A) the Lease Base for such Property as of the last day of the preceding calendar month (or as of the Commencement Date for such Property with respect to the amount payable for the first month of the Term), multiplied by (B) the Applicable Lease Rate relating thereto, divided by (C) twelve (12).  Lessor and Lessee acknowledge that the Base Rent is payable in advance and, accordingly, with respect to additions to the Lease Base and Capital Additions funded by Lessor with respect to any Property on or after the first (1st) day of any month (and, therefore, not included in the calculation of the Allocated Base Rent paid in advance for a particular month with respect to such Property), Allocated Base Rent for the next succeeding month shall include a per diem Allocated Base Rent for the prior month (prorated based upon a three hundred sixty (360) day year) to be calculated by multiplying the amount of any such advance by the Applicable Lease Rate for such Property.  Lessor shall provide Lessee with an invoice of such amounts prior to the twelfth (12th) day of the next calendar month (the “Interim Capital Addition Rent”); provided, however, Lessor’s failure to provide Lessee with an invoice for the Interim Capital Addition Rent relating to any Property prior to the twelfth (12th) day of the next calendar month shall not limit or affect the Lessee’s obligations hereunder to pay such Interim Capital Addition Rent.  

(b)Adjustment of Applicable Lease Rate.  

(i)All Property (other than New Property and New Projects that become subject to this Lease after June 1, 2021) and Massachusetts New Projects.  With respect to each Property (other than New Property and New Projects that become subject to this Lease after June 1, 2021) and each Massachusetts New Project, on each January 1 during the Term (each an “Adjustment Date”), the Applicable Lease Rate applicable to such Property or Massachusetts New Project shall be increased (and in no event decreased) and shall be equal to the sum of (A) the previous Applicable Lease Rate and (B) the product of the previous Applicable Lease Rate and the percentage by which the CPI published for

50

 

4834-1440-2281v12


 

the month of October prior to the applicable Adjustment Date shall have increased over the CPI figure published for the month of October prior to the previous Adjustment Date, with such sum being the new Applicable Lease Rate for such Property or Massachusetts New Project used for calculating Allocated Base Rent with respect thereto (in each case, such escalator used in calculating the adjusted Applicable Lease Rate for such Property or Massachusetts New Project being referred to herein as the “Legacy Escalator”); provided, however, that the Legacy Escalator shall in no event be less than Two Percent (2.0%) or greater than Five Percent (5.0%).  

(ii)New Property and New Projects that become subject to this Lease after June 1, 2021. With respect to each New Property and New Project (other than a Massachusetts New Project) that become subject to this Lease after June 1, 2021 (including, without limitation, each Tenet Property), commencing on January 1, 2022, and continuing on each Adjustment Date during the Term thereafter, the Applicable Lease Rate for such New Property or New Project shall be increased (and in no event decreased) and shall be equal to the sum of (A) the New Property/Project Lease Rate previously in effect, and (B) the product of such previous New Property/Project Lease Rate and the percentage by which the CPI published for the month of October prior to the applicable Adjustment Date shall have increased over the CPI figure published for the month of October prior to the previous Adjustment Date, with such sum being the new New Property/Project Lease Rate for such New Property or New Project used for calculating Allocated Base Rent with respect thereto (in each case, such escalator used in calculating the adjusted New Property/Project Lease Rate for such New Property or New Project being referred to herein as the “New Property/Project Escalator”); provided, however, that the New Property/ Project Escalator shall in no event be less than One Percent (1.0%) or greater than Four Percent (4.0%).

(iii)Unknown Variables.  For any monetary increases or adjustments that cannot be determined as of the applicable Adjustment Date due to then unknown variables (such as CPI), such amounts shall become due (and calculated retroactively to the Adjustment Date) and payable as of the time of determination.

(c)Rent Schedule.  Lessor shall, in its reasonable discretion, calculate the Base Rent and Interim Capital Addition Rent payable hereunder (the “Rent Schedule”), and provide a copy of such Rent Schedule to Lessee.  Base Rent, as calculated in accordance with Sections 3.1(a) and 3.1(b) above, shall include Interim Capital Addition Rent and Allocated Base Rent payable with respect to the entire Leased Property.  The Rent Schedule shall be adjusted and substituted on a periodic basis by Lessor, in its reasonable discretion (each, a “Revised Rent Schedule”), as the Interim Capital Addition Rent and Base Rent are adjusted and calculated during the Term as provided herein.  Lessor shall provide a copy of the Revised Rent Schedule to Lessee, together with a written summary setting forth in reasonable detail the basis for such adjustments. Lessee shall have the right within ten (10) days following the furnishing by Lessor of the Revised Rent Schedule and the corresponding explanation for such adjustments, to review the Revised Rent Schedule. In the event that Lessee determines that Lessor’s adjustments or calculations of the Revised Rent Schedule are materially incorrect, provided Lessor agrees, Lessor shall correct such error and provide a corrected Revised Rent Schedule to Lessee. Payments of Rent as described in the Revised Rent Schedule shall not become effective until challenge of the Revised Rent Schedule

51

 

4834-1440-2281v12


 

has been mutually resolved by the parties, provided that such adjustments shall be retroactive to the applicable Adjustment Date.

3.2.Additional Charges.  In addition to the Base Rent, (a) Lessee shall pay and discharge as and when due and payable other amounts, liabilities, obligations and Impositions related to the ownership, use, possession and operation of the Leased Property, including, without limitation, all costs of owning and operating each Facility, all Real Estate Taxes, Insurance Premiums, maintenance and capital improvements, all violations of and defaults under any of the Permitted Exceptions, and all licensure violations, civil monetary penalties and fines (except to the extent such violations, defaults, penalties or fines are caused by the gross negligence or willful misconduct of Lessor), and (b) in the event of any failure on the part of Lessee to pay any of those items referred to in clause (a) above, Lessee will also promptly pay and reimburse Lessor, and/or its Affiliates for all such amounts paid by Lessor, and/or its Affiliates and promptly pay and discharge every fine, penalty, interest and cost which may be added for non-payment or late payment of such items (the items referred to in clauses (a) and (b) above being referred to herein collectively as the “Additional Charges”), and Lessor shall have all legal, equitable and contractual rights, powers and remedies provided in this Lease, by statute, or otherwise, in the case of non-payment of the Additional Charges, as in the case of the Base Rent. If any installment of Base Rent or Additional Charges shall not be paid within ten (10) days after the applicable due date, Lessee, in addition to all other obligations hereunder, will pay to Lessor on demand as Additional Charges, a late charge computed at the Overdue Rate on the amount of such installment from the due date of such installment to the date of payment thereof, and a Late Payment Penalty with respect to such installment.  To the extent that Lessee pays any Additional Charges to Lessor pursuant to clause (b) above or pursuant to any other requirement of this Lease, Lessee shall be relieved of its obligation to pay such Additional Charges to the entity to which they would otherwise be due.  If required by Lessor following the occurrence of an Event of Default, then, upon written request to Lessee, Lessee shall make monthly payments to Lessor in such amounts as Lessor shall estimate to be necessary to pay any Real Estate Taxes and/or some or all Insurance Premiums.  If Lessor exercises this option, it shall include in its written request an invoice in reasonable detail (the “Escrow Invoice”) specifying the amount to be paid on account of Real Estate Taxes and/or Insurance Premiums (the “Monthly Escrow Amount”).  Lessee shall pay to Lessor the Monthly Escrow Amount on the first (1st) day of each month after receipt of the initial Escrow Invoice.  At any time, with at least five (5) Business Days’ notice prior to the end of any month during the Term, Lessor may deliver to Lessee a substituted, adjusted or amended Escrow Invoice providing for a new Monthly Escrow Amount, and thereafter Lessee shall pay the revised Monthly Escrow Amount on the first (1st) day of each succeeding month (subject to further adjustment as provided for in this sentence).  Any sums paid to Lessor pursuant to this Section 3.2 shall bear interest and may not be commingled with Lessor’s books and accounts.  Lessor shall use any amounts so paid to pay the relevant Real Estate Taxes and Insurance Premiums, as applicable, in each case prior to delinquency.  Lessor shall refund to Lessee at the end of the Term any such remaining amounts collected in excess of the amounts ultimately required to pay the relevant Real Estate Taxes or Insurance Premiums. Nothing in this Section 3.2 limits the provisions of Article XXII.

3.3.Continuation of Ground Lease Base Rent with Respect to Severed Ground Leases. Lessee shall pay all Severed Ground Lease Base Rent due and payable under the Severed Ground Leases, that relate solely to the period on or after the applicable Commencement Date (under this Lease) for the applicable Severed Ground Lease Property, directly to the applicable

52

 

4834-1440-2281v12


 

“Landlord” or “Lessor” under each Severed Ground Lease as and when the same becomes due and payable under the Severed Ground Leases. Upon request by Lessor, Lessee shall provide Lessor with reasonable evidence of such payments confirming that all Severed Ground Lease Base Rent and all other charges and amounts due and payable under the Severed Ground Leases have been timely paid. As of July 24, 2020, Lessee shall (i) not be required to pay any “Additional Rent” (as defined in the applicable Severed Ground Lease) or other sums due and payable with respect to the Severed Ground Lease Property pursuant to the terms of the applicable Severed Ground Lease and (ii) be released from all obligations, liabilities, and indemnifications under this Lease resulting from any defaults of the Severed Ground Leases for the Severed Ground Lease Property which are not the direct result of Lessee’s failure to make payments of Severed Ground Lease Base Rent.

3.4.Acknowledgment of Certain Inducement Fees.

(a)Pharmacy PFDA Lease Inducement Fee. Lessor and Lessee acknowledge that (i) Lessor previously paid Lessee a fee in the aggregate amount of Ten Million and No/100 Dollars ($10,000,000.00) (the “Pharmacy PFDA Lease Inducement Fee”), as an inducement for Steward Health and the applicable Facility Lessees to enter into an amendment to the Original Lease and the Pharmacy Improvements PFDA, which Pharmacy PFDA Lease Inducement Fee represented the estimated incremental increase in value that the Pharmacy Improvements Project will cause with respect to the applicable Properties and (ii) such Pharmacy PFDA Lease Inducement Fee was previously added to and included in the applicable Lease Bases for the Properties being improved pursuant to the Pharmacy Improvements PFDA.

(b)Florence Lease Inducement Fee. Lessor and Lessee acknowledge that (i) Florence Lessor previously paid Florence Lessee a fee in the aggregate amount of Six Million and No/100 Dollars ($6,000,000.00) (the “Florence Lease Inducement Fee”), as an inducement for Steward Health and Florence Lessee to enter into the Arizona Master Agreement and (ii) such Florence Lease Inducement Fee was previously added to and included in the Lease Base for the Florence Property.  

3.5.Certain Deferred Rent. Notwithstanding anything to the contrary in this Lease, the portion of Base Rent related to the Utah Property for the period from July 8, 2020 through August 7, 2020 (the “Deferred Utah Rent”) shall be payable in twelve (12) equal monthly installments (each a “Deferred Utah Rent Payment”) over the succeeding twelve (12) month period with the first such installment (which is equal to 1/12th of the Deferred Utah Rent) due on August 12, 2020 and each successive Deferred Utah Rent Payment shall be payable with all other Base Rent at such times and on such terms as provided in this Lease.

3.6.Lease Severance Fee.

(a)Generally. As a substitute for future Base Rent which would have been due under this Lease with respect to certain properties located in Katy, Texas and Victory Lakes, Texas, which were severed from this Lease prior to the Effective Date (the “Lease Severance Fee Properties”), Lessee, jointly and severally, shall pay the lease severance fee specified in, and in the manner set forth in, this Section 3.6 (the “Lease Severance Fee”).

(b)Payment of Lease Severance Fee. Beginning on September 12, 2021, and continuing on the twelfth (12th) day of each calendar month during the Term until October 31,

53

 

4834-1440-2281v12


 

2031 (prorated for the partial payment period ending on such date), Lessee, jointly and severally, shall pay to Lessor, in advance and without notice, demand, set off, or counterclaim, in lawful money of the United States of America, at such place and in such manner as specified for the payment of Rent in Section 3.1, the Lease Severance Fee as calculated pursuant to Section 3.6(c), and subject to adjustment as specified in Section 3.6(e).

(c)Amount of Lease Severance Fee Payment. Subject to adjustment as provided in Section 3.6(e), the monthly payment of the Lease Severance Fee shall be an amount equal to the product of (i) Eight Million One Hundred Four Thousand Six Hundred Thirty Five and 18/100 Dollars ($8,104,635.18), multiplied by (ii) the Severance Fee Rate, divided by (iii) twelve (12).

(d)Severance Fee Rate. The term “Severance Fee Rate” shall mean Nine Percent (9.0%), subject to adjustment pursuant to the Severance Fee Escalator as provided in Section 3.6(e).

(e)Adjustment to Severance Fee Rate. On each Adjustment Date during the Term, the Severance Fee Rate shall be increased (and in no event decreased) and shall be equal to the sum of (i) the Severance Fee Rate previously in effect, and (ii) the product of such previous Severance Fee Rate and the percentage by which the CPI published for the month of October prior to the applicable Adjustment Date shall have increased over the CPI figure published for the month of October prior to the previous Adjustment Date, with such sum being the new Severance Fee Rate (in each case, such escalator used in calculating the adjusted Severance Fee Rate being referred to herein as the “Severance Fee Escalator”); provided, however, that the Severance Fee Escalator shall not be less than One Percent (1.0%) or greater than Four Percent (4.0%).

(f)Unknown Variables. For any monetary increases or adjustments to the Severance Fee Rate that cannot be determined as of the applicable Adjustment Date due to then unknown variables (such as CPI), such amounts shall become due (and calculated retroactively to the Adjustment Date) and payable as of the time of determination.

(g)Option to Pay Lump Sum Lease Severance Fee. At any time during the Term, Lessee may, at its option, in lieu of making future Lease Severance Fee payments pursuant to Section 3.6(b), pay Lessor an amount equal to the Lump Sum Severance Fee (as defined in this Section 3.6(g)), in which case, Lessee shall have no further or additional obligation with respect to the Lease Severance Fee and the Lease Severance Fee shall be deemed paid in full. The “Lump Sum Severance Fee” shall be an amount equal to the lesser of (i) Eight Million One Hundred Four Thousand Six Hundred Thirty Five and 18/100 Dollars ($8,104,635.18) and (ii) the sum of all remaining monthly Lease Severance Fee payments for the remainder of the Term during which the Lease Severance Fee is payable, discounted to present value at a rate equal to the 5-Year U.S. Treasury Rate plus Two Percent (2%) per annum in effect upon the date of determination.

(h)Effect of Sale.  If the applicable Facility Lessor sells its interest in a Lease Severance Fee Property, then Lessee shall receive, without duplication, (i) a credit against Lessee’s obligation to make future Lease Severance Fee payments in the amount of Net Proceeds (as herein defined) received by Lessor; and (ii) in the event that the Net Proceeds received by Lessor exceed the amount of future Lease Severance Fee payments (or if there are no future Lease Severance Fee payments as a result of Lessees having paid the Lump Sum Severance Fee), the remaining Net

54

 

4834-1440-2281v12


 

Proceeds received by Lessor up to the aggregate amount of Lease Severance Fee payments made by Lessee (including, if applicable, payment of the Lump Sum Severance Fee).  As used herein, “Net Proceeds” means an amount equal to the net sale proceeds received by the applicable Facility Lessor, as adjusted for Lessor’s carrying costs for the applicable Lease Severance Fee Property (including, without limitation, taxes, utilities, insurance, security, and property management fees), and Lessor’s transaction expenses incurred in connection with such sale (including, without limitation, taxes, legal fees, and brokerage commissions).

(i)Event of Default. For avoidance of doubt, Lessee’s failure to make any Lease Severance Fee payment when the same is due and payable shall constitute an Event of Default under Section 16.1(a) of this Lease, subject to the applicable notice and cure periods set forth in Section 16.1(a) of this Lease.

3.7.Advance for Capital Improvements.  Contemporaneously herewith, Lessor has funded the aggregate amount of Seventy-Five Million and No/100 Dollars ($75,000,000.00) (the “Funding Amount”) to Lessee for anticipated Capital Additions (and other improvements and renovations) to the Tenet Properties, which, upon completion in each case, shall be deemed Capital Additions funded by Lessor for all purposes under the Master Lease.  From and after the Effective Date, the Funding Amount shall accrue interest at Three Percent (3%) per annum and, upon completion of such Capital Additions (and other improvements and renovations), such portions of the Funding Amount utilized in respect thereof shall be added (together with accrued interest) to the Allocated Lease Base for the applicable Tenet Property.  Lessee shall utilize the entire Funding Amount for such Capital Additions (and other improvements and renovations) as soon as reasonably practicable, but in no event later than August 31, 2024.  If any portion of the Funding Amount has not been utilized for such Capital Additions (and other improvements and renovations) by August 31, 2024, then Lessee shall repay to Lessor such unused Funding Amount with accrued interest through August 31, 2024. Lessee shall complete all Capital Additions (and other improvements and renovations) pursuant to the applicable provisions of Articles IX and X hereof and shall provide periodic written updates no less frequently than monthly to Lessor with respect to the status thereof and the corresponding use of the Funding Amount.

ARTICLE IV.
IMPOSITIONS

4.1.Payment of Impositions.  Subject to and without limiting Article XII relating to permitted contests, Lessee will pay, or cause to be paid, all Impositions before any fine, penalty, interest or cost may be added for non-payment, with such payments to be made directly to the taxing or assessing authorities, unless, in the case of escrows and deposits, such Impositions are required to be paid to Lessor or a Facility Lender as provided in Section 3.2, and Lessee will promptly furnish to Lessor copies of official receipts or other satisfactory proof evidencing such payments.  Lessee’s obligation to pay such Impositions shall be deemed absolutely fixed upon the date that any such Imposition becomes a lien upon the Leased Property or any part thereof.  If any such Imposition may lawfully be paid in installments (whether or not interest shall accrue on the unpaid balance of such Imposition), Lessee may, without Lessor’s consent exercise the option to pay the same (and any accrued interest on the unpaid balance of such Imposition) in installments and, in such event, shall pay such installments during the Term (subject to and without limiting Lessee’s right of contest pursuant to the provisions of Article XII and subject to the requirement

55

 

4834-1440-2281v12


 

to pay escrows and deposits as required in Section 3.2) as the same respectively become due.  Lessor, at its expense, shall, to the extent permitted by applicable law, prepare and file all tax returns and reports as may be required by governmental authorities in respect of Lessor’s net income, gross receipts, franchise taxes and taxes on its capital stock, and Lessee, at its expense, shall, to the extent permitted by applicable laws and regulations, prepare and file all other tax returns and reports in respect of any Imposition as may be required by governmental authorities.  If any refund shall be due from any taxing authority with respect to any Imposition paid by Lessee, the same shall be paid over to, or retained by, Lessee.  Lessor and Lessee shall, upon request of the other, provide any data (i) that is maintained by the party to whom the request is made, and (ii) that pertains to the Leased Property, as may be necessary to prepare any required returns and reports.  In the event that any Governmental Body classifies any property covered by this Lease as personal property, Lessee shall file all personal property tax returns in such jurisdictions where it may legally so file.  Lessor, to the extent it possesses the same, and Lessee, to the extent it possesses the same, will provide the other party, upon request, with cost and depreciation records necessary for filing returns for any property so classified as personal property.  In the event that Lessor is legally required to file personal property tax returns, Lessee will be provided with copies of assessment notices indicating a value in excess of the reported value in sufficient time for Lessee to file a protest.  So long as no Event of Default exists, Lessee may, at Lessee’s sole cost and expense, protest, appeal, or institute such other proceedings as Lessee may deem appropriate to effect a reduction of real estate or personal property assessments and Lessor, at Lessee’s expense as aforesaid, shall fully cooperate with Lessee in such protest, appeal, or other action.  Billings for reimbursement by Lessee to Lessor of personal property taxes shall be accompanied by copies of a bill therefor and payments thereof which identify the personal property with respect to which such payments are made.

4.2.Adjustment of Impositions.  Impositions that are levied or assessed with respect to the tax-fiscal period during which the Term terminates, shall be adjusted and prorated between Lessor and Lessee, whether or not such Imposition is imposed before or after such termination, and Lessee’s obligation to pay its prorated share thereof shall survive such termination.

4.3.Utility Charges.  Lessee will contract for, in its own name, and will pay or cause to be paid all charges for electricity, power, gas, oil, sewer, water and other utilities used in connection with the Leased Property during the Term, including, without limitation, all impact and tap fees necessary for the operation of the Facilities.

4.4.Insurance Premiums.  Subject to Section 13.1(a), Lessee shall contract for, in its own name, and shall pay or cause to be paid all premiums for the insurance coverage required to be maintained pursuant to Article XIII during the Term (the “Insurance Premiums”); provided, however, if required by Lessor pursuant to Section 3.2, such Insurance Premiums shall be paid as required under Section 3.2.

56

 

4834-1440-2281v12


 

ARTICLE V.
ABSOLUTE NET LEASE; NO TERMINATION; TERMINATION WITH RESPECT TO FEWER THAN ALL PROPERTIES

5.1.Absolute Net Lease; No Termination.  The parties understand, acknowledge and agree that this is an absolute net lease and this Lease shall yield to Lessor the full amount of the installments of Base Rent and the payments of Additional Charges throughout the Term.  Lessee further acknowledges and agrees that all charges, assessments or payments of any kind are due and payable without notice, demand, set off or counterclaim (other than notices to Lessee that are expressly required hereunder) and shall be paid by Lessee as they become due and payable.  Lessee shall remain bound by this Lease in accordance with its terms and shall neither take any action without the consent of Lessor to modify, surrender or terminate the same, nor seek nor be entitled to any abatement, deduction, deferment or reduction of Rent (except as expressly provided herein), or set-off against the Rent, nor shall the respective obligations of Lessor and Lessee be otherwise affected by reason of (a) any damage to, or destruction of, any Property from whatever cause or any Taking of any Property or any portion thereof (except as expressly provided herein), (b) the lawful or unlawful prohibition of, or restriction upon, Lessee’s use of the Leased Property, or any portion thereof, or the interference with such use by any person, corporation, partnership or other entity, or by reason of eviction by paramount title; (c) any claim which Lessee has or might have against Lessor or by reason of any default or breach of any warranty by Lessor under this Lease or any other agreement between Lessor and Lessee, or to which Lessor and Lessee are parties, (d) any bankruptcy, insolvency, reorganization, composition, readjustment, liquidation, dissolution, winding up or other proceedings affecting Lessor or any assignee or transferee of Lessor, or (e) any other cause whether similar or dissimilar to any of the foregoing other than a discharge of Lessee from any such obligations as a matter of law.  Lessee hereby specifically waives all rights, arising from any occurrence whatsoever, which may now or hereafter be conferred upon it by law to (i) modify, surrender or terminate this Lease or quit or surrender the Leased Property or any portion thereof, or (ii) entitle Lessee to any abatement, reduction, suspension or deferment of the Rent or other sums payable by Lessee hereunder, except as otherwise specifically provided in this Lease.  The obligations of Lessor and Lessee hereunder shall be separate and independent covenants and agreements and the Rent and all other sums payable by Lessee hereunder shall continue to be payable in all events unless the obligations to pay the same shall be terminated pursuant to the express provisions of this Lease or by termination of this Lease other than by reason of an Event of Default.  

5.2.Termination with Respect to Fewer than All Properties.  Wherever in this Lease the action of terminating this Lease with respect to a particular Property (or action of similar import) is described or permitted, such action shall mean the termination of Lessee’s rights in and to such Property.  Notwithstanding anything in this Lease to the contrary, if this Lease shall be terminated by Lessor or Lessee pursuant to rights granted hereunder with respect to any particular Property, such termination shall not affect the Term of this Lease with respect to the balance of the Leased Property relating to Properties not so terminated and this Lease shall continue in full force and effect with respect to such portion of the Leased Property, except that (a) the total Base Rent payable hereunder shall be reduced by the amount of Allocated Base Rent with respect to the Property as to which this Lease has been so terminated, (b) all references herein to Leased Property shall thereafter no longer include such terminated Property, (c) the terminated Property shall no longer be leased hereunder, and (d) provided that all of Lessee’s obligations hereunder with respect

57

 

4834-1440-2281v12


 

to such portion of the Leased Property (excluding unasserted contingent indemnification obligations) have been paid in full to Lessor, the relevant Facility Lessee shall no longer be a Facility Lessee hereunder or a party hereto with respect to such Property (and for the avoidance of doubt, if all Properties of a Facility Lessee shall have been so terminated, such Facility Lessee shall no longer be a Facility Lessee hereunder or a party hereto); subject, however, to Lessor’s right, in the event of any such termination because of an Event of Default, to recover damages with respect to any such terminated Property.

ARTICLE VI.
OWNERSHIP OF LEASED PROPERTY AND PERSONAL PROPERTY

6.1.Ownership of the Leased Property.  Lessee acknowledges that the Leased Property is the property of Lessor and that Lessee has only the right to the possession and use of the Leased Property as a lessee of Lessor and upon and subject to the terms, provisions and conditions of this Lease.

6.2.Lessee’s Personal Property.  Lessee, at its expense, shall install, affix, assemble and place on the Leased Property the Lessee’s Personal Property. Lessee shall not, without the prior written consent of Lessor (such consent not to be unreasonably withheld, conditioned or delayed provided that no Event of Default then exists), remove any of Lessee’s Personal Property from the Leased Property except for removal (a) of inventory, (b) because of damage, obsolescence, upgrade or replacement or (c) in the ordinary course of Lessee’s Business.  Lessee shall provide and maintain during the entire Term all such Lessee’s Personal Property as shall be necessary to operate each Property in material compliance with all licensure and certification requirements, in material compliance with all applicable Legal Requirements and Insurance Requirements, and otherwise in accordance with customary practice in the industry for the Primary Intended Use.  Following the expiration or earlier termination of this Lease with respect to any one or more of the Properties and subject to Lessor’s option to purchase such Lessee Personal Property as provided in Section 34.1, Lessee agrees that all of Lessee’s Personal Property relating to such one or more Properties (for which Lessor has authorized removal as provided above) not removed by Lessee within fifteen (15) days following the expiration or earlier termination of this Lease with respect thereto shall be considered abandoned by Lessee and may be appropriated, sold, destroyed or otherwise disposed of by Lessor (at Lessee’s cost) with prior written notice thereof to Lessee, without any payment to Lessee and without any obligation to Lessee to account therefor.  Lessee will, at its expense, restore the Leased Property and repair all damage to the Leased Property caused by the installation or removal of Lessee’s Personal Property, whether affected by Lessee, Lessor, any Lessee lender, or any Facility Lender.

ARTICLE VII.
CONDITION AND USE OF LEASED PROPERTY

7.1.Condition of the Leased Property.  Lessee acknowledges receipt and delivery of possession of the Leased Property and that Lessee has examined and otherwise has acquired knowledge of the condition of the Leased Property prior to the execution and delivery of this Lease and has found the same to be satisfactory for its purpose hereunder.  Lessee is leasing the Leased Property “as is” and “where is” in its present condition. Lessee has not relied on any representation or warranty by Lessor and hereby waives any claim or action against Lessor in respect of the

58

 

4834-1440-2281v12


 

condition of the Leased Property.  LESSOR MAKES NO WARRANTY OR REPRESENTATION, EXPRESS OR IMPLIED, IN RESPECT OF THE LEASED PROPERTY OR ANY PART THEREOF, EITHER AS TO ITS FITNESS FOR USE, SUITABILITY, DESIGN OR CONDITION FOR ANY PARTICULAR USE OR PURPOSE OR OTHERWISE, AS TO QUALITY OF THE MATERIAL OR WORKMANSHIP THEREIN, LATENT OR PATENT, IT BEING AGREED THAT ALL SUCH RISKS ARE TO BE BORNE BY LESSEE.  LESSEE ACKNOWLEDGES THAT THE LEASED PROPERTY HAS BEEN INSPECTED BY LESSEE AND IS SATISFACTORY TO IT.  ACCORDINGLY, LESSEE HEREBY ACKNOWLEDGES THAT LESSOR HAS NOT MADE AND WILL NOT MAKE, NOR SHALL LESSOR BE DEEMED TO HAVE MADE ANY WARRANTY OR REPRESENTATION, WHETHER EXPRESS OR IMPLIED, INCLUDING WITHOUT LIMITATION, ALL WARRANTIES THAT THE LEASED PROPERTY IS FREE FROM VICES, DEFECTS AND DEFICIENCIES, WHETHER HIDDEN OR APPARENT OR ANY WARRANTY AS TO THE FITNESS, DESIGN OR CONDITION OF THE LEASED PROPERTY FOR ANY PARTICULAR USE OR PURPOSE OF SUCH LEASED PROPERTY.  THE PROVISIONS OF THIS SECTION 7.1 HAVE BEEN NEGOTIATED, AND ARE INTENDED TO BE A COMPLETE EXCLUSION AND NEGATION OF ANY WARRANTIES BY LESSOR, EXPRESS, IMPLIED OR CREATED BY APPLICABLE LAW, WITH RESPECT TO THE CONDITION OF THE LEASED PROPERTY.

7.2.Use of the Leased Property.  Each Property shall be used and operated as a healthcare facility or in such manner as is consistent with its current use and for such other legal ancillary uses as may be necessary in connection with or incidental to such uses and, in each case, subject to all covenants, restrictions, easements and all other matters of record (including those set forth in the Permitted Exceptions) relating to the applicable Property (individually with respect to each Property, and collectively as to all Properties, the “Primary Intended Use”). Lessee shall be in material compliance with all Legal Requirements and Healthcare Laws and shall maintain all material Licenses and Participation Agreements, including, but not limited to, Medicare and/or Medicaid certifications, provider numbers and agreements, certificates of need, governmental approvals, and full accreditation from all applicable governmental authorities, if any, that are necessary for the operation of the Business with respect to the applicable Property consistent with the Primary Intended Use; provided, however, that the foregoing shall not restrict a Facility Lessee from terminating, amending, restating, extending, supplementing, or modifying any Participation Agreement in the ordinary course or as may be required by applicable law (other than any termination of any Participation Agreement relating to rights to payment or reimbursement from Medicare, which termination is hereby expressly prohibited).

(a)Except as expressly authorized herein, Lessee shall not use any Property for any use other than as provided herein, to the extent such change in use or decrease has a material adverse effect on the Primary Intended Use or the ability of the Lessee to meet its obligations under this Lease, without the prior written consent of Lessor, not to be unreasonably withheld, conditioned or delayed.

(b)No use shall be made or permitted to be made of the Leased Property and no acts shall be done which will cause the cancellation of any insurance policy covering the Leased Property or any part thereof, nor shall Lessee sell or otherwise provide to residents or patients therein, or permit to be kept, used or sold in or about the Leased Property any article which is

59

 

4834-1440-2281v12


 

prohibited by law or by the standard form of fire insurance policies, any other insurance policies required to be carried hereunder, or fire underwriters regulations.  Lessee shall, at its sole cost, comply, in all material respects, with all of the requirements, covenants and restrictions pertaining to the Leased Property, including, without limitation, all of the Permitted Exceptions, and other requirements of any insurance board, association, organization or company necessary for the maintenance of the insurance, as herein provided, covering the Leased Property and Lessee’s Personal Property.

(c)Lessee shall operate the Leased Property only in accordance with the Primary Intended Use and as a provider of goods and services incidental thereto.

(d)Lessee shall not commit or suffer to be committed any material waste on the Leased Property, or in any of the Facilities, nor shall Lessee cause or permit any nuisance thereon.

(e)Lessee shall neither suffer nor permit the Leased Property, or any portion thereof, including any Capital Addition whether or not funded by Lessor, or Lessee’s Personal Property, to be used in such a manner as (i) could reasonably tend to impair Lessor’s (or Lessee’s, as the case may be) title thereto or to any portion thereof, or (ii) may reasonably make possible a claim or claims of adverse usage or adverse possession by the public, as such, or of implied dedication of the Leased Property, or any portion thereof.

(f)With respect to each Property, Lessor shall, subject to applicable laws (including but not limited to the Healthcare Laws), have the right and option to erect a sign on such Property stating that such Property is owned by Lessor.  Such sign shall be in a size, and shall be erected in a location acceptable to Lessor and approved by Lessee, which approval shall not be unreasonably withheld, conditioned or delayed.  Lessor shall be responsible for all costs related to such signage and complying with all Legal Requirements with respect to such signage.

7.3.Lessor to Grant Easements.  From time to time during the Term, upon the request of Lessee, and so long as no Event of Default then exists, and no event has then occurred which with the giving of notice or the passage of time or both would constitute such an Event of Default, Lessor shall, and at Lessee’s cost and expense: (a) grant easements and other rights in the nature of easements, (b) release existing easements or other rights in the nature of easements which are for the benefit of the Leased Property or any portion thereof; (c) dedicate or transfer unimproved portions of the Leased Property for road, highway or other public purposes; (d) execute petitions to have the Leased Property or any portion thereof annexed to any municipal corporation or utility district; (e) execute amendments to any covenants and restrictions affecting the Leased Property or any portion thereof; and (f) execute and deliver to any Person any instrument appropriate to confirm or effect such grants, releases, dedications and transfers (to the extent of its interest in the Leased Property), but only upon delivery to Lessor of such information as Lessor may reasonably require confirming that such grant, release, dedication, transfer, petition or amendment is (i) required for, and not materially detrimental to, the proper conduct of the Primary Intended Use on the Leased Property and (ii) does not materially reduce the value of the Leased Property or any portion thereof or does not reduce such value by an amount greater than the amount of any consideration paid to Lessor in connection therewith.

60

 

4834-1440-2281v12


 

ARTICLE VIII.
LEGAL AND INSURANCE REQUIREMENTS

8.1.Compliance with Legal and Insurance Requirements.   Subject to Article XII relating to permitted contests, Lessee, at its expense, (a) shall comply, in all material respects with all Legal Requirements and Insurance Requirements applicable to Lessee and the use, operation, maintenance, repair and restoration of the Facilities and the Leased Property, whether or not compliance therewith shall require structural change in any of the Leased Improvements or interfere with the use and enjoyment of the Leased Property; (b) shall not use the Leased Property and Lessee’s Personal Property for any unlawful purpose; (c) shall procure, maintain and comply with all material Licenses and any other licenses, certificates, certifications, consents, permits, governmental approvals, and authorizations required under the Legal Requirements for any use of the Leased Property and Lessee’s Personal Property then being made, and for the proper erection, installation, operation and maintenance of the Leased Property or any part thereof, including, without limitation, any Capital Additions; and (d) shall use its commercially reasonable efforts to require under the Tenant Leases that all Tenants acquire and maintain all material Licenses necessary to operate any portion of the Leased Property subleased to them for any appropriate and permitted uses conducted on the Leased Property as may be permitted from time to time hereunder, it being acknowledged by Lessor that any failure by any Tenant under this clause (d) shall not cause (or be deemed to cause) a breach by Lessee of this Section 8.1 unless Lessee has so failed to use commercially reasonable efforts.  Lessee’s use of the Leased Property, the use of all Lessee’s Personal Property used in connection with the Leased Property, and the maintenance, alteration, and operation of the same, and all parts thereof, shall at all times conform in all material respects to all Legal Requirements.  Upon Lessor’s request, Lessee shall deliver to Lessor copies of all such Licenses that are currently held by Lessee or its Affiliates to the extent applicable to the Leased Property.  Lessee shall indemnify and defend, at Lessee’s sole cost and expense, and hold Lessor, its Affiliates and their respective successors and assigns harmless from and against and agrees to reimburse Lessor, its Affiliates and their respective successors and assigns with respect to any and all claims, demands, actions, causes of action, losses, damages, liabilities, reasonable, out-of-pocket costs and expenses (including, without limitation, reasonable attorneys’ fees and court costs) of any and every kind or character, known or unknown, fixed or contingent, asserted against or incurred by Lessor, its Affiliates and their respective successors and assigns, at any time and from time to time by reason or arising out of any breach by Lessee of any of the provisions of this Article VIII or any breach or violation by Lessee of any Legal Requirements, including any and all such claims, demands, liabilities, damages, costs and expenses relating to immaterial violations or breaches of the Legal requirements, except to the extent arising solely as a result of the gross negligence or willful misconduct of Lessor or its Affiliates. All such damages and reasonable out-of-pocket costs and expenses payable to Lessor under this Section 8.1 shall be due and payable by Lessee within thirty (30) days after delivery of written demand from Lessor, its Affiliates or their respective successors and assigns.

8.2.Hazardous Materials and Medical Waste.

(a)Lessee shall ensure that the Leased Property and the operation of the Business thereon complies in all material respects with all Hazardous Materials Laws.  Except for Hazardous Materials generated, used, installed, manufactured, treated, handled, refined, produced, processed, stored or disposed of in the normal course of business regarding the Primary Intended

61

 

4834-1440-2281v12


 

Use or the conduct of the Business or operation and maintenance of the Leased Property (which Hazardous Materials shall be handled and disposed of in material compliance with all Hazardous Materials Laws), Lessee shall not cause any Hazardous Materials to be installed, used, generated, manufactured, treated, handled, refined, produced, processed, stored or disposed of, or otherwise present in, on or under any Property or in connection with the conduct of the Business thereon in a manner that reasonably could be expected result in a material violation of any Hazardous Materials Laws. No activity shall be undertaken by Lessee on any Property or in connection with the operation of the Business thereon which would cause (i) any Property to become a RCRA Part B treatment, storage or disposal facility of hazardous waste, infectious waste, biomedical or medical waste, (ii) a release of Hazardous Materials from any Property that is reportable within the meaning of CERCLA or SARA or any similar Hazardous Materials Laws, (iii) the discharge of Hazardous Materials into any watercourse, surface or subsurface of body of water or wetland, or the discharge into the atmosphere of any Hazardous Materials, except as authorized under a permit under any Hazardous Materials Laws or at quantities or concentrations below the standard regulated by Hazardous Materials Laws, in a manner that would give rise to a material liability under Hazardous Materials Laws, or (iv) a material violation under RCRA, CERCLA, SARA or any Hazardous Materials Laws with respect to the Property.  Lessee shall, at its sole cost, expense, risk and liability, remove or cause to be removed from any Property all Hazardous Materials generated in connection with the Primary Intended Use and as found in hospital and healthcare facilities, including, without limitation, all infectious waste materials, syringes, needles and any materials contaminated with bodily fluids of any type, character or description of whatsoever nature to the extent required to comply with all Hazardous Materials Laws.  Lessee shall not dispose of any such infectious waste and Hazardous Materials in any receptacles used for the disposal of normal refuse to the extent such disposal is not in compliance in all material respects with any Hazardous Materials Laws.

(b)Lessee shall ensure that the Leased Property and the operation of the Business thereon complies in all material respects with all Medical Waste Laws.  Except for Medical Waste generated, used, installed, treated, handled, refined, produced, processed, stored or disposed of in the normal course of business regarding the Primary Intended Use or the conduct of the Business (which Medical Waste shall be handled and disposed of in compliance in all material respects with all Medical Waste Laws), Lessee shall not cause any Medical Waste to be installed, used, generated, treated, handled, refined, produced, processed, stored or disposed of, or otherwise present in, on or under any Property or in connection with the conduct of the Business thereon in a manner that could result in a material violation of any Medical Waste Laws. Lessee shall undertake no activity on any Property or in connection with the operation of the Business thereon which would reasonably be expected to cause a material violation of any Medical Waste Laws. Lessee shall, at its sole cost, expense, risk and liability, remove or cause to be removed from any Property all Medical Waste generated, used, installed, treated, handled, refined, produced, processed, stored or disposed of by or on behalf of Lessee on such Property to the extent required to comply in all material respects with all Medical Waste Laws.  Lessee shall not dispose of any such Medical Waste in any receptacles used for the disposal of normal refuse to the extent such disposal is not in material compliance with any Medical Waste Laws.

(c)Lessee shall indemnify and defend, at its sole cost and expense, and hold harmless and reimburse the Lessor, its Affiliates and their respective officers, directors, members, (general and limited) partners, shareholders, employees, agents, representatives, successors and

62

 

4834-1440-2281v12


 

assigns (collectively, the “MPT Indemnified Parties”) from and against any and all claims, demands, actions, causes of action, losses, damages, liabilities, penalties, taxes, reasonable out-of-pocket costs and expenses (including, without limitation, reasonable out-of-pocket attorneys’ and accountants’ fees, settlement costs, arbitration costs and any reasonable other expenses for investigating or defending any action or threatened action) (each, a “Claim”) of any and every kind or character, known or unknown, fixed or contingent, asserted against or incurred by any of the MPT Indemnified Parties at any time and from time to time by reason of, arising out of or resulting from (i) events, conditions or circumstances which occurred or existed on, under, in, about, to or from the Property prior to execution of this Lease and that give rise to a liability under Hazardous Materials Laws or Medical Waste Laws, (ii) any liability under Hazardous Materials Laws or Medical Waste Laws arising out of the Lessee’s operation of the Property, or (iii) any Claim arising out of or, in connection with or resulting from any breach by Lessee of  Section 8.2(a) or 8.2(b) or any other violation of Sections 8.2(a) or 8.2(b) or any Hazardous Materials Laws or Medical Waste Laws by any Person other than the MPT Indemnified Parties, including any and all such claims, demands, liabilities, damages, costs and expenses relating to immaterial violations or breaches of this Section 8.2 or any Hazardous Materials Laws or Medical Waste Laws (collectively, “MPT Damages”), except to the extent any such Claim or MPT Damages is found to have resulted from the, bad faith, gross negligence or willful misconduct of any MPT Indemnified Party.  All such MPT Damages shall be due and payable by Lessee within thirty (30) days after any MPT Indemnified Party’s demand therefor.

(d)In the event of any Claim related to Hazardous Materials or Medical Waste on the Property resulting from the assertion of liability by a third party against any MPT Indemnified Party, the applicable Facility Lessor will give Lessee notice of any such third-party Claim, and Lessee shall be jointly and severally obligated to undertake the defense thereof by counsel of its own choosing, except to the extent any such Claim is found to have resulted from the gross negligence or willful misconduct of any MPT Indemnified Party.  Lessee shall not settle any such third-party Claim related to Hazardous Materials or Medical Waste on the Property that is asserted against any MPT Indemnified Party without the consent of the MPT Indemnified Parties, which consent shall not be unreasonably withheld, conditioned or delayed.  Any of the MPT Indemnified Parties may, by counsel, participate in such proceedings, negotiations or defense, at their own expense.  The MPT Indemnified Parties shall furnish to Lessee in reasonable detail such information as the MPT Indemnified Parties may have with respect to such Claim, including all records and materials that are reasonably required in the defense of such third-party Claim. In the event that Lessee does not collectively defend the third-party Claim in a diligent manner, any MPT Indemnified Party will have the right (at Lessee’s sole expense) to undertake the defense, compromise or settlement of such Claim and Lessee may elect to participate in such proceedings, negotiations or defense at any time at their own expense.  No MPT Indemnified Party shall settle any such third-party Claim without the consent of Lessee, which consent shall not be unreasonably withheld, conditioned or delayed.

(e)Lessor and Lessee acknowledge that, based upon recent environmental reports relating to the Leased Property, the potential for environmental liability for conditions occurring prior to (or existing as of) the Initial Commencement Date for all Facilities is remote; provided, that, such acknowledgment shall not limit or preclude any Claim by the MPT Indemnified Parties.

63

 

4834-1440-2281v12


 

8.3.Healthcare Laws.

(a)Lessor and Lessee acknowledge and agree that all compensation paid hereunder between the parties has been determined by the parties through good-faith and arm’s-length bargaining and is believed to represent fair market value for the Leased Property.  No payment made under this Lease is contingent on the referral of any patient or any other business.   Neither Lessor nor Lessee intends any portion of the payments made under this Lease to influence or reward the referral of any patients or other business that will be paid for from any state or federal health care insurance programs, including Medicare, Medicaid or any state medical assistance program.

(b)Lessee hereby covenants, warrants and represents to Lessor that throughout the Term, each Facility Lessee shall: (a) be validly licensed, Medicare and/or Medicaid certified, and, if required, accredited to operate the Facilities in material compliance with the applicable rules and regulations of the State in which the applicable Facility is located, federal governmental authorities, and accrediting bodies, including, but not limited to, DHHS and CMS; (b) be certified by and the holder of valid provider agreements with Medicare and/or Medicaid issued by DHHS, DHS and/or CMS and shall remain so certified and shall remain such a holder of such licenses and Medicare and/or Medicaid certifications for it to operate in accordance with the Primary Intended Use; (c) shall comply, in all material respects, with all Healthcare Laws; and (d) not abandon, terminate, vacate or fail to renew any material License or in any way commit any act which will or could reasonably be expected to cause any such material License to be revoked by any federal, state or local governmental authority or accrediting body having jurisdiction thereof.

(c)Lessee represents, warrants and covenants that Lessee, this Lease and all Tenant Leases are, and at all times during the Term will be, in material compliance with all Healthcare Laws. In the event it is determined that any provision of this Lease is in material violation of the Healthcare Laws, the parties in good faith shall renegotiate such provision so that same is in compliance with all Healthcare Laws. Lessee shall take commercially reasonable steps to add to all of its written third party agreements with physicians or physician groups relating to any portion of the Leased Property, including, without limitation, all Tenant Leases, that in the event it is determined that such agreement and/or Tenant Lease is in material violation of the Healthcare Laws, such agreement and/or Tenant Lease shall be renegotiated so that same are in material compliance with all Healthcare Laws or terminated. Lessee shall indemnify and defend, at Lessee’s sole cost and expense, and hold Lessor, its Affiliates and their respective successors and assigns, harmless from and against, and shall reimburse Lessor, its Affiliates and their successors and assigns with respect to, any and all claims, demands, actions, causes of action, losses, damages, liabilities, reasonable out-of-pocket costs and expenses (including, without limitation, reasonable out-of-pocket attorneys’ fees and court costs) of any and every kind or character, known or unknown, fixed or contingent, asserted against or incurred by Lessor, its Affiliates and their respective successors and assigns, at any time and from time to time by reason, or arising out, of any breach by Lessee of any of the provisions set forth in this Section 8.3 or any violation of any Healthcare Laws, including any and all such claims, demands, liabilities, damages, costs and expenses relating to immaterial violations or breaches of any Healthcare Laws. All such damages and reasonable out-of-pocket costs and expenses payable to Lessor under this Section 8.3 shall be due and payable by Lessee within thirty (30) days after delivery of written demand from Lessor, its Affiliates or their respective successors and assigns.

64

 

4834-1440-2281v12


 

8.4.Organizational Covenants.  Lessee shall not permit or suffer, without the prior written consent of Lessor, which consent shall not be unreasonably withheld, conditioned or delayed, (a) any material amendment or modification of any Facility Lessee’s Organizational Documents that modifies, adjusts or otherwise eliminates any of the MPT Required Provisions; (b) any dissolution or termination of any Facility Lessee’s existence or sale of substantially all of any Facility Lessee’s assets, whether by sale, transfer, merger, consolidation or otherwise; (c) any division, split-up, split-ff, spin-off, or similar transaction of or with respect to any Facility Lessee (including, without limitation, a division or similar transaction pursuant to Section 18-217 of the Delaware Limited Liability Company Act or other similar provision), or the approval of a plan of division for or with respect to any Facility Lessee; or (d) a change in any Facility Lessee’s state of formation or any Facility Lessee’s name. Lessee has, simultaneously with the execution of this Lease, delivered to Lessor a true and complete copy of each Facility Lessee’s Organizational Documents. Lessee represents and warrants that the Organizational Documents (i) were duly executed and delivered; and (ii) are in full force and effect, binding upon the applicable Facility Lessee, and enforceable in accordance with their terms.

8.5.Covenants under CHS Purchase Agreement. With respect to the CHS Property, Lessee, at its sole cost and expense, shall ensure that the CHS Property, and the operation of the Business thereon comply in all material respects (without duplication of any materiality qualifiers therein contained) with those post-closing covenants, agreements and obligations set forth and described in Sections 10.10 (Employee Matters), 10.11 (Indigent Care Policies), and 10.13 (Medical Staff Matters) of the CHS Purchase Agreement and all other material post-closing obligations set forth therein, in each case, for or within the required time periods described therein.  Lessee shall keep Lessor reasonably apprised of its compliance and progress under this Section and, upon Lessor's request, Lessee shall submit to Lessor a compliance report in reasonable detail describing Lessee's progress and compliance with the foregoing.  Nothing herein is intended or shall be deemed to limit or modify in any respect any of Lessor’s or its Affiliates’ respective rights and remedies (including consent or approval rights) under the Lease or any of the other Obligation Documents.

8.6.Covenants under Tenet Purchase Agreement. With respect to the Tenet Property, Lessee, at its sole cost and expense, shall ensure that the Tenet Property, and the operation of the Business thereon comply in all material respects (without duplication of any materiality qualifiers therein contained) with those post-closing covenants, agreements and obligations set forth and described in Sections 8.3 (Employee Matters), 8.4 (Medical Staff), 8.5 (Consents to Certain Assignments), 8.7 (Assistance with Agreements), 8.9 (Use of Seller Policies and Procedures), and 8.15 (Lease Guaranties) of the Tenet Purchase Agreement and all other material post-closing obligations set forth therein, in each case, for or within the required time periods described therein.  Lessee shall keep Lessor reasonably apprised of its compliance and progress under this Section 8.6 and, upon Lessor's request, Lessee shall submit to Lessor a compliance report in reasonable detail describing Lessee's progress and compliance with the foregoing.  Nothing herein is intended or shall be deemed to limit or modify in any respect any of Lessor’s or its Affiliates’ respective rights and remedies (including consent or approval rights) under this Lease or any of the other Obligation Documents.

65

 

4834-1440-2281v12


 

ARTICLE IX.
REPAIRS

9.1.Maintenance; Repair and Remodel.

(a)Lessee, at its expense, will keep the Leased Property and all private roadways, sidewalks and curbs appurtenant thereto (and Lessee’s Personal Property) in good order and repair (whether or not the need for such repairs occurs as a result of Lessee’s use, any prior use, the elements, the age of the Leased Property or any portion thereof) and, except as otherwise provided in Article XIV and Article XV, with reasonable promptness, will make all necessary and appropriate repairs thereto of every kind and nature whether interior or exterior, structural or non-structural, ordinary or extraordinary, foreseen or unforeseen, or arising by reason of a condition existing prior to the commencement of the Term (concealed or otherwise).  All repairs shall, to the extent reasonably achievable, be at least equivalent in quality to the original work.  Lessee will not take or omit to take any action the taking or omission of which is reasonably likely to materially impair the value or the usefulness of the Leased Property or any part thereof for the Primary Intended Use.

(b)Notwithstanding anything contained in this Lease to the contrary, from time to time Lessee may remodel, modify and make additions to the Leased Property, or any portion thereof, which remodeling, modifications and additions are not Capital Additions (it being understood that Capital Additions are subject to the requirements of Article X hereof) but which are necessary or advisable for the Primary Intended Use and which permit Lessee to fully comply with its obligations as set forth in this Lease.  Lessee shall undertake any such actions expeditiously and in a workmanlike manner and will not significantly alter the character or purpose, or detract from the value or operating efficiency of, the Leased Property nor significantly impair the revenue producing capability of the Leased Property nor adversely affect the ability of Lessee to comply with the provisions of this Lease, unless such changes are required by applicable law.

(c)Lessee shall notify Lessor of any and all repairs, improvements, additions, modifications and remodeling made to any portion of a particular Property in excess of Ten Million and No/100 Dollars ($10,000,000.00) during any consecutive twelve (12) month period for the applicable Property and obtain consent from Lessor (which consent shall not be unreasonably withheld, conditioned or delayed) prior to making such repairs, improvements, additions, modifications or remodeling.  

(d)Except as otherwise expressly provided in this Lease, Lessor shall not under any circumstances be required to build or rebuild any improvements on the Leased Property, or to make any repairs, replacements, alterations, restorations, or renewals of any nature or description to the Leased Property, whether ordinary or extraordinary or capital in nature, structural or non-structural, foreseen or unforeseen, or to make any expenditure whatsoever with respect thereto in connection with this Lease, or to maintain the Leased Property in any way.

(e)Nothing contained in this Lease and no action or inaction by Lessor shall be construed as (i) constituting the consent or request of Lessor, expressed or implied, to any contractor, subcontractor, laborer, materialman or vendor for the provision or performance of any labor or services or the furnishing of any materials or other property for the construction, alteration, addition, repair or demolition of or to the Leased Property or any part thereof, or (ii) giving Lessee

66

 

4834-1440-2281v12


 

any right, power or permission to contract for, or permit the performance of, any labor or services or the furnishing of any materials or other property in such fashion as would permit the making of any claim against Lessor in respect thereof or to make any agreement that may create, or in any way be the basis for, any right, title, interest, lien, claim or other encumbrance upon the estate of Lessor in the Leased Property or any portion thereof.

(f)Unless Lessor conveys any of the Leased Property to Lessee pursuant to Section 34.2 of this Lease, Lessee will, upon the expiration or prior termination of the Term, vacate and surrender the Leased Property to Lessor in the condition in which the Leased Property was originally received from Lessor, except as improved, constructed, repaired, rebuilt, restored, altered or added to as permitted or required by the provisions of this Lease and except for (i) ordinary wear and tear (subject to the obligation of Lessee to maintain the Leased Property in good order and repair during the entire Term), (ii) damage caused by the gross negligence or willful misconduct of Lessor, and (iii) damage or destruction as described in Article XIV or resulting from a Taking as described in Article XV, which Lessee is not required by the terms of this Lease to repair or restore.  

9.2.Encroachments; Restrictions.  If any of the Leased Improvements shall, at any time, materially encroach upon any property, street or right-of-way adjacent to any portion of the Leased Property, or shall materially violate the agreements or conditions contained in any federal, state or local law, restrictive covenant or other agreement affecting the Leased Property, or any part thereof, or shall materially impair the rights of others under any easement or right-of-way to which the Leased Property or any portion thereof is subject, then, promptly upon the request of Lessor, Lessee shall, at its expense, subject to its right to contest the existence of any encroachment, violation or impairment, (a) use commercially reasonable efforts to obtain valid and effective waivers or settlements of all claims, liabilities and damages resulting from each such encroachment, violation or impairment, whether the same shall affect Lessor or Lessee or (b) make such changes in the Leased Improvements, and take such other actions, as Lessor reasonably determines, to remove such encroachment, or to end such violation or impairment, including, if necessary, the alteration of any of the Leased Improvements, and, in any event, take all such actions as may be necessary to continue the operation of the applicable Property without such violation, encroachment or impairment.  Any such alteration shall be made in conformity with the applicable requirements of Article X.  Lessee’s obligations under this Section 9.2 shall be in addition to, and shall in no way discharge or diminish any obligation of, any insurer under any policy of title or other insurance, and Lessee shall be entitled to a credit for any sums paid by Lessee and recovered by Lessor under any such policy of title or other insurance, less Lessor’s reasonable, out-of-pocket costs and expenses to recover such sums.

ARTICLE X.
CAPITAL ADDITIONS

10.1.Construction of Capital Additions to the Leased Property.

(a)If no Event of Default has occurred, and no event has then occurred which with the giving of notice or passage of time or both would constitute an Event of Default hereunder, and be continuing, Lessee shall have the right (but not the obligation) upon and subject to the terms and conditions set forth below, to construct or install Capital Additions on any Property with the

67

 

4834-1440-2281v12


 

prior written consent of Lessor, not to be unreasonably withheld, conditioned or delayed (provided that such consent is not required with respect to any Capital Addition that will cost less than Ten Million and No/100 Dollars ($10,000,000.00)). Lessee shall not be permitted to create any Lien on such Property in connection with such Capital Addition, except as provided in Section 10.2.  In order to obtain Lessor’s prior written consent, Lessee shall submit to Lessor in writing a proposal setting forth in reasonable detail any such proposed Capital Addition. In addition, Lessee shall promptly furnish to Lessor such additional information relating to such proposed Capital Addition as Lessor may reasonably request.  Lessor shall have ten (10) days following receipt of the last information so requested relating to the proposed Capital Addition to respond whether Lessor has approved of such proposed Capital Addition, it being agreed that failure to timely respond shall be deemed a rejection of the proposed Capital Addition.  

(b)Prior to commencing construction of any Capital Addition on any Property for which Lessee intends to finance with a third-party lender, Lessee shall first grant to Lessor a right of first offer to provide funds to pay for such Capital Addition in accordance with the provisions of Section 10.3.  If Lessor declines or is unable to provide such funding, or if the ROFO Exercise Notice is not accepted by Lessee, the provisions of Section 10.2 shall apply.  Notwithstanding any other provision of this Article X to the contrary, unless required by applicable law, no Capital Addition shall be made which would tie-in or connect any portion of a particular Property and/or any Leased Improvements thereon with any other improvements on property adjacent to such Property (and not part of the Leased Property covered by this Lease) including, without limitation, tie-ins of buildings or other structures or utilities, unless Lessee shall have obtained the prior written approval of Lessor, which approval may be granted or withheld in Lessor’s reasonable discretion. All proposed Capital Additions shall be architecturally integrated and consistent with the applicable Property as determined in the reasonable discretion of Lessor.

10.2.Capital Additions Financed by Lessee. If Lessee provides or arranges to finance any Capital Addition with a third-party lender (except for Capital Additions arranged by Lessee but funded by Lessor), this Lease shall be and hereby is amended to provide as follows:

(a)There shall be no adjustment in the Base Rent by reason of any such Capital Addition.

(b)Such Capital Addition shall revert to, and become the property of Lessor upon the expiration or termination of this Lease with respect to the applicable Property.

In connection with any such Capital Addition financed by Lessee (or any Person other than Lessor), Lessee shall be permitted to place (or cause to be placed) a Lien on such Capital Addition as collateral for Lessee’s financing, provided, that, in the reasonable determination of Lessor such Lien shall not interfere with Lessor’s ability to finance the applicable Property with first-priority lien, fixed rate debt having a term of at least ten (10) years; it being understood and agreed that (i) Lessor and Lessee shall cooperate in good faith to properly divide such Capital Addition from the applicable Property and to grant such easements and use restrictions as shall be necessary to avoid any disruption of Lessee’s Business on such Property; (ii) to the extent not inconsistent with the provisions of this Section 10.2, such Capital Addition shall remain subject to the other terms and provisions of this Lease; and (iii) upon the expiration or termination of this Lease with respect to

68

 

4834-1440-2281v12


 

such Property, Lessee, at its sole cost and expense, shall cause all such Lien(s) to be released from such Capital Addition and within ten (10) Business Days after such expiration or termination.

10.3.Capital Additions Funded by Lessor

(a)If Lessee desires for Lessor to fund a Capital Addition on the Property, Lessee shall request the same by submitting to Lessor a written request, including a written proposal setting forth in reasonable detail any such proposed Capital Addition (a “Request”).   In addition, Lessee shall promptly furnish to Lessor such additional information relating to such proposed Capital Addition as Lessor may reasonably request.  Lessor shall have thirty (30) days following receipt of the last of the information so requested to respond by delivering to Lessee (the “ROFO Exercise Notice”) a written offer to fund the proposed Capital Addition, including the proposed terms thereof and the terms of any amendments to this Lease to be executed in connection therewith; it being agreed that Lessor’s failure to timely deliver a ROFO Exercise Notice shall be deemed a rejection of the Request to provide the funding for such proposed Capital Addition. If Lessee accepts the offer set forth in the ROFO Exercise Notice, the parties shall consummate the funding contemplated thereby within sixty (60) days on the terms and conditions set forth in the ROFO Exercise Notice.  If Lessee does not accept the offer set forth in a ROFO Exercise Notice, Lessee may, for a period of one hundred eighty (180) days from the date of receipt by Lessee of the ROFO Exercise Notice, obtain a commitment to finance a Capital Addition from any Person on terms and conditions no more favorable, in the aggregate, to the applicable lender than those set forth in such ROFO Exercise Notice.  If Lessee does not obtain a commitment for third-party financing before the end of such one hundred eighty (180) day period, Lessee shall not finance such Capital Addition without repeating the foregoing procedures of this Article X.

(b)Lessor and Lessee acknowledge that prior to the Effective Date, Lessor funded to Lessee all amounts required to be funded by Lessor with respect to the “Preferred Lessor Funded Capital Additions” (as defined in Section 10.2(b) of the Original Lease) pursuant to Section 10.2(b) of the Original Lease and such funded amounts are reflected in the Lease Base for the applicable Properties.

(c)In connection with any Capital Addition funded by Lessor, the terms and conditions set forth on Schedule 10.3 shall apply.  The costs of any such Capital Addition funded by Lessor hereunder shall be added to the Lease Base related to the applicable Property as provided on Schedule 3.1(a); provided, however, that notwithstanding the foregoing or Section 3.1 hereof, the Allocated Base Rent solely for any such Capital Addition funded by Lessor with respect to (i) any IASIS Property shall be determined at the time of such funding utilizing an adjusted “Applicable Lease Rate” equal to the then current fair market lease rate (as reasonably determined by Lessor in good faith), subject to the applicable Escalator as set forth in Section 3.1(b) hereof and (ii) any New Property or New Project (other than a Massachusetts New Project) that becomes subject to this Lease after June 1, 2021, shall be subject to the New Property/Project Lease Rate.

(d)Lessor and Lessee acknowledge (i) the development and construction of the Sebastian Project pursuant to the Sebastian PFDA, and (ii) that Sebastian Lessor shall provide the funding for the construction and development of the Sebastian Project in accordance with the terms and conditions of the Sebastian PFDA. The construction and development of the Sebastian Project shall be treated as a Capital Addition funded by Lessor for all purposes under this Lease.

69

 

4834-1440-2281v12


 

Notwithstanding the terms of Section 3.1(a), Section 10.3(c), or any other provisions of this Lease to the contrary, the Sebastian Project Development Costs shall not be added to the Lease Base for the Sebastian Property until the Sebastian Project Completion Date and, on and after such date, shall be included in the calculation of Allocated Base Rent for the Sebastian Property.

(e)Lessor and Lessee acknowledge (i) the development and construction of the Pharmacy Improvements Project pursuant to the Pharmacy Improvements PFDA, and (ii) that the applicable Lessors shall provide the funding for the construction and development of the Pharmacy Improvements Project in accordance with the terms and conditions of the Pharmacy Improvements PFDA. The construction and development of the Pharmacy Improvements Project shall be treated as a Capital Addition funded by Lessor for all purposes under this Lease. Notwithstanding the terms of Section 3.1(a), Section 10.3(c), or any other provisions of this Lease to the contrary, the Pharmacy Improvements Project Development Costs shall not be added to the Lease Base for the applicable Properties until the Pharmacy Improvements Project Completion Date and, on and after such date, shall be included in the calculation of Allocated Base Rent for the applicable Properties. For the avoidance of doubt, Lessor and Lessee acknowledge that, from and after July 7, 2020, the construction and development of the Pharmacy Improvements Project at the Davis Property and the West Jordan Property pursuant to the Pharmacy Improvements PFDA shall be treated as a Capital Addition funded by the Davis Lessor and the West Jordan Lessor in accordance with this Section 10.3(e).

(f)Lessor and Lessee acknowledge (i) the development and construction of the St. Elizabeth Project pursuant to the St. Elizabeth PFDA, and (ii) that St. Elizabeth Lessor shall provide the funding for the construction and development of the St. Elizabeth Project in accordance with the terms and conditions of the St. Elizabeth PFDA. The construction and development of the St. Elizabeth Project shall be treated as a Capital Addition funded by Lessor for all purposes under this Lease. Notwithstanding the terms of Section 3.1(a), Section 10.3(c), or any other provisions of this Lease to the contrary, the St. Elizabeth Project Development Costs shall not be added to the Lease Base for the St. Elizabeth Property until the St. Elizabeth Project Completion Date and, on and after such date, shall be included in the calculation of Allocated Base Rent for the St. Elizabeth Property.

(g)Lessor and Lessee acknowledge (i) the development and construction of the Odessa Project pursuant to the Odessa PFDA, and (ii) that Odessa Lessor shall provide the funding for the construction and development of the Odessa Project in accordance with the terms and conditions of the Odessa PFDA.  The construction and development of the Odessa Project shall be treated as a Capital Addition funded by Lessor for all purposes under this Lease.  Notwithstanding the terms of Section 3.1(a), Section 10.3(c), or any other provisions of this Lease to the contrary, the Odessa Project Development Costs shall not be added to the Lease Base for the Odessa Property until the Odessa Project Completion Date and, on and after such date, shall be included in the calculation of Allocated Base Rent for the Odessa Property.

(h)Lessor and Lessee acknowledge (i) the development and construction of the Wuesthoff Melbourne Project pursuant to the Wuesthoff Melbourne PFDA, and (ii) that Wuesthoff Melbourne Lessor shall provide the funding for the construction and development of the Wuesthoff Melbourne Project in accordance with the terms and conditions of the Wuesthoff Melbourne PFDA.  The construction and development of the Wuesthoff Melbourne Project shall be treated as

70

 

4834-1440-2281v12


 

a Capital Addition funded by Lessor for all purposes under this Lease.  Notwithstanding the terms of Section 3.1(a), Section 10.3(c), or any other provisions of this Lease to the contrary, the Wuesthoff Melbourne Project Development Costs shall not be added to the Lease Base for the Wuesthoff Melbourne Property until the Wuesthoff Melbourne Project Completion Date and, on and after such date, shall be included in the calculation of Allocated Base Rent for the Wuesthoff Melbourne Property.

(i)Lessor and Lessee acknowledge (i) the development and construction of the West Jordan Project pursuant to the West Jordan PFDA, and (ii) that West Jordan Lessor shall provide the funding for the construction and development of the West Jordan Project in accordance with the terms and conditions of the West Jordan PFDA.  The construction and development of the West Jordan Project shall be treated as a Capital Addition funded by Lessor for all purposes under this Lease.  Notwithstanding the terms of Section 3.1(a), Section 10.3(c), or any other provisions of this Lease to the contrary, the West Jordan Project Development Costs shall not be added to the Lease Base for the West Jordan Property until the West Jordan Project Completion Date and, on and after such date, shall be included in the calculation of Allocated Base Rent for the West Jordan Property.

(j)Lessor and Lessee acknowledge (i) the development and construction of the Davis Project pursuant to the Davis PFDA, and (ii) that Davis Lessor shall provide the funding for the construction and development of the Davis Project in accordance with the terms and conditions of the Davis PFDA.  The construction and development of the Davis Project shall be treated as a Capital Addition funded by Lessor for all purposes under this Lease.  Notwithstanding the terms of Section 3.1(a), Section 10.3(c), or any other provisions of this Lease to the contrary, the Davis Project Development Costs shall not be added to the Lease Base for the Davis Property until the Davis Project Completion Date and, on and after such date, shall be included in the calculation of Allocated Base Rent for the Davis Property.

(k)Lessor and Lessee acknowledge (i) the development and construction of the Morton Project pursuant to the Morton PFDA, and (ii) that Morton Lessor shall provide the funding for the construction and development of the Morton Project in accordance with the terms and conditions of the Morton PFDA. The construction and development of the Morton Project shall be treated as a Capital Addition funded by Lessor for all purposes under this Lease. Notwithstanding the terms of Section 3.1(a), Section 10.3(c), or any other provisions of this Lease to the contrary, the Morton Project Development Costs shall not be added to the Lease Base for the Morton Property until the Morton Project Completion Date and, on and after such date, shall be included in the calculation of Allocated Base Rent for the Morton Property.

10.4.Salvage.  All materials that are scrapped or removed in connection with the making of either Capital Additions or repairs hereunder shall be or become the property of Lessee, and Lessee shall remove the same at its sole cost and expense.

71

 

4834-1440-2281v12


 

ARTICLE XI.
LIENS

11.1.General Restrictions; Acknowledgment of Intercreditor.

(a)Subject to the provisions of Article XII relating to permitted contests, Lessee will not directly or indirectly create or allow to remain and will promptly discharge at its expense any lien, encumbrance, attachment, title retention agreement or claim upon any Property or any attachment, levy, claim or encumbrance in respect of the Rent or any funds or amounts that are or will be provided by Lessor or its Affiliates to Lessee at any time during the Term in accordance with this Lease; excluding, however, (a) this Lease; (b) the Permitted Exceptions; (c) restrictions, liens and other encumbrances which are consented to in writing by Lessor, or any easements granted pursuant to the provisions of Section 7.3; (d) liens for those taxes of Lessor which Lessee is not required to pay hereunder; (e) liens for Impositions or for sums resulting from noncompliance with Legal Requirements so long as (1) the same are not yet payable or are payable without the addition of any fine or penalty or (2) such liens are in the process of being contested as permitted by Article XII; (f) liens of mechanics, laborers, materialmen, suppliers or vendors for sums either disputed or not yet due, provided that (i) the payment of such sums shall not be postponed for more than sixty (60) days after the completion of the action giving rise to such lien and such reserve or other appropriate provisions as shall be required by law or GAAP shall be been made therefore, or (ii) any such liens are in the process of being contested as permitted by Article XII; (g) the Tenant Leases; (h) Liens which are permitted in accordance with Section 10.2 hereof; (i) solely with respect to the Florence Property, any liens, encumbrances, attachments, title retention agreements, or claims relating to the Florence Property (other than the Permitted Exceptions) arising or attaching to the Florence Property prior to the Commencement Date with respect to the Florence Property; and (j) any liens which are the responsibility of Lessor pursuant to the provisions of Article XXXVI of this Lease.  Lessee shall not mortgage or grant any interest or security interest in, or otherwise assign, any part of Lessee’s rights and interests in this Lease or any Property during the Term.

(b)Lessor acknowledges and consents (i) to Steward Health, its Subsidiaries and applicable Affiliates entering into the ABL Credit Agreement, (ii) to the incurrence of the obligations thereunder and (iii) to the granting of liens and security interests in favor of the lenders as contemplated under the ABL Credit Agreement, in each case, subject to the terms and conditions of the Intercreditor Agreement.

ARTICLE XII.
PERMITTED CONTESTS

12.1.Permitted Contests.  Lessee, at Lessee’s expense, may contest, by appropriate legal proceedings conducted in good faith and with due diligence, the amount, validity or application, in whole or in part, of any Imposition, Legal Requirement, Insurance Requirement, lien, attachment, levy, encumbrance, charge or claim not otherwise permitted by Article XI, provided that (a) in the case of an unpaid Imposition, lien, attachment, levy, encumbrance, charge or claim, the commencement and continuation of such proceedings shall suspend the collection thereof from Lessor and from the Leased Property (or if not so suspended, clause (b) shall be true); (b) neither the Leased Property nor any Rent therefrom nor any part thereof or interest therein

72

 

4834-1440-2281v12


 

would, as determined in Lessor’s reasonable discretion, be in any immediate danger of being sold, forfeited, attached or lost; (c) in the case of a Legal Requirement, Lessor would not be in any immediate danger of civil or criminal liability for failure to comply therewith pending the outcome of such proceedings; (d) in the event that any such contest shall involve a sum of money or potential loss in excess of One Million and No/100 Dollars ($1,000,000.00), then, in any such event, the applicable Facility Lessee shall deliver to Lessor an Officer’s Certificate from a duly authorized officer of the applicable Facility Lessee regarding the matters set forth in clauses (a), (b) and (c), to the extent applicable (it being understood if the relevant amount involved in such contest (or the potential loss) is less than such amount, no such certification is required); (e) in the case of a Legal Requirement and/or an Imposition, lien, encumbrance or charge involving potential loss in excess of One Million and No/100 Dollars ($1,000,000.00), Lessee shall deposit with Lessor an amount equal to the contested amount as security to ensure the ultimate payment of the Imposition, lien, attachment, levy, encumbrance, charge or claim and to prevent any sale or forfeiture of the affected Property or the Rent by reason of such non-payment or non-compliance; provided, however, the provisions of this Article XII shall not be construed to permit Lessee to contest the payment of Rent (except as to contests concerning the method of computation or the basis of levy of any Imposition or the basis for the assertion of any other claim) or any other sums payable by Lessee to Lessor hereunder; (f) in the case of an Insurance Requirement, the coverage required by Article XIII shall be maintained; and (g) if such contest be finally resolved against Lessor or Lessee, Lessee shall, as Additional Charges due hereunder, promptly pay the amount required to be paid, together with all interest and penalties accrued thereon, or comply with the applicable Legal Requirement or Insurance Requirement.  Lessor, at Lessee’s expense, shall execute and deliver to Lessee such authorizations and other documents as may reasonably be required in any such contest and, if reasonably requested by Lessee or if Lessor so desires, Lessor shall join as a party therein.  Lessee shall indemnify and hold Lessor harmless against any liability, cost or expense of any kind that may be imposed upon Lessor in connection with any such contest and any loss resulting therefrom.

ARTICLE XIII.
INSURANCE

13.1.General Insurance Requirements.

(a)During the Term, Lessee shall at all times keep the Leased Property and Lessee’s Personal Property, insured against loss or damage from such causes as are customarily insured against, by prudent owners of similar facilities.  Without limiting the generality of the foregoing, throughout the Term, Lessee shall maintain at its sole cost and expense (except as otherwise provided in this Article XIII), at a minimum, the insurance coverages required herein.  This insurance shall be written in form reasonably satisfactory to Lessor and by insurance companies (i) reasonably acceptable to Lessor (Lessor acknowledging that Tailored Risk Assurance Company, Ltd. (“Traco”)  is acceptable to Lessor for the provision of the coverages described in subsections (ii), (iv) and (vi) below), (ii) that are rated at least an “A-VIII” or better by Best’s Insurance Guide (except for Traco, for which no rating is required), and (iii) unless otherwise approved by Lessor, authorized, licensed and qualified to do insurance business in the state in which the Leased Property is located. The aggregate amount of coverage by a single company must not exceed Five Percent (5%) of the insurance company’s policyholders’ surplus.  The minimum limits required herein may be met through a combination of underlying and excess

73

 

4834-1440-2281v12


 

policies.  With respect to each Property, the policies required hereunder relating to such Property shall insure against the following:

(i)Commercial Property insurance written on a broad “all risk” or special cause of loss policy form covering physical loss or damage to the Leased Property including building and improvements and betterments on a replacement cost basis (provided that such commercial property coverage shall be in an amount of one hundred ten percent (110%) of the replacement cost of each such Property). Such coverage shall be written on a blanket limit basis. This coverage shall be placed by the Lessor. Lessee shall reimburse Lessor for the costs of such coverages, including any required deductibles or retention payments, promptly upon request by Lessor.  Such deductible or retentions shall not exceed Three percent (3%) of the insurable value of the Leased Property, to the extent that such a deductible is commercially available.  In the event of a loss, Lessee shall abide by all provisions of the insurance contract, including proper and timely notice of the loss to Lessor.  The policy shall also include the following coverages: (A) Flood and earthquake insurance shall be required only in the event that a Property is located in a 100 or 500 year flood plain or high hazard seismic zone with limits in accordance with standard industry practice; and (B) Business interruption insurance covering rents and other impositions otherwise payable to Lessor for a period of not less than twelve (12) months. Coverage shall be written on an “actual loss sustained” form.

(ii)Commercial General Liability insurance in a minimum amount of One Million and No/100 Dollars ($1,000,000.00) per claim and Two Million Dollars ($2,000,000) in the aggregate for bodily injury or death of any one person and for Property Damage for damage to or loss of the property of others, subject to a Two Million ($2,000,000.00) annual aggregate policy limit for all bodily injury and property damage claims, occurring on or about such Property or in any way related to such Property, including but not limited to, any swimming pools or other rehabilitation and recreational facilities or areas that are located on such Property or otherwise related to such Property.

(iii)Automobile and vehicle liability insurance coverage for all owned, non-owned, leased or hired automobiles and vehicles with a limit of One Million ($1,000,000.00) per accident for bodily injury and property damage.

(iv)Professional liability insurance for Lessee and all employed professionals (including any physicians) in an amount of not less than One Million and No/100 Dollars ($1,000,000.00) per individual claim and Three Million and No/100 Dollars ($3,000,000.00) annual aggregate.  All contractors, agents and other persons (including physicians) who perform professional services for Lessee shall meet such required minimum insurance requirements of One Million and No/100 Dollars ($1,000,000.00) per individual claim and Three Million and No/100 Dollars ($3,000,000.00) annual aggregate.

(v)Worker’s Compensation insurance for all persons employed by Lessee on such Property with statutory limits in accordance with the requirements of the particular state(s) in which they are operating and Employer’s Liability insurance with minimum limits of One Million and No/100 ($1,000,000) each accident and disease.

74

 

4834-1440-2281v12


 

(vi)Umbrella/Excess Liability insurance in the minimum amount of Twenty Million and No/100 Dollars ($20,000,000.00) for each claim and aggregate.  The Umbrella Liability policy shall name in its underlying schedule the Commercial General Liability, Automobile liability, Professional liability and Employer’s Liability insurance policies. The Umbrella policy shall provide follow form coverage for each of the underlying policies.  

(vii)Pollution Liability/Environmental Impairment Liability with minimum limits of Two Million Dollars ($2,000,000) per claim, covering bodily injury or death of any one person and for property damage to, loss of use of, or clean-up costs of the property of others, as well as first party clean-up costs, subject to an aggregate of Four Million Dollars ($4,000,000). These limits shall be applicable collectively to all Properties, with coverage including, but not limited to, liability from storage tanks, healthcare medical waste (including at non-owned disposal sites), mold, fungi and/or Legionella Pneumophilia conditions, or other exposures typical to healthcare facilities.  Deductible amounts shall be reasonably acceptable to Lessor.

(viii)Cyber Liability insurance with minimum limits of Ten Million Dollars ($10,000,000) per claim and in the aggregate covering Lessee and its employees. Such policy shall include coverage for claims, demands and regulatory investigations resulting from Lessee’s or its subcontractor’s wrongful acts in the performance of or failure to perform all services or support for services including but not limited to claims, demands, fines, penalties and other payments Lessor may be legally or contractually obligated to pay for infringement of intellectual property, failures in systems and information security, breach of confidentiality and invasion of or breach of privacy.  Reasonable sublimits for ancillary coverages shall be allowed as commercially available subject to further discussion on an annual basis. To the extent that independent contractors or other subcontractors are hired or retained by Lessee to perform or contribute to any part of the services or support of services, Lessee shall require that such contractors shall maintain insurance with limits in accordance with standard industry practice. Lessor reserves the right to review and accept the evidence of such insurance for Lessee, its independent contractors and subcontractors.

(ix)Crime/Employee Dishonesty insurance covering all employees with a minimum limit of not less than Two Hundred Fifty Thousand and No/100 Dollars ($250,000.00) per claim.

(x)Non-Owned Aviation and Premises Liability insurance including coverage for the helipad and any other aviation exposures at the premises with minimum limits of Five Million Dollars ($5,000,000) per occurrence.

13.2.Additional Insurance.  Notwithstanding anything contained herein to the contrary, Lessor shall not be prohibited, at its sole cost and expense, from purchasing and maintaining such additional insurance as it may reasonably determine to be necessary to protect its interest in all or any portion of the Leased Property.

13.3.Endorsements and Other Requirements.  The insurance as required in this Article XIII shall comply with the following:

75

 

4834-1440-2281v12


 

(a)Except for Worker’s Compensation/Employer’s Liability and crime insurance policies, all other insurance policies required herein shall name Lessor (and any other entity that Lessor may deem reasonably necessary) as Additional Insureds with respect to any liability arising from Lessee’s use, occupancy or maintenance of the Leased Property.

(b)All policies of insurance required herein (i) shall include clauses providing that each underwriter shall waive its rights of recovery, under subrogation or otherwise, against Lessor or any of Lessor’s affiliates or subsidiary companies; and (ii) shall be primary and non-contributory to the extent commercially available, (except for Worker’s Compensation/Employer’s Liability, crime and cyber insurance ) to any other insurance available to Lessor.

(c)Lessee shall, prior to any cancellation, non-renewal or material change to reduce limits or coverage terms, provide at least thirty (30) days’ prior written notice or ten (10) days prior written notice for non-payment of premium at Lessor’s notice address as specified in this Lease (the “Lessor’s Notice Address”), with a simultaneous copy to MPT Operating Partnership, L.P., Attention: Risk Management, 1000 Urban Center Drive, Suite 501, Birmingham, Alabama  35242 (or such other address as Lessor may designate from time to time).

(d)Lessee shall be responsible for funding all deductibles and retentions, including those which may be applicable to Lessor as an additional insured or named insured thereunder.

13.4.Evidence of Insurance.  Lessee shall deliver “verification” of insurance to Lessor as set forth below.  

(a)At least five (5) Business Days prior to the applicable Commencement Date, Lessee shall provide verification of required insurance coverage which shall include the following:

(i)True and certified copies of the insurance policies, including evidence of all specific coverage requirements and endorsements,  as required herein.

(ii)A statement of values for all property locations if Lessee maintains blanket insurance covering facilities other than the Leased Property; and

(iii)A summary of insurance program showing significant coverage limits, sublimits, deductibles and retentions.

(b)At least ten (10) Business Days prior to any insurance policy expiration date, Lessee shall provide verification of the renewal for the required insurance coverage for the following year which shall include the following:

(i)Insurance certificates acceptable to Lessor evidencing coverage for the renewed insurance policies, including evidence of specific coverage requirements and endorsements as required herein.

(ii)No later than ninety (90) days, after the renewal date of such policies, or such other reasonable timeframce as mutually agreed upon by Lessor and Lessee, Lessee

76

 

4834-1440-2281v12


 

shall provide true and certified copies of all required insurance policies, including evidence of specific coverage requirements and endorsements as stated herein.

(c)In the event Lessee does not provide timely or proper verification, or does not maintain the insurance required hereunder or pay the premiums as required hereunder, Lessor shall be entitled after notice to Lessee, but shall have no obligation, to obtain such insurance and pay the premiums therefor, which premiums shall be repayable to Lessor promptly following request by Lessor (but in no event later than fifteen (15) days after delivery of such request).

13.5.Increase in Limits.  In the event that Lessor shall at any time in its reasonable discretion deem the limits of the personal injury, property damage or general public liability insurance then carried to be insufficient, the parties shall endeavor to agree on the proper and reasonable limits for such insurance to be carried and such insurance shall thereafter be carried with the limits thus agreed on until further change pursuant to the provisions of this Section 13.5.  If the parties shall be unable to agree thereon, the proper and reasonable limits for such insurance to be carried shall be determined by an impartial third party selected by the parties.

13.6.Blanket Policy.  Notwithstanding anything to the contrary contained in this Article XIII, Lessee’s obligations to carry the insurance provided for herein may be brought within the coverage of a so-called blanket policy or policies of insurance carried and maintained by Lessee provided that:

(a)Any such blanket policy or policies are acceptable to and have been approved by Lessor, which approval shall not be unreasonably withheld, conditioned or delayed;

(b)Any such blanket policy or policies shall not be changed, altered or modified without the prior written consent of Lessor, which consent shall not be unreasonably withheld, conditioned or delayed; and

(c)Any such blanket policy or policies shall otherwise satisfy the insurance requirements of this Article XIII.  

13.7.No Separate Insurance.  Lessee shall not, on Lessee’s own initiative or pursuant to the request or requirement of any third party, take out separate insurance concurrent in form or contributing in the event of loss with that required in this Article XIII to be furnished by, or which may reasonably be required to be furnished by, Lessee, or increase the amounts of any then existing insurance by securing an additional policy or additional policies, unless all parties having an insurable interest in the subject matter of the insurance, including in all cases Lessor and all Facility Lenders, are included therein as additional insureds and the loss is payable under said insurance in the same manner as losses are required to be payable under this Lease.  Lessee shall promptly notify Lessor of the taking out of any such separate insurance or of the increasing of any of the amounts of the then existing insurance by securing an additional policy or policies.

77

 

4834-1440-2281v12


 

ARTICLE XIV.
FIRE AND CASUALTY

14.1.Insurance Proceeds.  Except for the proceeds from Lessee’s business interruption insurance policy which shall be paid to Lessee so long as Lessee continues to pay Rent to Lessor in accordance with the terms of this Lease, all proceeds payable by reason of any loss or damage to the Leased Property, or any portion thereof, and insured under any policy of insurance required by Article XIII shall be paid to Lessor and held by Lessor in trust (subject to the provisions of Section 14.7) and shall be made available for reconstruction or repair, as the case may be, of any damage to or destruction of the Leased Property, or any portion thereof, and shall be paid out by Lessor from time to time for the reasonable cost of such reconstruction or repair. Any excess proceeds of insurance remaining after the completion of the restoration or reconstruction of the Leased Property, or any portion thereof (or in the event neither Lessor nor Lessee is required or elects to repair and restore), all such insurance proceeds shall be retained by Lessor, free and clear of trust, upon completion of any such repair and restoration except as otherwise specifically provided below in this Article XIV. All salvage resulting from any risk covered by insurance shall belong to Lessor and any salvage relating to Capital Additions paid for by Lessee as described in Section 10.2 or to Lessee’s Personal Property shall belong to Lessee.

14.2.Reconstruction in the Event of Damage or Destruction Covered by Insurance.

(a)Except as provided in Section 14.7, with respect to any Property, if during the Term such Property is totally or partially destroyed from a risk covered by the insurance described in Article XIII and such Property is thereby rendered Unsuitable for its Primary Intended Use (the “Casualty Impacted Property”), Lessee shall elect, by giving written notice to Lessor within sixty (60) days following the date of such destruction, one of the following:  (i) to restore such Casualty Impacted Property to substantially the same condition as existed immediately before the damage or destruction, or (ii) so long as the damage or destruction was not caused by the negligence of Lessee, its agents, servants, employees or contractors, to terminate this Lease with respect to the Casualty Impacted Property and, in this event, the total Base Rent payable hereunder shall be reduced in accordance with Section 5.2, Lessor shall be entitled to retain the insurance proceeds, and Lessee shall pay to Lessor on demand, the amount of any deductible or uninsured loss arising in connection therewith.

(b)Except as provided in Section 14.7, with respect to any Property, if, during the Term, such Property is totally or partially destroyed from a risk covered by the insurance described in Article XIII, but such Property is not thereby rendered Unsuitable for its Primary Intended Use, Lessee shall restore such Property to substantially the same condition as existed immediately before the damage or destruction.  Such damage or destruction shall not terminate this Lease with respect to such Property.

14.3.Reconstruction in the Event of Damage or Destruction Not Covered by Insurance.  Except as provided in Section 14.7 and without limiting Section 14.2, if during the Term a Property is totally or partially damaged or destroyed from a risk not covered by the insurance described in Article XIII but that would have been covered if Lessee carried the insurance customarily maintained by, and generally available to, the operators of reputable health care facilities in the region in which such Property is located, then, whether or not such damage or

78

 

4834-1440-2281v12


 

destruction renders such Property Unsuitable for its Primary Intended Use, Lessee shall, at its sole cost and expense, restore such Property to substantially the same condition it was in immediately before such damage or destruction and such damage or destruction shall not terminate this Lease with respect to such Property.

14.4.Lessee’s Personal Property.  All insurance proceeds payable by reason of any loss of or damage to any Lessee’s Personal Property or any Capital Addition shall be paid to Lessee to pay the cost of repairing or replacing the damage to Lessee’s Personal Property or the Capital Additions paid for by Lessee with respect thereto.

14.5.Restoration of Lessee’s Property.  If Lessee is required or elects to restore any Property as provided in Sections 14.2 or 14.3, Lessee shall also restore all alterations and improvements made to Lessee’s Personal Property with respect thereto and all Capital Additions paid for by Lessee with respect thereto.

14.6.No Abatement of Rent.  This Lease shall remain in full force and effect, and Lessee’s obligation to pay Rent and all other charges required by this Lease shall remain unabated during any period required for repair and restoration; provided however, the proceeds of all rental stream inurance, if any, will first be paid to or retained by Lessor in satisfaction of Lessee’s obligations to pay Rent.

14.7.Damage Near End of Term.  Notwithstanding any provisions of Sections 14.2 (but without limiting Lessee’s rights under Section 14.2(a)) or 14.3 to the contrary, if damage to or destruction of any Property occurs during the last twenty-four (24) months of the Term, and if such damage or destruction cannot be fully repaired and restored within six (6) months immediately following the date of such loss as determined in Lessor’s reasonable discretion, either party shall have the right to terminate this Lease with respect to such Property by giving notice to the other within thirty (30) days after the date of damage or destruction, in which event Lessor shall be entitled to retain the insurance proceeds and Lessee shall pay to Lessor on demand the amount of any deductible or uninsured loss arising in connection therewith; provided, however, that any such notice given by Lessor shall be void and of no force and effect if Lessee exercises an available option to extend the Term for one (1) Extension Term within thirty (30) days following receipt of such termination notice.

14.8.Waiver.  Lessee hereby waives any statutory or common law rights of termination which may arise by reason of any damage to or destruction of any portion of the Leased Property.

ARTICLE XV.
CONDEMNATION

15.1.Parties’ Rights and Obligations.  If during the Term there is any Taking of all or any part of a Property or any interest in this Lease relating to such Property by Condemnation, the rights and obligations of the parties shall be determined by this Article XV.

15.2.Total Taking.  If there is a Taking of all of a Property by Condemnation, this Lease shall terminate with respect to such Property on the Date of Taking.

79

 

4834-1440-2281v12


 

15.3.Partial Taking.  

(a)If there is a Taking of a part, but not all, of a Property by Condemnation, this Lease shall remain in effect with respect to such Property if such Property is not thereby rendered Unsuitable for its Primary Intended Use.

(b)If, however, such portion of such Property is thereby rendered Unsuitable for its Primary Intended Use, Lessee shall elect (i) to restore such portion of such Property, at its own expense and to the extent possible, to substantially the same condition as existed immediately before the partial Taking, (ii) to terminate this Lease with respect to such Property (in which event the Base Rent payable hereunder shall be reduced in accordance with Section 5.2, or (iii) to continue using the remaining portion of such Property despite the Taking, in which case Rent for the Property shall be reduced proportionately based on the amount of any Award received by Lessor.  Lessee shall exercise such election by giving Lessor notice thereof within sixty (60) days after Lessee receives notice of the Taking.  

15.4.Award Distribution.  In the event of a Taking, the entire Award shall belong to and be paid to Lessor; provided, however, that if this Lease is terminated pursuant to this Article XV with respect to such Property, Lessee shall be entitled to receive a sum attributable to Lessee’s Personal Property relating thereto and any reasonable removal and relocation costs, provided in each case the Award specifically includes such items.  If Lessee is required or elects to restore such Property, Lessor agrees that the Award shall be used for that restoration, and it shall hold such portion of the Award in trust for application to the cost of the restoration.  

15.5.Temporary Taking.  The Taking of any Property or any part thereof by military or other public authority shall constitute a Taking by Condemnation only when the use and occupancy by the Taking authority has continued for longer than six (6) months.  During any such six (6)-month period all the provisions of this Lease shall remain in full force and effect and the Rent with respect to such Property shall not be abated or reduced during such period of Taking.

ARTICLE XVI.
DEFAULT

16.1.Events of Default.  The occurrence of any one or more of the following events (individually, an “Event of Default”) shall constitute Events of Default hereunder:

(a)if Lessee shall fail to make a payment of the Rent or any other monetary obligation when the same becomes due and payable by Lessee under this Lease (including, but not limited to, the failure to pay Insurance Premiums or Impositions) and the same shall remain unpaid for more than ten (10) days following receipt by Lessee of written notice thereof from Lessor; provided, however, in no event shall Lessor be required to give more than two (2) such written notices hereunder during any consecutive twelve (12) month period; or

(b)if Lessee shall fail to observe or perform any other term, covenant or condition of this Lease and such failure is not cured by Lessee within a period of thirty (30) days after receipt by Lessee of written notice thereof from Lessor (except that in the event Lessee shall fail to comply with any request pursuant to Sections 38.3 and 38.4 hereof, and such failure shall continue for ten (10) days after receipt by Lessee of such request from Lessor), unless such failure

80

 

4834-1440-2281v12


 

cannot, in Lessor’s reasonable determination, with due diligence be cured within a period of thirty (30) days, in which case such failure shall not be deemed to continue if, in Lessor’s reasonable determination, Lessee commences to cure such failure within the thirty (30) day period and proceeds with due diligence to complete the curing thereof; provided, however, in no event shall Lessor be required to give more than two (2) such written notices hereunder for Lessee’s failure to observe or perform the same (or repetitive) covenant or condition in any consecutive twelve (12) month period; or

(c)if (i) any Facility Lessee or the Guarantor shall admit in writing its inability to pay its debts as they become due; or (ii) any Facility Lessee or the Guarantor shall file a petition in bankruptcy as a petition to take advantage of any insolvency act; or (iii) any Facility Lessee or the Guarantor shall be declared insolvent according to any law; or (iv) any Facility Lessee or the Guarantor shall make any general assignment for the benefit of its creditors; or (v) if the estate or interest of any Facility Lessee in the Leased Property or any part thereof shall be levied upon or attached in any proceeding and the same shall not be vacated or discharged within the later of ninety (90) days after commencement thereof or sixty (60) days after receipt by such Facility Lessee of written notice thereof from Lessor (unless such Facility Lessee shall be contesting such lien or attachment in good faith in accordance with Article XII); or (vi) any petition shall be filed against any Facility Lessee or the Guarantor to declare such Facility Lessee or the Guarantor bankrupt, to take advantage of any insolvency act, or to delay, reduce or modify such Facility Lessee’s or the Guarantor’s capital structure and the same shall not be removed or vacated within ninety (90) days from the date of its creation, service or attachment; or (vii) any Facility Lessee or the Guarantor shall, after a petition in bankruptcy is filed against it, be adjudicated a bankrupt, or a court of competent jurisdiction shall enter an order or decree, with or without the consent of such Facility Lessee or the Guarantor, as the case may be, appointing a trustee, examiner or receiver of such Facility Lessee or the Guarantor or the whole or substantially all of its property, or approving a petition filed against such Facility Lessee or the Guarantor seeking reorganization or arrangement of such Facility Lessee or the Guarantor under the federal bankruptcy laws or any other applicable law or statute of the United States of America or any state thereof, and such judgment, order or decree shall not be vacated or set aside or stayed within ninety (90) days from the date of the entry thereof; or

(d)if any Facility Lessee shall have any of its material Licenses, material Participation Agreements (including participation or certification in Medicare or Medicaid or any material other third-party payor program) terminated by the applicable government program for fraud or willful violation of the terms of such program; or

(e)a Change of Control Transaction shall occur with respect to any Facility Lessee or Guarantor which is not approved by Lessor in advance; or

(f)if, with respect to any Property, the applicable Facility Lessee that operates the Business at such Property abandons or vacates the same (such Facility Lessee’s absence therefrom for thirty (30) consecutive days shall constitute abandonment) and thereafter fails to comply with any other covenants or conditions set forth in this Lease with respect to such Facility Lessee or such Property (subject to any other applicable notice and cure periods set forth herein); it being understood that such Facility Lessee may cease operations of the Business at such Property

81

 

4834-1440-2281v12


 

so long as such Facility Lessee complies with all other non-operational covenants and conditions set forth in this Agreement; or

(g)if any Facility Lessee or the Guarantor shall be liquidated or dissolved, or shall begin proceedings toward such liquidation or dissolution, or shall, in any manner, permit the sale or divestiture of substantially all of its assets, or any such Facility Lessee or the Guarantor shall enter into an agreement respecting same; or

(h)if a “Major Event of Default” shall occur under and as defined in the Mortgage Loan Agreement or a monetary default shall occur under any other Obligation Document (other than this Lease) which is not waived in writing or cured within the cure period as provided therein; or

(i)if (A) any monetary default or monetary event of default occurs with respect to any Material Obligation of any Facility Lessee or Guarantor which is not waived in writing or cured within the applicable notice and cure period provided by the document evidencing the Material Obligation or (B) any default or event of default occurs with respect to any financial covenant described in Section 6.12 of the ABL Credit Agreement which is not waived in writing or cured within the applicable notice and cure period provided under the ABL Credit Agreement; or

(j)subject to Section 16.6 and 16.7, if, at any time during the Term, for two (2) consecutive calendar quarters, EBITDAR of Steward Health and its Subsidiaries shall be less than Two Hundred Percent (200%) of the Realty Payments (as determined utilizing the trailing twelve (12) month operating and financial results of Steward Health and its Subsidiaries and measured on a calendar quarterly basis); or  

(k)subject to Sections 16.6 and 16.7, if, at any time during the Term, for two (2) consecutive calendar quarters, EBITDAR of Steward Health and its Subsidiaries shall be less than One Hundred and Ten Percent (110%) of Consolidated Fixed Charges (as determined utilizing the trailing twelve (12) month operating and financial results of Steward Health and its Subsidiaries and measured on a calendar quarterly basis); or

(l)if a monetary or material non-monetary default or event of default shall occur with respect to the landlord’s or lessor’s obligations under any Pass-Through Lease, which is not waived in writing or cured within the cure period as provided therein.

If an Event of Default has occurred, Lessor shall have the right at its election, then or at any time thereafter, to pursue any one or more of the following remedies (subject to applicable law), in addition to any remedies which may be permitted by law, by other provisions of this Lease or otherwise, without notice or demand, except as hereinafter provided:

A.If Lessee deserts, abandons or vacates any Property (the “Vacated Property”), Lessor may enter upon and take possession of either (i) the Vacated Property; or (ii) if there has occurred a Major Event of Default, any one or more (including all, if so elected by Lessor) of the Properties, regardless of whether such Event of Default emanated from or related primarily to a single Property (whether one or more, and whether pursuant to clause (i) or (ii), the “Entered Property”), to protect it from deterioration and continue to demand from Lessee Rent and other

82

 

4834-1440-2281v12


 

charges as provided in this Lease, without any obligation to relet (except to the extent required by applicable law); but if Lessor does relet the Entered Property (on such terms and conditions as Lessor, in its sole discretion, shall deem reasonable), such action by Lessor shall not be deemed an acceptance of Lessee’s surrender of the Entered Property unless Lessor expressly notifies Lessee of such acceptance in writing, Lessee hereby acknowledging that Lessor shall otherwise be reletting as Lessee’s agent and Lessee furthermore hereby agreeing to pay to Lessor on demand any deficiency that may arise between the Rent and other charges as provided in this Lease and that are actually collected by Lessor relating to the Entered Property.

B.Lessor, or anyone acting on Lessor’s behalf, may without notice or demand to Lessee, either (i) enter the Property from which such Event of Default emanated or to which such Event of Default related primarily; or (ii) if there has occurred a Major Event of Default, peaceably enter any one or more (including all, if so elected by Lessor) of the Properties, regardless of whether such Event of Default emanated from or related primarily to a single Property (whether one or more, and whether pursuant to clause (i) or (ii), the “Defaulted Property”), to the extent permitted by applicable laws and regulations without liability to action for prosecution or damages for such entry or for the manner thereof, and do whatever Lessee is obligated or permitted to do under this Lease. Lessee hereby releases and discharges Lessor and its agents from all claims, actions, suits, damages and penalties for or by reason of any such entry.  Lessee agrees to reimburse Lessor on demand for all expenses, including, without limitation, attorneys’ fees and expenses, that Lessor may incur in effecting compliance with Lessee’s obligations under this Lease, and Lessee further agrees that Lessor shall not be liable for any damages resulting to Lessee from such action.

C.Lessor may immediately terminate Lessee’s right of possession of the Defaulted Property, but not terminate this Lease with respect to the Defaulted Property, and without notice or demand, except as may be required and/or permitted by applicable law, enter upon such Defaulted Property or any part thereof and take absolute possession of the same, and at Lessor’s sole option may relet such Defaulted Property or any part thereof for such terms and such rents as Lessor may reasonably elect.  In the event of such reletting, the rent received by Lessor from such reletting shall be applied in the manner set forth in Section 16.4, and Lessee shall satisfy and pay any deficiency upon demand therefor from time to time.  Any entry into and possession of the Defaulted Property by Lessor shall be without liability or responsibility to Lessee and shall not be in lieu of or in substitution for any other legal rights of Lessor hereunder.  Lessee further agrees that Lessor may file suit to recover any sums due under the terms of this Lease and that no recovery of any portion due Lessor hereunder shall be any defense to any subsequent action brought by Lessor for any other amounts not reduced to judgment in favor of Lessor.  Reletting any portion of the Defaulted Property relating to any one or more of the Properties shall not be construed as an election on the part of Lessor to terminate this Lease with respect to such Defaulted Property and, notwithstanding any such reletting without termination, Lessor may at any time thereafter elect to terminate this Lease for default with respect to the Defaulted Property.

D.Lessor may terminate this Lease with respect to the Defaulted Property (whether one or more, the “Terminated Property”), by written notice to Lessee, in which event Lessee shall immediately surrender to Lessor such Terminated Property, and if Lessee fails to do so, Lessor may, without prejudice to any other remedy which Lessor may have for possession or arrearages in Rent or any other payments under this Lease (including any interest and payment penalty which

83

 

4834-1440-2281v12


 

may have accrued pursuant to the terms of this Lease), peaceably enter upon and take possession of such Terminated Property and remove the applicable Facility Lessee and any other Person who may be occupying such Terminated Property or any part thereof, to the extent permitted by applicable laws and regulations without being liable for prosecution or any claim for damages therefor.  Except as otherwise may be required by applicable law, Lessee hereby waives any statutory requirement of prior written notice for filing eviction or damage suits for nonpayment of Rent or any other payments under this Lease.  In addition, Lessee agrees to pay to Lessor on demand the amount of all loss and damage which Lessor may suffer by reason of any termination effected pursuant to this Section 16.1D, which loss and damage shall be determined, at Lessor’s option, by either of the following alternative measures of damages:

(i)Until Lessor is able to relet such Terminated Property, although Lessor shall be under no obligation to attempt to do so (unless required by applicable law), Lessee shall pay to Lessor, on or before the first day of each calendar month, the monthly rentals and other charges provided in this Lease relating to such Terminated Property.  After such Terminated Property has been relet by Lessor, Lessee shall pay to Lessor on the tenth (10th) day of each calendar month the difference between the monthly rentals and other charges provided in this Lease related to such Terminated Property for the preceding calendar month (had this Lease not been terminated) and those actually collected by Lessor with respect to such reletting for that month.  If it is necessary for Lessor to bring suit to collect any deficiency, Lessor shall have the right to allow such deficiencies to accumulate and to bring an action on several or all of the accrued deficiencies at one time.  Any such suit shall not prejudice in any way the right of Lessor to bring a similar action for any subsequent deficiency or deficiencies.  Any amount collected by Lessor from subsequent Tenants related to such Terminated Property for any calendar month in excess of the monthly Rent (including Additional Charges) herein allocated to such Terminated Property had this Lease not been terminated with respect thereto shall be credited to Lessee in reduction of Lessee’s liability for any calendar month for which the amount collected by Lessor will be less than the monthly Rent (including Additional Charges) herein allocated to such Terminated Property had this Lease not been terminated with respect thereto such Terminated Facility, but Lessee shall have no right to any excess other than the above described credit.

(ii)When Lessor desires, Lessor may demand a final settlement with respect to such Terminated Property.  Upon demand for a final settlement, Lessor shall have a right to, and Lessee hereby agrees to pay, the difference between the total of all monthly Rent (including Additional Charges) allocated to such Terminated Property for the remainder of the Term and the reasonable rental value thereof for such period, with such difference to be discounted to present value at a rate equal to the 5-Year U.S. Treasury Rate plus Two Percent (2%) per annum in effect upon the date of determination.

If Lessor elects to exercise the remedies prescribed in subsections A or B above, this election shall in no way prejudice Lessor’s right at any time thereafter to cancel said election in favor of the remedy prescribed in Section 16.1D or elsewhere in this Lease.  Similarly, if Lessor elects to compute damages in the manner prescribed by Section 16.1D(i) above, this election shall in no way prejudice Lessor’s right at any time thereafter to demand a final settlement in accordance with Section 16.1D(ii).  Pursuit of any of the above remedies shall not preclude pursuit of any

84

 

4834-1440-2281v12


 

other remedies prescribed in other sections of this Lease and any other remedies provided by law or equity.  Forbearance by Lessor to enforce one or more of the remedies herein provided upon an Event of Default shall not be deemed or construed to constitute a waiver of such default.

E.In the event that Lessor has either repossessed a Vacated Property pursuant to Section 16.1A, repossessed a Defaulted Property pursuant to Section 16.1C, or terminated this Lease with respect to one or more (or all, if so elected by Lessor) Defaulted Properties pursuant to Section 16.1D, and Lessor elects to enter upon such portion of the Leased Property as provided herein, Lessor may change, alter, and/or modify the door locks on all entry doors of such portion of the Leased Property, thereby permanently excluding Lessee and its officers, principals, agents, employees, representatives and invitees therefrom, but only to the extent that such exclusion does not interfere with patient care and safety.  Lessor shall not thereafter be obligated to provide Lessee with a key to such portion of Leased Property at any time, regardless of any amounts subsequently paid by Lessee; provided, however, that in any such instance, during Lessor’s normal business hours and at the convenience of Lessor, and upon receipt of written request from Lessee accompanied by such written waivers and releases as Lessor may reasonably require, Lessor may escort Lessee or its authorized personnel to such Leased Property to retrieve any personal belonging or other property of Lessee, whereupon Lessor shall remove such property and make it available to Lessee at a time and place designated by Lessor.  However, Lessee shall pay, in cash in advance, all reasonable out-of-pocket costs and expenses estimated by Lessor to be incurred in removing such property and making it available to Lessee and all moving and/or storage charges theretofore incurred by Lessor with respect to such property (plus an additional Seven Percent (7%) thereof to cover Lessor’s administrative costs).  If Lessor elects to exclude Lessee from any Defaulted Property (or all of the Defaulted Properties if so elected by Lessor) without repossessing or terminating pursuant to the foregoing provisions of this Lease, then Lessor shall not be obligated to provide Lessee a key to re-enter such Property or Properties until such time as all delinquent Rent has been paid in full and all other defaults, if any, have been completely cured to Lessor’s satisfaction (if such cure occurs prior to any actual repossession or termination), and Lessor has been given assurance reasonably satisfactory to Lessor evidencing Lessee’s ability to satisfy its remaining obligations under this Lease.  To the extent permitted by law, the foregoing provision shall override and control any conflicting provisions of any applicable statute governing the right of a lessor to change the door locks of commercial leases.

F.Intentionally Omitted.

G.In addition to any other available remedies, at Lessor’s option, with respect to each Defaulted Property or Entered Property, Lessor shall have those rights (i) to purchase Lessee’s Personal Property in the manner provided in Section 34.1 hereof and (ii) to effect a transfer of the Licenses pursuant to the terms of Article XXXVIII hereof.

H.Exercise any and all other rights and/or remedies granted or allowed to landlords by any existing or future statute or other law of the applicable State where the Entered Property or the Defaulted Property, as applicable, is located.

I.Lessor shall use reasonable efforts to the extent required by applicable law to relet such Property or Properties on such terms and conditions as Lessor, in its sole good faith judgment, may determine (including, without limitation, a lease term different than the Term, rental

85

 

4834-1440-2281v12


 

concessions, alterations and repair any such Property); provided, however, that, with respect to any such Property or Properties (i) Lessor shall not be obligated to relet such Property before leasing other vacant space owned or operated by Lessor, (ii) Lessor reserves the right to refuse to lease such Property to any potential tenant that does not meet Lessor’s reasonable standards and criteria for leasing any other comparable space owned or operated by Lessor (it being understood and agreed that it shall be deemed reasonable for Lessor to refuse to lease to a prospective tenant who owns, leases or operates a business similar to that conducted on such Property within  ten (10) miles of any point on or within which such Property is located), and (iii) Lessor shall not be obligated to undertake any greater efforts to relet such portion of the Leased Property than Lessor utilizes to lease any other vacant space owned or operated by Lessor.  In any proceeding in which Lessor’s efforts to mitigate damages and/or its compliance with this subsection is at issue, Lessor shall be presumed to have used reasonable efforts to mitigate damages and Lessee shall bear the burden of proof to establish that such reasonable efforts were not used.

J.No receipt of moneys by Lessor from Lessee after a termination of this Lease with respect to any one or more of the Properties or of Lessee’s rights under this Lease by Lessor with respect thereto shall reinstate, continue or extend the Term of this Lease with respect to such one or more Properties or affect any notice theretofore given to Lessee, or operate as a waiver of the right of Lessor to enforce the payment of Rent and any related amounts to be paid by Lessee to Lessor then due or thereafter falling due, it being agreed that after the commencement of suit for possession of any such Property, or after final order or judgment for the possession of any such Property, Lessor may demand, receive and collect any moneys due or thereafter falling due without in any manner affecting such suit, order or judgment, all such money collected being deemed payments on account of the use and occupation of any such Property or, at the election of Lessor, on account of Lessee’s liability hereunder.  Lessee hereby waives any and all rights of redemption provided by any law, statute or ordinance now in effect or which may hereafter be enacted.

K.No right or remedy herein conferred upon or reserved to Lessor is intended to be exclusive of any other right or remedy, and every right and remedy shall be cumulative and in addition to any other legal or equitable right or remedy given hereunder, or at any time existing.  The failure of Lessor to insist upon the strict performance of any provision or to exercise any option, right, power or remedy contained in this Lease shall not be construed as a waiver or a relinquishment thereof for the future, and no acceptance of full or partial payment of Rent or any other payment due under the terms of this Lease during the continuance of any such breach shall constitute a waiver of any such breach or any such term.  To the extent permitted by law, no waiver of any breach shall affect or alter this Lease, which shall continue in full force and effect with respect to any other then existing or subsequent breach.  Lessor and Lessee agree that no waiver shall be effective hereunder unless it is in writing.

L.Notwithstanding anything to the contrary herein contained, or any other provisions of this Lease or any other Obligation Document, if Lessor is exercising remedies due solely to an Event of Default caused by the failure to comply with the obligations set forth in Sections 16.1(e), (h), or (i) above (each, a “Limited Remedy Event of Default”), the aggregate amount Lessee shall be required to pay to Lessor from and after the date of the occurrence of such Limited Remedy Event of Default (the "Occurrence Date") for all damages incurred by Lessor, including without limitation, any costs incurred to relet the Property, tenant improvement costs, and brokerage commissions, shall be limited to the sum of (i) the present value as of the Occurrence Date,

86

 

4834-1440-2281v12


 

discounted at the annual rate equal to Seven and One-Half Percent (7.50%) per annum in effect upon the date of determination, of all basic rent for the unexpired portion after the Occurrence Date of the Term devised herein as if this Lease had not expired or been terminated, (ii) any Additional Charges which are due and payable or have accrued under this Lease through the Occurrence Date, and (iii) any Additional Charges which are due and payable or have accrued under this Lease after the Occurrence Date while the Lessee remains in possession of the Leased Property and which relate to Real Estate Taxes, insurance, utilities, repairs, maintenance, environmental maintenance, remediation and compliance and other routine and customary costs and expenses of operating and maintaining the Leased Property in substantial compliance with the terms of this Lease. Furthermore, additional reimbursement for any unpaid damages caused solely by a Limited Remedy Event of Default may not be claimed by Lessor under any other provision of this Lease or Obligation Documents.  In the event of a conflict between the provisions under this Section 16.1L and any other provision of any other Obligation Document with respect to the subject matter of this Section 16.1L, the provisions contained in this Section 16.1L shall prevail.

16.2.Additional Expenses.  It is further agreed that, in addition to payments required pursuant to Section 16.1 above and the provisions of Section 39.3, Lessee shall compensate Lessor and its Affiliates for (a) all reasonable, out-of-pocket expenses incurred by Lessor and its Affiliates in enforcing the provisions of this Lease and in repossessing the Leased Property or any portion thereof (including among other expenses, any increase in insurance premiums caused by the vacancy of all or any portion of the Leased Property); (b) all reasonable, out-of-pocket expenses incurred by Lessor and its Affiliates in reletting (including among other expenses, repairs, remodeling, replacements, advertisements and brokerage fees); (c) all concessions granted to a new Tenant or Tenants upon reletting (including among other concessions, renewal options); (d) Lessor’s and its Affiliates’ reasonable, out-of-pocket attorneys’ fees and expenses arising from or related to an Event of Default; and (e) all losses incurred by Lessor and its Affiliates as a direct or indirect result of such Event of Default (including, among other losses, any adverse action by Facility Lenders).

16.3.Waivers.

(a)If this Lease is terminated pursuant to Section 16.1, Lessee waives, to the extent permitted by applicable law, (i) any right to a trial by jury in the event of summary proceedings to enforce the remedies set forth in this Article XVI and (ii) the benefit of any laws now or hereafter in force exempting property from liability for rent or for debt.  Lessee acknowledges and agrees that no waiver by Lessor of any provision of this Lease shall be deemed to have been made unless made under signature of an authorized representative of Lessor.

(b)To the extent permitted by applicable law, Lessee waives any and all rights or defenses arising by reason of: (i) any “one action” or “anti-deficiency” law or any other law which may prevent Lessor from bringing any action, including a claim for deficiency, against Lessee or any one or more of the Facility Lessees or the Guarantor, before or after Lessor’s commencement or completion of any foreclosure or similar action or actions, either judicially or by exercise of a power of sale; (ii) any election of remedies by Lessor which destroys or otherwise adversely affects Lessee or any one or more of the Facility Lessee’s or Guarantor’s subrogation rights or rights to proceed against any Person for reimbursement, including, without limitation, any loss of rights Lessee or the Guarantor may suffer by reason of any law limiting, qualifying, or

87

 

4834-1440-2281v12


 

discharging Lessee’s and Guarantor’s obligations under this Lease or the other Obligation Documents (as applicable); (iii) any right to claim discharge of the obligations under this Lease on the basis of unjustified impairment of any collateral for such obligations; or (iv) any defenses given to guarantors, sureties, and/or co-makers at law or in equity other than actual payment and performance of Lessee’s and Guarantor’s obligations under this Lease or the other Obligation Documents (as applicable).

16.4.Application of Funds.  Any payments otherwise payable by Lessee which are received by Lessor under any of the provisions of this Lease during the existence or continuance of any Event of Default shall be applied based on the obligations to which the Lessee made the payments. If the Lessor is unable to determine to which obligations the Lessee intended to make the payments, the Lessor may apply the payments to the obligations in the order which Lessor may reasonably determine.  

16.5.Notices by Lessor.  The provisions of this Article XVI concerning notices shall be liberally construed insofar as the contents of such notices are concerned, and any such notice shall be sufficient if reasonably designed to apprise Lessee of the nature and approximate extent of any default, it being agreed that Lessee is in as good or a better position than Lessor to ascertain the exact extent of any default by Lessee hereunder.

16.6.Equity Cure Right.

(a)Notwithstanding Section 16.1(j) and (k), in the event that Lessee fails (or, but for the operation of this Section 16.6, would fail) to comply with the requirements of Section 16.1(j) or (k), until the thirtieth (30th) day subsequent to the earlier of (i) the date Lessee becomes aware of such noncompliance or (ii) the date of delivery of written notice from Lessor to Lessee relating to such failure (the “Equity Cure Expiration Date”), Steward Health shall have the right to issue its equity interests for cash or to receive an equity contribution in respect of its equity interests (the “Equity Cure Right”), and upon the receipt by Steward Health of such cash (the “Specified Equity Contribution”) EBITDAR shall be recalculated giving effect to the following pro forma adjustments:

(i)EBITDAR for the applicable calendar quarter (and any four-quarter period that contains such quarter) shall be increased, solely for the purpose of determining compliance with Section 16.1(j) and (k), by an amount equal to the Specified Equity Contribution; and

(ii)if, after giving effect to the foregoing recalculations, Lessee shall then be in compliance with the requirements of Section 16.1(j) and (k), Lessee shall be deemed to have satisfied the requirements of such Section 16.1(j) and (k) as of the relevant date of determination with the same effect as though there had been no failure to comply therewith at such date, and the applicable Event of Default that had occurred shall be deemed cured for purposes of this Lease.  

(b)Notwithstanding anything in this Lease to the contrary, after the failure to comply with the requirements of Section 16.1(j) and (k), if Lessee has given Lessor notice that Lessee intends to cure such failure with the proceeds of a Specified Equity Contribution, Lessor shall not exercise any rights or remedies under Section 16 available during the continuance of any

88

 

4834-1440-2281v12


 

Event of Default on the basis of any actual or purported failure to comply with Section 16.1(j) or (k) until such failure is not cured on or prior to the Equity Cure Expiration Date.  

16.7.Financial Covenant Testing with Respect to Tenet Property and Certain New Properties. Notwithstanding anything in this Lease to the contrary, with respect to the financial covenants described in Section 16.1(j) and (k), with respect to (a) the Tenet Property and (B) any New Property joined to this Lease on or after the Effective Date, the portion of the earnings and payment obligations of the applicable Facility Lessee attributable to such Tenet Property or such New Property, as the case may be, shall not be subject to and shall not be included in the calculations of compliance with such financial covenants set forth in Section 16.1(j) and (k) until the eighth (8th) full calendar quarter after the Commencement Date applicable to such Tenet Property or such New Property.

ARTICLE XVII.
LESSOR’S RIGHT TO CURE

Subject to the provisions of Article XII relating to permitted contests, if Lessee shall fail to make any payment, or to perform any act required to be made or performed under this Lease and to cure the same within the relevant time periods provided in Section 16.1, after reasonable written notice to Lessee, Lessor, without waiving or releasing any obligation or Event of Default, may (but shall be under no obligation to) at any time thereafter make such reasonable payment or perform such reasonable act for the account and at the expense of Lessee, and may, to the extent permitted by law, enter upon any portion of the Leased Property, but only in accordance with Lessee’s reasonable security procedures and all applicable laws, including, but not limited to all Information Privacy and Security Laws, for such purpose and take all such action thereon as, in Lessor’s opinion, may be necessary or appropriate therefor.  No such entry shall be deemed an eviction of Lessee.  

All sums so paid by Lessor and all reasonable, out-of-pocket costs and expenses (including, without limitation, reasonable, documented, out-of-pocket attorneys’ fees and expenses, in each case, to the extent permitted by law) so incurred, together with a late charge thereon (to the extent permitted by law) at the Overdue Rate from the date on which such sums or expenses are paid or incurred by Lessor until reimbursed, shall be paid by Lessee to Lessor on demand.

ARTICLE XVIII.
INTENTIONALLY OMITTED

ARTICLE XIX.
HOLDING OVER

19.1.Holding Over. Except to the extent provided in Section 19.2, if Lessee shall for any reason remain in possession of any Property after the expiration of the Term or any earlier termination of the Term with respect to thereto, such possession shall be as a tenancy at will, during which time Lessee shall pay, as rental each month, one and one-half (1-1/2) times the aggregate of (a) one-twelfth (1/12) of the aggregate Allocated Base Rent relating to such Property payable with respect to the last complete twelve (12) month period prior to the expiration of the Term, (b) all Additional Charges relating to such Property accruing during the month, and (c) all other sums, if any, payable by Lessee pursuant to the provisions of this Lease with respect to such Property.  

89

 

4834-1440-2281v12


 

During such period of tenancy, Lessee shall be obligated to perform and observe all of the terms, covenants and conditions of this Lease, but shall have no rights hereunder other than the right, to the extent given by law to tenancies at will, to continue its occupancy and use of such Property.  Except to the extent provided in Section 19.2, nothing contained herein shall constitute the consent, express or implied, of Lessor to the holding over of Lessee after the expiration or earlier termination of this Lease.

ARTICLE XX.
PASS-THROUGH LEASES

20.1.Pass-Through Leases.

(a)With respect to (i) the Hialeah Pass-Through Lease, Hialeah Lessee, (ii) the Hialeah Palmetto Pass-Through Leases, Hialeah Palmetto Lessee, (iii) the Lauderdale Lakes Pass-Through Leases, Lauderdale Lakes Lessee, and (iv) the Miami Pass-Through Lease, Miami Lessee, in each case, shall perform all of the terms, conditions, covenants, duties, and obligations imposed upon Hialeah Lessor, Hialeah Palmetto Lessor, Lauderdale Lakes Lessor, and Miami Lessor, respectively, under the applicable Pass-Through Lease, in each case, to be performed by such Facility Lessors, as landlord until the earlier of (A) the expiration or earlier termination of this Lease (or Lessee’s right of possession hereunder) (subject to Article XIX for any holdover periods), and (B) the termination of any such Pass-Through Lease, as applicable. It is hereby acknowledged and agreed that all such terms, conditions, covenants, duties, and obligations as lessor or landlord under the Pass-Through Leases that accrue or arise prior to the expiration or earlier termination of this Lease (or Lessees’ right of possession hereunder) (including any holdover period pursuant to Article XIX) shall remain the obligations and liabilities of Lessee. Notwithstanding anything to the contrary in this Section 20.1, during the Term, Hialeah Lessor, Hialeah Palmetto Lessor, Lauderdale Lakes Lessor, and Miami Lessor shall reasonably cooperate (at Lessee’s expense) with Hialeah Lessee, Hialeah Palmetto Lessee, Lauderdale Lakes Lessee, and Miami Lessee in their performance of all applicable terms, conditions, covenants, duties, and obligations under the Pass-Through Leases to the extent such terms, conditions, covenants, duties, and obligations are only capable of being performed by such Facility Lessor, as the fee owner of such portions of the Leased Property; provided, however, that (I) Lessor shall be reimbursed by Lessee for any reasonable and documented out of pocket costs or expenses incurred by Lessor with respect to the performance of any such obligations undertaken at the request of Lessee, (II) Lessee understands and is familiar with the extent to which such terms, conditions, covenants, duties, and obligations are only capable of being performed by each applicable Facility Lessor as the fee owner thereof, (III) Lessee shall use its best efforts to provide Lessor with reasonable advanced written notice to enable Lessor to perform any such terms, conditions, covenants, duties, and obligations in a timely manner, and (IV) Lessee shall consult, assist, and otherwise cooperate with Lessor in the performance thereof. So long as no Event of Default has occurred, (X) Hialeah Lessee, Hialeah Palmetto Lessee, Lauderdale Lakes Lessee, and Miami Lessee, respectively, shall be entitled to collect the rental payments due under the respective Pass-Through Leases directly from the tenant thereunder, and (Y) Lessor shall reasonably cooperate with Lessee (at Lessee’s expense) to notify the tenants under the respective Pass-Through Leases that rental payments should be made directly to the applicable Facility Lessee, including, without limitation, by executing and delivering an instruction letter to such tenant instructing them to pay such rental payments directly to such Facility Lessee; provided, that, Lessee agrees and acknowledges that upon the occurrence of an

90

 

4834-1440-2281v12


 

Event of Default, Lessor shall be authorized to revoke any such tenant instruction letter and instruct such tenant to pay all rental payments directly to Lessor (or Lessor’s designee) from and after the occurrence of such Event of Default.

(b)If any Pass-Through Lease expires or terminates prior to the expiration of the Term, then any property and improvements subject thereto shall be subject to the terms and conditions of this Lease. For the avoidance of doubt, Lessor and Lessee agree that (i) during the Term and prior to the termination and/or expiration of any Pass-Through Lease, the applicable Facility Lessor shall have the right to receive and apply all condemnation awards or insurance proceeds with respect to such Pass-Through Lease in accordance with the ground lessor’s obligations under the applicable Pass-Through Lease, and (ii) during the Term and following the termination and/or expiration of any applicable Pass-Through Lease, any such condemnation awards and insurance proceeds shall be applied in accordance with the provisions of this Lease.

20.2.Other Terms and Provisions Relating to Pass-Through Leases.

(a)Lessee shall not, without Lessor’s prior written consent, which consent shall not be unreasonably withheld, conditioned, or delayed, (i) terminate, modify, amend, or restate any Pass-Through Lease or attempt to do any of the same, or (ii) exercise or attempt to exercise any right of offer, right of refusal, purchase options, or put options relating to any Pass-Through Lease or related Pass-Through Lease Improvements (if available under the applicable Pass-Through Lease).

(b)Lessor and Lessee agree that each will, promptly upon receipt, forward to the other copies of all notices, requests, demands, and other correspondence and documents directed to and/or received from the “tenant” or “lessee” under any Pass-Through Lease.

(c)Any and all purchase options, put options, rights of first refusal, or rights of first offer under the Pass-Through Leases shall be (i) exercised in the sole and absolute discretion of Lessor and (ii) at the sole cost and expense of Lessor, and, upon any purchase by Lessor of all or any portion of the Pass-Through Lease Improvements, such Pass-Through Lease Improvements shall remain subject to the terms and conditions of this Lease (and shall constitute Leased Improvements hereunder). For the avoidance of doubt, unless otherwise mutually agreed to by Lessor and Lessee in writing, none of the costs or expenses of Lessor incurred in connection with Lessor’s purchase of any Pass-Through Lease Improvements shall be passed through to Lessee, as an increase to the Lease Base for the applicable Property or otherwise.  

(d)Notwithstanding any provision in this Lease to the contrary, in the event Lessee purchases the Hialeah Property, Hialeah Palmetto Property, Lauderdale Lakes Property, or Miami Property pursuant to any right of first refusal provided to Lessee under the terms of this Lease, with respect to any applicable Pass-Through Lease Property, such purchase shall be subject to all terms, provisions, and conditions of the applicable Pass-Through Lease. In such event, with respect to such Pass-Through Lease, Lessor shall assign its right, title, and interest in such Pass-Through Lease to Lessee and Lessee shall assume such Pass-Through Lease from Lessor, pursuant to an assignment and assumption agreement reasonably satisfactory to the parties.

20.3.Reversionary and Other Rights. In the event that there is any purchase option, right of first refusal, reversionary right, or other similar right in favor of the applicable Facility

91

 

4834-1440-2281v12


 

Lessor with respect to any Pass-Through Lease Property, then Lessee shall (i) provide Lessor prompt notice of the accrual of any rights with respect thereto, (ii) promptly provide such other information as Lessor may reasonable request from time to time to the extent the same are in Lessee’s possession, (iii) cooperate with Lessor to ensure that the Lessor receives the benefit thereof (including the benefit of any reversionary rights or purchase option or receipt of any option purchase price, it being understood and agreed that it is Lessor who shall be solely entitled to exercise all such options and receive all such reversions), and (iv) take such other actions and deliver such documents as shall be necessary to effect the foregoing. Lessor agrees to cooperate with Lessee in connection herewith.       

ARTICLE XXI.
RISK OF LOSS

During the Term, the risk of loss of, or decrease in, the enjoyment and beneficial use of the Leased Property in consequence of the damage or destruction thereof by fire, the elements, casualties, thefts, riots, wars or otherwise, or in consequence of foreclosures, attachments, levies or executions (other than by Lessor and those claiming from, through or under Lessor) is assumed by Lessee and, Lessor shall in no event be answerable or accountable therefor nor shall any of the events mentioned in this Article XXI entitle Lessee to any abatement of Rent except as specifically provided in this Lease.

ARTICLE XXII.
INDEMNIFICATION

NOTWITHSTANDING THE EXISTENCE OF ANY INSURANCE OR SELF INSURANCE PROVIDED FOR IN ARTICLE XIII, AND WITHOUT REGARD TO THE POLICY LIMITS OF ANY SUCH INSURANCE OR SELF INSURANCE, IN ADDITION TO ANY OTHER INDEMNIFICATION OBLIGATIONS OF LESSEE AND GUARANTOR AS PROVIDED IN THIS LEASE, LESSEE WILL PROTECT, INDEMNIFY, SAVE HARMLESS AND DEFEND LESSOR FROM AND AGAINST ALL LIABILITIES, OBLIGATIONS, CLAIMS, DAMAGES, PENALTIES, CAUSES OF ACTION, REASONABLE, OUT-OF-POCKET COSTS AND EXPENSES (INCLUDING, WITHOUT LIMITATION, REASONABLE ATTORNEYS’ FEES AND EXPENSES TO THE EXTENT PERMITTED BY LAW), IMPOSED UPON OR INCURRED BY OR ASSERTED AGAINST LESSOR BY REASON OF:  (A) ANY ACCIDENT, INJURY TO OR DEATH OF PERSONS OR LOSS OF PERSONAL PROPERTY OCCURRING ON OR ABOUT THE LEASED PROPERTY OR ADJOINING SIDEWALKS, INCLUDING WITHOUT LIMITATION ANY CLAIMS OF MALPRACTICE DURING THE TERM OR WHICH RELATE TO THE PERIOD OF LESSEE’S POSSESSION DURING THE TERM, (B) ANY USE, MISUSE, NON USE, CONDITION, MAINTENANCE OR REPAIR BY LESSEE OF THE LEASED PROPERTY DURING THE TERM OR WHICH RELATE TO THE PERIOD OF LESSEE’S POSSESSION DURING THE TERM, (C) ANY IMPOSITIONS (WHICH ARE THE OBLIGATIONS OF LESSEE TO PAY PURSUANT TO THE APPLICABLE PROVISIONS OF THIS LEASE), (D) ANY FAILURE ON THE PART OF LESSEE TO PERFORM OR COMPLY WITH ANY OF THE TERMS OF THIS LEASE, (E) THE NON-PERFORMANCE OF ANY OF THE TERMS AND PROVISIONS OF ANY AND ALL EXISTING AND FUTURE SUBLEASES OF THE LEASED

92

 

4834-1440-2281v12


 

PROPERTY TO BE PERFORMED BY THE LANDLORD (LESSEE) THEREUNDER DURING THE TERM OR WHICH RELATE TO THE PERIOD OF LESSEE’S POSSESSION DURING THE TERM, (F) ANY AND ALL LAWFUL ACTION THAT MAY BE TAKEN BY LESSOR IN CONNECTION WITH THE ENFORCEMENT OF THE PROVISIONS OF THIS LEASE, WHETHER OR NOT SUIT IS FILED IN CONNECTION WITH SAME, OR IN CONNECTION WITH LESSEE OR A GUARANTOR AND/OR ANY PARTNER, JOINT VENTURER, MEMBER OR SHAREHOLDER THEREOF BECOMING A PARTY TO A VOLUNTARY OR INVOLUNTARY FEDERAL OR STATE BANKRUPTCY, INSOLVENCY OR SIMILAR PROCEEDING, (G) WITH RESPECT TO EACH PROPERTY, TO THE EXTENT ARISING DURING THE TERM OR WHICH RELATE TO THE PERIOD OF LESSEE’S POSSESSION DURING THE TERM, ANY (i) ENCROACHMENTS ONTO OR FROM ADJACENT PROPERTIES; (ii) VIOLATIONS OF SET-BACK, BUILDING OR SIDE LINES; (iii) ENCROACHMENTS ONTO ANY EASEMENTS OR SERVITUDES LOCATED ON SUCH PROPERTY; (iv) PENDING OR THREATENED BOUNDARY LINE DISPUTES; (v) PORTIONS OF SUCH PROPERTY LOCATED IN A FLOOD PLAIN OR IN AN AREA DEFINED AS A WETLAND UNDER APPLICABLE STATE OR FEDERAL LAW; (vi) CEMETERIES OR GRAVESITES LOCATED ON, WITHIN OR UNDER SUCH PROPERTY; OR (vii) MINE SHAFTS UNDER SUCH PROPERTY OR ANY OTHER LATENT DEFECTS, SUCH AS SINKHOLES, REGARDING OR AFFECTING SUCH PROPERTY, (H) ANY GRANTS, CONVEYANCES OR TRANSFERS OF ANY INTERESTS OR RIGHTS IN OR TO THE LEASED PROPERTY (INCLUDING, WITHOUT LIMITATION, EASEMENTS, RIGHTS-WAY, RESTRICTIONS) MADE BY LESSEE OR ANY OTHER PERSON WHICH ARE NOT APPROVED BY LESSOR PRIOR TO PLACING THE SAME OF RECORD ON THE LEASED PROPERTY, INCLUDING, WITHOUT LIMITATION, THOSE PRIOR TO THE LESSOR TAKING TITLE TO THE LEASED PROPERTY, (I) TO THE EXTENT ARISING DURING THE TERM, THE IMPROVEMENTS HAVING INSUFFICIENT ACCESS TO A PUBLIC RIGHT OF WAY OR FAILING TO BE IN COMPLIANCE WITH ALL RULES, REGULATIONS AND ORDINANCES OF ALL GOVERNMENTAL BODIES HAVING JURISDICTION OVER THE IMPROVEMENTS AND THE LAND, INCLUDING, WITHOUT LIMITATION, THOSE PERTAINING TO ZONING AND PARKING, (J) ANY FAILURE ON THE PART OF LESSEE TO PERFORM OR COMPLY WITH ANY OF THE TERMS AND CONDITIONS OF ANY ONE OR MORE OF THE PASS-THROUGH LEASES, AND (K) ANY REVERSION OF ANY IMPROVEMENTS UNDER ANY SEVERED GROUND LEASE TO THE “LANDLORD” THEREUNDER DURING THE TERM OF THIS LEASE AS A RESULT OF LESSEE’S FAILURE TO PAY SEVERED GROUND LEASE BASE RENT IN ACCORDANCE WITH THE TERMS OF THIS LEASE, WHICH INDEMNIFICATION OBLIGATIONS UNDER THIS ARTICLE XXII(K) SHALL INCLUDE AT LEAST AN AMOUNT EQUAL TO THE FAIR MARKET VALUE OF THE APPLICABLE REVERTED IMPROVEMENTS (UNLESS SUCH REVERSION IS DUE TO LESSOR’S (OR THE APPLICABLE GROUND LESSEE’S) VOLUNTARY NONRENEWAL OF SUCH SEVERED GROUND LEASE, IN WHICH CASE, THERE SHALL BE NO INDEMNIFICATION UNDER THIS ARTICLE XXII(K) BY REASON OF SUCH REVERSION). ANY AMOUNTS WHICH BECOME PAYABLE BY LESSEE UNDER THIS ARTICLE XXII SHALL BE PAID WITHIN FIFTEEN (15) DAYS AFTER DEMAND THEREFOR BY LESSOR AND, IF NOT TIMELY PAID, SHALL BEAR A LATE

93

 

4834-1440-2281v12


 

CHARGE (TO THE EXTENT PERMITTED BY LAW) AT THE OVERDUE RATE FROM THE EXPIRATION OF SAID FIFTEEN (15) DAY PERIOD UNTIL THE DATE OF PAYMENT AND A LATE PAYMENT PENALTY ON SUCH AMOUNT.  LESSEE, AT ITS EXPENSE, SHALL CONTEST, RESIST AND DEFEND ANY SUCH CLAIM, ACTION OR PROCEEDING ASSERTED OR INSTITUTED AGAINST LESSOR AND MAY COMPROMISE OR OTHERWISE DISPOSE OF THE SAME, SUBJECT TO THE APPROVAL OF LESSOR.  NOTHING HEREIN SHALL BE CONSTRUED AS INDEMNIFYING LESSOR AGAINST ITS OWN BAD FAITH, GROSSLY NEGLIGENT ACTS OR OMISSIONS, WILLFUL MISCONDUCT OR ANY WILLFUL BREACH OF ITS OBLIGATIONS UNDER THIS LEASE.

ARTICLE XXIII.
ASSIGNMENT, SUBLETTING AND SUBLEASE SUBORDINATION

23.1.Assignment and Subletting.

(a)Lessee shall not assign this Lease without Lessor’s prior written consent; provided, however, that Lessor’s consent shall not be required for an assignment of this Lease to a Qualified Transferee (provided, that, if such assignment is in connection with an asset based transfer, such Qualified Transferee and its Affiliates shall enter into such guaranty agreements, security agreements, assignments of rents and leases, pledge agreements, non-competition agreements, environmental indemnification agreements, and other similar security documents (collectively, the “Qualified Transferee Credit Enhancements”) as are necessary in Lessor’s reasonable determination to assure that Lessor receives such collateral and other credit enhancements as are comparable to those provided by Lessee, Guarantor and their respective Affiliates in connection with this Lease). Lessor shall not unreasonably withhold, condition or delay its consent to any assignment, provided, that (i) such assignee shall assume in writing and agree to keep and perform all of the terms of this Lease on the part of Lessee to be kept and performed; and (ii) an original counterpart of the assignment, duly executed by Lessee and such assignee in form and substance reasonably satisfactory to Lessor, shall be delivered promptly to Lessor; it being understood and agreed, however, that if, in connection with any such assignment, Lessee desires that Lessor release Lessee from its obligations under this Lease, Lessor’s review and approval of any assignee shall be in Lessor’s sole and absolute discretion.  The parties agree that Lessor’s failure or refusal to approve an assignment to an assignee that does not have the financial or operating characteristics reasonably satisfactory to Lessor shall be reasonable on its face. Notwithstanding anything contained in this Lease to the contrary, any assignment must be of all of Lessee’s right, title and interest in and to this Lease and the Leased Property such that this Lease is not severed with respect to any one or more of the Properties.

(b)Lessee shall not sublease any portion of a particular Property if such Tenant Lease would exceed Ten Million and No/100 Dollars ($10,000,000.00) in annual rent without Lessor’s prior written consent, which consent shall not be unreasonably withheld, conditioned or delayed.  Lessee agrees that (i) each Tenant Lease shall comply with the provisions of Sections 23.1(b), 23.2 and 23.3, (ii) subject to Section 23.2, a copy of each such Tenant Lease, duly executed by Lessee and such Tenant in form and substance reasonably satisfactory to Lessor, shall be delivered promptly to Lessor and (iii) Lessee shall remain primarily liable, as principal rather than as surety, for the prompt payment of the Rent and for the performance and observance of all of the

94

 

4834-1440-2281v12


 

obligations, covenants and conditions to be performed by Lessee hereunder and under all of the other documents executed in connection herewith.  Any modifications, amendments and restatements of any Tenant Leases (but excluding renewals and extensions) hereafter entered into (other than those having less than Ten Million and No/100 Dollars ($10,000,000.00) in annual rent) must be approved by Lessor in accordance with this Article XXIII.  

(c)In no event shall Lessee sublease all or substantially all of any Property without Lessor’s prior written consent, which may be withheld in Lessor’s sole discretion.

23.2.Sublease Limitations.  In addition to the sublease limitations as set forth in Section 23.1, above, and notwithstanding anything contained in this Lease to the contrary, Lessee shall not sublet the Leased Property on any basis such that the rental to be paid by the Tenant thereunder would be based, in whole or in part, on either (a) the income or profits derived by the business activities of the Tenant, or (b) any other formula such that any portion of the Tenant Lease rental received by Lessor would fail to qualify as “rents from real property” within the meaning of Section 856(d) of the Code, or any similar or successor provision thereto.  Moreover, Lessee shall not sublet any portion of the Leased Property for a term extending beyond the Fixed Term without the express consent of Lessor.  In addition, all Tenant Leases shall comply in all material respects with the Healthcare Laws. Lessor and Lessee acknowledge and agree that all Tenant Leases entered into relating to the Leased Property, whether or not approved by Lessor, shall not, without the prior written consent of Lessor, be deemed to be a direct lease between Lessor and any Tenant.  Lessee agrees that all Tenant Leases executed after the Initial Commencement Date must include provisions to the effect that (i) such sublease is subject and subordinate to all of the terms and provisions of this Lease, to the rights of Lessor hereunder, and to all financing documents relating to any Facility Loan in connection with the Leased Property, (ii) in the event this Lease shall terminate or be terminated before the expiration of the Tenant Lease, the Tenant will, at Lessor’s option, exercisable at any time in Lessor’s discretion, attorn to Lessor and waive any right the Tenant may have to terminate the sublease or to surrender possession thereunder as a result of the termination of this Lease, (iii) in the event of a termination of this Lease with respect to all or the applicable Property, at Lessor’s option, exercisable at any time in Lessor’s discretion, the sublease may be terminated or left in place by Lessor, (iv) Tenant shall from time to time upon request of Lessee or Lessor furnish within twenty (20) days from request an estoppel certificate in form and content reasonably acceptable to Lessor or any Facility Lender relating to the Tenant Lease, (v) in the event the Tenant receives a written notice from Lessor or Lessor’s assignees, if any, stating that an Event of Default under this Lease has occurred, the Tenant shall, to the extent specified in such notice, thereafter be obligated to pay all rentals accruing under said Tenant Lease directly to the Person giving such notice, or as such Person may direct, and such Tenant shall be entitled to conclusively rely on such notice (all rentals received from the Tenant by Lessor or Lessor’s assignees, if any, as the case may be, shall be credited against the amounts owing by Lessee under this Lease), and (vi) such Tenant Lease shall at all times be subject to the obligations and requirements as set forth in this Article XXIII.  Lessee acknowledges and agrees that the provisions of this Section 23.2 shall be applicable to all tenants, subtenants or licensees of any material portion of the Leased Property, whether under a Tenant Lease or any other written Lease, sublease, license or rental agreement.

23.3.Sublease Subordination and Non-Disturbance.

95

 

4834-1440-2281v12


 

(a)With respect to the Existing Subleases, and within twenty (20) days after the Initial Commencement Date, Lessee shall use commercially reasonable efforts to cause such Tenant to execute and deliver to Lessor a subordination, non-disturbance and attornment agreement relating to each such Existing Sublease, which subordination, non-disturbance and attornment agreement shall be in reasonable form mutually satisfactory to Lessor and Lessee.  

(b)At any time during the Term, within twenty (20) days following written request by Lessor with respect to any Tenant, Lessee shall use commercially reasonable efforts to cause any applicable Tenant to execute and deliver to Lessor (a) an estoppel certifying such matters as Lessor may reasonably request, including, without limitation, that such Tenant Lease is unmodified and in full force and effect (or setting forth the modifications), the term and expiration thereof and the dates to which the Rent has been paid; and/or (b) a subordination, non-disturbance and attornment agreement relating to the applicable Tenant Lease, which subordination, non-disturbance and attornment agreement shall be in reasonable form mutually satisfactory to Lessor and Lessee.

(c)Within twenty (20) days from the date of request of Lessor, a Facility Lender or Lessee, with respect to any Tenant, Lessee shall use commercially reasonable efforts to cause such Tenant and Lessor shall cause such Facility Lender to enter into a written agreement in a form reasonably acceptable to such Facility Lender and such Tenant whereby (i) such Tenant subordinates the Tenant Lease and all of its rights and estate thereunder to the lien of each such mortgage or deed of trust that encumbers the Leased Property or any part thereof and agrees with each such Facility Lender that such Tenant will attorn to and recognize such Facility Lender or the purchaser at any foreclosure sale or any sale under a power of sale contained in any such mortgage or deed of trust, as the case may be, as Lessor under this Lease for the balance of the Term then remaining, subject to all of the terms and provisions of the Tenant Lease and (ii) such Facility Lender shall agree that Tenant shall not be disturbed in peaceful enjoyment of the applicable portion of the Leased Property nor shall the applicable Tenant Lease be terminated or canceled at any time, except as specified in the applicable Tenant Lease.

23.4.Existing Subleases.  Notwithstanding anything contained herein to the contrary, Lessor and Lessee acknowledge that there currently exist certain leases, subleases or licenses on the Leased Property, with annual rental payments in excess of Ten Million and No/100 Dollars ($10,000,000) as described on Exhibit C (collectively the “Existing Subleases”).  Any material modifications, amendments and restatements of the Existing Subleases or any Tenant Lease hereafter entered into (but excluding renewals and extensions that do not otherwise materially modify or amend the relevant Existing Sublease or Tenant Lease) must be approved by Lessor in accordance with this Article XXIII.  

ARTICLE XXIV.
OFFICER’S CERTIFICATES; FINANCIAL STATEMENTS; NOTICES AND OTHER CERTIFICATES

(a)At any time and from time to time, but not more than once per calendar quarter, within twenty (20) days following reasonable written request by Lessor, each Facility Lessee shall furnish to Lessor an Officer’s Certificate certifying that this Lease is unmodified and in full force and effect (or that this Lease is in full force and effect as modified and setting forth

96

 

4834-1440-2281v12


 

the modifications) and the dates to which the Rent has been paid.  Any such Officer’s Certificate furnished pursuant to this Article may be relied upon by Lessor and any prospective purchaser of the Leased Property.

(b)Each Facility Lessee shall furnish, or cause to be furnished, to Lessor the following statements, notices and certificates in such form and detail as Lessor may reasonably require:

(i)within ninety (90) days after the end of each year, audited Consolidated Financial Statements of Steward Health (which shall provide a supplementary schedule of each Facility Lessee’s balance sheets and statements of operations and, if such Facility Lessee owns any assets or conducts any other operations other than the Business, then of the Facility separately), prepared by a nationally recognized accounting firm or an independent certified public accounting firm reasonably acceptable to Lessor, all in accordance with GAAP for the year then ended; and

 

(ii)within (x) ninety (90) days after the end of the fourth quarter of each year, and (y) forty-five (45) days after the end of each other quarter, (A) the most recent calendar quarterly Consolidated Financial Statements of Steward Health and a written calculation of the then current EBITDAR (as determined utilizing the trailing twelve (12) month operating and financial results of Steward Health and its Subsidiaries and measured on a calendar quarterly basis), and (B) quarterly Financial Statements of each Facility Lessee, and, if such Facility Lessee owns any assets or conducts any other operations other than the Business, then of its Facility separately, certified to be true and correct by an officer of Steward Health; and

 

(iii)within thirty (30) days after the end of each month, monthly income statements (if available or produced in the ordinary course of business) of each such Facility Lessee and statistics of its Facility, including, but not limited to, the number of patient discharges, the number of inpatient days, the case mix index, the payor sources for inpatient days (by inpatient days) and outpatient utilization by service (ER, non-ER); and

(iv)within ten (10) days after receipt, any and all material written notices from any and all licensing and/or certifying agencies that any license or certification, including, without limitation, the Medicare and/or Medicaid certification and/or material managed care contract necessary for the operation of the Facility for the Primary Intended Use is being revoked, or suspended, or that action is pending or being considered to revoke or suspend such Facility’s license or certification; and

(v)with reasonable promptness, such other information respecting the financial condition of such Facility Lessee, Steward Health and their respective Subsidiaries as Lessor may reasonably request from time to time.

(c)Upon Lessor’s reasonable request, each Facility Lessee and Steward Health shall furnish to Lessor a certificate in form reasonably acceptable to Lessor certifying that no Event of Default then exists and to Lessee’s knowledge no event has occurred (that has not been cured) and no condition currently exists that would, but for the giving of any required notice or expiration

97

 

4834-1440-2281v12


 

of any applicable cure period, constitute an Event of Default, or disclosing that such an event or condition, if any, exists.

(d)Within five (5) Business Days after receipt, each Facility Lessee shall furnish to Lessor copies of all written notices and demands from any third-party payor, including, without limitation, Medicare and/or Medicaid, concerning any overpayment which will or could reasonably be expected to require a repayment or a refund in excess of Ten Million and No/100 Dollars ($10,000,000.00) with respect to such Facility Lessee.

(e)Each Facility Lessee shall furnish to Lessor within ten (10) Business Days written notice of, and any written information related to, any governmental investigations of such Facility Lessee or the Guarantor (or any of their respective Affiliates), or any inspections or investigations of the Facility operated by such Facility Lessee which are conducted by the United States Attorney, State Attorney General, the Office of the Inspector General of the Department of Health and Human Services (the “OIG”), the United States Department of Justice or any other Governmental Body (except for such inspections or investigations that are being conducted by a Governmental Body other than the United States Attorney, State Attorney General, OIG or the Department of Justice, unless such inspections or investigations by such other Governmental Body is reasonably expected to have a material adverse effect on such Facility Lessee or the Guarantor, in which event such Facility Lessee shall furnish all such information as contemplated herein), and provide to Lessor, on a monthly basis, ongoing status reports (in form and content acceptable to Lessor) of any such government investigations; provided that no Facility Lessee shall be required to furnish any such information to the extent attorney-client privileged information or disclosure thereof would violate any applicable law (including without limitation HIPAA).

(f)Each Facility Lessee shall furnish to Lessor within five (5) Business Days after receipt thereof copies of all written pre-termination notices from Medicare and/or Medicaid, all written notices of material adverse events or material deficiencies as defined by the regulations and standards of the state Medicare and/or Medicaid certification agency, the Joint Commission (formerly known as the Joint Commission on the Accreditation of Healthcare Organizations) (the “Joint Commission”) or the equivalent accrediting body relied upon by such Facility Lessee in the operation of the Facility operated by such Facility Lessee or any part thereof.

(g)Each Facility Lessee shall provide to Lessor prompt written notice of any monetary or material non-monetary default or event of default with respect to any Material Obligation of such Facility Lessee or the Guarantor and, upon Lessor’s request, such Facility Lessee or the Guarantor shall furnish to Lessor a certificate in form reasonably acceptable to Lessor certifying that, with respect to each Material Obligation, no monetary or material non-monetary event of default, to such Facility Lessee or such Guarantor’s knowledge, then exists thereunder.

(h)Lessor reserves the right to require such other financial information from Lessee at such other times as it shall deem reasonably necessary.  All financial statements and information must be in such form and detail as Lessor shall from time to time, but not unreasonably, request.

98

 

4834-1440-2281v12


 

ARTICLE XXV.
INSPECTIONS

Upon reasonable prior written notice, Lessee shall permit Lessor, or its designated Affiliate, and their respective authorized representatives to inspect the Leased Property during usual business hours subject to any security, health, safety or confidentiality requirements of Lessee and Lessee’s policies with respect to facility security and/or HIPAA compliance, any governmental agency, any Insurance Requirements relating to the Leased Property, or imposed by law or applicable regulations, except that, in the event of an emergency, Lessor shall have the right to inspect the Leased Property upon reasonable notice (which in this circumstance may be verbal) under the circumstances to Lessee.

ARTICLE XXVI.
NO WAIVER

Any provision of this Lease or Exhibits hereto may be amended or waived only in a writing signed by the parties hereto.  No waiver of any provision hereunder or any breach or default thereof shall extend to or affect in any way any other provision or prior or subsequent breach or default.

ARTICLE XXVII.
REMEDIES CUMULATIVE

To the extent permitted by law, each legal, equitable or contractual right, power and remedy of Lessor or Lessee now or hereafter provided either in this Lease or by statute or otherwise shall be cumulative and concurrent and shall be in addition to every other right, power and remedy and the exercise or beginning of the exercise by Lessor or Lessee of any one or more of such rights, powers and remedies shall not preclude the simultaneous or subsequent exercise by Lessor or Lessee of any or all of such other rights, powers and remedies.

ARTICLE XXVIII.
SURRENDER

No surrender to Lessor of this Lease or of the Leased Property, or of any part thereof or interest therein, shall be valid or effective unless agreed to and accepted in writing by Lessor, and no act by Lessor or any representative or agent of Lessor, other than such a written acceptance by Lessor, shall constitute an acceptance of any such surrender.

ARTICLE XXIX.
NO MERGER OF TITLE

There shall be no merger of this Lease or of the leasehold estate created hereby by reason of the fact that the same person, firm, corporation or other entity may acquire, own or hold, directly or indirectly, (a) this Lease or the leasehold estate created hereby or any interest in this Lease or such leasehold estate and (b) the fee estate in the Leased Property.

99

 

4834-1440-2281v12


 

ARTICLE XXX.
TRANSFERS BY LESSOR; SEVERANCE RIGHTS

30.1.Transfers by Lessor.  Lessee acknowledges that Lessor may sell its interest in the Leased Property in whole or in part, and that Lessor may assign its interest in this Lease in whole or in part, in any such case, to any other Person without Lessee’s prior written consent or approval, so long as such Person is not a Non-Permitted Assignee; provided, however, that (i) if an Event of Default has occurred and is continuing, Lessor may sell, assign or transfer any such rights and obligations to a Non-Permitted Assignee without the written consent of Lessee, and (ii) such restrictions to a sale or assignment shall not apply to or otherwise restrict any actions, negotiations or agreements in respect of any Portfolio Sale.  If Lessor or any successor owner of any Property shall convey such Property in accordance with the terms hereof, other than as security for a debt, the grantee or transferee of such Property shall expressly assume all obligations of Lessor hereunder arising or accruing from and after the date of such conveyance or transfer, and Lessor or such successor owner, as the case may be, shall thereupon be released from all future liabilities and obligations of Lessor under this Lease relating to such Property arising or accruing from and after the date of such conveyance or other transfer and all such future liabilities and obligations shall thereupon be binding upon the new owner.  Lessee agrees that any successor purchaser may exercise any and all rights of Lessor; provided, however, such successor purchaser shall be subject to the same restrictions imposed upon Lessor hereunder. Subject to the execution by a prospective purchaser of a written confidentiality agreement on terms reasonably acceptable to Lessee,  Lessor may divulge to any such prospective purchaser all information, reports, financial statements, certificates and documents obtained by it from Lessee (including all such information and documents relating to the Guarantor).

30.2.Lessor Severance Rights.  Notwithstanding the unitary nature of this Lease, Lessor may at any time and from time to time (including, without limitation, in connection with a partial assignment under Section 30.1 hereof) cause this Lease to be severed with respect to any one or more of the Properties (each, a “Severed Property”).  If Lessor shall desire to sever this Lease pursuant to this Section 30.2, Lessor shall deliver written notice (each, a “Severance Notice”) to Lessee not less than thirty (30) days prior to the date that this Lease shall be severed with respect to the Severed Property or Severed Properties identified in the Severance Notice (such date identified in a Severance Notice, a “Severance Date”).  The Severance Notice shall specify the Severed Property and the Severance Date.  Effective upon a Severance Date, the applicable Severed Property shall no longer be part of the Leased Property under this Lease and such Severed Property shall be deemed to be and shall be leased by Lessor (or an assignee of Lessor) to Lessee for the amount of Rent allocable to such Severed Property pursuant to a separate lease (a “Severed Lease”) upon the same terms and conditions as provided in this Lease (except for such provisions as by their terms are not applicable to such Severed Property); it being agreed, however, that the liability of the applicable lessor under the Severed Lease shall be limited to such lessor’s interest in the Severed Property.  The portion of the Base Rent allocable to the Severed Property shall be the Allocated Base Rent for such Severed Property.  Effective upon the Severance Date, (a) the Rent payable with respect to each Severed Property shall no longer be payable by Lessee under this Lease and shall instead be payable under the Severed Lease applicable to such Severed Property, and (b) the parties shall enter into the Severed Lease, an amendment of this Lease, and an amendment of the applicable other Obligation Documents that assures (i) that Lessor continues to receive the benefits currently provided by such Obligations Documents for this Lease as so

100

 

4834-1440-2281v12


 

amended, and (ii) Lessor (or Lessor’s assignee) also receives the benefit of such items (the “Other Credit Enhancements”) under and with respect to the Severed Lease.  For so long as Lessor under this Lease shall be the lessor under a Severed Lease, any such Severed Lease and the related Other Credit Enhancements shall be deemed “Obligation Documents” for all purposes under this Lease, any Event of Default under such Severed Lease or Other Credit Enhancements shall constitute an Event of Default under this Lease, any Event of Default under this Lease or the other Obligation Documents shall constitute an Event of Default under such Severed Lease, and the lessee(s) under the Severed Lease shall be deemed a “Subsidiary” of Steward Health for purposes of calculating compliance under Section 16.1(j) and (k) and the same or comparable covenant under the Mortgage Loan Agreement.  Lessor will prepare the Severed Lease, the Other Credit Enhancements, the Lease amendment and, if necessary, the amendments to the other applicable Obligation Documents with respect to each Severed Property consistent with the provisions of this Section 30.2 and the parties agree to execute and deliver or cause to be executed and delivered each of the foregoing documents.

ARTICLE XXXI.
QUIET ENJOYMENT

So long as Lessee shall pay all Rent as the same becomes due and shall fully comply with all of the terms of this Lease and fully perform its obligations hereunder, Lessee shall peaceably and quietly have, hold and enjoy the Leased Property for the Term hereof, free of any claim or other action by Lessor or anyone claiming by, through or under Lessor, but subject to the Permitted Exceptions, any Facility Loan and all liens and encumbrances of record.  No failure by Lessor to comply with the foregoing covenant shall give Lessee any right to cancel or terminate this Lease, or to fail to pay any other sum payable under this Lease, or to fail to perform any other obligation of Lessee hereunder.  Notwithstanding the foregoing, Lessee shall have the right by separate and independent action to pursue any claim it may have against Lessor as a result of a breach by Lessor of the covenant of quiet enjoyment contained in this Article XXXI.

ARTICLE XXXII.
NOTICES

All notices, demands and other communications to be given or delivered under or by reason of the provisions of this Lease shall be in writing and shall be deemed to have been given or delivered (a) when personally delivered, (b) when transmitted via telecopy (or other facsimile device) to the number set out below if the sender on the same day sends a confirming copy of such notice by a recognized overnight delivery service (charges prepaid), (c) the day following the day (except if not a Business Day then the next Business Day) on which the same has been delivered prepaid to a reputable national overnight air courier service or (d) the third Business Day following the day on which the same is sent by certified or registered mail, postage prepaid.  Notices, demands and communications, in each case to the respective parties, shall be sent to the applicable address set forth below, unless another address has been previously specified in writing:

 

if to Lessee:

c/o Steward Health Care System LLC

 

1900 Pearl Street, Suite 2400

 

Dallas, Texas 75201

 

Attn: Chief Executive Officer

101

 

4834-1440-2281v12


 

 

Fax: (469) 341-8999

 

 

with a copy to:

Sidley Austin LLP

 

One South Dearborn

 

Chicago, Illinois 60603

 

Attn: Ankur Gupta, Esq.

 

Fax: (312) 853-7036

 

 

if to Lessor:

c/o MPT Operating Partnership, L.P.

 

1000 Urban Center Drive, Suite 501

 

Birmingham, Alabama 35242

 

Attn: Legal Department

 

Fax: (205) 969-3756

 

 

with a copy to:

Baker, Donelson, Bearman, Caldwell &

 

Berkowitz, P.C.

 

420 20th Street North, Suite 1400

 

Birmingham, Alabama 35203

 

Attn: Thomas O. Kolb

 

Fax: (205) 322-8007

 

or to such other address as either party may hereafter designate in writing, and shall be effective upon receipt.  A notice, demand, consent, approval, request and other communication shall be deemed to be duly received if delivered in person or by a recognized delivery service, when left at the address of the recipient and if sent by facsimile, upon receipt by the sender of an acknowledgment or transmission report generated by the machine from which the facsimile was sent indicating that the facsimile was sent in its entirety to the recipient’s facsimile number; provided that if a notice, demand, consent, approval, request or other communication is served by hand or is received by facsimile on a day which is not a Business Day, or after 5:00 p.m. on any Business Day (based upon Birmingham, Alabama time), such notice or communication shall be deemed to be duly received by the recipient at 9:00 a.m. (based upon Birmingham, Alabama time) on the first Business Day thereafter.

ARTICLE XXXIII.
APPRAISAL

If it becomes necessary to determine the Fair Market Value of any Property, each party, within ten (10) Business Days following the date of the event which makes such determination necessary, shall, by notice to the other, appoint an appraiser (each of whom must be a member of AI and adhere to the USPAP standards in the preparation of the appraisal).  The appraisers thus appointed shall appoint a third appraiser (such third appraiser must also be a member of AI and adhere to the USPAP standards in the preparation of the appraisal) and such third appraiser shall appraise such Property to determine the Fair Market Value thereof; provided, however, that if a party fails to appoint an appraiser within such required period, the sole appraiser appointed shall conduct the appraisal and the parties shall use commercially reasonable efforts to cause such appraisal to be completed within forty-five (45) days following the event which makes such determination necessary.  This provision for determination by appraisal shall be specifically

102

 

4834-1440-2281v12


 

enforceable to the extent such remedy is available under applicable law, and any determination hereunder shall be final and binding upon the parties except as otherwise provided by applicable law.  Lessor and Lessee shall each pay one-half (1/2) of all costs and expenses incurred in connection with such appraisal.  Any appraisal shall assess the Fair Market Value of the applicable Property or Lessee’s Personal Property as of the date of the event which makes such assessment necessary.

ARTICLE XXXIV.
PURCHASE RIGHTS

34.1.Lessor’s Option to Purchase Lessee’s Personal Property.  Upon the occurrence and continuance of an Major Event of Default, continuing for thirty (30) days beyond any applicable notice and cure period, in addition to other rights and remedies Lessor may have in this Lease and at law and in equity, Lessor shall have the right and option, but not the obligation, to purchase from Lessee, all (but not less than all) of the applicable Facility Lessee’s Personal Property with respect to such Facility and all rights title, and interest of the applicable Facility Lessee therein for an amount equal to the then fair market value of the Facility Lessee’s Personal Property with respect to such Facility as determined by independent, third party appraisal reasonably acceptable to Lessor and Lessee, subject in all cases to, and with appropriate price adjustments for, all equipment leases, conditional sale contracts, security interests and other encumbrances to which such Personal Property is subject.  If the Lessor determines to exercise its option pursuant hereto, then Lessor shall provide Lessee with written notice of its intent to exercise such option and Lessee shall be obligated to sell, assign, transfer and convey to Lessor, its designee or assignee, on an AS IS, WHERE IS BASIS, and without representation or warranty of any kind or nature whatsoever, express or implied, all such Facility Lessee’s Personal Property with respect to such Facility and all rights title, and interest of the applicable Facility Lessee therein subject to the terms and conditions set forth herein.  Notwithstanding anything contained in this Section 34.1 to the contrary, the options to purchase granted under this Section 34.1, do not pertain to any of the Licenses, it being understood and agreed that all matters relating to the transfer of the Licenses are addressed in Section 38.4.

34.2.Lessee’s First Right of Refusal.

(a)Subject to the limitations described in Section 34.2(b) below, upon the expiration of the Fixed Term and during the continuation of the Extension Term, and so long as no Event of Default has occurred and is continuing, Lessee shall have a first refusal option to purchase the Leased Property as provided herein.  In the event that Lessor or its Affiliate receives a bona fide written offer during the Extension Term from an unaffiliated third party in a letter of intent form (which offer the Lessor or its Affiliate intends to accept) to purchase all or any portion of the Leased Property (in each case, a “Third Party Offer”), then Lessor shall promptly (but in no event later than ten (10) Business Days following Lessor’s delivery to Lessee of an executed letter of intent) provide Lessee with a copy of such Third Party Offer (the “Third Party Offer Notice”) and Lessee shall have the Decision Period (as hereinafter defined) in which to confirm in writing its intention to purchase all or such portion of the Leased Property (as applicable) on the same terms and conditions contained in the Third Party Offer.  If Lessee shall fail to provide a written response to Lessor within the Decision Period, then Lessee shall be deemed to have elected not to exercise its option and Lessor and the third party shall be entitled to proceed with the sale of the

103

 

4834-1440-2281v12


 

Leased Property on the same terms as those set forth in the letter of intent, free and clear of any Lessee rights of first refusal to purchase the Leased Property.  As used herein, the term “Decision Period” shall mean the period of time commencing on the date that Lessee receives the Third Party Offer Notice and ending on the later to occur of (i) the sixtieth (60th) day immediately following the date that Lessee receives the Third Party Offer Notice, or (ii) the thirtieth (30th) day immediately following the date that the Lessor or its Affiliate enters into a binding definitive agreement accepting the Third Party Offer (the “Binding Agreement”).  

(b)If, prior to the closing of any such sale of the Leased Property in accordance with any Third Party Offer, Lessor agrees to reduce the offering price set forth in the Third Party Offer to an amount which is less than ninety-eight (98%) of the original offered amount, or to modify or amend any material terms or conditions set forth in the Third Party Offer or the Binding Agreement such that they are materially more favorable to the third party purchaser than those terms and conditions initially set forth in the Third Party Offer on which the sale of the Leased Property was initially offered to Lessee, then Lessor shall give Lessee written notice thereof and all supporting documentation (the “Revised Sale Terms”).  Lessee shall have fifteen (15) days after the receipt of said notice and Revised Sale Terms in which to confirm in writing its intention to purchase the Leased Property on the same terms and conditions contained in the Third Party Offer or Binding Agreement, as applicable and as modified by the Revised Sale Terms.  If Lessee shall fail to provide a written response to Lessor within such fifteen (15) day time period, then Lessee shall be deemed to have elected not to exercise its option and Lessor and the third party shall be entitled to proceed with the sale of the Leased Property free and clear of any Lessee rights of first refusal to purchase the Leased Property.  

(c)If Lessee exercises the foregoing option, then such purchase shall be consummated on the earlier of (i) the closing date specified in the Third Party Offer or Binding Agreement, as applicable, but no earlier than expiration of the Decision Period, or (ii) the thirtieth (30th) day immediately following Lessor’s receipt of Lessee’s written confirmation of Lessee’s intent to exercise its option as provided herein.

(d)In the event that such sale of the Leased Property to such third party fails to close for whatever reason, Lessee shall be entitled to exercise its right of first refusal as provided in this Section 34.2 as to any subsequent Third Party Offer that occurs during the Term of this Lease.  In the event that Lessee shall fail to exercise its option as provided herein, and Lessor shall consummate a sale of the Leased Property to such third party during the Term, then the Lessee shall remain entitled to exercise its right of first refusal as provided in this Section 34.2 as to any subsequent sale or transfer during the Term by such third party of the Leased Property which is subject to Lessee’s right of first refusal granted herein.

(e)In addition to the conditions and limitations set forth in Section 34.2(a), Lessee’s first refusal option with respect to the Leased Property shall not apply to or otherwise restrict any actions, negotiations or agreements in respect of (i) the sale, transfer of other disposition of the Leased Property to any unaffiliated third party third party prior to the expiration of the Fixed Term, or (ii) the sale, transfer or other disposition of the Leased Property which constitutes a Portfolio Sale.

104

 

4834-1440-2281v12


 

ARTICLE XXXV.
INTENTIONALLY
OMITTED

ARTICLE XXXVI.
FINANCING OF THE LEASED PROPERTY

Lessor agrees that, if it grants or creates any mortgage, deed of trust, pledge, hypothecation, assignment, charge or deposit agreement, lien (statutory or otherwise) or preference, security interest or other encumbrance of any kind or nature whatsoever (“Liens”) upon any Property after the Commencement Date, Lessor will obtain an agreement from the holder of each such Lien whereby such holder agrees (a) to give the Facility Lessee which operates such Property the same notice, if any, given to Lessor of any default or acceleration of any obligation underlying any such Lien or any sale in foreclosure of such Lien, (b) to permit such Facility Lessee, after twenty (20) days’ prior written notice, to cure any such default on Lessor’s behalf within any applicable cure period, (c) to permit such Facility Lessee to appear with its representatives and to bid at any foreclosure sale with respect to any such Lien, (d) that, if subordination by such Facility Lessee is requested by the holder of each such Lien, to enter into an agreement with such Facility Lessee containing the provisions described in Article XXXVII, and (e) to execute and deliver to such Facility Lessee a written agreement consenting to this Lease and agreeing that, notwithstanding any such other Facility Instrument or any default, expiration, termination, foreclosure, sale, entry or other act or omission thereunder, such Facility Lessee shall not be disturbed in peaceful enjoyment of such portion of the Leased Property nor shall this Lease be terminated or canceled at any time, except in accordance with Article XVI as a result of an Event of Default.  

ARTICLE XXXVII.
SUBORDINATION AND NON‑DISTURBANCE

At the request from time to time by one or more Facility Lenders with respect to any Facility Lessee, within twenty (20) days from the date of request, such Facility Lessee shall execute and deliver within such twenty (20)-day period, to such Facility Lender, an estoppel certificate along with a written agreement in form and content reasonably acceptable to such Facility Lender and Facility Lessee whereby, as to any Property of such Facility Lessee encumbered by a Facility Instrument of such Facility Lender, such Facility Lessee subordinates this Lease and all of its rights and estate hereunder to each such Facility Instrument and agrees with each such Facility Lender that such Facility Lessee will attorn to and recognize such Facility Lender or the purchaser at any foreclosure sale or any sale under a power of sale contained in any such Facility Instrument, as the case may be, as Lessor under this Lease with respect to such Property for the balance of the Term then remaining, subject to all of the terms and provisions of this Lease; provided, however, that each such Facility Lender simultaneously executes and delivers to such Facility Lessee a written agreement in form and content reasonably acceptable to such Facility Lessee consenting to this Lease and agreeing that, notwithstanding any such other mortgage, deed of trust, right, title or interest, or any default, expiration, termination, foreclosure, sale, entry or other act or omission under, pursuant to or affecting any of the foregoing, such Facility Lessee shall not be disturbed in peaceful enjoyment of such Property nor shall this Lease be terminated or canceled at any time, except as a result of an Event of Default.

105

 

4834-1440-2281v12


 

ARTICLE XXXVIII.
LICENSES

38.1.Maintenance of Licenses.  With respect to each Facility, each Facility Lessee (a) shall maintain at all times during the Term and any holdover period, (i) the Operating Agreements, (ii) the Participation Agreements and (iii) all material federal, state and local governmental licenses, approvals, qualifications, variances, certificates of need, franchises, accreditations, certificates, certifications, consents, permits and other authorizations and contracts, which may be necessary for the operation of the Facility operated by such Facility Lessee for the Primary Intended Use, or required for certification and participation under Medicare and Medicaid legislation and regulations, the provider programs of the State Regulatory Authorities for each particular Facility (DHS”), the United States Department of Health and Human Services (“DHHS”), and the Centers for Medicare and Medicaid Services (“CMS”), and/or state or federal Title XVIII and/or Title XIX provider programs applicable for each such Facility (the items described in this subsection (iii), collectively, the “Licenses”);  (provided, however, that no Facility Lessee shall be required to maintain any Operating Agreements or Participation Agreements unless such agreements are required for participation in Medicare and Medicaid programs and/or required for the maintenance of federal, state, and local licenses) and (b) shall remain in compliance, in all material respects, with all state and federal laws, rules, regulations and procedures with regard to the operation of the Facility operated by such Facility Lessee, including, without limitation, HIPAA and the regulations promulgated by the State Regulatory Authorities, as applicable for each such Facility, as they may from time to time exist.

38.2.No Transfers or Alterations of Licenses.  Except in connection with a permitted assignment of this Lease, Lessee covenants and agrees that during the Term it shall not, without the prior written consent of Lessor, which consent shall not be unreasonably withheld, conditioned or delayed, (a) sell, move, modify, cancel, surrender, transfer, assign, sell, relocate, pledge, secure, convey or in any manner encumber any material Licenses (including, without limitation, any Medicare provider number or agreement), or (b) effect or attempt to effect any change in the license category or status of any Facility or any part thereof to the extent such change (as described in (a) or (b) above) has a material adverse effect on the Primary Intended Use or the ability of the Lessee to meet its obligations under this Lease.

38.3.Notifications; Corrective Actions.  Each Facility Lessee shall notify Lessor in writing within five (5) Business Days after such Facility Lessee’s receipt of any written notice, action, proceeding or inquiry of any governmental agency, bureau or other authority, whether federal, state or local, of any kind, nature or description, which could adversely affect any material License for the Facility operated by such Facility Lessee, or the ability of such Facility Lessee to maintain its status as the licensed and accredited operator of such Facility, or which alleges any material noncompliance with any law.  At the time of delivery of such notification to Lessor, such Facility Lessee shall furnish Lessor with a copy of any and all such notices or inquiries.  Each Facility Lessee shall act diligently to correct any deficiency or deal effectively with any material “adverse action” or other proceedings, inquiries or other governmental actions, so as to maintain the material Licenses and Medicare and/or Medicaid certification, status for the Facility operated by such Facility Lessee in good standing at all times.  No Facility Lessee shall agree to any settlement exceeding Five Million and No/100 Dollars ($5,000,000.00) or other action with respect to such proceedings or inquiries which affects the use of all or any portion of the Leased Property

106

 

4834-1440-2281v12


 

or any part thereof for the Primary Intended Use without the prior written consent of Lessor, which consent shall not be unreasonably conditioned or delayed.

38.4.Termination of Lease.  SUBJECT TO SECTION 38.6, UPON THE TERMINATION OF THIS LEASE OR LESSEE’S RIGHT OF POSSESSION HEREUNDER WITH RESPECT TO ANY ONE OR MORE PROPERTIES, WITHOUT ANY ADDITIONAL CONSIDERATION TO ANY FACILITY LESSEE, THE APPLICABLE FACILITY LESSEE SHALL, FOR REASONABLE PERIODS OF TIME AFTER SUCH TERMINATION, USE ITS COMMERCIALLY REASONABLE EFFORTS TO FACILITATE AN ORDERLY TRANSFER OF THE OPERATION AND OCCUPANCY OF SUCH PROPERTY TO LESSOR OR ITS DESIGNEE, AND SUCH COOPERATION SHALL INCLUDE, WITHOUT LIMITATION, (1) SUCH FACILITY LESSEE’S EXECUTION AND SUBMISSION TO THE APPROPRIATE AUTHORITY OF ANY AND ALL DOCUMENTS REQUIRED TO EFFECT THE TRANSFER, ISSUANCE OR ASSIGNMENT TO LESSOR OR ITS DESIGNEE OF ANY AND ALL LICENSES AND PARTICIPATION AGREEMENTS, (2) SUCH FACILITY LESSEE’S MAINTENANCE OF THE EFFECTIVENESS OF ANY AND ALL SUCH LICENSES AND PARTICIPATION AGREEMENTS UNTIL SUCH TIME AS ANY NEW LICENSES NECESSARY FOR ANY NEW LESSEE OR OPERATOR TO OPERATE THE FACILITY OPERATED BY SUCH FACILITY LESSEE HAVE BEEN ISSUED, AND (3) THE TAKING OF SUCH OTHER ACTIONS AS REASONABLY REQUESTED BY LESSOR OR REQUIRED BY APPLICABLE LAW; IT BEING UNDERSTOOD AND AGREED THAT THE PERFORMANCE OR EXERCISE OF ANY OF THE FOREGOING RIGHTS, REMEDIES, DUTIES AND OBLIGATIONS SHALL BE WITHOUT ANY ADDITIONAL CONSIDERATION TO SUCH FACILITY LESSEE.

38.5.Material Condition of Lease.  IT IS AN INTEGRAL CONDITION OF THIS LEASE, AND A MATERIAL INDUCEMENT TO LESSOR’S AGREEMENT TO ENTER INTO THIS LEASE, THAT EACH FACILITY LESSEE ACKNOWLEDGES AND AGREES TO COOPERATE WITH AND ASSIST LESSOR AND/OR ITS DESIGNEE IN CONNECTION WITH ANY TRANSFER OF THE LICENSES AND PARTICIPATION AGREEMENTS OR THE OPERATIONS OF THE FACILITIES IN ACCORDANCE WITH THIS ARTICLE XXXVIII. INCLUDING, WITHOUT LIMITATION, IN CONNECTION WITH A TERMINATION OF THIS LEASE OR REMOVAL OF LESSEE FROM POSSESSION OF ONE OR MORE PROPERTIES IN THE MANNER SET FORTH IN SECTION 38.4 ABOVE, WHICH COOPERATION AND ASSISTANCE SHALL BE WITHOUT ANY ADDITIONAL CONSIDERATION TO LESSEE.

38.6.Cooperation; Applicable Transfer Requirements.  The obligations of each Facility Lessee set forth in Sections 38.4 and 38.5 shall include, without limitation, such Facility Lessee using its commercially reasonable efforts to assist and cooperate with Lessor (or its designee) in (i) obtaining any new material Licenses and Participation Agreements or (ii) transferring or assigning any existing material Licenses and Participation Agreement, which shall include, without limitation, each Facility Lessee using its commercially reasonable efforts to execute and deliver such change of ownership documentation required to transfer any material Licenses and Participation Agreements (including, without limitation, any Form CMS 855 to assign any Medicare provider agreements) to Lessor or its designee. Lessor acknowledges that the obligations of each Facility Lessee set forth in Sections 38.4 and 38.5 shall be subject to all

107

 

4834-1440-2281v12


 

applicable notice, review, or approval requirements of any Governmental Body including, without limitation, any requirements of the Massachusetts Department of Health and Human Services or other State Regulatory Authority (collectively, the “Transfer Requirements”); provided, however, that until such time as all applicable Transfer Requirements have been satisfied, each Facility Lessee shall continue to use its commercially reasonable efforts to satisfy the obligations set forth in Sections 38.4 and 38.5.  

ARTICLE XXXIX.
MISCELLANEOUS

39.1.General.  The parties agree that each provision of this Lease shall be interpreted in such manner as to be effective and valid under applicable law, but if any provision of this Lease or any application of this Lease to any party or otherwise) is held to be prohibited by or invalid under applicable law, such provision or application shall be ineffective only to the extent of such prohibition or invalidity, without invalidating the remainder of such provision or the remaining provisions of this Lease or any other applications of this Lease.  If any late charges provided for in any provision of this Lease are based upon a rate in excess of the maximum rate permitted by applicable law, the parties agree that such charges shall be fixed at the maximum permissible rate.  All the terms and provisions of this Lease shall be binding upon and inure to the benefit of the parties and their respective successors and assigns (subject to Article XXIII); provided, however, that (a) this Lease shall not inure to the benefit of any assignee pursuant to an assignment which violates the terms of this Lease and (b) neither this Lease nor any other document or agreement contemplated under this Lease shall be deemed to confer upon any Person not a party (other than any Non-Recourse Party with respect to Section 39.7) to this Lease any rights or remedies contained in this Lease.  The headings in this Lease are for convenience of reference only and shall not limit or otherwise affect its meaning.

39.2.Bankruptcy Waivers.

(a)Unitary and Non-Severable Lease.  The parties agree that for the purposes of any assumption, rejection or assignment of this Lease under 11 U.S.C. Section 365 or any amendment or successor section thereof, this is one indivisible and non-severable lease dealing with and covering one legal and economic unit which must be assumed, rejected or assigned as a whole with respect to all (and only all) the Leased Property covered hereby.

(b)Relief from Stay.  Lessee acknowledges and agrees that in the event any Lessee or any Leased Property relating to any Facility shall become the subject of any bankruptcy or insolvency estate, then (i) Lessee shall not oppose any request by Lessor to obtain an order from the court granting relief from the automatic stay pursuant to Section 362 of the Bankruptcy Code so as to permit the exercise of all rights and remedies pursuant to this Lease, and (ii) the occurrence or existence of any Event of Default under this Lease shall, in and of itself, constitute “cause” for relief from the automatic stay pursuant to the provisions of Section 362(d)(1) of the Bankruptcy Code, based on the fact that the non-existence of a bankruptcy proceeding was a material inducement for the entry by Lessor into this Lease.

(c)Automatic Stay.  Lessee hereby waives the stay imposed by 11 U.S.C. Section 362(a) as to actions by the Lessor against each Facility.  Lessee acknowledges and agrees that in the event of the filing of any voluntary or involuntary petition in bankruptcy by or against

108

 

4834-1440-2281v12


 

Lessee, it shall not assert or request that any other party assert that the automatic stay provided by Section 362 of the Bankruptcy Code shall operate or be interpreted to stay, interdict, condition, reduce or inhibit the ability of Lessor to enforce any rights or remedies held by virtue of the Lease or applicable law.

(d)Patient Care Ombudsman.  Lessee hereby agrees (i) to use its best efforts to contest the necessity of the appointment of a Patient Care Ombudsman for such Facility as that term is defined in 11 U.S.C. Section 333, and/or (ii) to join with Lessor in requesting a waiver of or contesting the appointment of such a Patient Care Ombudsman.

39.3.Lessor’s Expenses.  In addition to the other provisions of this Lease, including, without limitation, Section 16.2 hereof, Lessee agrees and shall pay and/or reimburse Lessor and its Affiliates’ reasonable and documented out-of-pocket costs and expenses, including, without limitation, the costs and expenses of reports and investigations and reasonable legal fees and expenses incurred or resulting from or relating to (a) requests by Lessee for approval or consent under this Lease or any other Obligation Document (including any consents relating to management, the placing of liens on Lessee’s Personal property and any intercreditor issues which arise in connection with any Material Obligations), (b) any circumstances or developments which give rise to Lessor or its Affiliates’ right of consent or approval under this Lease or any other Obligation Document, (c) a request for changes, including, but not limited to, (i) the permitted use of the Leased Property, (ii) alterations and improvements to the Leased Improvements, (iii) subletting or assignment, and (iv) any other changes in the terms, conditions or provisions of this Lease or any other Obligation Document, and (d) enforcement by Lessor or its Affiliates of any of the provisions of this Lease or any other Obligation Document.  Such expenses and fees shall be paid by Lessee within thirty (30) days of the submission of a statement in reasonable detail for the same or such amount(s) shall be subject to interest at the Overdue Rate from the expiration of said thirty (30) day period to the date of payment, plus a Late Payment Penalty with respect to such unpaid amount.

39.4.Prevailing Party Expenses.  In addition to the other provisions of this Lease but subject to the provisions of Section 39.3, if any of the Lessee Parties on the one hand or the Lessor Parties on the other hand brings any action, suit or other legal action or proceeding to enforce or establish any right of such party under this Lease, the party prevailing in such action, suit or proceeding shall be entitled to recover all reasonable and documented out-of-pocket costs and expenses incurred by the prevailing party in connection therewith, including, without limitation, court costs and documented out-of-pocket attorneys’ fees.

39.5.Entire Agreement; Modifications; Effect of Amendment and Restatement.  This Lease, together with all exhibits, schedules and the other documents referred to herein, embody and constitute the entire understanding between the parties with respect to the transactions contemplated herein, and all prior and contemporaneous agreements, understandings, representations and statements (oral or written) are merged into this Lease. This Lease amends, restates, and supersedes, in all respects, the Original Lease. Notwithstanding the foregoing, and for the avoidance of doubt, nothing set forth in this Lease shall limit or eliminate any existing continuing indemnification or other obligations of Lessee or any indemnnification obligation relating to a “Severed Lessee” (as defined or more particularly identified in any Severed Facility Amendment) set forth in any Severed Facility Amendment with respect to (a) any Severed Facility

109

 

4834-1440-2281v12


 

regarding any acts, omissions, or events occuring or accruing prior to the effective date of the severance of such Severed Facility or (b) Severed Ground Lease Base Rent, in each case, in accordance with the terms of such Severed Facility Amendment , except to the extent any claim giving rise to such indemnification is found to have resulted from any MPT Indemnified Party's bad faith or willful misconduct. Neither this Lease, any exhibit or schedule attached hereto, nor any provision hereof or thereof may be modified or amended except by an instrument in writing signed by Lessor and Lessee.

39.6.Lessor Securities Offering and Filings.  Notwithstanding anything contained herein to the contrary, Lessee shall, at Lessor’s sole cost and expense, cooperate with Lessor in connection with any securities offerings and filings, or Lessor’s efforts to procure or maintain financing for, or related to, the Leased Property, or any portion thereof and, in connection therewith, Lessee shall furnish Lessor, in a timely fashion, with such financial and other information (including audited financial statements and consents of auditors) as Lessor shall reasonably request, provided that the disclosure of such information is not prohibited under any Information Privacy and Secruity Laws.  In accordance with all Information Privacy and Secruity Laws, Lessor may disclose that Lessor has entered into this Lease with Lessee and may provide and disclose information regarding this Lease, Lessee, the Guarantor, the Leased Property and each Facility, and such additional information which Lessor may reasonably deem necessary, to its proposed investors in such public offering or private offering of securities, or any current or prospective lenders with respect to such financing, and to investors, analysts and other parties in connection with earnings calls and other normal communications with investors, analysts, and other parties.  In accordance with all Information Privacy and Secruity Laws, upon reasonable advance notice, Lessor, its legal and financial representatives, and any lender providing financing for all or any portion of the Leased Property shall have the right to access, examine and copy all agreements, records, documentation and information relating to Lessee, the Guarantor, and such Leased Property, and to discuss such affairs and information with the officers, employees and independent public accountants of Lessee as often as reasonably necessary.  The additional costs of Lessee in complying with the foregoing shall be reimbursed to Lessee by Lessor.

39.7.Non-Recourse as to Parties.

(a)Anything contained herein to the contrary notwithstanding, any claim based on, or in respect of, any liability of Lessor under this Lease shall be enforced only against the Lessor’s interest in the Leased Property and any proceeds therefrom and not against any other assets, properties or funds of (i) Lessor, (ii) any director, officer, general partner, member, shareholder, limited partner, beneficiary, employee, representative, contractor or agent of Lessor or any of its Affiliates (collectively, the “Lessor Parties”) (or any legal representative, heir, estate, successor or assign of Lessor or any of the Lessor Parties), (iii) any predecessor or successor partnership or corporation (or other entity) of Lessor or any of the Lessor Parties, either directly or through Lessor or the Lessor Parties, or (iv) any person or entity affiliated with any of the foregoing.  

(b)Notwithstanding anything that may be expressed or implied in this Lease, or in any document or instrument delivered in connection herewith, the Lessor Parties by their execution hereof and by their acceptance, directly or indirectly, of the benefits of this Lease, expressly covenants, acknowledges and agrees that no Person other than the Lessee or Guarantor

110

 

4834-1440-2281v12


 

shall have any obligation hereunder (and with respect thereto, only to the extent expressly provided herein) and that no recourse hereunder shall be had against, and no personal liability whatsoever shall attach to, be imposed on or otherwise be incurred by any of such Obligors’ former, current and future direct or indirect equity holders, controlling persons, directors, officers, employees, agents, advisors, members, managers, general or limited partners, assignees, or  representatives or any of their respective former, current or future direct or indirect equity holders, controlling persons, directors, officers, employees, agents, advisors, members, managers, general or limited partners or assignees, or representatives (each being referred to as a “Non-Recourse Party”, and together with the Lessee and Guarantor, collectively, the “Lessee Parties”), for any obligations of the Lessee or Guarantor under this Lease, or for any claim based on, in respect of, or by reason of any such obligations or their creation, through Lessee, Guarantor or otherwise, whether by or through attempted piercing of the corporate veil, by or through a claim by or on behalf of any Lessor Party against Lessee or Guarantor, by the enforcement of any judgment or assessment or by any legal or equitable proceeding, by virtue of any law, statute, or regulation, or otherwise.  Lessor Parties hereby covenant and agree that they shall not institute, and shall cause each of their Affiliates and their equity holders and representatives not to attempt to assign or institute, directly or indirectly, any claim, suit or proceeding or bring, or attempt to assign, any other claim arising under, or in connection with, this Lease, against any Non-Recourse Party.

39.8.Covenants, Restrictions and Reciprocal Easements.  Lessor shall not place of record any covenants, restrictions or reciprocal easements on all or any portion of the Land (collectively, the “Declarations”) without Lessee’s prior written consent, not to be unreasonably withheld, conditioned or delayed.

39.9.Force Majeure.  Except for Rent and other monetary obligations payable pursuant to the terms of this Lease (which shall not be extended or excused), in the event that Lessor or Lessee shall be delayed, hindered in or prevented from the performance of any act required under this Lease by reason of strikes, lockouts, labor troubles, or other industrial disturbances, inability to procure materials, failure of power, unavailability of any utility service, restrictive governmental laws or regulations, acts of public enemies, war, blockades, riots, insurrections, earthquakes, fires, storms, floods, civil disturbances, weather-related acts of God, failure to act, or default of another party, or other reason beyond Lessor’s or Lessee’s control (individually “Force Majeure”), then performance of such act shall be excused for the period of the delay, and the period of the performance of any such act shall be extended for a period equivalent to the period of such delay.  Within ten (10) Business Days following the occurrence of Force Majeure, the party claiming a delay due to such event shall give written notice to the other setting forth a reasonable estimate of such delay.

39.10.Management Agreements.  Lessee shall not engage, terminate, remove or replace any Management Company without providing Lessor with fifteen (15) days’ prior written notice and an opportunity to provide consultation as to any successor manager. Lessee shall require any Management Company to execute and deliver to Lessor within ten (10) Business Days from Lessor’s request an estoppel certificate, as required by Lessor and/or any Facility Lender, in such form and content as is reasonably acceptable to Lessor and/or such Facility Lender.

39.11.Non-Competition.  Each Facility Lessee hereby acknowledges the Non-Competition Agreement and, as an inducement to Lessor to enter into this Lease and as a condition

111

 

4834-1440-2281v12


 

precedent to this Lease, each Facility Lessee agrees that the terms, covenants and conditions of the Non-Competition Agreement are binding on it and incorporated herein by reference.

39.12.Governing Law.  THIS LEASE SHALL BE GOVERNED BY AND CONSTRUED IN ACCORDANCE WITH THE LAWS OF THE STATE OF DELAWARE APPLICABLE TO CONTRACTS EXECUTED AND PERFORMED IN SUCH STATE, WITHOUT GIVING EFFECT TO CONFLICTS OF LAW PRINCIPLES.  NOTWITHSTANDING THE FOREGOING, ALL PROVISIONS OF THIS LEASE RELATING TO THE CREATION OF THE LEASEHOLD ESTATE AND ALL REMEDIES SET FORTH IN ARTICLE XVI RELATING TO THE RECOVERY OF POSSESSION OF THE LEASED PROPERTY (SUCH AS AN ACTION FOR UNLAWFUL DETAINER OR OTHER SIMILAR ACTION) SHALL BE GOVERNED BY, CONSTRUED AND ENFORCED IN ACCORDANCE WITH THE LAWS OF THE STATE IN WHICH THE LEASED PROPERTY IS LOCATED.

39.13.Jurisdiction and Venue.  LESSOR AND LESSEE CONSENT TO PERSONAL JURISDICTION IN THE STATE OF DELAWARE.  EXCEPT AS OTHERWISE PROVIDED IN THIS SECTION 39.13, LESSOR AND LESSEE AGREE THAT ANY ACTION OR PROCEEDING ARISING FROM OR RELATED TO THIS LEASE SHALL BE BROUGHT AND TRIED EXCLUSIVELY IN THE STATE OR FEDERAL COURTS OF DELAWARE.  EACH OF THE PARTIES IRREVOCABLY AND UNCONDITIONALLY WAIVES ANY OBJECTION TO THE LAYING OF VENUE OF ANY SUCH ACTION OR PROCEEDING BROUGHT IN ANY SUCH COURT.  LESSOR AND LESSEE EXPRESSLY ACKNOWLEDGE THAT DELAWARE IS A FAIR, JUST AND REASONABLE FORUM AND AGREE NOT TO SEEK REMOVAL OR TRANSFER OF ANY ACTION FILED BY THE OTHER PARTY IN SAID COURTS.  FURTHER, LESSOR AND LESSEE IRREVOCABLY AND UNCONDITIONALLY WAIVE ANY CLAIM THAT SUCH SUIT, ACTION OR PROCEEDING HAS BEEN BROUGHT IN AN INCONVENIENT FORUM.  SERVICE OF ANY PROCESS, SUMMONS, NOTICE OR DOCUMENT BY CERTIFIED MAIL ADDRESSED TO A PARTY AT THE ADDRESS DESIGNATED PURSUANT TO ARTICLE XXXII SHALL BE EFFECTIVE SERVICE OF PROCESS AGAINST SUCH PARTY FOR ANY ACTION OR PROCEEDING BROUGHT IN ANY SUCH COURT.  A FINAL JUDGMENT IN ANY SUCH ACTION OR PROCEEDING BROUGHT IN ANY SUCH COURT MAY BE ENFORCED IN ANY OTHER COURT TO WHOSE JURISDICTION ANY OF THE PARTIES IS OR MAY BE SUBJECT.  NOTWITHSTANDING THE FOREGOING, THE PARTIES FURTHER AGREE THAT ALL ACTIONS AND PROCEEDINGS RELATING TO THE CREATION OF THE LEASEHOLD ESTATE AND ALL REMEDIES RELATING TO THE RECOVERY OF POSSESSION OF ALL OR ANY PORTION OF THE LEASED PROPERTY (SUCH AS AN ACTION FOR UNLAWFUL DETAINER OR OTHER SIMILAR ACTION) MAY BE BROUGHT IN ANY STATE OR FEDERAL COURT OF THE STATE WHERE THE APPLICABLE PORTION OF THE LEASED PROPERTY IS LOCATED.

39.14.True Operating Lease.  Lessor and Lessee agree that this Lease is intended as and shall for all purposes constitute a true operating lease and not a capital lease or financing and nothing herein shall be construed as conveying to Lessee any right, title or interest in or to the Leased Property or to any remainder or reversionary estates in the Leased Property held by any Person, except, in each instance, as a lessee.  Under no circumstances shall this Lease be regarded as an assignment of all of Lessor’s interest in and to the Leased Property; instead, Lessor and

112

 

4834-1440-2281v12


 

Lessee shall have the relationship between them of Lessor and Lessee, pursuant to the terms and provisions of this Lease. In no event shall Lessee, Steward or any of their respective Subsidiaries claim depreciation, amortization or interest deductions as owner of any portion of the Leased Property for United States federal, state or local income tax purposes (except as to Capital Additions not funded by Lessor). It is an integral condition of this Lease, and a material inducement to Lessor’s agreement to enter into this Lease, that Lessee agrees this Lease is an operating lease and not a capital lease or financing.  Neither Lessor nor Lessee shall shall assert, and each hereby waives, any right to demand, request or plead for the re-characterization of this Lease or any other Obligation Document, whether or not in a proceeding related to any bankruptcy or insolvency of Lessor or Lessee.

39.15.Intentionally Omitted.

39.16.Compliance with Anti-Terrorism Laws.  Lessor hereby notifies Lessee that pursuant to the requirements of certain Anti-Terrorism Laws (including, without limitation, the Patriot Act) and Lessor’s policies and practices, Lessor is required to obtain, verify and record certain information and documentation that identifies Lessee, which information includes the name, address and identification number of Lessee.  Lessee will not, directly or indirectly, knowingly enter into any lease for the operation of any part of a Facility or any other lease or any material contracts with any person listed on the OFAC List.  Lessee shall promptly notify Lessor if Lessee has knowledge that Lessee or any of its principals or Affiliates or the Guarantor is listed on the OFAC List or (a) is convicted on, (b) pleads nolo contendere to, (c) is indicted on, or (d) is arraigned and held over on charges involving money laundering or predicate crimes to money laundering.  Lessee will not, directly or indirectly (i) conduct any business or engage in any transaction or dealing with any Blocked Person, including, without limitation, the making or receiving of any contribution of funds, goods or services to or for the benefit of any Blocked Person, (ii) deal in, or otherwise engage in any transaction relating to, any property or interests in property blocked pursuant to Executive Order No. 13224, any similar executive order or other Anti-Terrorism Law, or (iii) engage in or conspire to engage in any transaction that evades or avoids, or has the purpose of evading or avoiding, or attempts to violate, any of the prohibitions set forth in Executive Order No. 13224, or other Anti-Terrorism Law.

39.17.Electronically Transmitted Signatures.  In order to expedite the execution of this Lease, telecopied signatures or signatures sent by electronic mail may be used in the place of original signatures on this Lease.  The parties intend to be bound by the signatures of the telecopied or electronically mailed signatures, and hereby waive any defenses to the enforcement of the terms of this Lease based on the form of the signature. Following any facsimile or electronic mail transmittal, the party shall promptly deliver the original instrument by reputable overnight courier in accordance with the notice provisions of this Lease.

39.18.Waiver of Jury Trial.  TO THE MAXIMUM EXTENT PERMITTED BY LAW, LESSOR AND LESSEE HEREBY KNOWINGLY, VOLUNTARILY AND INTENTIONALLY WAIVE THE RIGHT TO A TRIAL BY JURY IN RESPECT OF ANY LITIGATION BASED HEREON, ARISING OUT OF, UNDER OR IN CONNECTION WITH THIS LEASE, OR ANY COURSE OF CONDUCT, COURSE OF DEALING, STATEMENT (WHETHER VERBAL OR WRITTEN) OR ACTION OF EITHER PARTY OR ANY EXERCISE OF ANY PARTY OF THEIR RESPECTIVE RIGHTS HEREUNDER OR IN ANY WAY RELATING TO THIS

113

 

4834-1440-2281v12


 

LEASE OR THE LEASED PROPERTY (INCLUDING ANY CLAIM OR DEFENSE ASSERTING THAT THIS LEASE WAS FRAUDULENTLY INDUCED OR IS OTHERWISE VOID OR VOIDABLE).  THIS WAIVER IS A MATERIAL INDUCEMENT FOR LESSOR TO ENTER INTO THIS LEASE.

39.19.Counterparts.  This Lease may be executed in any number of counterparts, each of which shall be an original, but all of which together shall constitute one and the same instrument.

39.20.Survival.  Notwithstanding any provision of this Lease to the contrary, the parties acknowledge and agree that, all claims against, and liabilities of, Lessee or Lessor which relate to acts or omissions prior to the date of expiration or termination of this Lease, and the covenants and obligations under this Lease which expressly relate to periods after the expiration or earlier termination of Lessee’s tenancy under this Lease, including, without limitation, all indemnification obligations and those covenants and obligations described in Sections 8.1 (final two sentences only), 8.2(c),  8.2(d),  8.3(c) (final two sentences only), 16.2, 38.4, 38.5, 39.3, 39.4, and Articles XIX and XXII, shall survive such expiration or earlier termination.

39.21.Continuation of Defaults.  Notwithstanding any provision hereof to the contrary, whenever in this Lease the phrases “continuing,” “continuation of” or similar words or phrases are used in connection with Events of Default, defaults, or events which with notice or passage of time would constitute Events of Default, such phrases or words shall not be construed to create any right in the Lessee to have additional periods of time to cure such defaults or Events of Default other than those specific cure periods provided in this Lease.

39.22.Specific Performance.  In addition to any rights and remedies available to the parties hereunder or at law, each party shall be entitled to bring an action for specific performance and to seek other equitable relief in connection with any breach or violation, or any attempted breach or violation, of the provisions of this Lease, without the necessity of showing actual damages or furnishing bond or other security.

39.23.Joint Drafting.  The parties hereto and their respective counsel have participated in the drafting and redrafting of this Lease and the general rules of construction which would construe any provisions of this Lease in favor of or to the advantage of one party as opposed to the other as a result of one party drafting this Lease as opposed to the other or in resolving any conflict or ambiguity in favor of one party as opposed to the other on the basis of which party drafted this Lease are hereby expressly waived by all parties to this Lease.

39.24.Joint and Several Obligations.  Each Facility Lessee shall be jointly and severally liable for all of the liabilities and obligations of Lessee under this Lease.  Additionally, each Facility Lessee acknowledges and agrees that all of the representations, warranties, covenants, obligations, conditions, agreements and other terms contained in this Lease shall be applicable to and shall be binding upon and enforceable against any one or more Facility Lessees.

39.25.Representations, Agreements and Covenants relating to Certain Properties.  Further representations, agreements and covenants regarding certain of the Properties are set forth on Schedule 39.25 attached hereto and are hereby incorporated herein by reference.

114

 

4834-1440-2281v12


 

39.26.Necessary Actions. Each party shall perform any further acts and execute and delivery any documents that may be reasonably necessary to carry out the provisions of this Lease.

39.27.Intentionally Omitted.

39.28.Intercreditor Agreement. Notwithstanding anything to the contrary contained in this Lease, the liens, security interests and rights granted pursuant to this Lease or any other Obligation Document shall be as set forth in, and subject to the terms and conditions of (and the exercise of any right or remedy by Lessor hereunder or thereunder shall be subject to the terms and conditions of), the Intercreditor Agreement. In the event of any conflict between this Lease or any other Obligation Document and the Intercreditor Agreement, the Intercreditor Agreement shall control, and no right, power, or remedy granted to Lessor hereunder or under any other Obligation Document shall be exercised by Lessor, and no direction shall be given by Lessor, in contravention of the Intercreditor Agreement.

39.29.Lessee Representative. Each of the Facility Lessees hereby appoints Holy Family Lessee as their duly authorized agent and representative (the "Lessee Representative") to take all actions and enforce all rights of Lessee under this Lease, including, without limitation, (a) giving and receiving any notice or instruction permitted or required under this Lease; (b) interpreting all of the terms and provisions of this Lease; (c) authorizing payments or obtaining reimbursement as may be provided for herein; (d) consenting to, compromising or settling all disputes with Lessor under this Lease; (e) conducting negotiations and dealing with Lessor under this Lessor; and (f) taking any other actions on behalf of Lessee relating to Lessees' rights, claims, duties and obligations under this Lease. In the performance of Lessor's duties and obligations hereunder, Lessor shall be authorized and permitted to correspond and transact with the Lessee Representative on behalf of all the Facility Lessees and shall be entitled to rely upon any document or instrument executed and delivered by the Lessee Representative.

39.30.State Specific Provisions. Further representations, agreements and covenants regarding states where certain of the Properties are located are set forth on Schedule 39.30 attached hereto and are hereby incorporated herein by reference.

ARTICLE XL.
MEMORANDUM OF LEASE

Lessor and Lessee shall, promptly upon the request of either, enter into a short form memorandum of this Lease, in form suitable for recording under the laws of the state in which the Leased Property is located, in which reference to this Lease, the Term and all options contained herein, shall be made.  Lessee shall pay any recording taxes and other costs in connection therewith.

115

 

4834-1440-2281v12


 

[Signatures appear on following pages.]

 

[Remainder of this page intentionally left blank.]

116

 

4834-1440-2281v12


 

 

IN WITNESS WHEREOF, the parties have caused this Amended and Restated Master Lease Agreement to be executed by their respective officers thereunto duly authorized.

 

LESSOR:

MPT OF BRIGHTON-STEWARD, LLC      

MPT of Brockton-Steward, LLC

MPT of Fall River-Steward, LLC

MPT OF HILLSIDE-STEWARD, LLC

MPT of Melbourne-Steward, LLC

MPT of Methuen-Steward, LLC

MPT of Rockledge-Steward, LLC

MPT of Sebastian-Steward, LLC

MPT of Sharon-Steward, LLC

MPT of Taunton-Steward, LLC

MPT of Warren-Steward, LLC

MPT of Youngstown-Steward, LLC

MPT OF MESA, LLC

MPT OF WEST MONROE, LLC

MPT OF PORT ARTHUR, LLC

MPT OF WEST VALLEY CITY, LLC

MPT OF HOPE-STEWARD, LLC

MPT OF ODESSA-STEWARD, LLC

MPT OF PHOENIX-STEWARD, LLC

MPT of PHOENIX Behavioral-Steward, llc

MPT OF SALT LAKE CITY-STEWARD, LLC

MPT OF SAN ANTONIO-STEWARD, LLC

MPT OF TEMPE-STEWARD, LLC

MPT OF TEXARKANA-STEWARD, LLC

MPT OF MARICOPA RE - STEWARD, LLC

MPT OF ODESSA RE - STEWARD, LLC

MPT OF OGDEN RE - STEWARD, LLC

MPT OF PHOENIX RE - STEWARD, LLC

MPT OF PORT ARTHUR RE - STEWARD, LLC

MPT OF SAN ANTONIO RE - STEWARD, LLC

MPT OF LEHI-STEWARD, LLC

MPT OF NORWOOD-STEWARD, LLC

MPT OF AYER-STEWARD, LLC

mpt of haverhill-steward, llc

MPT OF HOUSTOn-STEWARD, LLC

MPT OF HOUSTON RE-STEWARD, LLC

MPT OF DORCHESTER-STEWARD, LLC

MPT OF BIG SPRING-STEWARD, LLC

MPT OF FLORENCE, LLC

MPT OF CORAL GABLES-STEWARD, LLC

MPT OF LAUDERDALE LAKES-STEWARD, LLC

MPT OF HIALEAH-STEWARD, LLC

[CONTINUES ON FOLLOWING PAGE]

 

117

 

4834-1440-2281v12


 

 

 

mPT OF HIALEAH PALMETTO-STEWARD, LLC

MPT OF MIAMI-STEWARD, LLC

 

 

 

 

By:

MPT Operating Partnership, L.P

 

Its:

Sole Member of each above-referenced entity

 

 

 

 

By:

/s/ R. Steven Hamner

 

Name:

R. Steven Hamner

 

Title:

Executive Vice President & CFO

 

 

MPT OF WEST JORDAN-STEWARD PROPERTY, LLC

MPT OF LAYTON-STEWARD PROPERTY, LLC

 

 

 

 

By:

MPT of Utah-Steward, LLC

 

Its:

Sole Member of each above-referenced entity

 

 

 

 

By:

MPT of Utah-Steward Holdings, LLC

 

Its:

Manager

 

 

 

 

By:

MPT Operating Partnership, L.P.

 

Its:

Sole Member

 

 

 

 

 

 

 

By:

/s/ R. Steven Hamner_

 

Name:

R. Steven Hamner

 

Title:

Executive Vice President & CFO_

 

Signed, sealed and delivered

in the presence of the following witnesses:

 

 

/s/ Jodi Jackson

Name Printed

Jodi Jackson

 

/s/ Allison R. Turner

Name Printed

Allison R. Turner

 

 

4834-1440-2281v12


 

 

 

STATE OF ALABAMA

)

 

) SS:

COUNTY OF JEFFERSON

)

 

The foregoing instrument was acknowledged before me this __ day of August, 2021, by ____________, _________________ of MPT OPERATING PARTNERSHIP, L.P., a Delaware limited partnership, as the sole member of MPT OF BRIGHTON-STEWARD, LLC, MPT OF BROCKTON-STEWARD, LLC, MPT OF FALL RIVER-STEWARD, LLC, MPT OF METHUEN-STEWARD, LLC, MPT OF TAUNTON-STEWARD, LLC, MPT OF WARREN-STEWARD, LLC, MPT OF YOUNGSTOWN-STEWARD, LLC, MPT OF SHARON-STEWARD, LLC, MPT OF ROCKLEDGE-STEWARD, LLC, MPT OF MELBOURNE-STEWARD, LLC, MPT OF HILLSIDE-STEWARD, LLC, MPT OF SEBASTIAN-STEWARD, LLC, MPT OF MESA, LLC, MPT OF WEST MONROE, LLC, MPT OF PORT ARTHUR, LLC, MPT OF WEST VALLEY CITY, LLC, MPT OF HOPE-STEWARD, LLC, MPT OF ODESSA-STEWARD, LLC, MPT OF PHOENIX-STEWARD, LLC, MPT OF PHOENIX BEHAVIORAL-STEWARD, LLC, MPT OF SALT LAKE CITY-STEWARD, LLC, MPT OF SAN ANTONIO-STEWARD, LLC, MPT OF TEMPE-STEWARD, LLC, MPT OF TEXARKANA-STEWARD, LLC,  MPT OF MARICOPA RE - STEWARD, LLC, MPT OF ODESSA RE - STEWARD, LLC, MPT OF OGDEN RE - STEWARD, LLC, MPT OF PHOENIX RE - STEWARD, LLC, MPT OF PORT ARTHUR RE - STEWARD, LLC, MPT OF SAN ANTONIO RE - STEWARD, LLC, MPT OF LEHI-STEWARD, LLC, MPT OF NORWOOD-STEWARD, LLC, MPT OF AYER-STEWARD, LLC, MPT OF HAVERHILL-STEWARD, LLC, MPT OF HOUSTON-STEWARD, LLC, MPT OF HOUSTON RE-STEWARD, LLC,  MPT OF DORCHESTER-STEWARD, LLC, MPT OF BIG SPRING-STEWARD, LLC, MPT OF FLORENCE, LLC, MPT OF CORAL GABLES-STEWARD, LLC, MPT OF LAUDERDALE LAKES-STEWARD, LLC, MPT OF HIALEAH-STEWARD, LLC, MPT OF HIALEAH PALMETTO-STEWARD, LLC, and MPT OF MIAMI-STEWARD, LLC, each a Delaware limited liability company, on behalf of such limited partnership as the sole member of such limited liability companies.

 

NOTARIAL SEAL

 

 

 

Notary Public

 

 

My commission expires:

 

 

 

 

4834-1440-2281v12


 

 

 

STATE OF ALABAMA

)

 

) SS:

COUNTY OF JEFFERSON

)

 

The foregoing instrument was acknowledged before me this ___ day of August, 2021, by __________________________, of MPT OPERATING PARTNERSHIP, L.P., a Delaware limited partnership, as the sole member of MPT of Utah-Steward Holdings, LLC, as sole manager of MPT of Utah-Steward, LLC, as sole Member of MPT OF LAYTON-STEWARD PROPERTY, LLC, and MPT OF WEST JORDAN-STEWARD PROPERTY, LLC, each a Delaware limited liability company.

 

NOTARIAL SEAL

 

 

 

Notary Public

 

 

My commission expires:

 

 

 

 

 

4834-1440-2281v12


 

 

LESSEE:

STEWARD HOLY FAMILY HOSPITAL, INC.

MORTON HOSPITAL, A STEWARD FAMILY HOSPITAL, INC.

STEWARD GOOD SAMARITAN MEDICAL CENTER, INC.

STEWARD ST. ANNE’S HOSPITAL CORPORATION

STEWARD ST. ELIZABETH’S MEDICAL CENTER OF BOSTON, INC.

STEWARD HILLSIDE REHABILITATION HOSPITAL, INC.

STEWARD TRUMBULL MEMORIAL HOSPITAL, INC.
STEWARD NORTHSIDE MEDICAL CENTER, INC.

STEWARD MEDICAL GROUP, INC.

SHC YOUNGSTOWN OHIO PSC LLC

STEWARD SHARON REGIONAL HEALTH SYSTEM, INC.

STEWARD SEBASTIAN RIVER MEDICAL CENTER, INC.

BREVARD SHC HOLDINGS LLC

STEWARD ROCKLEDGE HOSPITAL, INC.

STEWARD FLORIDA ASC LLC

STEWARD MELBOURNE HOSPITAL, INC.

MOUNTAIN VISTA MEDICAL CENTER, LP

IASIS GLENWOOD REGIONAL MEDICAL CENTER, LP

THE MEDICAL CENTER OF SOUTHEAST TEXAS, LP

JORDAN VALLEY MEDICAL CENTER, LP

ST. LUKE'S MEDICAL CENTER, LP

ST. LUKE'S BEHAVIORAL HOSPITAL, LP

BRIM HOLDING COMPANY, INC.

ODESSA REGIONAL HOSPITAL, LP

SOUTHWEST GENERAL HOSPITAL, LP

SALT LAKE REGIONAL MEDICAL CENTER, LP

MESA GENERAL HOSPITAL, LP

IASIS HEALTHCARE HOLDINGS, INC.

IASIS FINANCE TEXAS HOLDINGS, LLC

SEABOARD DEVELOPMENT LLC

SEABOARD DEVELOPMENT PORT ARTHUR LLC

BRIM HEALTHCARE OF TEXAS, LLC

IASIS MANAGEMENT COMPANY

BEAUMONT HOSPITAL HOLDINGS, INC.

STEWARD NORWOOD HOSPITAL, INC.

NASHOBA VALLEY MEDICAL CENTER, A STEWARD FAMILY HOSPITAL, INC.

SJ MEDICAL CENTER, LLC

STEWARD CARNEY HOSPITAL, INC.

STEWARD TEXAS HOSPITAL HOLDINGS LLC

 

 

4834-1440-2281v12


 

PERMIAN PREMIER HEALTH SERVICES, INC.

DAVIS HOSPITAL & MEDICAL CENTER, LP

[CONTINUED ON FOLLOWING PAGE]

STEWARD CGH, INC.

STEWARD NSMC, INC.

STEWARD HH, INC.

STEWARD PGH, INC.

 

By:

/s/ John M. Doyle

Name:

John M. Doyle

Title:

Treasurer

 

Signed, sealed and delivered

in the presence of the following witnesses:

 

 

/s/ Kelly Pink

Name Printed

Kelly Pink

 

/s/ Tamele Kelley

Name Printed

Tamele Kelley

 

 

_ _______________________

 

4834-1440-2281v12


 

 

STATE OF TEXAS

)

 

) SS:

COUNTY OF

 

 

)

 

 

The foregoing instrument was acknowledged before me this __ day of August, 2021, by __________________, _____________ of Steward Holy Family Hospital, Inc., Morton Hospital, A Steward Family Hospital, Inc., Steward Good Samaritan Medical Center, Inc., Steward St. Anne’s Hospital Corporation, Steward St. Elizabeth's Medical Center of Boston, Inc., STEWARD TRUMBULL MEMORIAL HOSPITAL, INC., STEWARD HILLSIDE REHABILITATION HOSPITAL, INC., STEWARD NORTHSIDE MEDICAL CENTER, INC., STEWARD SHARON REGIONAL HEALTH SYSTEM, INC., STEWARD ROCKLEDGE HOSPITAL, INC., STEWARD MELBOURNE HOSPITAL, INC., STEWARD SEBASTIAN RIVER MEDICAL CENTER, INC., STEWARD NORWOOD HOSPITAL, INC., NASHOBA VALLEY MEDICAL CENTER, A STEWARD FAMILY HOSPITAL, INC., STEWARD CARNEY HOSPITAL, INC., STEWARD CGH, INC., STEWARD NSMC, INC., STEWARD HH, INC., STEWARD PGH, INC., each a Delaware corporation, STEWARD MEDICAL GROUP, INC., a Massachusetts corporation, SHC YOUNGSTOWN OHIO PSC LLC, BREVARD SHC HOLDINGS LLC, STEWARD FLORIDA ASC LLC, each a Delaware limited liability company, and Brim Holding Company, Inc., IASIS Healthcare Holdings, Inc., IASIS Management Company, and Beaumont Hospital Holdings, Inc., each a Delaware corporation, IASIS Finance Texas Holdings, LLC, Seaboard Development Port Arthur LLC, and Brim Healthcare of Texas, LLC, each a Delaware limited liability company, Mountain Vista Medical Center, LP, IASIS Glenwood Regional Medical Center, LP, The Medical Center of Southeast Texas, LP, Jordan Valley Medical Center, LP, St. Luke’s Medical Center, LP, St. Luke’s Behavioral Hospital, LP, Odessa Regional Hospital, LP, Southwest General Hospital, LP, Salt Lake Regional Medical Center, LP, Mesa General Hospital, LP, AND DAVIS HOSPITAL & MEDICAL CENTER, LP, each a Delaware limited partnership, and Seaboard Development LLC, a Utah limited liability company, SJ MEDICAL CENTER, LLC, and STEWARD TEXAS HOSPITAL HOLDINGS LLC, each a Texas limited liability company, and PERMIAN PREMIER HEALTH SERVICES, INC., a Texas nonprofit corporation that is certified as a nonprofit health organization by the Texas Medical Board, on behalf of the said corporations, limited liability companies, and limited partnerships.

 

IN TESTIMONY WHEREOF, I have hereunto set my hand and official seal this ____ day of August, 2021.

 

NOTARIAL SEAL

 

 

 

Notary Public

 

 

My commission expires:

 

 

 

 

4834-1440-2281v12


 

 

LIST OF EXHIBITS AND SCHEDULES

 

Exhibit A-1

Good Samaritan Land

Exhibit A-2

Holy Family Land

Exhibit A-3

Morton Land

Exhibit A-4

St. Anne’s Land

Exhibit A-5

St. Elizabeth Land

Exhibit A-6

Hillside Land

Exhibit A-7

Northside Medical Land

Exhibit A-8

Sebastian Land

Exhibit A-9

Sharon Land

Exhibit A-10

Trumbull Land

Exhibit A-11

Wuesthoff Melbourne Land

Exhibit A-12

Wuesthoff Rockledge Land

Exhibit A-13

Glenwood Land

Exhibit A-14

Jordan Valley Land

Exhibit A-15

Odessa Land

Exhibit A-16

Mountain Point Land

Exhibit A-17

Mountain Vista Land

Exhibit A-18

Salt Lake Land

Exhibit A-19

Southeast Texas Land

Exhibit A-20

Southwest General Land

Exhibit A-21

St. Joseph Land

Exhibit A-22

St. Luke’s Land

Exhibit A-23

St. Luke’s Behavioral Land

Exhibit A-24

Tempe Land

Exhibit A-25

Wadley Land

Exhibit A-26

Ancillary Land

Exhibit A-27

Nashoba Land

Exhibit A-28

Norwood Land

Exhibit A-29

St. Anne’s Fall River Parking Lot Land

Exhibit A-30

Coral Gables Land

Exhibit A-31

Lauderdale Lakes Land

Exhibit A-32

Holy Family Merrimack Land

Exhibit A-33

Carney Land

Exhibit A-34

Florence Land

Exhibit A-35

Big Spring Land

Exhibit A-36

West Jordan Land

Exhibit A-37

Davis Land

Exhibit A-38

Hialeah Land

Exhibit A-39

Hialeah Palmetto Land

Exhibit A-40

Miami Land

Exhibit B-1

Permitted Exceptions - Good Samaritan Land

Exhibit B-2

Permitted Exceptions - Holy Family Land

Exhibit B-3

Permitted Exceptions - Morton Land

Exhibit B-4

Permitted Exceptions - St. Anne’s Land

Exhibit B-5

Permitted Exceptions - St. Elizabeth Land

 

4834-1440-2281v12


 

Exhibit B-6

Permitted Exceptions - Hillside Land

Exhibit B-7

Permitted Exceptions - Northside Medical Land

Exhibit B-8

Permitted Exceptions - Sebastian Land

Exhibit B-9

Permitted Exceptions - Sharon Land

Exhibit B-10

Permitted Exceptions - Trumbull Land

Exhibit B-11

Permitted Exceptions - Wuesthoff Melbourne Land

Exhibit B-12

Permitted Exceptions - Wuesthoff Rockledge Land

Exhibit B-13

Permitted Exceptions - Glenwood Land

Exhibit B-14

Permitted Exceptions - Jordan Valley Land

Exhibit B-15

Permitted Exceptions - Odessa Land

Exhibit B-16

Permitted Exceptions - Mountain Point Land

Exhibit B-17

Permitted Exceptions - Mountain Vista Land

Exhibit B-18

Permitted Exceptions - Salt Lake Land

Exhibit B-19

Permitted Exceptions - Southeast Texas Land

Exhibit B-20

Permitted Exceptions - Southwest General Land

Exhibit B-21

Permitted Exceptions - St. Joseph Land  

Exhibit B-22

Permitted Exceptions - St. Luke’s Land

Exhibit B-23

Permitted Exceptions - St. Luke’s Behavioral Land

Exhibit B-24

Permitted Exceptions - Tempe Land

Exhibit B-25

Permitted Exceptions - Wadley Land

Exhibit B-26

Permitted Exceptions - Ancillary Land

Exhibit B-27

Permitted Exceptions - Nashoba Land

Exhibit B-28

Permitted Exceptions - Norwood Land

Exhibit B-29

Permitted Exceptions - St. Anne’s Fall River Parking Lot Land

Exhibit B-30

Permitted Exceptions – Coral Gables Land

Exhibit B-31

Permitted Exceptions – Lauderdale Lakes Land

Exhibit B-32

Permitted Exceptions - Holy Family Merrimack Land

Exhibit B-33

Permitted Exceptions - Carney Land

Exhibit B-34

Permitted Exceptions – Florence Land

Exhibit B-35

Permitted Exceptions - Big Spring Land

Exhibit B-36

Permitted Exceptions - West Jordan Land

Exhibit B-37

Permitted Exceptions - Davis Land

Exhibit B-38

Permitted Exceptions – Hialeah Land

Exhibit B-39

Permitted Exceptions – Hialeah Palmetto Land

Exhibit B-40

Permitted Exceptions – Miami Land

Exhibit C

Existing Subleases

Exhibit D

Excluded Subsidiaries

Schedule 1-A

Lessors

Schedule 1-B

Lessees

Schedule 1-C

Non-Permitted Assignees

Schedule 1-D

Ancillary Parties and Properties

Schedule 3.1(a)

Lease Bases

Schedule 3.1(b)

Applicable Lease Rates

Schedule 10.3

Capital Additions

Schedule 39.25

Property Specific Provisions

Schedule 39.30

State Specific Provisions

 

 

4834-1440-2281v12

mpw-ex102_106.htm

Exhibit 10.2

AMENDMENT NO. 1 TO AMENDED AND

RESTATED REVOLVING CREDIT AND TERM LOAN AGREEMENT

This AMENDMENT NO. 1 TO AMENDED AND RESTATED REVOLVING CREDIT AND TERM LOAN AGREEMENT, dated as of September 29, 2021 (this “Amendment No. 1”), is by and among MEDICAL PROPERTIES TRUST, INC., a Maryland corporation (“Holdings”), MPT OPERATING PARTNERSHIP, L.P., a Delaware limited partnership (the “Borrower”), the Additional Guarantors party hereto, the financial institutions listed on the signature pages hereof (the “Lenders”) and JPMORGAN CHASE BANK, N.A., as administrative agent for the Lenders (the “Administrative Agent”).  Reference is made to that certain Amended and Restated Revolving Credit and Term Loan Agreement, dated as of January 15, 2021 (as amended, restated, replaced, supplemented or modified from time to time, the “Credit Agreement”), by and among Holdings, the Borrower, the Lenders referenced therein and the Administrative Agent. Capitalized terms used herein without definition shall have the same meanings as set forth in the Credit Agreement.

RECITALS

WHEREAS, the Borrower has requested that the Lenders and the Administrative Agent make certain amendments to the Credit Agreement; and

WHEREAS, the Borrower, the Lenders and the Administrative Agent are willing to make such amendments as set forth herein;

NOW, THEREFORE, in consideration of the premises and the agreements, provisions and covenants herein contained, the parties hereto agree as follows:

SECTION 1.  AMENDMENTS TO CREDIT Agreement.  As of the Amendment Effective Date (as defined in Section 4 hereof), the Credit Agreement is hereby amended as follows:

1.1Amendment to Section 7.1(f).  Section 7.1(f) of the Credit Agreement is amended by adding to the following proviso to the end of such Section 7.1(f): “; and provided further that such ratio may exceed 65% for the fiscal quarters ending September 30, 2021 and December 31, 2021 so long as such ratio does not exceed 70% as of such date of determination”.

SECTION 2.  REPRESENTATIONS AND WARRANTIES OF BORROWER AND HOLDINGS

In order to induce Lenders and Administrative Agent to enter into this Amendment No. 1, Borrower and Holdings each represents and warrants to each Lender and Administrative Agent that the following statements are true, correct and complete:

(i)each Loan Party has the power and authority, and the legal right, to make, deliver and perform its obligations under this Amendment No. 1 and, as applicable, the Credit Agreement as amended by this Amendment No. 1 (the “Amended Agreement”);

 

DB3/ 204012913.4

 

 


 

(ii)each Loan Party has taken all necessary organizational action to authorize the execution, delivery and performance of this Amendment No. 1;

(iii)no consent or authorization of, filing with, notice to or other act by or in respect of, any Governmental Authority or any other Person is required in connection with the execution, delivery, performance, validity or enforceability of this Amendment No. 1, except consents, authorizations, filings and notices which have been obtained or made and are in full force and effect;

(iv)the execution, delivery and performance of this Amendment No. 1 will not violate (i) the charter, by-laws or other constitutive documents of any Loan Party or (ii) any Requirement of Law or any Contractual Obligation of any Group Member, except, in the case of this clause (ii) for any such violation which could not reasonably be expected to have a Material Adverse Effect, and will not result in, or require, the creation or imposition of any Lien on any of their respective properties or revenues pursuant to any Requirement of Law or any such Contractual Obligation;

(v)this Amendment No. 1 has been duly executed and delivered by each Loan Party and this Amendment No. 1 and the Amended Agreement and are the legal, valid and binding obligations of each Loan Party party thereto, enforceable against such Person in accordance with their respective terms, except as enforceability may be limited by applicable bankruptcy, insolvency, reorganization, moratorium or similar laws affecting the enforcement of creditors’ rights generally and by general equitable principles (whether enforcement is sought by proceedings in equity or at law);

(vi)the representations and warranties contained in Section 4 of the Credit Agreement are and will be true and correct in all material respects (other than any representation or warranty qualified as to “materiality”, “Material Adverse Effect” or similar language, which shall be true and correct in all respects) on and as of the date hereof and the Amendment Effective Date to the same extent as though made on and as of such dates, except to the extent such representations and warranties specifically relate to an earlier date, in which case they were true and correct in all material respects on and as of such earlier date; and

(vii)no event has occurred and is continuing or will result from the consummation of the transactions contemplated by this Amendment No. 1 that would constitute a Default or Event of Default.

SECTION 3.  ACKNOWLEDGEMENT AND CONSENT

Each of Holdings and the undersigned Additional Guarantors (as defined in the Guarantee Agreement described below) has read this Amendment No. 1 and consents to the terms hereof and further hereby confirms and agrees that, notwithstanding the effectiveness of this Amendment No. 1, the obligations of Holdings and such Additional Guarantor under each of the Loan Documents to which Holdings and such Additional Guarantor is a party shall not be impaired and each of the Loan Documents to which Holdings and such Additional Guarantor is a party is, and shall continue to be, in full force and effect and is hereby confirmed and ratified in all respects.

 

DB3/ 204012913.4

-2-

 


 

Each of Holdings, the Additional Guarantors, and the Borrower hereby acknowledges and agrees that each reference to the “Credit Agreement” in the defined term “Guarantor Obligations” under, and as defined in, the Amended and Restated Guarantee Agreement, dated as of January 15, 2021, by and among Holdings, the Additional Guarantors, and the Administrative Agent (the “Guarantee Agreement”) will be understood to refer to the Credit Agreement (as amended hereby).

SECTION 4.CONDITIONS TO EFFECTIVENESS

Except as set forth below, Section 1 of this Amendment No. 1 shall become effective only upon the satisfaction of the following conditions precedent (the date of satisfaction of such conditions being referred to as the “Amendment Effective Date”):

A.The Borrower, Holdings, the Additional Guarantors, the Administrative Agent and the Required Lenders shall have indicated their consent hereto by the execution and delivery of the signature pages hereof to the Administrative Agent.

B.The Lenders and the Administrative Agent shall have received all reasonable out-of-pocket costs and expenses for which invoices have been presented (including the reasonable fees and expenses of legal counsel for which the Borrower agrees it is responsible pursuant to Section 10.5 of the Credit Agreement), incurred in connection with this Amendment No. 1.

SECTION 5.MISCELLANEOUS

A.Reference to and Effect on the Credit Agreement and the Other Loan Documents.

(i)On and after the effective date of this Amendment No. 1, each reference in the Credit Agreement to “this Agreement”, “hereunder”, “hereof”, “herein” or words of like import referring to the Credit Agreement and each reference in the other Loan Documents to the “Credit Agreement”, “thereunder”, “thereof” or words of like import referring to the Credit Agreement shall mean and be a reference to the Credit Agreement as amended hereby.

(ii)Except as specifically amended by this Amendment No. 1, the Credit Agreement and the other Loan Documents shall remain in full force and effect and are hereby ratified and confirmed.

(iii)The execution, delivery and performance of this Amendment No. 1 shall not, except as expressly provided herein, constitute a waiver of any provision of, or operate as a waiver of any right, power or remedy of the Administrative Agent or any Lender under the Credit Agreement or any of the other Loan Documents.

(iv)This Amendment No. 1 shall be deemed to be a “Loan Document”.

B.Headings.  Section and subsection headings in this Amendment No. 1 are included herein for convenience of reference only and shall not constitute a part of this Amendment No. 1 for any other purpose or be given any substantive effect.

 

DB3/ 204012913.4

-3-

 


 

C.Applicable Law.  THIS AMENDMENT NO. 1 AND THE RIGHTS AND OBLIGATIONS OF THE PARTIES HEREUNDER SHALL BE GOVERNED BY, AND CONSTRUED AND INTERPRETED IN ACCORDANCE WITH, THE LAW OF THE STATE OF NEW YORK.

D.Counterparts; Effectiveness.  This Amendment No. 1 may be executed in any number of counterparts and by different parties hereto in separate counterparts, each of which when so executed and delivered shall be deemed an original, but all such counterparts together shall constitute but one and the same instrument; signature pages may be detached from multiple separate counterparts and attached to a single counterpart so that all signature pages are physically attached to the same document.  Delivery of an executed counterpart of a signature page of this Amendment No. 1 by telecopy, emailed pdf. or any other electronic means that reproduces an image of the actual executed signature page shall be effective as delivery of a manually executed counterpart of this Amendment No. 1.  The words “execution,” “signed,” “signature,” “delivery,” and words of like import in or relating to this Amendment No. 1 and/or any document to be signed in connection with this Amendment No. 1 and the transactions contemplated hereby shall be deemed to include Electronic Signatures (as defined below), deliveries or the keeping of records in electronic form, each of which shall be of the same legal effect, validity or enforceability as a manually executed signature, physical delivery thereof or the use of a paper-based recordkeeping system, as the case may be.  As used herein, “Electronic Signatures” means any electronic symbol or process attached to, or associated with, any contract or other record and adopted by a person with the intent to sign, authenticate or accept such contract or record.

[Remainder of Page Intentionally Left Blank]

 

 

DB3/ 204012913.4

-4-

 


 

 

IN WITNESS WHEREOF, the parties hereto have caused this Amendment No. 1 to be duly executed and delivered by their respective officers thereunto duly authorized as of the date first written above.

 

MEDICAL PROPERTIES TRUST, INC.

 

 

 

 

 

 

 

 

By:

/s/ R. Steven Hamner

 

Name: R. Steven Hamner

 

Title: Executive Vice President and Chief Financial Officer

 

MPT OPERATING PARTNERSHIP, L.P.

 

 

 

 

By:

MEDICAL PROPERTIES TRUST, LLC, its general partner

 

By:

 

MEDICAL PROPERTIES TRUST, INC., its sole member

 

 

By:

/s/ R. Steven Hamner

 

Name: R. Steven Hamner

 

Title: Executive Vice President and Chief Financial Officer

 

 

 

 

[Signature Page – Amendment No. 1]


 

 

ADDITIONAL GUARANTORS:

 

MPT HARROW LTD

 

 

 

 

 

 

 

 

By:

/s/ James Barber-Lomax

 

Name: James Barber-Lomax

 

Title: Director

 

MPT GLASGOW LTD

 

 

 

 

 

 

 

 

By:

/s/ James Barber-Lomax

 

Name: James Barber-Lomax

 

Title: Director

 

MPT OSBORNE LTD

 

 

 

 

 

 

 

 

By:

/s/ James Barber-Lomax

 

Name: James Barber-Lomax

 

Title: Director

 

MPT STEPNEY GREEN LTD

 

 

 

 

 

 

 

 

By:

/s/ James Barber-Lomax

 

Name: James Barber-Lomax

 

Title: Director

 

MPT FULWOOD LTD

 

 

 

 

 

 

 

 

By:

/s/ James Barber-Lomax

 

Name: James Barber-Lomax

 

Title: Director

 

MPT GREAT MISSENDEN LTD

 

 

 

 

 

 

 

 

By:

/s/ James Barber-Lomax

 

Name: James Barber-Lomax

 

Title: Director

 

 

[Signature Page – Amendment No. 1]


 

 

 

MPT ARNOLD LTD

 

 

 

 

 

 

 

 

By:

/s/ James Barber-Lomax

 

Name: James Barber-Lomax

 

Title: Director

 

MPT COMBE DOWN LTD

 

 

 

 

 

 

 

 

By:

/s/ James Barber-Lomax

 

Name: James Barber-Lomax

 

Title: Director

 

MPT GUILDFORD LTD

 

 

 

 

 

 

 

 

By:

/s/ James Barber-Lomax

 

Name: James Barber-Lomax

 

Title: Director

 

MPT BASINGSTOKE LTD

 

 

 

 

 

 

 

 

By:

/s/ James Barber-Lomax

 

Name: James Barber-Lomax

 

Title: Director

 

MPT CANTERBURY LTD

 

 

 

 

 

 

 

 

By:

/s/ James Barber-Lomax

 

Name: James Barber-Lomax

 

Title: Director

 

MPT CROYDON LTD

 

 

 

 

 

 

 

 

By:

/s/ James Barber-Lomax

 

Name: James Barber-Lomax

 

Title: Director

 

[Signature Page – Amendment No. 1]


 

 

 

MPT ROCHDALE LTD

 

 

 

 

 

 

 

 

By:

/s/ James Barber-Lomax

 

Name: James Barber-Lomax

 

Title: Director

 

MPT ORPINGTON LTD

 

 

 

 

 

 

 

 

By:

/s/ James Barber-Lomax

 

Name: James Barber-Lomax

 

Title: Director

 

MPT SWINDON LTD

 

 

 

 

 

 

 

 

By:

/s/ James Barber-Lomax

 

Name: James Barber-Lomax

 

Title: Director

 

MPT MILTON KEYNES LTD

 

 

 

 

 

 

 

 

By:

/s/ James Barber-Lomax

 

Name: James Barber-Lomax

 

Title: Director

 

MPT ABERDEEN LTD

 

 

 

 

 

 

 

 

By:

/s/ James Barber-Lomax

 

Name: James Barber-Lomax

 

Title: Director

 

MPT WINCHESTER LTD

 

 

 

 

 

 

 

 

By:

/s/ James Barber-Lomax

 

Name: James Barber-Lomax

 

Title: Director

 

[Signature Page – Amendment No. 1]


 

 

 

MPT HENDON LTD

 

 

 

 

 

 

 

 

By:

/s/ James Barber-Lomax

 

Name: James Barber-Lomax

 

Title: Director

 

 

MPT BECKENHAM LTD

 

 

 

 

 

 

 

 

By:

/s/ James Barber-Lomax

 

Name: James Barber-Lomax

 

Title: Director

 

MPT CARMARTHEN LTD

 

 

 

 

 

 

 

 

By:

/s/ James Barber-Lomax

 

Name: James Barber-Lomax

 

Title: Director

 

MPT BLACKBURN LTD

 

 

 

 

 

 

 

 

By:

/s/ James Barber-Lomax

 

Name: James Barber-Lomax

 

Title: Director

 

MPT BIDDENHAM LTD

 

 

 

 

 

 

 

 

By:

/s/ James Barber-Lomax

 

Name: James Barber-Lomax

 

Title: Director

 

MPT BLACKHEATH LTD

 

 

 

 

 

 

 

 

By:

/s/ James Barber-Lomax

 

Name: James Barber-Lomax

 

Title: Director

 

[Signature Page – Amendment No. 1]


 

 

 

MPT WORTHING LTD

 

 

 

 

 

 

 

 

By:

/s/ James Barber-Lomax

 

Name: James Barber-Lomax

 

Title: Director

 

MPT BOLTON LTD

 

 

 

 

 

 

 

 

By:

/s/ James Barber-Lomax

 

Name: James Barber-Lomax

 

Title: Director

 

MPT EDGBASTON LTD

 

 

 

 

 

 

 

 

By:

/s/ James Barber-Lomax

 

Name: James Barber-Lomax

 

Title: Director

 

MPT DROITWICH SPA LTD

 

 

 

 

 

 

 

 

By:

/s/ James Barber-Lomax

 

Name: James Barber-Lomax

 

Title: Director

 

MPT DORCHESTER LTD

 

 

 

 

 

 

 

 

By:

/s/ James Barber-Lomax

 

Name: James Barber-Lomax

 

Title: Director

 

MPT CHEADLE LTD

 

 

 

 

 

 

 

 

By:

/s/ James Barber-Lomax

 

Name: James Barber-Lomax

 

Title: Director

 

 

[Signature Page – Amendment No. 1]


 

 

 

EXECUTED by Evolution Trustees Limited

)

(ABN 29 611 839 519) as trustee of the MPT

)

Australia Realty Trust

 

/s/ Rupert Clive Smoker

 

/s/ Masri Huuck

Signature of director

 

Signature of director / company secretary (delete as applicable)

 

 

 

 

 

 

Rupert Clive Smoker

 

Masri Huuck

Name of director (print)

 

Name of director / company secretary (print)

 

 

 

 

[Signature Page – Amendment No. 1]


 

 

 

JPMORGAN CHASE BANK, N.A., as Administrative Agent and as a Lender, Issuing Lender and Swingline Lender

 

 

 

 

 

 

 

 

By:

/s/ Lance Buxkemper

 

Name: Lance Buxkemper

 

Title: Executive Director

 

 

 

[Signature Page – Amendment No. 1]


 

 

 

BANK OF AMERICA, N.A., as a Lender, Issuing Lender and Swingline Lender

 

 

 

 

 

 

 

 

By:

/s/ H. Hope Walker

 

Name: H. Hope Walker

 

Title: Senior Vice President

 

 

 

[Signature Page – Amendment No. 1]


 

 

 

BARCLAYS BANK PLC, as a Lender, Issuing Lender and Swingline Lender

 

 

 

 

 

 

 

 

By:

/s/ Craig J. Malloy

 

Name: Craig J. Malloy

 

Title: Director

 

 

 

[Signature Page – Amendment No. 1]


 

 

 

KEYBANK NATIONAL ASSOCIATION, as a Lender, Issuing Lender and Swingline Lender

 

 

 

 

 

 

 

 

By:

/s/ Peter Trazzera

 

Name: Peter Trazzera

 

Title: Vice President

 

 

 

[Signature Page – Amendment No. 1]


 

 

 

GOLDMAN SACHS BANK USA, as a Lender, Issuing Lender and Swingline Lender

 

 

 

 

 

 

 

 

By:

/s/ Dan Morris

 

Name: Dan Morris

 

Title: Authorized Signatory

 

 

 

[Signature Page – Amendment No. 1]


 

 

 

CREDIT AGRICOLE CORPORATE AND INVESTMENT BANK, as a Lender

 

 

 

 

 

 

 

 

By:

/s/ Andrew Sidford

 

Name: Andrew Sidford

 

Title: Managing Director

 

 

 

 

By:

/s/ Rose Mary Perez

 

Name: Rose Mary Perez

 

Title: Managing Director

 

 

 

[Signature Page – Amendment No. 1]


 

 

 

ROYAL BANK OF CANADA, as a Lender

 

 

 

 

 

 

 

 

By:

/s/ Jake Sigmund

 

Name: Jake Sigmund

 

Title: Authorized Signatory

 

 

 

 

[Signature Page – Amendment No. 1]


 

 

 

TRUIST BANK, as a Lender

 

 

 

 

 

 

 

 

By:

/s/ James Ford

 

Name: James Ford

 

Title: Managing Director

 

 

 

 

[Signature Page – Amendment No. 1]


 

 

 

WELLS FARGO BANK, NATIONAL ASSOCIATION, as a Lender

 

 

 

 

 

 

 

 

By:

/s/ Andrea S Chen

 

Name: Andrea S Chen

 

Title: Managing Director

 

[Signature Page – Amendment No. 1]


 

 

 

CITIZENS BANK, NATIONAL ASSOCIATION, as a Lender

 

 

 

 

 

 

 

 

By:

/s/ Kerri Colwell

 

Name: Kerri Colwell

 

Title: Senior Vice President

 

 

[Signature Page – Amendment No. 1]


 

 

 

CREDIT SUISSE AG, NEW YORK BRANCH, as a Lender

 

 

 

 

 

 

 

 

By:

/s/ Doreen Barr

 

Name: Doreen Barr

 

Title: Authorized Signatory

 

 

 

 

 

 

 

 

By:

/s/ Komal Shah

 

Name: Komal Shah

 

Title: Authorized Signatory

 

[Signature Page – Amendment No. 1]


 

 

 

FIRST HORIZON BANK, as a Lender

 

 

 

 

 

 

 

 

By:

/s/ Cathy Wind

 

Name: Cathy Wind

 

Title: SVP

 

 

[Signature Page – Amendment No. 1]


 

 

 

MUFG BANK, LTD., as a Lender

 

 

 

 

 

 

 

 

By:

/s/ Kevin Wood

 

Name: Kevin Wood

 

Title: Director

 

 

[Signature Page – Amendment No. 1]


 

 

 

THE BANK OF NOVA SCOTIA, as a Lender

 

 

 

 

 

 

 

 

By:

/s/ Arjun Talwalkar

 

Name: Arjun Talwalkar

 

Title: Director

 

 

[Signature Page – Amendment No. 1]


 

 

 

HANCOCK WHITNEY BANK, as a Lender

 

 

 

 

 

 

 

 

By:

/s/ Michael Woodnorth

 

Name: Michael Woodnorth

 

Title: Vice President – Healthcare Banking

 

 

[Signature Page – Amendment No. 1]


 

 

 

BNP PARIBAS, as a Lender

 

 

 

 

 

 

 

 

By:

/s/ John Bosco

 

Name: John Bosco

 

Title: Managing Director

 

By:

/s/ David J. Foster

 

Name: David J. Foster

 

Title: Director

 

 

[Signature Page – Amendment No. 1]

mpw-ex311_9.htm

Exhibit 31.1

CERTIFICATION OF CHIEF EXECUTIVE OFFICER

PURSUANT TO RULE 13a-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934

I, Edward K. Aldag, Jr., certify that:

1)

I have reviewed this quarterly report on Form 10-Q of Medical Properties Trust, Inc.;

2)

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3)

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4)

The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

a.

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

b.

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

c.

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

d.

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5)

The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

a.

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

b.

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

 

 

 

Date: November 9, 2021

 

/s/ Edward K. Aldag, Jr.

 

 

Edward K. Aldag, Jr.

 

 

Chairman, President and Chief Executive Officer

 

mpw-ex312_6.htm

Exhibit 31.2

CERTIFICATION OF CHIEF FINANCIAL OFFICER

PURSUANT TO RULE 13a-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934

I, R. Steven Hamner, certify that:

1)

I have reviewed this quarterly report on Form 10-Q of Medical Properties Trust, Inc.;

2)

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3)

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4)

The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

a.

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

b.

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

c.

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

d.

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5)

The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

a.

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

b.

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: November 9, 2021

 

/s/ R. Steven Hamner

 

 

R. Steven Hamner

 

 

Executive Vice President and Chief Financial Officer

 

mpw-ex313_11.htm

Exhibit 31.3

CERTIFICATION OF CHIEF EXECUTIVE OFFICER

PURSUANT TO RULE 13a-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934

I, Edward K. Aldag, Jr., certify that:

1)

I have reviewed this quarterly report on Form 10-Q of MPT Operating Partnership, L.P.;

2)

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3)

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4)

The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

a.

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

b.

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

c.

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

d.

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5)

The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

a.

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

b.

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: November 9, 2021

 

/s/ Edward K. Aldag, Jr.

 

 

Edward K. Aldag, Jr.

 

 

Chairman, President and Chief Executive Officer of the sole member of the general partner of MPT Operating Partnership, L.P.

 

mpw-ex314_8.htm

Exhibit 31.4

CERTIFICATION OF CHIEF FINANCIAL OFFICER

PURSUANT TO RULE 13a-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934

I, R. Steven Hamner, certify that:

1)

I have reviewed this quarterly report on Form 10-Q of MPT Operating Partnership, L.P.;

2)

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3)

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4)

The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

a.

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

b.

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

c.

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

d.

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5)

The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

a.

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

b.

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: November 9, 2021

 

/s/ R. Steven Hamner

 

 

R. Steven Hamner

 

 

Executive Vice President and Chief Financial Officer of the sole member of the general partner of MPT Operating Partnership, L.P.

 

mpw-ex321_7.htm

Exhibit 32.1

CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER

PURSUANT TO RULE 13a-14(b) UNDER THE SECURITIES EXCHANGE ACT OF 1934 AND 18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with this quarterly report on Form 10-Q of Medical Properties Trust, Inc. (the “Company”) for the quarter ended September 30, 2021 (the “Report”), each of the undersigned, Edward K. Aldag, Jr. and R. Steven Hamner, certifies, pursuant to Section 18 U.S.C. Section 1350, that:

1.

The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2.

The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Date: November 9, 2021

 

/s/ Edward K. Aldag, Jr.

 

 

Edward K. Aldag, Jr.

 

 

Chairman, President and Chief Executive Officer

 

 

 

 

 

/s/ R. Steven Hamner

 

 

R. Steven Hamner

 

 

Executive Vice President and Chief Financial Officer

 

mpw-ex322_10.htm

Exhibit 32.2

CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER

PURSUANT TO RULE 13a-14(b) UNDER THE SECURITIES EXCHANGE ACT OF 1934 AND 18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with this quarterly report on Form 10-Q of MPT Operating Partnership, L.P. (the “Company”) for the quarter ended September 30, 2021 (the “Report”), each of the undersigned, Edward K. Aldag, Jr. and R. Steven Hamner, certifies, pursuant to Section 18 U.S.C. Section 1350, that:

1.

The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2.

The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

 

 

 

Date: November 9, 2021

 

/s/ Edward K. Aldag, Jr.

 

 

Edward K. Aldag, Jr.

 

 

Chairman, President and Chief Executive Officer of the sole member of the general partner of MPT Operating Partnership, L.P.

 

 

 

 

/s/ R. Steven Hamner

 

 

R. Steven Hamner

 

 

Executive Vice President and Chief Financial Officer of the sole member of the general partner of MPT Operating Partnership, L.P.